VARIDT - Variability of Drug Transporter Database Title - Exogenous factors (environmental factors, medications, dietary constituents, etc.) altering DT activity Version 1.8.1 (2019.08.20) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Any question about data provided here, please contact with: Dr. Yin (yinjiayi@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn) -------------------------------------------------------------------------------------------------------- Abbreviations: TRANSPID VARIDT Drug Transporter (DT) ID GENENAME DT Gene Name PROTNAME DT Protein Name UNIPROID Uniprot ID EXOFACTO Exogenous Factor Name HIGHSTIT Types of Exogenous Factors (environmental factors, medications, dietary constituents, etc.) DESCRIPT Description of Exogenous Factor Altering DT Activity MOACRIVE Modulation Type (inducer, inhibitor, etc.) CELLLINE Cell System -------------------------------------------------------------------------------------------------------- DTD0001 TRANSPID DTD0001 DTD0001 GENENAME ABCC1 DTD0001 PROTNAME Multidrug resistance-associated protein 1 DTD0001 GENEDBID 4363 DTD0001 UNIPROID P33527 DTD0001 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0001 EXOFACTO Acetaminophen DESCRIPT Acetaminophen induces the activity of ABCC1 DTD0001 EXOFACTO Acetaminophen MOACRIVE Inducer DTD0001 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0001 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the activity of ABCC1 DTD0001 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0001 EXOFACTO Benzbromarone CELLLINE Spodoptera frugiperda (Sf9) cells-MRP1 DTD0001 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0001 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the activity of ABCC1 DTD0001 EXOFACTO Budesonide MOACRIVE Inhibition DTD0001 EXOFACTO Calcitriol HIGHSTIT Approved Drug DTD0001 EXOFACTO Calcitriol DESCRIPT Calcitriol inhibits the activity of ABCC1 DTD0001 EXOFACTO Calcitriol MOACRIVE Inhibition DTD0001 EXOFACTO Calcitriol CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP1 DTD0001 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0001 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the activity of ABCC1 DTD0001 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0001 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0001 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the activity of ABCC1 DTD0001 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0001 EXOFACTO Curcumin HIGHSTIT Drug in Phase 3 Trial DTD0001 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Ethacrynic acid glutathione by ABCC1 (IC50 = 15 microM) DTD0001 EXOFACTO Curcumin MOACRIVE Inhibition DTD0001 EXOFACTO Curcumin CELLLINE Spodoptera frugiperda (Sf9) cells-MRP1 DTD0001 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0001 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 5 microM) DTD0001 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC1 (IC50 = 5 microM) DTD0001 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCC1 DTD0001 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0001 EXOFACTO Cyclosporine CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Cyclosporine CELLLINE Baby Hamster Kidney fibroblasts-21-MRP1 DTD0001 EXOFACTO Daunorubicin HIGHSTIT Approved Drug DTD0001 EXOFACTO Daunorubicin DESCRIPT Daunorubicin induces the activity of ABCC1 DTD0001 EXOFACTO Daunorubicin MOACRIVE Inducer DTD0001 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0001 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the activity of ABCC1 DTD0001 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0001 EXOFACTO Disulfiram HIGHSTIT Approved Drug DTD0001 EXOFACTO Disulfiram DESCRIPT Disulfiram inhibits the activity of ABCC1 DTD0001 EXOFACTO Disulfiram MOACRIVE Inhibition DTD0001 EXOFACTO Epirubicin HIGHSTIT Approved Drug DTD0001 EXOFACTO Epirubicin DESCRIPT Epirubicin induces the activity of ABCC1 DTD0001 EXOFACTO Epirubicin MOACRIVE Inducer DTD0001 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0001 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of ABCC1 DTD0001 EXOFACTO Estradiol MOACRIVE Inducer DTD0001 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0001 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 0.45 microM) DTD0001 EXOFACTO Estrone sulfate MOACRIVE Inhibition DTD0001 EXOFACTO Estrone sulfate CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Ethanol HIGHSTIT Approved Drug DTD0001 EXOFACTO Ethanol DESCRIPT Ethanol induces the activity of ABCC1 DTD0001 EXOFACTO Ethanol MOACRIVE Inducer DTD0001 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0001 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 DTD0001 EXOFACTO Etoposide MOACRIVE Inhibition DTD0001 EXOFACTO Etoposide CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0001 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 80 microM) DTD0001 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of Rhodamine 123 by ABCC1 DTD0001 EXOFACTO Genistein MOACRIVE Inhibition DTD0001 EXOFACTO Genistein CELLLINE Human erythrocytes-MRP1 DTD0001 EXOFACTO Genistein CELLLINE Large-cell lung cancer cell line (COR-L23/P)-MRP1 DTD0001 EXOFACTO Genistin HIGHSTIT Natural Product DTD0001 EXOFACTO Genistin DESCRIPT Genistin inhibits the transportation of Rhodamine 123 by ABCC1 DTD0001 EXOFACTO Genistin MOACRIVE Inhibition DTD0001 EXOFACTO Genistin CELLLINE Large-cell lung cancer cell line (COR-L23/P)-MRP1 DTD0001 EXOFACTO GF-109203 HIGHSTIT Investigative Drug DTD0001 EXOFACTO GF-109203 DESCRIPT GF-109203 inhibits the transportation of Rhodamine 123 by ABCC1 DTD0001 EXOFACTO GF-109203 MOACRIVE Inhibition DTD0001 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0001 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Calcein by ABCC1 DTD0001 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Antimony salts by ABCC1 DTD0001 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of ABCC1 DTD0001 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0001 EXOFACTO Glibenclamide CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Glycyrrhetinic acid HIGHSTIT Natural Product DTD0001 EXOFACTO Glycyrrhetinic acid DESCRIPT Glycyrrhetinic acid inhibits the transportation of Calcein by ABCC1 DTD0001 EXOFACTO Glycyrrhetinic acid MOACRIVE Inhibition DTD0001 EXOFACTO Glycyrrhetinic acid CELLLINE Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MRP1 DTD0001 EXOFACTO Idarubicin HIGHSTIT Approved Drug DTD0001 EXOFACTO Idarubicin DESCRIPT Idarubicin inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 DTD0001 EXOFACTO Idarubicin MOACRIVE Inhibition DTD0001 EXOFACTO Idarubicin CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Indocyanine green HIGHSTIT Approved Drug DTD0001 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 DTD0001 EXOFACTO Indocyanine green MOACRIVE Inhibition DTD0001 EXOFACTO Indocyanine green CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0001 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 7 microM) DTD0001 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Doxorubicin by ABCC1 DTD0001 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the activity of ABCC1 DTD0001 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0001 EXOFACTO Indomethacin CELLLINE Human erythrocytes-MRP1 DTD0001 EXOFACTO Indomethacin CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP1 DTD0001 EXOFACTO Ivermectin HIGHSTIT Approved Drug DTD0001 EXOFACTO Ivermectin DESCRIPT Ivermectin inhibits the activity of ABCC1 DTD0001 EXOFACTO Ivermectin MOACRIVE Inhibition DTD0001 EXOFACTO Kaempferol HIGHSTIT Investigative Drug DTD0001 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 2.4 microM) DTD0001 EXOFACTO Kaempferol MOACRIVE Inhibition DTD0001 EXOFACTO Kaempferol CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0001 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the activity of ABCC1 DTD0001 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0001 EXOFACTO Menadione HIGHSTIT Approved Drug DTD0001 EXOFACTO Menadione DESCRIPT Menadione induces the activity of ABCC1 DTD0001 EXOFACTO Menadione MOACRIVE Inducer DTD0001 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Calcein AM by ABCC1 (IC50 = 5 microM) DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Doxorubicin by ABCC1 (Ki = 134.7 microM) DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Leukotriene C4 by ABCC1 (IC50 = 0.6 microM) DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 3.5 microM) DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Calcein AM by ABCC1 DTD0001 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the activity of ABCC1 DTD0001 EXOFACTO MK-571 MOACRIVE Inhibition DTD0001 EXOFACTO MK-571 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP1 DTD0001 EXOFACTO MK-571 CELLLINE Human 2008/MRP1 ovarian carcinoma cells DTD0001 EXOFACTO MK-571 CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO MK-571 CELLLINE Human erythrocytes-MRP1 DTD0001 EXOFACTO Myricetin HIGHSTIT Investigative Drug DTD0001 EXOFACTO Myricetin DESCRIPT Myricetin inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 13.3 microM) DTD0001 EXOFACTO Myricetin MOACRIVE Inhibition DTD0001 EXOFACTO Myricetin CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Ofloxacin HIGHSTIT Approved Drug DTD0001 EXOFACTO Ofloxacin DESCRIPT Ofloxacin inhibits the transportation of Vincristine by ABCC1 DTD0001 EXOFACTO Ofloxacin MOACRIVE Inhibition DTD0001 EXOFACTO Ouabain HIGHSTIT Approved Drug DTD0001 EXOFACTO Ouabain DESCRIPT Ouabain induces the activity of ABCC1 DTD0001 EXOFACTO Ouabain MOACRIVE Inducer DTD0001 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0001 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of ABCC1 DTD0001 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0001 EXOFACTO Phenobarbital CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP1 DTD0001 EXOFACTO Plant polyphenols HIGHSTIT Natural Product DTD0001 EXOFACTO Plant polyphenols DESCRIPT Plant polyphenols inhibits the transportation of 2,4-dinitrophenyl-S-glutathione by ABCC1 DTD0001 EXOFACTO Plant polyphenols MOACRIVE Inhibition DTD0001 EXOFACTO Plant polyphenols CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP1 DTD0001 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0001 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of ABCC1 DTD0001 EXOFACTO Probenecid MOACRIVE Inhibition DTD0001 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0001 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Calcein by ABCC1 DTD0001 EXOFACTO Progesterone MOACRIVE Inhibition DTD0001 EXOFACTO Progesterone CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0001 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 8.1 microM) DTD0001 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Rhodamine 123 by ABCC1 DTD0001 EXOFACTO Quercetin DESCRIPT Quercetin induces the activity of ABCC1 DTD0001 EXOFACTO Quercetin MOACRIVE Inhibition DTD0001 EXOFACTO Quercetin MOACRIVE Inducer DTD0001 EXOFACTO Quercetin CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Quercetin CELLLINE Large-cell lung cancer cell line (COR-L23/P)-MRP1 DTD0001 EXOFACTO Quercetin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-MRP1 DTD0001 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0001 EXOFACTO Quinine DESCRIPT Quinine inhibits the activity of ABCC1 DTD0001 EXOFACTO Quinine MOACRIVE Inhibition DTD0001 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0001 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Calcein by ABCC1 DTD0001 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0001 EXOFACTO Rifampicin CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Rifamycin B HIGHSTIT Approved Drug DTD0001 EXOFACTO Rifamycin B DESCRIPT Rifamycin B inhibits the transportation of Calcein by ABCC1 DTD0001 EXOFACTO Rifamycin B MOACRIVE Inhibition DTD0001 EXOFACTO Rifamycin B CELLLINE Human multidrug resistant lung cancer GLC4/ADR cells DTD0001 EXOFACTO Rimonabant HIGHSTIT Drug Withdrawn DTD0001 EXOFACTO Rimonabant DESCRIPT Rimonabant inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC1 DTD0001 EXOFACTO Rimonabant MOACRIVE Inhibition DTD0001 EXOFACTO Rimonabant CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP1 DTD0001 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0001 EXOFACTO Ritonavir DESCRIPT Ritonavir induces the activity of ABCC1 DTD0001 EXOFACTO Ritonavir MOACRIVE Inducer DTD0001 EXOFACTO Rofecoxib HIGHSTIT Approved Drug DTD0001 EXOFACTO Rofecoxib DESCRIPT Rofecoxib induces the activity of ABCC1 DTD0001 EXOFACTO Rofecoxib MOACRIVE Inducer DTD0001 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0001 EXOFACTO Saquinavir DESCRIPT Saquinavir induces the activity of ABCC1 DTD0001 EXOFACTO Saquinavir MOACRIVE Inducer DTD0001 EXOFACTO Silymarin HIGHSTIT Drug in Phase 4 Trial DTD0001 EXOFACTO Silymarin DESCRIPT Silymarin inhibits the activity of ABCC1 DTD0001 EXOFACTO Silymarin MOACRIVE Inhibition DTD0001 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0001 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the activity of ABCC1 DTD0001 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0001 EXOFACTO Temozolomide HIGHSTIT Approved Drug DTD0001 EXOFACTO Temozolomide DESCRIPT Temozolomide induces the activity of ABCC1 DTD0001 EXOFACTO Temozolomide MOACRIVE Inducer DTD0001 EXOFACTO Tiopronin HIGHSTIT Approved Drug DTD0001 EXOFACTO Tiopronin DESCRIPT Tiopronin inhibits the transportation of Calcein AM by ABCC1 DTD0001 EXOFACTO Tiopronin MOACRIVE Inhibition DTD0001 EXOFACTO Trastuzumab HIGHSTIT Approved Drug DTD0001 EXOFACTO Trastuzumab DESCRIPT Trastuzumab inhibits the activity of ABCC1 DTD0001 EXOFACTO Trastuzumab MOACRIVE Inhibition DTD0001 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0001 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 27 microM) DTD0001 EXOFACTO Valspodar MOACRIVE Inhibition DTD0001 EXOFACTO Valspodar CELLLINE Human cervical cancer cell line (Hela)-MRP1 DTD0001 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0001 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Doxorubicin by ABCC1 (Ki = 13.2 microM) DTD0001 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the activity of ABCC1 DTD0001 EXOFACTO Verapamil MOACRIVE Inhibition DTD0001 EXOFACTO Verapamil CELLLINE Human 2008/MRP1 ovarian carcinoma cells DTD0001 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0001 EXOFACTO Vinblastine DESCRIPT Vinblastine induces the activity of ABCC1 DTD0001 EXOFACTO Vinblastine MOACRIVE Inducer DTD0001 EXOFACTO Vinblastine CELLLINE Human breast adenocarcinoma cell line (MCF-7)-MRP1 DTD0002 TRANSPID DTD0002 DTD0002 GENENAME ABCC2 DTD0002 PROTNAME Multidrug resistance-associated protein 2 DTD0002 GENEDBID 1244 DTD0002 UNIPROID Q92887 DTD0002 EXOFACTO Acitretin HIGHSTIT Approved Drug DTD0002 EXOFACTO Acitretin DESCRIPT Acitretin inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Acitretin MOACRIVE Inhibition DTD0002 EXOFACTO Aged garlic extract HIGHSTIT Natural Product DTD0002 EXOFACTO Aged garlic extract DESCRIPT Aged garlic extract induces the transportation of 2,4-Dinitrophenyl-S-glutathione by ABCC2 DTD0002 EXOFACTO Aged garlic extract MOACRIVE Inducer DTD0002 EXOFACTO Aged garlic extract CELLLINE Human enterocyte-like 2 cell (Caco-2)-MRP2 DTD0002 EXOFACTO Arsenic trioxide HIGHSTIT Approved Drug DTD0002 EXOFACTO Arsenic trioxide DESCRIPT Arsenic trioxide induces the activity of ABCC2 DTD0002 EXOFACTO Arsenic trioxide MOACRIVE Inducer DTD0002 EXOFACTO Atazanavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Atazanavir MOACRIVE Inhibition DTD0002 EXOFACTO Belinostat HIGHSTIT Approved Drug DTD0002 EXOFACTO Belinostat DESCRIPT Belinostat inhibits the activity of ABCC2 DTD0002 EXOFACTO Belinostat MOACRIVE Inhibition DTD0002 EXOFACTO Belinostat CELLLINE Non-small cell lung cancer (NSCLC) cell lines DTD0002 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0002 EXOFACTO Benzbromarone DESCRIPT Benzbromarone induces the activity of ABCC2 DTD0002 EXOFACTO Benzbromarone MOACRIVE Inducer DTD0002 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0002 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin induces the activity of ABCC2 DTD0002 EXOFACTO Benzylpenicillin MOACRIVE Inducer DTD0002 EXOFACTO Boldine HIGHSTIT Natural Product DTD0002 EXOFACTO Boldine DESCRIPT Boldine induces the activity of ABCC2 DTD0002 EXOFACTO Boldine MOACRIVE Inducer DTD0002 EXOFACTO Boldine CELLLINE Model organism in vivo (rat) DTD0002 EXOFACTO Bosentan HIGHSTIT Approved Drug DTD0002 EXOFACTO Bosentan DESCRIPT Bosentan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Bosentan MOACRIVE Inhibition DTD0002 EXOFACTO Canagliflozin HIGHSTIT Approved Drug DTD0002 EXOFACTO Canagliflozin DESCRIPT Canagliflozin inhibits the activity of ABCC2 (IC50 = 19.3 microM) DTD0002 EXOFACTO Canagliflozin MOACRIVE Inhibition DTD0002 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0002 EXOFACTO Cefaclor CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0002 EXOFACTO Cefadroxil CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0002 EXOFACTO Cefamandole CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefmetazole HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefmetazole MOACRIVE Inhibition DTD0002 EXOFACTO Cefmetazole CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0002 EXOFACTO Cefoperazone CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefoxitin HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefoxitin DESCRIPT Cefoxitin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefoxitin MOACRIVE Inhibition DTD0002 EXOFACTO Cefoxitin CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0002 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0002 EXOFACTO Ceftriaxone CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cefuroxime HIGHSTIT Approved Drug DTD0002 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cefuroxime MOACRIVE Inhibition DTD0002 EXOFACTO Cefuroxime CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0002 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0002 EXOFACTO Cephalexin CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Cephradine HIGHSTIT Approved Drug DTD0002 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the transportation of Estradiol-17beta-glucuronide by ABCC2 DTD0002 EXOFACTO Cephradine MOACRIVE Inhibition DTD0002 EXOFACTO Cephradine CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0002 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid induces the activity of ABCC2 DTD0002 EXOFACTO Chenodeoxycholic acid MOACRIVE Inducer DTD0002 EXOFACTO Chenodiol HIGHSTIT Approved Drug DTD0002 EXOFACTO Chenodiol DESCRIPT Chenodiol induces the activity of ABCC2 DTD0002 EXOFACTO Chenodiol MOACRIVE Inducer DTD0002 EXOFACTO Chenodiol CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP2 DTD0002 EXOFACTO Chinese herb Jianpijiedu HIGHSTIT Natural Product DTD0002 EXOFACTO Chinese herb Jianpijiedu DESCRIPT Chinese herb Jianpijiedu induces the activity of ABCC2 DTD0002 EXOFACTO Chinese herb Jianpijiedu MOACRIVE Inducer DTD0002 EXOFACTO Chinese herb Jianpijiedu CELLLINE Rat breast carcinoma cell (Walker-256)-MRP2 DTD0002 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0002 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Rhodamine 123 by ABCC2 (IC50 = 197.4 microM) DTD0002 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0002 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-MRP2 DTD0002 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0002 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of ABCC2 DTD0002 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0002 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0002 EXOFACTO Cisplatin DESCRIPT Cisplatin induces the activity of ABCC2 DTD0002 EXOFACTO Cisplatin MOACRIVE Inducer DTD0002 EXOFACTO Cisplatin CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP2 DTD0002 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0002 EXOFACTO Clotrimazole DESCRIPT Clotrimazole induces the activity of ABCC2 DTD0002 EXOFACTO Clotrimazole MOACRIVE Inducer DTD0002 EXOFACTO Clotrimazole CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP2 DTD0002 EXOFACTO Curcumin HIGHSTIT Drug in Phase 3 Trial DTD0002 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 5 microM) DTD0002 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the activity of ABCC2 (IC50 = 5 microM) DTD0002 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Resveratrol-3-O-glucuronide by ABCC2 DTD0002 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the activity of ABCC2 DTD0002 EXOFACTO Curcumin MOACRIVE Inhibition DTD0002 EXOFACTO Curcumin CELLLINE Spodoptera frugiperda (Sf9) cells-MRP2 DTD0002 EXOFACTO Curcumin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 4.7 microM) DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Vinblastine by ABCC2 (Ki = 8.11 microM) DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Monoglucuronosyl bilirubin by ABCC2 (Ki = 21 microM) DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 10 microM) DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCC2 DTD0002 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of ABCC2 DTD0002 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0002 EXOFACTO Cyclosporine CELLLINE LLC-PK1 vesicles-MRP2 DTD0002 EXOFACTO Cyclosporine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP2 DTD0002 EXOFACTO Darunavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Darunavir DESCRIPT Darunavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Darunavir MOACRIVE Inhibition DTD0002 EXOFACTO Daunorubicin HIGHSTIT Approved Drug DTD0002 EXOFACTO Daunorubicin DESCRIPT Daunorubicin inhibits the transportation of Vinblastine by ABCC2 (Ki = 49.4 microM) DTD0002 EXOFACTO Daunorubicin MOACRIVE Inhibition DTD0002 EXOFACTO Daunorubicin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Delavirdine HIGHSTIT Approved Drug DTD0002 EXOFACTO Delavirdine DESCRIPT Delavirdine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 DTD0002 EXOFACTO Delavirdine MOACRIVE Inhibition DTD0002 EXOFACTO Delavirdine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0002 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of ABCC2 DTD0002 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0002 EXOFACTO Drospirenone HIGHSTIT Approved Drug DTD0002 EXOFACTO Drospirenone DESCRIPT Drospirenone inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Drospirenone MOACRIVE Inhibition DTD0002 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0002 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 DTD0002 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0002 EXOFACTO Efavirenz CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Emtricitabine HIGHSTIT Approved Drug DTD0002 EXOFACTO Emtricitabine DESCRIPT Emtricitabine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC2 DTD0002 EXOFACTO Emtricitabine MOACRIVE Inhibition DTD0002 EXOFACTO Emtricitabine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Enoxolone HIGHSTIT Investigative Drug DTD0002 EXOFACTO Enoxolone DESCRIPT Enoxolone inhibits the activity of ABCC2 DTD0002 EXOFACTO Enoxolone MOACRIVE Inhibition DTD0002 EXOFACTO Eprosartan HIGHSTIT Approved Drug DTD0002 EXOFACTO Eprosartan DESCRIPT Eprosartan induces the activity of ABCC2 DTD0002 EXOFACTO Eprosartan MOACRIVE Inducer DTD0002 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0002 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of ABCC2 DTD0002 EXOFACTO Estradiol MOACRIVE Inducer DTD0002 EXOFACTO Estrone HIGHSTIT Approved Drug DTD0002 EXOFACTO Estrone DESCRIPT Estrone inhibits the activity of ABCC2 DTD0002 EXOFACTO Estrone MOACRIVE Inhibition DTD0002 EXOFACTO Etodolac HIGHSTIT Approved Drug DTD0002 EXOFACTO Etodolac DESCRIPT Etodolac inhibits the activity of ABCC2 DTD0002 EXOFACTO Etodolac MOACRIVE Inhibition DTD0002 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0002 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Vinblastine by ABCC2 (Ki = 756 microM) DTD0002 EXOFACTO Etoposide MOACRIVE Inhibition DTD0002 EXOFACTO Etoposide CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Gemifloxacin HIGHSTIT Approved Drug DTD0002 EXOFACTO Gemifloxacin DESCRIPT Gemifloxacin inhibits the transportation of Erythromycin by ABCC2 (IC50 = 16 microM) DTD0002 EXOFACTO Gemifloxacin MOACRIVE Inhibition DTD0002 EXOFACTO Gemifloxacin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0002 EXOFACTO Genistein DESCRIPT Genistein induces the transportation of Sorafenib by ABCC2 DTD0002 EXOFACTO Genistein DESCRIPT Genistein induces the activity of ABCC2 DTD0002 EXOFACTO Genistein MOACRIVE Inducer DTD0002 EXOFACTO Genistein CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP2 DTD0002 EXOFACTO Gentamicin HIGHSTIT Approved Drug DTD0002 EXOFACTO Gentamicin DESCRIPT Gentamicin induces the activity of ABCC2 DTD0002 EXOFACTO Gentamicin MOACRIVE Inducer DTD0002 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0002 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of ABCC2 DTD0002 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0002 EXOFACTO Glutathione HIGHSTIT Approved Drug DTD0002 EXOFACTO Glutathione DESCRIPT Glutathione inhibits the transportation of Dinitrophenyl-glutathione by ABCC2 DTD0002 EXOFACTO Glutathione MOACRIVE Inhibition DTD0002 EXOFACTO Glutathione CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MRP2 DTD0002 EXOFACTO Green tea extract (1mg/ml) HIGHSTIT Natural Product DTD0002 EXOFACTO Green tea extract (1mg/ml) DESCRIPT Green tea extract (1mg/ml) inhibits the activity of ABCC2 DTD0002 EXOFACTO Green tea extract (1mg/ml) MOACRIVE Inhibition DTD0002 EXOFACTO Green tea extract (1mg/ml) CELLLINE Human gastrointestinal epithelial cell line (LS-180)-MRP2 DTD0002 EXOFACTO Hydrocortisone HIGHSTIT Approved Drug DTD0002 EXOFACTO Hydrocortisone DESCRIPT Hydrocortisone induces the activity of ABCC2 DTD0002 EXOFACTO Hydrocortisone MOACRIVE Inducer DTD0002 EXOFACTO Hyperforin HIGHSTIT Investigative Drug DTD0002 EXOFACTO Hyperforin DESCRIPT Hyperforin induces the activity of ABCC2 DTD0002 EXOFACTO Hyperforin MOACRIVE Inducer DTD0002 EXOFACTO Hyperforin CELLLINE Hepatocyte-MRP2 DTD0002 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Indinavir MOACRIVE Inhibition DTD0002 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0002 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Methotrexate by ABCC2 (IC50 = 0.06 microM) DTD0002 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the activity of ABCC2 DTD0002 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0002 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP2 DTD0002 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0002 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of ABCC2 DTD0002 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0002 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0002 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of ABCC2 DTD0002 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0002 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0002 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Methotrexate by ABCC2 (IC50 = 1.4 microM) DTD0002 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0002 EXOFACTO Ketoprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP2 DTD0002 EXOFACTO Lansoprazole HIGHSTIT Approved Drug DTD0002 EXOFACTO Lansoprazole DESCRIPT Lansoprazole inhibits the activity of ABCC2 DTD0002 EXOFACTO Lansoprazole MOACRIVE Inhibition DTD0002 EXOFACTO Levonorgestrel HIGHSTIT Approved Drug DTD0002 EXOFACTO Levonorgestrel DESCRIPT Levonorgestrel inhibits the activity of ABCC2 DTD0002 EXOFACTO Levonorgestrel MOACRIVE Inhibition DTD0002 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0002 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0002 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Losartan MOACRIVE Inhibition DTD0002 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0002 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCC2 DTD0002 EXOFACTO Micafungin MOACRIVE Inhibition DTD0002 EXOFACTO Midecamycin HIGHSTIT Approved Drug DTD0002 EXOFACTO Midecamycin DESCRIPT Midecamycin inhibits the activity of ABCC2 DTD0002 EXOFACTO Midecamycin MOACRIVE Inhibition DTD0002 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0002 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the activity of ABCC2 DTD0002 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0002 EXOFACTO Mix silybin A silybin B HIGHSTIT Natural Product DTD0002 EXOFACTO Mix silybin A silybin B DESCRIPT Mix silybin A silybin B inhibits the activity of ABCC2 DTD0002 EXOFACTO Mix silybin A silybin B MOACRIVE Inhibition DTD0002 EXOFACTO Mix silybin A silybin B CELLLINE Spodoptera frugiperda 21-MRP2 DTD0002 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0002 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Irinotecan by ABCC2 (IC50 = 50 microM) DTD0002 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Ethacrynic acid glutathione by ABCC2 (IC50 = 4 microM) DTD0002 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Vinblastine by ABCC2 (Ki = 26.4 microM) DTD0002 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 13.1 microM) DTD0002 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO MK-571 MOACRIVE Inhibition DTD0002 EXOFACTO MK-571 CELLLINE Human enterocyte-like 2 cell (Caco-2)-MRP2 DTD0002 EXOFACTO MK-571 CELLLINE Spodoptera frugiperda (Sf9) cells-MRP2 DTD0002 EXOFACTO MK-571 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO MK-571 CELLLINE LLC-PK1 vesicles-MRP2 DTD0002 EXOFACTO Montelukast HIGHSTIT Approved Drug DTD0002 EXOFACTO Montelukast DESCRIPT Montelukast inhibits the activity of ABCC2 DTD0002 EXOFACTO Montelukast MOACRIVE Inhibition DTD0002 EXOFACTO Mycophenolic acid HIGHSTIT Approved Drug DTD0002 EXOFACTO Mycophenolic acid DESCRIPT Mycophenolic acid inhibits the activity of ABCC2 DTD0002 EXOFACTO Mycophenolic acid MOACRIVE Inhibition DTD0002 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0002 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of ABCC2 DTD0002 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0002 EXOFACTO Phenobarbital CELLLINE Hepatocyte-MRP2 DTD0002 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0002 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the activity of ABCC2 DTD0002 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0002 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0002 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of SN-38 by ABCC2 DTD0002 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of ABCC2 DTD0002 EXOFACTO Probenecid MOACRIVE Inhibition DTD0002 EXOFACTO Pyrethroids HIGHSTIT Natural Product DTD0002 EXOFACTO Pyrethroids DESCRIPT Pyrethroids inhibits the transportation of Probenecid by ABCC2 (IC50 = 48.2 microM) DTD0002 EXOFACTO Pyrethroids MOACRIVE Inhibition DTD0002 EXOFACTO Pyrethroids CELLLINE Human hepatoma HuH-7 cells-MRP2 DTD0002 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0002 EXOFACTO Quercetin DESCRIPT Quercetin induces the activity of ABCC2 DTD0002 EXOFACTO Quercetin MOACRIVE Inducer DTD0002 EXOFACTO Quercetin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MRP2 DTD0002 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0002 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Vinblastine by ABCC2 (Ki = 295 microM) DTD0002 EXOFACTO Reserpine MOACRIVE Inhibition DTD0002 EXOFACTO Reserpine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0002 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0002 EXOFACTO Rifampicin DESCRIPT Rifampicin induces the activity of ABCC2 DTD0002 EXOFACTO Rifampicin MOACRIVE Inducer DTD0002 EXOFACTO Rifampicin CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP2 DTD0002 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0002 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0002 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0002 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Calcein AM by ABCC2 (IC50 = 25 +/- 2 microM) DTD0002 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0002 EXOFACTO Simvastatin CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MRP2 DTD0002 EXOFACTO Sitaxsentan HIGHSTIT Drug Withdrawn DTD0002 EXOFACTO Sitaxsentan DESCRIPT Sitaxsentan inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Sitaxsentan MOACRIVE Inhibition DTD0002 EXOFACTO St Johns wort extract HIGHSTIT Natural Product DTD0002 EXOFACTO St Johns wort extract DESCRIPT St Johns wort extract induces the activity of ABCC2 DTD0002 EXOFACTO St Johns wort extract MOACRIVE Inducer DTD0002 EXOFACTO St Johns wort extract CELLLINE Model organism in vivo (rat) DTD0002 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0002 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0002 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0002 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the activity of ABCC2 DTD0002 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0002 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0002 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Probenecid by ABCC2 (IC50 = 65.5 microM) DTD0002 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0002 EXOFACTO Tetramethrin CELLLINE Human hepatoma HuH-7 cells-MRP2 DTD0002 EXOFACTO Tipranavir HIGHSTIT Approved Drug DTD0002 EXOFACTO Tipranavir DESCRIPT Tipranavir inhibits the activity of ABCC2 DTD0002 EXOFACTO Tipranavir MOACRIVE Inhibition DTD0002 EXOFACTO Triamcinolone HIGHSTIT Approved Drug DTD0002 EXOFACTO Triamcinolone DESCRIPT Triamcinolone induces the activity of ABCC2 DTD0002 EXOFACTO Triamcinolone MOACRIVE Inducer DTD0002 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0002 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC2 DTD0002 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0002 EXOFACTO Troleandomycin HIGHSTIT Approved Drug DTD0002 EXOFACTO Troleandomycin DESCRIPT Troleandomycin induces the activity of ABCC2 DTD0002 EXOFACTO Troleandomycin MOACRIVE Inducer DTD0002 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0002 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Leukotriene C4 by ABCC2 (Ki = 28.9 microM) DTD0002 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Vincristine by ABCC2 DTD0002 EXOFACTO Valspodar MOACRIVE Inhibition DTD0002 EXOFACTO Valspodar CELLLINE LLC-PK1 vesicles-MRP2 DTD0002 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0002 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of ABCC2 DTD0002 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0002 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0002 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the activity of ABCC2 DTD0002 EXOFACTO Verapamil MOACRIVE Inhibition DTD0002 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0002 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Calcein AM by ABCC2 (IC50 = 21 microM) DTD0002 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the activity of ABCC2 DTD0002 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0002 EXOFACTO Vinblastine CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MRP2 DTD0002 EXOFACTO Vincristine HIGHSTIT Approved Drug DTD0002 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Vinblastine by ABCC2 (Ki = 802 microM) DTD0002 EXOFACTO Vincristine MOACRIVE Inhibition DTD0002 EXOFACTO Vincristine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP2 DTD0003 TRANSPID DTD0003 DTD0003 GENENAME ABCB1 DTD0003 PROTNAME P-glycoprotein 1 DTD0003 GENEDBID 5243 DTD0003 UNIPROID P08183 DTD0003 EXOFACTO (-)Epicatechin HIGHSTIT Natural Product DTD0003 EXOFACTO (-)Epicatechin DESCRIPT (-)Epicatechin induces the transportation of LDS-751 by ABCB1 DTD0003 EXOFACTO (-)Epicatechin MOACRIVE Inducer DTD0003 EXOFACTO (-)Epicatechin CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO 2'-Hydroxychalcone HIGHSTIT Investigative Drug DTD0003 EXOFACTO 2'-Hydroxychalcone DESCRIPT 2'-Hydroxychalcone inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO 2'-Hydroxychalcone MOACRIVE Inhibition DTD0003 EXOFACTO 2'-Hydroxychalcone CELLLINE Doxorubicin resistant A2780adr cell lines-MDR1 DTD0003 EXOFACTO 6,7-dihydroxybergamottin HIGHSTIT Natural Product DTD0003 EXOFACTO 6,7-dihydroxybergamottin DESCRIPT 6,7-dihydroxybergamottin inhibits the transportation of Talinolol by ABCB1 (IC50 = 34 microM) DTD0003 EXOFACTO 6,7-dihydroxybergamottin MOACRIVE Inhibition DTD0003 EXOFACTO 6,7-dihydroxybergamottin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO 6,7-epoxybergamottin HIGHSTIT Natural Product DTD0003 EXOFACTO 6,7-epoxybergamottin DESCRIPT 6,7-epoxybergamottin inhibits the transportation of Talinolol by ABCB1 (IC50 = 0.7 microM) DTD0003 EXOFACTO 6,7-epoxybergamottin MOACRIVE Inhibition DTD0003 EXOFACTO 6,7-epoxybergamottin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0003 EXOFACTO Acetaminophen DESCRIPT Acetaminophen induces the activity of ABCB1 DTD0003 EXOFACTO Acetaminophen MOACRIVE Inducer DTD0003 EXOFACTO Acetochlor HIGHSTIT Natural Product DTD0003 EXOFACTO Acetochlor DESCRIPT Acetochlor inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 25 microM) DTD0003 EXOFACTO Acetochlor MOACRIVE Inhibition DTD0003 EXOFACTO Acetochlor CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Acetylcysteine HIGHSTIT Approved Drug DTD0003 EXOFACTO Acetylcysteine DESCRIPT Acetylcysteine induces the activity of ABCB1 DTD0003 EXOFACTO Acetylcysteine MOACRIVE Inducer DTD0003 EXOFACTO Acteoside HIGHSTIT Natural Product DTD0003 EXOFACTO Acteoside DESCRIPT Acteoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Acteoside MOACRIVE Inhibition DTD0003 EXOFACTO Acteoside CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Agnuside HIGHSTIT Natural Product DTD0003 EXOFACTO Agnuside DESCRIPT Agnuside inhibits the activity of ABCB1 DTD0003 EXOFACTO Agnuside MOACRIVE Inhibition DTD0003 EXOFACTO Agnuside CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Alachlor HIGHSTIT Natural Product DTD0003 EXOFACTO Alachlor DESCRIPT Alachlor inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 25 microM) DTD0003 EXOFACTO Alachlor MOACRIVE Inhibition DTD0003 EXOFACTO Alachlor CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Aldosterone HIGHSTIT Approved Drug DTD0003 EXOFACTO Aldosterone DESCRIPT Aldosterone induces the activity of ABCB1 DTD0003 EXOFACTO Aldosterone MOACRIVE Inducer DTD0003 EXOFACTO Alfentanil HIGHSTIT Approved Drug DTD0003 EXOFACTO Alfentanil DESCRIPT Alfentanil inhibits the transportation of Digoxin by ABCB1 (IC50 = 112 microM) DTD0003 EXOFACTO Alfentanil MOACRIVE Inhibition DTD0003 EXOFACTO Alfentanil CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Allicin HIGHSTIT Natural Product DTD0003 EXOFACTO Allicin DESCRIPT Allicin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 119.1 microM) DTD0003 EXOFACTO Allicin MOACRIVE Inhibition DTD0003 EXOFACTO Allicin CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Alprenolol HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Alprenolol DESCRIPT Alprenolol inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Alprenolol MOACRIVE Inhibition DTD0003 EXOFACTO Alprenolol CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Amiodarone HIGHSTIT Approved Drug DTD0003 EXOFACTO Amiodarone DESCRIPT Amiodarone inhibits the transportation of Digoxin by ABCB1 (IC50 = 45.6 microM) DTD0003 EXOFACTO Amiodarone DESCRIPT Amiodarone inhibits the transportation of Digoxin by ABCB1 (IC50 = 5.48 microM) DTD0003 EXOFACTO Amiodarone DESCRIPT Amiodarone inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 22.5 microM) DTD0003 EXOFACTO Amiodarone MOACRIVE Inhibition DTD0003 EXOFACTO Amiodarone CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Amlodipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Amlodipine DESCRIPT Amlodipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 22 microM) DTD0003 EXOFACTO Amlodipine DESCRIPT Amlodipine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Amlodipine MOACRIVE Inhibition DTD0003 EXOFACTO Amlodipine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Amlodipine CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Amprenavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Amprenavir DESCRIPT Amprenavir induces the activity of ABCB1 DTD0003 EXOFACTO Amprenavir MOACRIVE Inhibition DTD0003 EXOFACTO Amprenavir MOACRIVE Inducer DTD0003 EXOFACTO Amprenavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Apatinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Apatinib DESCRIPT Apatinib inhibits the transportation of Adriamycin by ABCB1 DTD0003 EXOFACTO Apatinib DESCRIPT Apatinib inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Apatinib MOACRIVE Inhibition DTD0003 EXOFACTO Aprindine HIGHSTIT Approved Drug DTD0003 EXOFACTO Aprindine DESCRIPT Aprindine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Aprindine MOACRIVE Inhibition DTD0003 EXOFACTO Aprindine CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Aripiprazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Aripiprazole DESCRIPT Aripiprazole inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Aripiprazole MOACRIVE Inhibition DTD0003 EXOFACTO Aripiprazole CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Arsenic trioxide HIGHSTIT Approved Drug DTD0003 EXOFACTO Arsenic trioxide DESCRIPT Arsenic trioxide inhibits the activity of ABCB1 DTD0003 EXOFACTO Arsenic trioxide MOACRIVE Inhibition DTD0003 EXOFACTO Artemisinin HIGHSTIT Approved Drug DTD0003 EXOFACTO Artemisinin DESCRIPT Artemisinin induces the activity of ABCB1 DTD0003 EXOFACTO Artemisinin MOACRIVE Inducer DTD0003 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of Digoxin by ABCB1 (IC50 = 2.73 microM) DTD0003 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Astemizole MOACRIVE Inhibition DTD0003 EXOFACTO Astemizole CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Astemizole CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Asunaprevir HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Asunaprevir DESCRIPT Asunaprevir inhibits the activity of ABCB1 DTD0003 EXOFACTO Asunaprevir MOACRIVE Inhibition DTD0003 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0003 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the activity of ABCB1 DTD0003 EXOFACTO Atorvastatin DESCRIPT Atorvastatin modulates the activity of ABCB1 DTD0003 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0003 EXOFACTO Atorvastatin MOACRIVE Modulator DTD0003 EXOFACTO Atovaquone HIGHSTIT Approved Drug DTD0003 EXOFACTO Atovaquone DESCRIPT Atovaquone inhibits the transportation of N-methyl quinidine by ABCB1 (IC50 = 6.8 microM) DTD0003 EXOFACTO Atovaquone MOACRIVE Inhibition DTD0003 EXOFACTO Atovaquone CELLLINE Human embryonic kidney 293 cells (HEK293)-MDR1 DTD0003 EXOFACTO Azelastine HIGHSTIT Approved Drug DTD0003 EXOFACTO Azelastine DESCRIPT Azelastine inhibits the transportation of Digoxin by ABCB1 (IC50 = 30 microM) DTD0003 EXOFACTO Azelastine DESCRIPT Azelastine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 16 microM) DTD0003 EXOFACTO Azelastine MOACRIVE Inhibition DTD0003 EXOFACTO Azelastine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Azithromycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Azithromycin DESCRIPT Azithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 21.8 microM) DTD0003 EXOFACTO Azithromycin MOACRIVE Inhibition DTD0003 EXOFACTO Azithromycin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Benzocaine HIGHSTIT Approved Drug DTD0003 EXOFACTO Benzocaine DESCRIPT Benzocaine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Benzocaine MOACRIVE Inhibition DTD0003 EXOFACTO Benzocaine CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Bepridil HIGHSTIT Approved Drug DTD0003 EXOFACTO Bepridil DESCRIPT Bepridil inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Bepridil MOACRIVE Inhibition DTD0003 EXOFACTO Bepridil CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Betamethasone HIGHSTIT Approved Drug DTD0003 EXOFACTO Betamethasone DESCRIPT Betamethasone induces the activity of ABCB1 DTD0003 EXOFACTO Betamethasone MOACRIVE Inducer DTD0003 EXOFACTO Bexarotene HIGHSTIT Approved Drug DTD0003 EXOFACTO Bexarotene DESCRIPT Bexarotene induces the activity of ABCB1 DTD0003 EXOFACTO Bexarotene MOACRIVE Inducer DTD0003 EXOFACTO Bexarotene CELLLINE Human BBB model derived from hematopoietic stem cells DTD0003 EXOFACTO Biricodar HIGHSTIT Approved Drug DTD0003 EXOFACTO Biricodar DESCRIPT Biricodar inhibits the activity of ABCB1 DTD0003 EXOFACTO Biricodar DESCRIPT Biricodar modulates the activity of ABCB1 DTD0003 EXOFACTO Biricodar MOACRIVE Inhibition DTD0003 EXOFACTO Biricodar MOACRIVE Modulator DTD0003 EXOFACTO Brecanavir HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Brecanavir DESCRIPT Brecanavir inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Brecanavir MOACRIVE Inhibition DTD0003 EXOFACTO Brecanavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Brilinta HIGHSTIT Approved Drug DTD0003 EXOFACTO Brilinta DESCRIPT Brilinta inhibits the activity of ABCB1 DTD0003 EXOFACTO Brilinta MOACRIVE Inhibition DTD0003 EXOFACTO Bromocriptine HIGHSTIT Approved Drug DTD0003 EXOFACTO Bromocriptine DESCRIPT Bromocriptine inhibits the transportation of Vinblastine by ABCB1 (Ki = 3.96 microM) DTD0003 EXOFACTO Bromocriptine DESCRIPT Bromocriptine inhibits the transportation of Calcein AM by ABCB1 (Ki = 2.81 microM) DTD0003 EXOFACTO Bromocriptine DESCRIPT Bromocriptine inhibits the activity of ABCB1 DTD0003 EXOFACTO Bromocriptine MOACRIVE Inhibition DTD0003 EXOFACTO Bromocriptine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0003 EXOFACTO Budesonide DESCRIPT Budesonide induces the activity of ABCB1 DTD0003 EXOFACTO Budesonide MOACRIVE Inducer DTD0003 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0003 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the activity of ABCB1 DTD0003 EXOFACTO Buspirone MOACRIVE Inhibition DTD0003 EXOFACTO Buspirone CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0003 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Caffeine MOACRIVE Inhibition DTD0003 EXOFACTO Caffeine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Calcitriol HIGHSTIT Approved Drug DTD0003 EXOFACTO Calcitriol DESCRIPT Calcitriol inhibits the activity of ABCB1 DTD0003 EXOFACTO Calcitriol MOACRIVE Inhibition DTD0003 EXOFACTO Calcitriol CELLLINE Human embryonic kidney 293 cells (HEK293)-MDR1 DTD0003 EXOFACTO Canagliflozin HIGHSTIT Approved Drug DTD0003 EXOFACTO Canagliflozin DESCRIPT Canagliflozin inhibits the activity of ABCB1 DTD0003 EXOFACTO Canagliflozin MOACRIVE Inhibition DTD0003 EXOFACTO Capsaicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Capsaicin DESCRIPT Capsaicin inhibits the transportation of Fexofenadine by ABCB1 DTD0003 EXOFACTO Capsaicin MOACRIVE Inhibition DTD0003 EXOFACTO Capsaicin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0003 EXOFACTO Captopril DESCRIPT Captopril inhibits the activity of ABCB1 DTD0003 EXOFACTO Captopril MOACRIVE Inhibition DTD0003 EXOFACTO Carbamazepine HIGHSTIT Approved Drug DTD0003 EXOFACTO Carbamazepine DESCRIPT Carbamazepine induces the transportation of Fexofenadine by ABCB1 DTD0003 EXOFACTO Carbamazepine DESCRIPT Carbamazepine induces the activity of ABCB1 DTD0003 EXOFACTO Carbamazepine MOACRIVE Inducer DTD0003 EXOFACTO Carbamazepine CELLLINE Twelve healthy Japanese volunteers DTD0003 EXOFACTO Carvedilol HIGHSTIT Approved Drug DTD0003 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the transportation of Doxorubicin by ABCB1 DTD0003 EXOFACTO Carvedilol MOACRIVE Inhibition DTD0003 EXOFACTO Caspofungin HIGHSTIT Approved Drug DTD0003 EXOFACTO Caspofungin DESCRIPT Caspofungin inhibits the transportation of Vinblastine by ABCB1 DTD0003 EXOFACTO Caspofungin MOACRIVE Inhibition DTD0003 EXOFACTO Catechin HIGHSTIT Natural Product DTD0003 EXOFACTO Catechin DESCRIPT Catechin inhibits the activity of ABCB1 DTD0003 EXOFACTO Catechin MOACRIVE Inhibition DTD0003 EXOFACTO Catechin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0003 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the activity of ABCB1 DTD0003 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0003 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0003 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid induces the activity of ABCB1 DTD0003 EXOFACTO Chenodeoxycholic acid MOACRIVE Inducer DTD0003 EXOFACTO Chlordecone HIGHSTIT Natural Product DTD0003 EXOFACTO Chlordecone DESCRIPT Chlordecone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 138.8 microM) DTD0003 EXOFACTO Chlordecone MOACRIVE Inhibition DTD0003 EXOFACTO Chlordecone CELLLINE Human breast adenocarcinoma cell line (MCF-7)-MDR1 DTD0003 EXOFACTO Chloroacetanilides HIGHSTIT Natural Product DTD0003 EXOFACTO Chloroacetanilides DESCRIPT Chloroacetanilides inhibits the transportation of Paclitaxel by ABCB1 DTD0003 EXOFACTO Chloroacetanilides MOACRIVE Inhibition DTD0003 EXOFACTO Chloroacetanilides CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Chlorogenic acid HIGHSTIT Investigative Drug DTD0003 EXOFACTO Chlorogenic acid DESCRIPT Chlorogenic acid inhibits the activity of ABCB1 DTD0003 EXOFACTO Chlorogenic acid MOACRIVE Inhibition DTD0003 EXOFACTO Chlorogenic acid CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Chlorpropamide HIGHSTIT Approved Drug DTD0003 EXOFACTO Chlorpropamide DESCRIPT Chlorpropamide inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Chlorpropamide MOACRIVE Inhibition DTD0003 EXOFACTO Chlorpropamide CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Chlorprothixene HIGHSTIT Approved Drug DTD0003 EXOFACTO Chlorprothixene DESCRIPT Chlorprothixene inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Chlorprothixene MOACRIVE Inhibition DTD0003 EXOFACTO Chlorprothixene CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Chlorzoxazone HIGHSTIT Approved Drug DTD0003 EXOFACTO Chlorzoxazone DESCRIPT Chlorzoxazone inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Chlorzoxazone MOACRIVE Inhibition DTD0003 EXOFACTO Chlorzoxazone CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0003 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 224.3 microM) DTD0003 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0003 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-MDR1 DTD0003 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0003 EXOFACTO Cisplatin DESCRIPT Cisplatin induces the activity of ABCB1 DTD0003 EXOFACTO Cisplatin MOACRIVE Inducer DTD0003 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 4.1 microM) DTD0003 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0003 EXOFACTO Clarithromycin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Clomipramine HIGHSTIT Approved Drug DTD0003 EXOFACTO Clomipramine DESCRIPT Clomipramine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Clomipramine MOACRIVE Inhibition DTD0003 EXOFACTO Clomipramine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Clotrimazole DESCRIPT Clotrimazole induces the activity of ABCB1 DTD0003 EXOFACTO Clotrimazole MOACRIVE Inducer DTD0003 EXOFACTO Clotrimazole CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Cobicistat HIGHSTIT Approved Drug DTD0003 EXOFACTO Cobicistat DESCRIPT Cobicistat inhibits the transportation of Dabigatran by ABCB1 DTD0003 EXOFACTO Cobicistat DESCRIPT Cobicistat inhibits the activity of ABCB1 DTD0003 EXOFACTO Cobicistat MOACRIVE Inhibition DTD0003 EXOFACTO Conivaptan HIGHSTIT Approved Drug DTD0003 EXOFACTO Conivaptan DESCRIPT Conivaptan inhibits the activity of ABCB1 DTD0003 EXOFACTO Conivaptan MOACRIVE Inhibition DTD0003 EXOFACTO Corticosterone HIGHSTIT Investigative Drug DTD0003 EXOFACTO Corticosterone DESCRIPT Corticosterone induces the activity of ABCB1 DTD0003 EXOFACTO Corticosterone MOACRIVE Inducer DTD0003 EXOFACTO Corticosterone CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Crizotinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Crizotinib DESCRIPT Crizotinib inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Crizotinib MOACRIVE Inhibition DTD0003 EXOFACTO Curcumin HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Curcumin MOACRIVE Inhibition DTD0003 EXOFACTO Curcumin CELLLINE Multidrug resistance human gastric carcinoma cell line (SGC7901/VCR)-MDR1 DTD0003 EXOFACTO Cyanidin-3-rutinoside HIGHSTIT Natural Product DTD0003 EXOFACTO Cyanidin-3-rutinoside DESCRIPT Cyanidin-3-rutinoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Cyanidin-3-rutinoside MOACRIVE Inhibition DTD0003 EXOFACTO Cyanidin-3-rutinoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0003 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 6.18 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Tetramethylrosamine by ABCB1 (IC50 = 2.1 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 1.7 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 1.4 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Vinblastine by ABCB1 (Ki = 1.3 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Verapamil by ABCB1 (Ki = 0.02 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 1.8 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Fluo-3-AM by ABCB1 (IC50 = 2.4 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Digoxin by ABCB1 (Ki = 0.46 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Digoxin by ABCB1 (Ki = 0.35 +/- 0.04 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Doxorubicin by ABCB1 (IC50 = 3.66 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.6 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.3 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (Ki = 4.66 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (Ki = 1.8 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 1.4 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Colchicine by ABCB1 (IC50 = 1.36 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 3.41 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 1.7 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 0.8 microM) DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Doxorubicin by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Saquinavir by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Colchicine by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Imatinib by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Indinavir by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Propranolol by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of JC-1 by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Vinblastine by ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of ABCB1 DTD0003 EXOFACTO Cyclosporine DESCRIPT Cyclosporine induces the activity of ABCB1 DTD0003 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0003 EXOFACTO Cyclosporine MOACRIVE Inducer DTD0003 EXOFACTO Cyclosporine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Spodoptera frugiperda (Sf9) cells-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE CEM/VLB100 drug-resistant cells-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Doxorubicin resistant A2780adr cell lines-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Human ileocecal adenocarcinoma cell lines (HCT-8)-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE LLC-PK1 porcine kidney epithelial (LLC-GA5-COL150) cells-MDR1 DTD0003 EXOFACTO Cyclosporine CELLLINE Human T-cell line (CEM)/Tumour cell line-MDR1 DTD0003 EXOFACTO Cytarabine HIGHSTIT Approved Drug DTD0003 EXOFACTO Cytarabine DESCRIPT Cytarabine induces the activity of ABCB1 DTD0003 EXOFACTO Cytarabine MOACRIVE Inducer DTD0003 EXOFACTO Daclatasvir HIGHSTIT Approved Drug DTD0003 EXOFACTO Daclatasvir DESCRIPT Daclatasvir inhibits the activity of ABCB1 DTD0003 EXOFACTO Daclatasvir MOACRIVE Inhibition DTD0003 EXOFACTO Dacomitinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Dacomitinib DESCRIPT Dacomitinib inhibits the activity of ABCB1 DTD0003 EXOFACTO Dacomitinib MOACRIVE Inhibition DTD0003 EXOFACTO Dactinomycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Dactinomycin DESCRIPT Dactinomycin induces the activity of ABCB1 DTD0003 EXOFACTO Dactinomycin MOACRIVE Inducer DTD0003 EXOFACTO Daidzein HIGHSTIT Investigative Drug DTD0003 EXOFACTO Daidzein DESCRIPT Daidzein induces the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Daidzein MOACRIVE Inducer DTD0003 EXOFACTO Daidzein CELLLINE Human colon carcinoma LS-180 cells (LS-180V)-MDR1 DTD0003 EXOFACTO Daunorubicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Daunorubicin DESCRIPT Daunorubicin induces the activity of ABCB1 DTD0003 EXOFACTO Daunorubicin MOACRIVE Inducer DTD0003 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0003 EXOFACTO Decitabine DESCRIPT Decitabine restores drug sensitivity by depressing ABCB1 activity through MAPK signaling pathway DTD0003 EXOFACTO Decitabine MOACRIVE Inhibition DTD0003 EXOFACTO Decitabine CELLLINE K562/ADR cells and MCF-7/ADR cells DTD0003 EXOFACTO Delphinidin-3-Glucoside HIGHSTIT Natural Product DTD0003 EXOFACTO Delphinidin-3-Glucoside DESCRIPT Delphinidin-3-Glucoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Delphinidin-3-Glucoside MOACRIVE Inhibition DTD0003 EXOFACTO Delphinidin-3-Glucoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0003 EXOFACTO Desloratadine HIGHSTIT Approved Drug DTD0003 EXOFACTO Desloratadine DESCRIPT Desloratadine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 43 microM) DTD0003 EXOFACTO Desloratadine MOACRIVE Inhibition DTD0003 EXOFACTO Desloratadine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0003 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of ABCB1 DTD0003 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0003 EXOFACTO Dexamethasone CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Diazinon HIGHSTIT Natural Product DTD0003 EXOFACTO Diazinon DESCRIPT Diazinon inhibits the transportation of Verapamil by ABCB1 (IC50 = 58.4 microM) DTD0003 EXOFACTO Diazinon MOACRIVE Inhibition DTD0003 EXOFACTO Diazinon CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0003 EXOFACTO Diclofenac DESCRIPT Diclofenac induces the activity of ABCB1 DTD0003 EXOFACTO Diclofenac MOACRIVE Inducer DTD0003 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0003 EXOFACTO Digoxin DESCRIPT Digoxin induces the activity of ABCB1 DTD0003 EXOFACTO Digoxin MOACRIVE Inducer DTD0003 EXOFACTO Digoxin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Dihydroergocristine HIGHSTIT Approved Drug DTD0003 EXOFACTO Dihydroergocristine DESCRIPT Dihydroergocristine inhibits the transportation of Vinblastine by ABCB1 (Ki = 16 microM) DTD0003 EXOFACTO Dihydroergocristine DESCRIPT Dihydroergocristine inhibits the transportation of Calcein AM by ABCB1 (Ki = 511 microM) DTD0003 EXOFACTO Dihydroergocristine MOACRIVE Inhibition DTD0003 EXOFACTO Dihydroergocristine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Dihydroergotamine HIGHSTIT Approved Drug DTD0003 EXOFACTO Dihydroergotamine DESCRIPT Dihydroergotamine inhibits the transportation of Vinblastine by ABCB1 (Ki = 119.94 microM) DTD0003 EXOFACTO Dihydroergotamine DESCRIPT Dihydroergotamine inhibits the transportation of Calcein AM by ABCB1 (Ki > 1000 microM) DTD0003 EXOFACTO Dihydroergotamine MOACRIVE Inhibition DTD0003 EXOFACTO Dihydroergotamine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Dihydromyricetin HIGHSTIT Approved Drug DTD0003 EXOFACTO Dihydromyricetin DESCRIPT Dihydromyricetin inhibits the transporation of adriamycin by ABCB1 through ERK/Akt signaling pathways (IC50 = 0.172 microM) DTD0003 EXOFACTO Dihydromyricetin MOACRIVE Inhibition DTD0003 EXOFACTO Dihydromyricetin CELLLINE Human myelogenous leukemia cell line (K562) DTD0003 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0003 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the activity of ABCB1 DTD0003 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0003 EXOFACTO Dimethyl sulfoxide HIGHSTIT Approved Drug DTD0003 EXOFACTO Dimethyl sulfoxide DESCRIPT Dimethyl sulfoxide induces the activity of ABCB1 DTD0003 EXOFACTO Dimethyl sulfoxide MOACRIVE Inducer DTD0003 EXOFACTO Dinoprostone HIGHSTIT Approved Drug DTD0003 EXOFACTO Dinoprostone DESCRIPT Dinoprostone induces the activity of ABCB1 DTD0003 EXOFACTO Dinoprostone MOACRIVE Inducer DTD0003 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0003 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Digoxin by ABCB1 (IC50 = 40 microM) DTD0003 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the activity of ABCB1 DTD0003 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0003 EXOFACTO Dipyridamole CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Dipyridamole CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Docetaxel HIGHSTIT Approved Drug DTD0003 EXOFACTO Docetaxel DESCRIPT Docetaxel induces the activity of ABCB1 DTD0003 EXOFACTO Docetaxel MOACRIVE Inducer DTD0003 EXOFACTO Dolutegravir HIGHSTIT Approved Drug DTD0003 EXOFACTO Dolutegravir DESCRIPT Dolutegravir inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Dolutegravir MOACRIVE Inhibition DTD0003 EXOFACTO Dolutegravir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Donepezil HIGHSTIT Approved Drug DTD0003 EXOFACTO Donepezil DESCRIPT Donepezil inhibits the activity of ABCB1 DTD0003 EXOFACTO Donepezil MOACRIVE Inhibition DTD0003 EXOFACTO Doxazosin HIGHSTIT Approved Drug DTD0003 EXOFACTO Doxazosin DESCRIPT Doxazosin inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Doxazosin MOACRIVE Inhibition DTD0003 EXOFACTO Doxazosin CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Doxorubicin DESCRIPT Doxorubicin induces the activity of ABCB1 DTD0003 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the activity of ABCB1 DTD0003 EXOFACTO Doxorubicin MOACRIVE Inducer DTD0003 EXOFACTO Doxorubicin MOACRIVE Inhibition DTD0003 EXOFACTO Dronedarone HIGHSTIT Approved Drug DTD0003 EXOFACTO Dronedarone DESCRIPT Dronedarone inhibits the transportation of Edoxaban by ABCB1 DTD0003 EXOFACTO Dronedarone MOACRIVE Inhibition DTD0003 EXOFACTO Echinacea extract HIGHSTIT Natural Product DTD0003 EXOFACTO Echinacea extract DESCRIPT Echinacea extract inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Echinacea extract MOACRIVE Inhibition DTD0003 EXOFACTO Echinacea extract CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Echinacea pallida roots extract HIGHSTIT Natural Product DTD0003 EXOFACTO Echinacea pallida roots extract DESCRIPT Echinacea pallida roots extract inhibits the activity of ABCB1 DTD0003 EXOFACTO Echinacea pallida roots extract MOACRIVE Inhibition DTD0003 EXOFACTO Echinacea pallida roots extract CELLLINE Human proximal tubule HK-2 cell line (HK-2)-MDR1 DTD0003 EXOFACTO Echinacea purpurea HIGHSTIT Natural Product DTD0003 EXOFACTO Echinacea purpurea DESCRIPT Echinacea purpurea inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Echinacea purpurea MOACRIVE Inhibition DTD0003 EXOFACTO Echinacea purpurea CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Eetuximab HIGHSTIT Approved Drug DTD0003 EXOFACTO Eetuximab DESCRIPT Eetuximab induces the activity of ABCB1 DTD0003 EXOFACTO Eetuximab MOACRIVE Inducer DTD0003 EXOFACTO Elacridar HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Digoxin by ABCB1 (Ki = 0.44 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Digoxin by ABCB1 (Ki = 0.39 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Vinblastine by ABCB1 (IC50 = 0.043 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.18 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.055 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Colchicine by ABCB1 (IC50 = 0.027 microM) DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Quinine by ABCB1 DTD0003 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Mitoxantrone by ABCB1 DTD0003 EXOFACTO Elacridar MOACRIVE Inhibition DTD0003 EXOFACTO Elacridar CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Elacridar CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Elacridar CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Elacridar CELLLINE LLC-PK1 porcine kidney epithelial (LLC-GA5-COL150) cells-MDR1 DTD0003 EXOFACTO Eliglustat HIGHSTIT Approved Drug DTD0003 EXOFACTO Eliglustat DESCRIPT Eliglustat inhibits the activity of ABCB1 DTD0003 EXOFACTO Eliglustat MOACRIVE Inhibition DTD0003 EXOFACTO Elobixibat HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Elobixibat DESCRIPT Elobixibat inhibits the activity of ABCB1 DTD0003 EXOFACTO Elobixibat MOACRIVE Inhibition DTD0003 EXOFACTO Endosulfan HIGHSTIT Natural Product DTD0003 EXOFACTO Endosulfan DESCRIPT Endosulfan inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) DTD0003 EXOFACTO Endosulfan MOACRIVE Inhibition DTD0003 EXOFACTO Endosulfan CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Epinephrine HIGHSTIT Drug in Preclinical Test DTD0003 EXOFACTO Epinephrine DESCRIPT Epinephrine induces the activity of ABCB1 DTD0003 EXOFACTO Epinephrine MOACRIVE Inducer DTD0003 EXOFACTO Epirubicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Epirubicin DESCRIPT Epirubicin induces the activity of ABCB1 DTD0003 EXOFACTO Epirubicin MOACRIVE Inducer DTD0003 EXOFACTO Epothilone D HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Epothilone D DESCRIPT Epothilone D inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Epothilone D MOACRIVE Inhibition DTD0003 EXOFACTO Ergonovine HIGHSTIT Approved Drug DTD0003 EXOFACTO Ergonovine DESCRIPT Ergonovine inhibits the transportation of Vinblastine by ABCB1 (Ki > 100 microM) DTD0003 EXOFACTO Ergonovine DESCRIPT Ergonovine inhibits the transportation of Calcein AM by ABCB1 (Ki = 115.5 microM) DTD0003 EXOFACTO Ergonovine MOACRIVE Inhibition DTD0003 EXOFACTO Ergonovine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Ergotamine HIGHSTIT Approved Drug DTD0003 EXOFACTO Ergotamine DESCRIPT Ergotamine inhibits the transportation of Vinblastine by ABCB1 (Ki = 14.25 microM) DTD0003 EXOFACTO Ergotamine DESCRIPT Ergotamine inhibits the transportation of Calcein AM by ABCB1 (Ki = 98.9 microM) DTD0003 EXOFACTO Ergotamine MOACRIVE Inhibition DTD0003 EXOFACTO Ergotamine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the transportation of Vincristine by ABCB1 (IC50 = 2 microM) DTD0003 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0003 EXOFACTO Erlotinib CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Ximelagatran by ABCB1 (IC50 = 119 microM) DTD0003 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 10 microM) DTD0003 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 22.7 microM) DTD0003 EXOFACTO Erythromycin DESCRIPT Erythromycin induces the activity of ABCB1 DTD0003 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0003 EXOFACTO Erythromycin MOACRIVE Inducer DTD0003 EXOFACTO Erythromycin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Estramustine HIGHSTIT Approved Drug DTD0003 EXOFACTO Estramustine DESCRIPT Estramustine inhibits the transportation of Vinblastine by ABCB1 DTD0003 EXOFACTO Estramustine MOACRIVE Inhibition DTD0003 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0003 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Taxol by ABCB1 (Ki = 276 microM) DTD0003 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Digoxin by ABCB1 (Ki = 768 microM) DTD0003 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) DTD0003 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Etoposide DESCRIPT Etoposide induces the activity of ABCB1 DTD0003 EXOFACTO Etoposide MOACRIVE Inhibition DTD0003 EXOFACTO Etoposide MOACRIVE Inducer DTD0003 EXOFACTO Etoposide CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Etoposide CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Etoposide CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Etravirine HIGHSTIT Approved Drug DTD0003 EXOFACTO Etravirine DESCRIPT Etravirine inhibits the activity of ABCB1 DTD0003 EXOFACTO Etravirine MOACRIVE Inhibition DTD0003 EXOFACTO Everolimus HIGHSTIT Approved Drug DTD0003 EXOFACTO Everolimus DESCRIPT Everolimus inhibits the activity of ABCB1 DTD0003 EXOFACTO Everolimus MOACRIVE Inhibition DTD0003 EXOFACTO Ezogabine HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Ezogabine DESCRIPT Ezogabine inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Ezogabine MOACRIVE Inhibition DTD0003 EXOFACTO Fangchinoline HIGHSTIT Natural Product DTD0003 EXOFACTO Fangchinoline DESCRIPT Fangchinoline inhibits the transportation of Verapamil by ABCB1 DTD0003 EXOFACTO Fangchinoline MOACRIVE Inhibition DTD0003 EXOFACTO Fangchinoline CELLLINE Human colon adenocarcinoma cell line (HCT15)-MDR1 DTD0003 EXOFACTO Felodipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 32.3 microM) DTD0003 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 > 60 microM) DTD0003 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 26.3 microM) DTD0003 EXOFACTO Felodipine MOACRIVE Inhibition DTD0003 EXOFACTO Felodipine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Fenbufen HIGHSTIT Approved Drug DTD0003 EXOFACTO Fenbufen DESCRIPT Fenbufen induces the activity of ABCB1 DTD0003 EXOFACTO Fenbufen MOACRIVE Inducer DTD0003 EXOFACTO Fentanyl HIGHSTIT Approved Drug DTD0003 EXOFACTO Fentanyl DESCRIPT Fentanyl inhibits the transportation of Digoxin by ABCB1 (IC50 = 6.5 microM) DTD0003 EXOFACTO Fentanyl MOACRIVE Inhibition DTD0003 EXOFACTO Fentanyl CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Fidaxomicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Fidaxomicin DESCRIPT Fidaxomicin inhibits the activity of ABCB1 DTD0003 EXOFACTO Fidaxomicin MOACRIVE Inhibition DTD0003 EXOFACTO Flibanserin HIGHSTIT Approved Drug DTD0003 EXOFACTO Flibanserin DESCRIPT Flibanserin inhibits the activity of ABCB1 DTD0003 EXOFACTO Flibanserin MOACRIVE Inhibition DTD0003 EXOFACTO Flucloxacillin HIGHSTIT Approved Drug DTD0003 EXOFACTO Flucloxacillin DESCRIPT Flucloxacillin induces the activity of ABCB1 DTD0003 EXOFACTO Flucloxacillin MOACRIVE Inducer DTD0003 EXOFACTO Fluconazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Fluconazole DESCRIPT Fluconazole inhibits the transportation of Vinblastine by ABCB1 (Ki > 400 microM) DTD0003 EXOFACTO Fluconazole DESCRIPT Fluconazole inhibits the transportation of Calcein AM by ABCB1 (Ki > 1000 microM) DTD0003 EXOFACTO Fluconazole MOACRIVE Inhibition DTD0003 EXOFACTO Fluconazole CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Fluorouracil HIGHSTIT Approved Drug DTD0003 EXOFACTO Fluorouracil DESCRIPT Fluorouracil induces the activity of ABCB1 DTD0003 EXOFACTO Fluorouracil MOACRIVE Inducer DTD0003 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0003 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of ABCB1 DTD0003 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0003 EXOFACTO Fluphenazine HIGHSTIT Approved Drug DTD0003 EXOFACTO Fluphenazine DESCRIPT Fluphenazine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 10.4 microM) DTD0003 EXOFACTO Fluphenazine DESCRIPT Fluphenazine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 5.7 microM) DTD0003 EXOFACTO Fluphenazine DESCRIPT Fluphenazine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 6.5 microM) DTD0003 EXOFACTO Fluphenazine MOACRIVE Inhibition DTD0003 EXOFACTO Fluphenazine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Fluvoxamine HIGHSTIT Approved Drug DTD0003 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Fluvoxamine MOACRIVE Inhibition DTD0003 EXOFACTO Fosamprenavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Fosamprenavir DESCRIPT Fosamprenavir induces the activity of ABCB1 DTD0003 EXOFACTO Fosamprenavir MOACRIVE Inducer DTD0003 EXOFACTO Fosphenytoin HIGHSTIT Approved Drug DTD0003 EXOFACTO Fosphenytoin DESCRIPT Fosphenytoin induces the activity of ABCB1 DTD0003 EXOFACTO Fosphenytoin MOACRIVE Inducer DTD0003 EXOFACTO Fructose HIGHSTIT Natural Product DTD0003 EXOFACTO Fructose DESCRIPT Fructose inhibits the transportation of Digoxin by decreasing the expression and activity of the ABCB1 DTD0003 EXOFACTO Fructose MOACRIVE Inhibition DTD0003 EXOFACTO Fructose CELLLINE Model organism in vivo (Male Sprague-Dawley rats) DTD0003 EXOFACTO Garlic extract HIGHSTIT Natural Product DTD0003 EXOFACTO Garlic extract DESCRIPT Garlic extract induces the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Garlic extract DESCRIPT Garlic extract induces the transportation of Saquinavir by ABCB1 DTD0003 EXOFACTO Garlic extract MOACRIVE Inducer DTD0003 EXOFACTO Garlic extract CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Garlic extract CELLLINE Healthy people DTD0003 EXOFACTO Genistein HIGHSTIT Natural Product DTD0003 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0003 EXOFACTO Genistein DESCRIPT Genistein induces the transportation of Sorafenib by increasing ABCB1 expression at translational and transcriptional levels DTD0003 EXOFACTO Genistein DESCRIPT Genistein induces the activity of ABCB1 DTD0003 EXOFACTO Genistein MOACRIVE Inducer DTD0003 EXOFACTO Genistein CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MDR1 DTD0003 EXOFACTO Gingerol HIGHSTIT Natural Product DTD0003 EXOFACTO Gingerol DESCRIPT Gingerol inhibits the transportation of Daunorubicin by ABCB1 DTD0003 EXOFACTO Gingerol DESCRIPT Gingerol inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Gingerol MOACRIVE Inhibition DTD0003 EXOFACTO Gingerol CELLLINE Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 DTD0003 EXOFACTO Ginkgo biloba extract HIGHSTIT Natural Product DTD0003 EXOFACTO Ginkgo biloba extract DESCRIPT Ginkgo biloba extract inhibits the transportation of Digoxin by ABCB1 (IC50 = 23.6 microM) DTD0003 EXOFACTO Ginkgo biloba extract MOACRIVE Inhibition DTD0003 EXOFACTO Ginkgo biloba extract CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Ginseng extract HIGHSTIT Natural Product DTD0003 EXOFACTO Ginseng extract DESCRIPT Ginseng extracts inhibits the transportation of Verapamil by ABCB1 DTD0003 EXOFACTO Ginseng extract MOACRIVE Inhibition DTD0003 EXOFACTO Ginsenoside Rg3 HIGHSTIT Natural Product DTD0003 EXOFACTO Ginsenoside Rg3 DESCRIPT Ginsenoside Rg3 inhibits the transportation of Rhodamine 123 by ABCB1 in a competitive manner DTD0003 EXOFACTO Ginsenoside Rg3 MOACRIVE Inhibition DTD0003 EXOFACTO Ginsenoside Rg3 CELLLINE Multidrug-resistant human fibroblast carcinoma cell line (KBV20C)-MDR1 DTD0003 EXOFACTO Glabridin HIGHSTIT Natural Product DTD0003 EXOFACTO Glabridin DESCRIPT Glabridin inhibits the transportation of Daunorubicin by ABCB1 DTD0003 EXOFACTO Glabridin MOACRIVE Inhibition DTD0003 EXOFACTO Glabridin CELLLINE Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 DTD0003 EXOFACTO Glecaprevir HIGHSTIT Approved Drug DTD0003 EXOFACTO Glecaprevir DESCRIPT Glecaprevir inhibits the activity of ABCB1 DTD0003 EXOFACTO Glecaprevir MOACRIVE Inhibition DTD0003 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0003 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Colchicine by ABCB1 DTD0003 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0003 EXOFACTO Glibenclamide CELLLINE Human T-cell line (CEM)/Tumour cell line-MDR1 DTD0003 EXOFACTO Glycyrrhetinic acid HIGHSTIT Natural Product DTD0003 EXOFACTO Glycyrrhetinic acid DESCRIPT Glycyrrhetinic acid inhibits the transportation of Daunorubicin by ABCB1 DTD0003 EXOFACTO Glycyrrhetinic acid MOACRIVE Inhibition DTD0003 EXOFACTO Glycyrrhetinic acid CELLLINE Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MDR1 DTD0003 EXOFACTO Glycyrrhizin (high concentration) HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Glycyrrhizin (high concentration) DESCRIPT Glycyrrhizin (high concentration) inhibits the activity of ABCB1 DTD0003 EXOFACTO Glycyrrhizin (high concentration) MOACRIVE Inhibition DTD0003 EXOFACTO Glycyrrhizin (high concentration) CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Grapefruit juice HIGHSTIT Dietary Constituent DTD0003 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juices induces the transportation of Fexofenadine by ABCB1 DTD0003 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juice inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juice peel inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juices inhibits the transportation of Talinolol by ABCB1 DTD0003 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juice induces the activity of ABCB1 DTD0003 EXOFACTO Grapefruit juice MOACRIVE Inducer DTD0003 EXOFACTO Grapefruit juice MOACRIVE Inhibition DTD0003 EXOFACTO Grapefruit juice CELLLINE Transfected cell lines-MDR1 DTD0003 EXOFACTO Grapefruit juice CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Grapefruit juice CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0003 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0003 EXOFACTO Haloperidol CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Haloperidol CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Hydrocortisone HIGHSTIT Approved Drug DTD0003 EXOFACTO Hydrocortisone DESCRIPT Hydrocortisone inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) DTD0003 EXOFACTO Hydrocortisone DESCRIPT Hydrocortisone inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Hydrocortisone MOACRIVE Inhibition DTD0003 EXOFACTO Hydrocortisone CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Hydrocortisone CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Hydroxyurea HIGHSTIT Approved Drug DTD0003 EXOFACTO Hydroxyurea DESCRIPT Hydroxyurea induces the activity of ABCB1 DTD0003 EXOFACTO Hydroxyurea MOACRIVE Inducer DTD0003 EXOFACTO Hyperforin HIGHSTIT Investigative Drug DTD0003 EXOFACTO Hyperforin DESCRIPT Hyperforin inhibits the transportation of Ritonavir by ABCB1 DTD0003 EXOFACTO Hyperforin DESCRIPT Hyperforin induces the activity of ABCB1 DTD0003 EXOFACTO Hyperforin MOACRIVE Inhibition DTD0003 EXOFACTO Hyperforin MOACRIVE Inducer DTD0003 EXOFACTO Hyperforin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Hyperforin CELLLINE Human gastrointestinal epithelial cell line (LS-180)-MDR1 DTD0003 EXOFACTO Hypericin HIGHSTIT Natural Product DTD0003 EXOFACTO Hypericin DESCRIPT Hypericin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 247 microM) DTD0003 EXOFACTO Hypericin DESCRIPT Hypericin induces the activity of ABCB1 DTD0003 EXOFACTO Hypericin MOACRIVE Inhibition DTD0003 EXOFACTO Hypericin MOACRIVE Inducer DTD0003 EXOFACTO Hypericin CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Hypericin CELLLINE Human gastrointestinal epithelial cell line (LS-180)-MDR1 DTD0003 EXOFACTO Hypericum perforatum HIGHSTIT Natural Product DTD0003 EXOFACTO Hypericum perforatum DESCRIPT Hypericum perforatum induces the transportation of Amitriptyline by ABCB1 DTD0003 EXOFACTO Hypericum perforatum MOACRIVE Inducer DTD0003 EXOFACTO Hypericum perforatum CELLLINE Depression patients DTD0003 EXOFACTO Icaritin HIGHSTIT Drug in Phase 2 Trial DTD0003 EXOFACTO Icaritin DESCRIPT Icaritin inhibits the activity of ABCB1 DTD0003 EXOFACTO Icaritin MOACRIVE Inhibition DTD0003 EXOFACTO Icaritin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Indinavir MOACRIVE Inhibition DTD0003 EXOFACTO Indinavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0003 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the activity of ABCB1 DTD0003 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0003 EXOFACTO Insulin HIGHSTIT Approved Drug DTD0003 EXOFACTO Insulin DESCRIPT Insulin inhibits the activity of ABCB1 DTD0003 EXOFACTO Insulin MOACRIVE Inhibition DTD0003 EXOFACTO Isavuconazole HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Isavuconazole DESCRIPT Isavuconazole inhibits the activity of ABCB1 DTD0003 EXOFACTO Isavuconazole MOACRIVE Inhibition DTD0003 EXOFACTO Isradipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Isradipine DESCRIPT Isradipine inhibits the activity of ABCB1 DTD0003 EXOFACTO Isradipine MOACRIVE Inhibition DTD0003 EXOFACTO Istradefylline HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Istradefylline DESCRIPT Istradefylline inhibits the transportation of Atorvastatin by ABCB1 DTD0003 EXOFACTO Istradefylline MOACRIVE Inhibition DTD0003 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 2 microM) DTD0003 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.95 microM) DTD0003 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0003 EXOFACTO Itraconazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Itraconazole CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Ivacaftor HIGHSTIT Approved Drug DTD0003 EXOFACTO Ivacaftor DESCRIPT Ivacaftor inhibits the activity of ABCB1 DTD0003 EXOFACTO Ivacaftor MOACRIVE Inhibition DTD0003 EXOFACTO Kaempferol HIGHSTIT Investigative Drug DTD0003 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Ritonavir by ABCB1 (IC50 = 146.7 microM) DTD0003 EXOFACTO Kaempferol MOACRIVE Inhibition DTD0003 EXOFACTO Kaempferol CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Vinblastine by ABCB1 (IC50 = 6.34 microM) DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 5.6 microM) DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 3.07 microM) DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.34 microM) DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Colchicine by ABCB1 (IC50 = 5.49 microM) DTD0003 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of ABCB1 DTD0003 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0003 EXOFACTO Ketoconazole CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Ketoconazole CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Ketoconazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Lapatinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Lapatinib DESCRIPT Lapatinib inhibits the activity of ABCB1 DTD0003 EXOFACTO Lapatinib MOACRIVE Inhibition DTD0003 EXOFACTO Ledipasvir HIGHSTIT Approved Drug DTD0003 EXOFACTO Ledipasvir DESCRIPT Ledipasvir inhibits the activity of ABCB1 DTD0003 EXOFACTO Ledipasvir MOACRIVE Inhibition DTD0003 EXOFACTO Liothyronine HIGHSTIT Approved Drug DTD0003 EXOFACTO Liothyronine DESCRIPT Liothyronine induces the activity of ABCB1 DTD0003 EXOFACTO Liothyronine MOACRIVE Inducer DTD0003 EXOFACTO Liothyronine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Lomerizine HIGHSTIT Approved Drug DTD0003 EXOFACTO Lomerizine DESCRIPT Lomerizine inhibits the transportation of Calcein by ABCB1 DTD0003 EXOFACTO Lomerizine MOACRIVE Inhibition DTD0003 EXOFACTO Lomerizine CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Lomitapide HIGHSTIT Approved Drug DTD0003 EXOFACTO Lomitapide DESCRIPT Lomitapide inhibits the activity of ABCB1 DTD0003 EXOFACTO Lomitapide MOACRIVE Inhibition DTD0003 EXOFACTO Loperamide HIGHSTIT Approved Drug DTD0003 EXOFACTO Loperamide DESCRIPT Loperamide inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Loperamide MOACRIVE Inhibition DTD0003 EXOFACTO Loperamide CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0003 EXOFACTO Lopinavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0003 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 11.4 microM) DTD0003 EXOFACTO Loratadine MOACRIVE Inhibition DTD0003 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 114.4 microM) DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of LDS-751 by ABCB1 (IC50 = 32.7 microM) DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Calcein AM by ABCB1 (IC50 = 10 +/- 4 microM) DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 67 microM) DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 26 microM) DTD0003 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0003 EXOFACTO Lovastatin CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Lovastatin CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Lovastatin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Malvidin-3-galactoside HIGHSTIT Natural Product DTD0003 EXOFACTO Malvidin-3-galactoside DESCRIPT Malvidin-3-galactoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Malvidin-3-galactoside MOACRIVE Inhibition DTD0003 EXOFACTO Malvidin-3-galactoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0003 EXOFACTO Malvidin-3-glucoside HIGHSTIT Natural Product DTD0003 EXOFACTO Malvidin-3-glucoside DESCRIPT Malvidin-3-glucoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Malvidin-3-glucoside MOACRIVE Inhibition DTD0003 EXOFACTO Malvidin-3-glucoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0003 EXOFACTO Maprotiline HIGHSTIT Approved Drug DTD0003 EXOFACTO Maprotiline DESCRIPT Maprotiline inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Maprotiline MOACRIVE Inhibition DTD0003 EXOFACTO Maprotiline CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Mebendazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Mebendazole DESCRIPT Mebendazole inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Mebendazole MOACRIVE Inhibition DTD0003 EXOFACTO Mebendazole CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0003 EXOFACTO Metformin DESCRIPT Metformin inhibits the activity of ABCB1 DTD0003 EXOFACTO Metformin MOACRIVE Inhibition DTD0003 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0003 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of Verapamil by ABCB1 (Ki = 200 microM) DTD0003 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0003 EXOFACTO Metoprolol CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0003 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCB1 DTD0003 EXOFACTO Micafungin MOACRIVE Inhibition DTD0003 EXOFACTO Miconazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Miconazole DESCRIPT Miconazole inhibits the transportation of Vinblastine by ABCB1 (Ki = 26.36 microM) DTD0003 EXOFACTO Miconazole DESCRIPT Miconazole inhibits the transportation of Calcein AM by ABCB1 (Ki = 55.5 microM) DTD0003 EXOFACTO Miconazole DESCRIPT Miconazole inhibits the transportation of Calcein AM by ABCB1 (IC50 = 3.5 microM) DTD0003 EXOFACTO Miconazole DESCRIPT Miconazole inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Miconazole MOACRIVE Inhibition DTD0003 EXOFACTO Miconazole CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Miconazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Midazolam HIGHSTIT Approved Drug DTD0003 EXOFACTO Midazolam DESCRIPT Midazolam induces the activity of ABCB1 DTD0003 EXOFACTO Midazolam MOACRIVE Inducer DTD0003 EXOFACTO Miltirone HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Miltirone DESCRIPT Miltirone inhibits the transportation of Doxorubicin by ABCB1 DTD0003 EXOFACTO Miltirone MOACRIVE Inhibition DTD0003 EXOFACTO Miltirone CELLLINE Human hepatoma HepaRG cells-MDR1 DTD0003 EXOFACTO Mirabegron HIGHSTIT Approved Drug DTD0003 EXOFACTO Mirabegron DESCRIPT Mirabegron inhibits the activity of ABCB1 DTD0003 EXOFACTO Mirabegron MOACRIVE Inhibition DTD0003 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0003 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone induces the activity of ABCB1 DTD0003 EXOFACTO Mitoxantrone MOACRIVE Inducer DTD0003 EXOFACTO Morphine HIGHSTIT Approved Drug DTD0003 EXOFACTO Morphine DESCRIPT Morphine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 50 microM) DTD0003 EXOFACTO Morphine DESCRIPT Morphine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Morphine MOACRIVE Inhibition DTD0003 EXOFACTO Morphine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Morphine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Naproxen HIGHSTIT Approved Drug DTD0003 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the activity of ABCB1 DTD0003 EXOFACTO Naproxen MOACRIVE Inhibition DTD0003 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0003 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Talinolol by ABCB1 (IC50 = 2409 microM) DTD0003 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Naringenin MOACRIVE Inhibition DTD0003 EXOFACTO Naringenin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Naringenin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Naringin HIGHSTIT Investigative Drug DTD0003 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Talinolol by ABCB1 (IC50 = 236 microM) DTD0003 EXOFACTO Naringin MOACRIVE Inhibition DTD0003 EXOFACTO Naringin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Nefazodone HIGHSTIT Approved Drug DTD0003 EXOFACTO Nefazodone DESCRIPT Nefazodone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 4.7 microM) DTD0003 EXOFACTO Nefazodone MOACRIVE Inhibition DTD0003 EXOFACTO Nefazodone CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Negundoside HIGHSTIT Natural Product DTD0003 EXOFACTO Negundoside DESCRIPT Negundoside induces the activity of ABCB1 DTD0003 EXOFACTO Negundoside MOACRIVE Inducer DTD0003 EXOFACTO Negundoside CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Nelfinavir DESCRIPT Nelfinavir induces the activity of ABCB1 DTD0003 EXOFACTO Nelfinavir MOACRIVE Inducer DTD0003 EXOFACTO Nifedipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 472 microM) DTD0003 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 113 microM) DTD0003 EXOFACTO Nifedipine DESCRIPT Nifedipine induces the activity of ABCB1 DTD0003 EXOFACTO Nifedipine MOACRIVE Inhibition DTD0003 EXOFACTO Nifedipine MOACRIVE Inducer DTD0003 EXOFACTO Nifedipine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Nifedipine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Nifedipine CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Nilotinib HIGHSTIT Approved Drug DTD0003 EXOFACTO Nilotinib DESCRIPT Nilotinib inhibits the activity of ABCB1 DTD0003 EXOFACTO Nilotinib MOACRIVE Inhibition DTD0003 EXOFACTO Nisoldipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Nisoldipine DESCRIPT Nisoldipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 44.1 microM) DTD0003 EXOFACTO Nisoldipine MOACRIVE Inhibition DTD0003 EXOFACTO Nisoldipine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Nitrendipine HIGHSTIT Approved Drug DTD0003 EXOFACTO Nitrendipine DESCRIPT Nitrendipine inhibits the transportation of Digoxin by ABCB1 (IC50 = 68.2 microM) DTD0003 EXOFACTO Nitrendipine DESCRIPT Nitrendipine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Nitrendipine MOACRIVE Inhibition DTD0003 EXOFACTO Nitrendipine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Nitrendipine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Nobiletin HIGHSTIT Natural Product DTD0003 EXOFACTO Nobiletin DESCRIPT Nobiletin inhibits the activity of ABCB1 DTD0003 EXOFACTO Nobiletin MOACRIVE Inhibition DTD0003 EXOFACTO Nobiletin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) HIGHSTIT Environmental toxicant DTD0003 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) DESCRIPT O,p'-DDT inhibits the transportation of Verapamil by ABCB1 (IC50 = 7.8 microM) DTD0003 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) MOACRIVE Inhibition DTD0003 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) CELLLINE Spodoptera frugiperda (Sf9) cells-MDR1 DTD0003 EXOFACTO Oleanolic acid HIGHSTIT Natural Product DTD0003 EXOFACTO Oleanolic acid DESCRIPT Oleanolic acid induces the activity of ABCB1 DTD0003 EXOFACTO Oleanolic acid MOACRIVE Inducer DTD0003 EXOFACTO Oleanolic acid CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.7 microM) DTD0003 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0003 EXOFACTO Omeprazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Ouabain HIGHSTIT Approved Drug DTD0003 EXOFACTO Ouabain DESCRIPT Ouabain induces the activity of ABCB1 DTD0003 EXOFACTO Ouabain MOACRIVE Inducer DTD0003 EXOFACTO Oxycodone HIGHSTIT Approved Drug DTD0003 EXOFACTO Oxycodone DESCRIPT Oxycodone induces the activity of ABCB1 DTD0003 EXOFACTO Oxycodone MOACRIVE Inducer DTD0003 EXOFACTO Oxytetracycline HIGHSTIT Approved Drug DTD0003 EXOFACTO Oxytetracycline DESCRIPT Oxytetracycline induces the activity of ABCB1 DTD0003 EXOFACTO Oxytetracycline MOACRIVE Inducer DTD0003 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) HIGHSTIT Environmental toxicant DTD0003 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) DESCRIPT p,p'-DDE inhibits the transportation of Verapamil by ABCB1 DTD0003 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) MOACRIVE Inhibition DTD0003 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) CELLLINE Spodoptera frugiperda (Sf9) cells-MDR1 DTD0003 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) HIGHSTIT Environmental toxicant DTD0003 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) DESCRIPT p,p'-DDT inhibits the transportation of Verapamil by ABCB1 (IC50 = 3.8 microM) DTD0003 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) MOACRIVE Inhibition DTD0003 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) CELLLINE Spodoptera frugiperda (Sf9) cells-MDR1 DTD0003 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) HIGHSTIT Environmental toxicant DTD0003 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) DESCRIPT p,p'-DDD inhibits the transportation of Verapamil by ABCB1 (IC50 = 10.7 microM) DTD0003 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) MOACRIVE Inhibition DTD0003 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) CELLLINE Spodoptera frugiperda (Sf9) cells-MDR1 DTD0003 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0003 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 54 microM) DTD0003 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0003 EXOFACTO Paclitaxel CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Pantoprazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.9 microM) DTD0003 EXOFACTO Pantoprazole MOACRIVE Inhibition DTD0003 EXOFACTO Pantoprazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0003 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the transportation of Calcein by ABCB1 (IC50 = 29.8 microM) DTD0003 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0003 EXOFACTO PEG 300 HIGHSTIT Pharmaceutical excipient DTD0003 EXOFACTO PEG 300 DESCRIPT PEG 300 inhibits the transportation of Ranitidine by ABCB1 DTD0003 EXOFACTO PEG 300 MOACRIVE Inhibition DTD0003 EXOFACTO PEG 300 CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO PEG 400 HIGHSTIT Pharmaceutical excipient DTD0003 EXOFACTO PEG 400 DESCRIPT PEG 400 inhibits the transportation of Ranitidine by ABCB1 DTD0003 EXOFACTO PEG 400 MOACRIVE Inhibition DTD0003 EXOFACTO PEG 400 CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Pelargonidin-3,5-diglucoside HIGHSTIT Natural Product DTD0003 EXOFACTO Pelargonidin-3,5-diglucoside DESCRIPT Pelargonidin-3,5-diglucoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Pelargonidin-3,5-diglucoside MOACRIVE Inhibition DTD0003 EXOFACTO Pelargonidin-3,5-diglucoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0003 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0003 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of ABCB1 DTD0003 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0003 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0003 EXOFACTO Phenytoin DESCRIPT Phenytoin induces the activity of ABCB1 DTD0003 EXOFACTO Phenytoin MOACRIVE Inducer DTD0003 EXOFACTO Phosalone HIGHSTIT Natural Product DTD0003 EXOFACTO Phosalone DESCRIPT Phosalone inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) DTD0003 EXOFACTO Phosalone MOACRIVE Inhibition DTD0003 EXOFACTO Phosalone CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Pibrentasvir HIGHSTIT Approved Drug DTD0003 EXOFACTO Pibrentasvir DESCRIPT Pibrentasvir inhibits the activity of ABCB1 DTD0003 EXOFACTO Pibrentasvir MOACRIVE Inhibition DTD0003 EXOFACTO Picroside-I HIGHSTIT Natural Product DTD0003 EXOFACTO Picroside-I DESCRIPT Picroside-I induces the activity of ABCB1 DTD0003 EXOFACTO Picroside-I MOACRIVE Inducer DTD0003 EXOFACTO Picroside-I CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Picroside-II HIGHSTIT Natural Product DTD0003 EXOFACTO Picroside-II DESCRIPT Picroside-II inhibits the activity of ABCB1 DTD0003 EXOFACTO Picroside-II MOACRIVE Inhibition DTD0003 EXOFACTO Picroside-II CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Pimozide HIGHSTIT Approved Drug DTD0003 EXOFACTO Pimozide DESCRIPT Pimozide inhibits the transportation of Calcein AM by ABCB1 (IC50 = 2.9 microM) DTD0003 EXOFACTO Pimozide DESCRIPT Pimozide inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Pimozide MOACRIVE Inhibition DTD0003 EXOFACTO Pimozide CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Pimozide CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Piperine HIGHSTIT Natural Product DTD0003 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.5 microM) DTD0003 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Cyclosporine A by ABCB1 (IC50 = 74.1 microM) DTD0003 EXOFACTO Piperine DESCRIPT Piperine induces the transportation of Diltiazem by inducing ABCB1 expression DTD0003 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Fexofenadine by ABCB1 DTD0003 EXOFACTO Piperine DESCRIPT Piperine induces the activity of ABCB1 DTD0003 EXOFACTO Piperine MOACRIVE Inhibition DTD0003 EXOFACTO Piperine MOACRIVE Inducer DTD0003 EXOFACTO Piperine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Piperine CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Piperine CELLLINE Multiple cell lines of human DTD0003 EXOFACTO Piperine (high concentration) HIGHSTIT Natural Product DTD0003 EXOFACTO Piperine (high concentration) DESCRIPT Piperine (high concentration) inhibits the activity of ABCB1 DTD0003 EXOFACTO Piperine (high concentration) MOACRIVE Inhibition DTD0003 EXOFACTO Piperine (high concentration) CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Posaconazole HIGHSTIT Approved Drug DTD0003 EXOFACTO Posaconazole DESCRIPT Posaconazole inhibits the activity of ABCB1 DTD0003 EXOFACTO Posaconazole MOACRIVE Inhibition DTD0003 EXOFACTO Prednisone HIGHSTIT Approved Drug DTD0003 EXOFACTO Prednisone DESCRIPT Prednisone inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Prednisone MOACRIVE Inhibition DTD0003 EXOFACTO Prednisone CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0003 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of ABCB1 DTD0003 EXOFACTO Probenecid MOACRIVE Inhibition DTD0003 EXOFACTO Prochlorperazine HIGHSTIT Approved Drug DTD0003 EXOFACTO Prochlorperazine DESCRIPT Prochlorperazine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Prochlorperazine MOACRIVE Inhibition DTD0003 EXOFACTO Prochlorperazine CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 192.2 microM) DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of LDS-751 by ABCB1 (IC50 = 88.1 microM) DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 96.2 microM) DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Cortisol by ABCB1 DTD0003 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Vinblastine by ABCB1 DTD0003 EXOFACTO Progesterone MOACRIVE Inhibition DTD0003 EXOFACTO Progesterone CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Progesterone CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Progesterone CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Promethazine HIGHSTIT Approved Drug DTD0003 EXOFACTO Promethazine DESCRIPT Promethazine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Promethazine MOACRIVE Inhibition DTD0003 EXOFACTO Promethazine CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0003 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of ABCB1 DTD0003 EXOFACTO Propafenone MOACRIVE Inhibition DTD0003 EXOFACTO Propiconazole HIGHSTIT Natural Product DTD0003 EXOFACTO Propiconazole DESCRIPT Propiconazole inhibits the transportation of Verapamil by ABCB1 (IC50 = 1.5 microM) DTD0003 EXOFACTO Propiconazole MOACRIVE Inhibition DTD0003 EXOFACTO Propiconazole CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Protopanaxatriol ginsenoside HIGHSTIT Natural Product DTD0003 EXOFACTO Protopanaxatriol ginsenoside DESCRIPT Protopanaxatriol ginsenoside inhibits the activity of ABCB1 DTD0003 EXOFACTO Protopanaxatriol ginsenoside MOACRIVE Inhibition DTD0003 EXOFACTO Protopanaxatriol ginsenoside CELLLINE Doxorubicin-resistant Acute myelogenous leukemia cell line (AML-2/D100)-MDR1 DTD0003 EXOFACTO Protriptyline HIGHSTIT Approved Drug DTD0003 EXOFACTO Protriptyline DESCRIPT Protriptyline inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Protriptyline MOACRIVE Inhibition DTD0003 EXOFACTO Protriptyline CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Pyrethroids HIGHSTIT Natural Product DTD0003 EXOFACTO Pyrethroids DESCRIPT Pyrethroids inhibits the transportation of Verapamil by ABCB1 (IC50 = 65.5 microM) DTD0003 EXOFACTO Pyrethroids MOACRIVE Inhibition DTD0003 EXOFACTO Pyrethroids CELLLINE Human embryonic kidney 293 cells (HEK293)-MDR1 DTD0003 EXOFACTO Pyronaridine HIGHSTIT Approved Drug DTD0003 EXOFACTO Pyronaridine DESCRIPT Pyronaridine inhibits the transportation of doxorubicin by ABCB1 DTD0003 EXOFACTO Pyronaridine DESCRIPT Pyronaridine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Pyronaridine MOACRIVE Inhibition DTD0003 EXOFACTO Pyronaridine CELLLINE Human breast adenocarcinoma cell line (MCF-7)/ADR DTD0003 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0003 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Ritonavir by ABCB1 (IC50 = 26.4 microM) DTD0003 EXOFACTO Quercetin DESCRIPT Quercetin induces the transportation of Ritonavir by ABCB1 DTD0003 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Quercetin MOACRIVE Inhibition DTD0003 EXOFACTO Quercetin MOACRIVE Inducer DTD0003 EXOFACTO Quercetin CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Quercetin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Quercetin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Quinidine HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Quinidine DESCRIPT Quinidine inhibits the activity of ABCB1 DTD0003 EXOFACTO Quinidine MOACRIVE Inhibition DTD0003 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 22.9 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (Ki = 8.59 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (Ki = 3.23 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 22.4 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 14.9 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 9.52 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Digoxin by ABCB1 (IC50 = 9.4 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Colchicine by ABCB1 (IC50 = 51.7 microM) DTD0003 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Quinine MOACRIVE Inhibition DTD0003 EXOFACTO Quinine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Quinine CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Quinine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Quinine CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Quinine CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Ranolazine HIGHSTIT Approved Drug DTD0003 EXOFACTO Ranolazine DESCRIPT Ranolazine inhibits the activity of ABCB1 DTD0003 EXOFACTO Ranolazine MOACRIVE Inhibition DTD0003 EXOFACTO Reboxetine HIGHSTIT Approved Drug DTD0003 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of Calcein by ABCB1 DTD0003 EXOFACTO Reboxetine MOACRIVE Inhibition DTD0003 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0003 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Repaglinide MOACRIVE Inhibition DTD0003 EXOFACTO Repaglinide CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Rescinnamine HIGHSTIT Approved Drug DTD0003 EXOFACTO Rescinnamine DESCRIPT Rescinnamine induces the activity of ABCB1 DTD0003 EXOFACTO Rescinnamine MOACRIVE Inducer DTD0003 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0003 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Digoxin by ABCB1 (Ki = 1.38 microM) DTD0003 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Reserpine DESCRIPT Reserpine induces the activity of ABCB1 DTD0003 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the activity of ABCB1 DTD0003 EXOFACTO Reserpine MOACRIVE Inhibition DTD0003 EXOFACTO Reserpine MOACRIVE Inducer DTD0003 EXOFACTO Reserpine CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Reserpine CELLLINE Human breast adenocarcinoma cell line (MCF-7)-MDR1 DTD0003 EXOFACTO Reserpine CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0003 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Azidopine by ABCB1 DTD0003 EXOFACTO Rifampicin DESCRIPT Rifampicin induces the activity of ABCB1 DTD0003 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0003 EXOFACTO Rifampicin MOACRIVE Inducer DTD0003 EXOFACTO Rifampicin CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Rifampicin CELLLINE Human colon carcinoma cell lines (LS174T)-MDR1 DTD0003 EXOFACTO Rifaximin HIGHSTIT Approved Drug DTD0003 EXOFACTO Rifaximin DESCRIPT Rifaximin inhibits the activity of ABCB1 DTD0003 EXOFACTO Rifaximin MOACRIVE Inhibition DTD0003 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 5 microM) DTD0003 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 28.2 microM) DTD0003 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Digoxin by ABCB1 (IC50 = 3.8 microM) DTD0003 EXOFACTO Ritonavir DESCRIPT Ritonavir induces the activity of ABCB1 DTD0003 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0003 EXOFACTO Ritonavir MOACRIVE Inducer DTD0003 EXOFACTO Ritonavir CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Ritonavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Rolapitant HIGHSTIT Approved Drug DTD0003 EXOFACTO Rolapitant DESCRIPT Rolapitant inhibits the activity of ABCB1 DTD0003 EXOFACTO Rolapitant MOACRIVE Inhibition DTD0003 EXOFACTO Roxithromycin HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Roxithromycin DESCRIPT Roxithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.4 microM) DTD0003 EXOFACTO Roxithromycin MOACRIVE Inhibition DTD0003 EXOFACTO Roxithromycin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Rutin HIGHSTIT Natural Product DTD0003 EXOFACTO Rutin DESCRIPT Rutin inhibits the activity of ABCB1 DTD0003 EXOFACTO Rutin MOACRIVE Inhibition DTD0003 EXOFACTO Rutin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Santonin HIGHSTIT Natural Product DTD0003 EXOFACTO Santonin DESCRIPT Santonin inhibits the activity of ABCB1 DTD0003 EXOFACTO Santonin MOACRIVE Inhibition DTD0003 EXOFACTO Santonin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0003 EXOFACTO Saquinavir DESCRIPT Saquinavir induces the activity of ABCB1 DTD0003 EXOFACTO Saquinavir MOACRIVE Inducer DTD0003 EXOFACTO Schisandra chinensis extract HIGHSTIT Natural Product DTD0003 EXOFACTO Schisandra chinensis extract DESCRIPT Schisandra chinensis extract inhibits the transportation of Talinolol by ABCB1 DTD0003 EXOFACTO Schisandra chinensis extract MOACRIVE Inhibition DTD0003 EXOFACTO Schisandra chinensis extract CELLLINE Healthy people DTD0003 EXOFACTO Sertindole HIGHSTIT Drug Withdrawn DTD0003 EXOFACTO Sertindole DESCRIPT Sertindole inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Sertindole MOACRIVE Inhibition DTD0003 EXOFACTO Sertindole CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0003 EXOFACTO Sertraline HIGHSTIT Approved Drug DTD0003 EXOFACTO Sertraline DESCRIPT Sertraline inhibits the transportation of Calcein by ABCB1 (IC50 = 31.8 microM) DTD0003 EXOFACTO Sertraline MOACRIVE Inhibition DTD0003 EXOFACTO Sesamin HIGHSTIT Natural Product DTD0003 EXOFACTO Sesamin DESCRIPT Sesamin inhibits the transportation of Rhodamine 123 by significantly increasing the mRNA expression of ABCB1 DTD0003 EXOFACTO Sesamin MOACRIVE Inhibition DTD0003 EXOFACTO Sesamin CELLLINE Human colon carcinoma LS-180 cells (LS-180V)-MDR1 DTD0003 EXOFACTO Sesquiterpene HIGHSTIT Approved Drug DTD0003 EXOFACTO Sesquiterpene DESCRIPT Sesquiterpene inhibits the transportation of Colchicine by ABCB1 DTD0003 EXOFACTO Sesquiterpene MOACRIVE Inhibition DTD0003 EXOFACTO Silibinin HIGHSTIT Drug in Phase 2/3 Trial DTD0003 EXOFACTO Silibinin DESCRIPT Silibinin inhibits the transportation of Ritonavir by ABCB1 DTD0003 EXOFACTO Silibinin MOACRIVE Inhibition DTD0003 EXOFACTO Silibinin CELLLINE Madin darby canine kidney strain cell line (MDCK)-MDR1 DTD0003 EXOFACTO Simeprevir HIGHSTIT Approved Drug DTD0003 EXOFACTO Simeprevir DESCRIPT Simeprevir inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Simeprevir MOACRIVE Inhibition DTD0003 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0003 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Calcein AM by ABCB1 (IC50 = 10 +/- 8 microM) DTD0003 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0003 EXOFACTO Simvastatin CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Sirolimus HIGHSTIT Approved Drug DTD0003 EXOFACTO Sirolimus DESCRIPT Sirolimus induces the activity of ABCB1 DTD0003 EXOFACTO Sirolimus MOACRIVE Inducer DTD0003 EXOFACTO St Johns wort extract HIGHSTIT Natural Product DTD0003 EXOFACTO St Johns wort extract DESCRIPT St Johns wort extract inhibits the transportation of Digoxin by ABCB1 (IC50 = 15.4 microM) DTD0003 EXOFACTO St Johns wort extract DESCRIPT St Johns wort extract induces the transportation of Digoxin by increasing the expression of ABCB1 DTD0003 EXOFACTO St Johns wort extract MOACRIVE Inhibition DTD0003 EXOFACTO St Johns wort extract MOACRIVE Inducer DTD0003 EXOFACTO St Johns wort extract CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO St Johns wort extract CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Sufentanil HIGHSTIT Approved Drug DTD0003 EXOFACTO Sufentanil DESCRIPT Sufentanil inhibits the transportation of Digoxin by ABCB1 (IC50 = 4.5 microM) DTD0003 EXOFACTO Sufentanil MOACRIVE Inhibition DTD0003 EXOFACTO Sufentanil CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Suvorexant HIGHSTIT Approved Drug DTD0003 EXOFACTO Suvorexant DESCRIPT Suvorexant inhibits the activity of ABCB1 DTD0003 EXOFACTO Suvorexant MOACRIVE Inhibition DTD0003 EXOFACTO Tacrolimus HIGHSTIT Approved Drug DTD0003 EXOFACTO Tacrolimus DESCRIPT Tacrolimus induces the activity of ABCB1 DTD0003 EXOFACTO Tacrolimus MOACRIVE Inducer DTD0003 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0003 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 7.1 microM) DTD0003 EXOFACTO Tamoxifen DESCRIPT Tamoxifen induces the activity of ABCB1 DTD0003 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0003 EXOFACTO Tamoxifen MOACRIVE Inducer DTD0003 EXOFACTO Tamoxifen CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Tangeretin HIGHSTIT Natural Product DTD0003 EXOFACTO Tangeretin DESCRIPT Tangeretin inhibits the activity of ABCB1 DTD0003 EXOFACTO Tangeretin MOACRIVE Inhibition DTD0003 EXOFACTO Tangeretin CELLLINE Model organism in vivo (rat) DTD0003 EXOFACTO Tariquidar HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Tariquidar DESCRIPT Tariquidar inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Tariquidar DESCRIPT Tariquidar inhibits the activity of ABCB1 DTD0003 EXOFACTO Tariquidar MOACRIVE Inhibition DTD0003 EXOFACTO Tariquidar CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0003 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the transportation of Calcein by ABCB1 DTD0003 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of ABCB1 DTD0003 EXOFACTO Telaprevir MOACRIVE Inhibition DTD0003 EXOFACTO Telithromycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Telithromycin DESCRIPT Telithromycin inhibits the transportation of Digoxin by ABCB1 (IC50 = 1.8 microM) DTD0003 EXOFACTO Telithromycin MOACRIVE Inhibition DTD0003 EXOFACTO Telithromycin CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0003 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the activity of ABCB1 DTD0003 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0003 EXOFACTO Tetracaine HIGHSTIT Approved Drug DTD0003 EXOFACTO Tetracaine DESCRIPT Tetracaine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Tetracaine MOACRIVE Inhibition DTD0003 EXOFACTO Tetracaine CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Tetrahydrocurcumin HIGHSTIT Natural Product DTD0003 EXOFACTO Tetrahydrocurcumin DESCRIPT Tetrahydrocurcumin inhibits the activity of ABCB1 DTD0003 EXOFACTO Tetrahydrocurcumin MOACRIVE Inhibition DTD0003 EXOFACTO Tetrahydrocurcumin CELLLINE Multidrug-resistant subclone KB-V-1 cells DTD0003 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0003 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Verapamil by ABCB1 (IC50 = 100 microM) DTD0003 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0003 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-MDR1 DTD0003 EXOFACTO Tetrandine HIGHSTIT Natural Product DTD0003 EXOFACTO Tetrandine DESCRIPT Tetrandine inhibits the transportation of Verapamil by ABCB1 DTD0003 EXOFACTO Tetrandine MOACRIVE Inhibition DTD0003 EXOFACTO Tetrandine CELLLINE Human colon adenocarcinoma cell line (HCT15)-MDR1 DTD0003 EXOFACTO Ticagrelor HIGHSTIT Approved Drug DTD0003 EXOFACTO Ticagrelor DESCRIPT Ticagrelor inhibits the activity of ABCB1 DTD0003 EXOFACTO Ticagrelor MOACRIVE Inhibition DTD0003 EXOFACTO Tolvaptan HIGHSTIT Approved Drug DTD0003 EXOFACTO Tolvaptan DESCRIPT Tolvaptan inhibits the activity of ABCB1 DTD0003 EXOFACTO Tolvaptan MOACRIVE Inhibition DTD0003 EXOFACTO Trabectedin HIGHSTIT Drug in Phase 3 Trial DTD0003 EXOFACTO Trabectedin DESCRIPT Trabectedin inhibits the activity of ABCB1 DTD0003 EXOFACTO Trabectedin MOACRIVE Inhibition DTD0003 EXOFACTO Trazodone HIGHSTIT Approved Drug DTD0003 EXOFACTO Trazodone DESCRIPT Trazodone induces the activity of ABCB1 DTD0003 EXOFACTO Trazodone MOACRIVE Inducer DTD0003 EXOFACTO Tretinoin HIGHSTIT Approved Drug DTD0003 EXOFACTO Tretinoin DESCRIPT Tretinoin induces the activity of ABCB1 DTD0003 EXOFACTO Tretinoin MOACRIVE Inducer DTD0003 EXOFACTO Trifluoperazine HIGHSTIT Approved Drug DTD0003 EXOFACTO Trifluoperazine DESCRIPT Trifluoperazine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 10.9 microM) DTD0003 EXOFACTO Trifluoperazine DESCRIPT Trifluoperazine inhibits the transportation of LDS-751 by ABCB1 (IC50 = 6.3 microM) DTD0003 EXOFACTO Trifluoperazine DESCRIPT Trifluoperazine inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 7.2 microM) DTD0003 EXOFACTO Trifluoperazine DESCRIPT Trifluoperazine inhibits the activity of ABCB1 DTD0003 EXOFACTO Trifluoperazine MOACRIVE Inhibition DTD0003 EXOFACTO Trifluoperazine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Trimipramine HIGHSTIT Approved Drug DTD0003 EXOFACTO Trimipramine DESCRIPT Trimipramine inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Trimipramine MOACRIVE Inhibition DTD0003 EXOFACTO Trimipramine CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Troleandomycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Troleandomycin DESCRIPT Troleandomycin inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 86.3 microM) DTD0003 EXOFACTO Troleandomycin DESCRIPT Troleandomycin inhibits the transportation of Vinblastine by ABCB1 (Ki = 87.64 microM) DTD0003 EXOFACTO Troleandomycin DESCRIPT Troleandomycin inhibits the transportation of LDS-751 by ABCB1 (IC50 = 78.2 microM) DTD0003 EXOFACTO Troleandomycin DESCRIPT Troleandomycin inhibits the transportation of Calcein AM by ABCB1 (Ki = 483.3 microM) DTD0003 EXOFACTO Troleandomycin DESCRIPT Troleandomycin inhibits the transportation of Daunorubicin by ABCB1 (IC50 = 68.3 microM) DTD0003 EXOFACTO Troleandomycin MOACRIVE Inhibition DTD0003 EXOFACTO Troleandomycin CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Troleandomycin CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0003 EXOFACTO Valproic Acid DESCRIPT Valproic Acid induces the activity of ABCB1 DTD0003 EXOFACTO Valproic Acid MOACRIVE Inducer DTD0003 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Vinblastine by ABCB1 (IC50 = 1.06 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Doxorubicin by ABCB1 (IC50 = 0.291 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.11 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Digoxin by ABCB1 (IC50 = 0.0222 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Verapamil by ABCB1 (Ki = 0.134 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Calcein AM by ABCB1 (Ki = 1.3 microM) DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Cyclosporin A by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Indinavir by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Iodoaryl-azidoprazosin by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of mitoxantrone by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Nelfinavir by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Saquinavir by ABCB1 DTD0003 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Valspodar MOACRIVE Inhibition DTD0003 EXOFACTO Valspodar CELLLINE LLC-PK1 vesicles-MDR1 DTD0003 EXOFACTO Valspodar CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Valspodar CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Valspodar CELLLINE CEM/VLB100 drug-resistant cells-MDR1 DTD0003 EXOFACTO Valspodar CELLLINE Human breast adenocarcinoma cell line (MCF-7)-MDR1 DTD0003 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0003 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of ABCB1 DTD0003 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0003 EXOFACTO Vandetanib HIGHSTIT Approved Drug DTD0003 EXOFACTO Vandetanib DESCRIPT Vandetanib inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Vandetanib MOACRIVE Inhibition DTD0003 EXOFACTO Velpatasvir HIGHSTIT Approved Drug DTD0003 EXOFACTO Velpatasvir DESCRIPT Velpatasvir inhibits the activity of ABCB1 DTD0003 EXOFACTO Velpatasvir MOACRIVE Inhibition DTD0003 EXOFACTO Vemurafenib HIGHSTIT Approved Drug DTD0003 EXOFACTO Vemurafenib DESCRIPT Vemurafenib inhibits the activity of ABCB1 DTD0003 EXOFACTO Vemurafenib MOACRIVE Inhibition DTD0003 EXOFACTO Venlafaxine HIGHSTIT Approved Drug DTD0003 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the transportation of Calcein by ABCB1 DTD0003 EXOFACTO Venlafaxine MOACRIVE Inhibition DTD0003 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Vincristine by ABCB1 (IC50 = 0.2 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Vinblastine by ABCB1 (IC50 = 33.5 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 4.2 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 4.78 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Irinotecan by ABCB1 (Ki = 29 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Fexofenadine by ABCB1 (IC50 = 8.44 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Digoxin by ABCB1 (Ki = 15.1 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Digoxin by ABCB1 (Ki = 8.11 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Digoxin by ABCB1 (IC50 = 10.7 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Colchicine by ABCB1 (IC50 = 17.3 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Paclitaxel by ABCB1 (IC50 = 2.21 microM) DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Calcein AM by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Calcein by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Daunomycin by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Digoxin by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Adriamycin by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Doxorubicin by ABCB1 DTD0003 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the activity of ABCB1 DTD0003 EXOFACTO Verapamil MOACRIVE Inhibition DTD0003 EXOFACTO Verapamil CELLLINE Myelogenous leukemia cell line (K562)-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE Human uterine cancer cells (MES-SA/Dx5) DTD0003 EXOFACTO Verapamil CELLLINE Human enterocyte-like 2 cell (Caco-2)-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE Human colon cancer cell lines (HCT-15)-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE Adriamycin-Resistant Human Ovarian Cancer A2780 cells-MDR1 DTD0003 EXOFACTO Verapamil CELLLINE NIH 3T3 cells-MDR1 DTD0003 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Vinblastine by ABCB1 (IC50 = 89.7 microM) DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Rhodamine 123 by ABCB1 (IC50 = 18 microM) DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Calcein AM by ABCB1 (IC50 = 29 microM) DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Digoxin by ABCB1 (IC50 = 17.8 microM) DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Colchicine by ABCB1 (IC50 = 30.1 microM) DTD0003 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0003 EXOFACTO Vinblastine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MDR1 DTD0003 EXOFACTO Vinblastine CELLLINE NIH-3T3-G185-MDR1 DTD0003 EXOFACTO Vinblastine CELLLINE Madin-Darby Canine Kidney (MDCK) cells-MDR1 DTD0003 EXOFACTO Vincamine HIGHSTIT Approved Drug DTD0003 EXOFACTO Vincamine DESCRIPT Vincamine inhibits the activity of ABCB1 DTD0003 EXOFACTO Vincamine MOACRIVE Inhibition DTD0003 EXOFACTO Vincristine HIGHSTIT Approved Drug DTD0003 EXOFACTO Vincristine DESCRIPT Vincristine induces the activity of ABCB1 DTD0003 EXOFACTO Vincristine MOACRIVE Inducer DTD0003 EXOFACTO Vismodegib HIGHSTIT Approved Drug DTD0003 EXOFACTO Vismodegib DESCRIPT Vismodegib inhibits the activity of ABCB1 DTD0003 EXOFACTO Vismodegib MOACRIVE Inhibition DTD0003 EXOFACTO Xanthohumol HIGHSTIT Natural Product DTD0003 EXOFACTO Xanthohumol DESCRIPT Xanthohumol inhibits the transportation of Tetraethylammonium by ABCB1 DTD0003 EXOFACTO Xanthohumol MOACRIVE Inhibition DTD0003 EXOFACTO Xanthohumol CELLLINE Human enterocyte-like 2 cell (Caco-2); LLC-PK1 vesicles DTD0003 EXOFACTO Yohimbine HIGHSTIT Approved Drug DTD0003 EXOFACTO Yohimbine DESCRIPT Yohimbine induces the activity of ABCB1 DTD0003 EXOFACTO Yohimbine MOACRIVE Inducer DTD0003 EXOFACTO Ziprasidone HIGHSTIT Approved Drug DTD0003 EXOFACTO Ziprasidone DESCRIPT Ziprasidone inhibits the transportation of Rhodamine 123 by ABCB1 DTD0003 EXOFACTO Ziprasidone MOACRIVE Inhibition DTD0003 EXOFACTO Ziprasidone CELLLINE Mouse T-lymphoma L5178-MDR1 DTD0004 TRANSPID DTD0004 DTD0004 GENENAME ABCG2 DTD0004 PROTNAME Breast cancer resistance protein DTD0004 GENEDBID 9429 DTD0004 UNIPROID Q9UNQ0 DTD0004 EXOFACTO Abacavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Abacavir DESCRIPT Abacavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 385 microM) DTD0004 EXOFACTO Abacavir MOACRIVE Inhibition DTD0004 EXOFACTO Abacavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Amprenavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 181 microM) DTD0004 EXOFACTO Amprenavir MOACRIVE Inhibition DTD0004 EXOFACTO Amprenavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Anidulafungin HIGHSTIT Approved Drug DTD0004 EXOFACTO Anidulafungin DESCRIPT Anidulafungin inhibits the transportation of Fluorescent protein by ABCG2 (IC50 = 7 microM) DTD0004 EXOFACTO Anidulafungin MOACRIVE Inhibition DTD0004 EXOFACTO Anidulafungin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Atazanavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 69.1 microM) DTD0004 EXOFACTO Atazanavir MOACRIVE Inhibition DTD0004 EXOFACTO Atazanavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0004 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 14.3 microM) DTD0004 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0004 EXOFACTO Atorvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Atovaquone HIGHSTIT Approved Drug DTD0004 EXOFACTO Atovaquone DESCRIPT Atovaquone inhibits the transportation of Estrone sulphate by ABCG2 (IC50 = 0.23 microM) DTD0004 EXOFACTO Atovaquone MOACRIVE Inhibition DTD0004 EXOFACTO Atovaquone CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Azoxystrobin HIGHSTIT Natural Product DTD0004 EXOFACTO Azoxystrobin DESCRIPT Azoxystrobin inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 1860 microM) DTD0004 EXOFACTO Azoxystrobin MOACRIVE Inhibition DTD0004 EXOFACTO Azoxystrobin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Berry anthocyanins HIGHSTIT Natural Product DTD0004 EXOFACTO Berry anthocyanins DESCRIPT Berry anthocyanins inhibits the activity of ABCG2 (IC50 = 7.8 microM) DTD0004 EXOFACTO Berry anthocyanins MOACRIVE Inhibition DTD0004 EXOFACTO Berry anthocyanins CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Black cohosh extract (1mg/ml) HIGHSTIT Natural Product DTD0004 EXOFACTO Black cohosh extract (1mg/ml) DESCRIPT Black cohosh extract (1mg/ml) inhibits the activity of ABCG2 DTD0004 EXOFACTO Black cohosh extract (1mg/ml) MOACRIVE Inhibition DTD0004 EXOFACTO Black cohosh extract (1mg/ml) CELLLINE Mammalian cells expressing human wild-type BCRP DTD0004 EXOFACTO Calcitriol HIGHSTIT Approved Drug DTD0004 EXOFACTO Calcitriol DESCRIPT Calcitriol inhibits the activity of ABCG2 DTD0004 EXOFACTO Calcitriol MOACRIVE Inhibition DTD0004 EXOFACTO Calcitriol CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Carbendazim HIGHSTIT Environmental toxicant DTD0004 EXOFACTO Carbendazim DESCRIPT Carbendazim inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 525 microM) DTD0004 EXOFACTO Carbendazim MOACRIVE Inhibition DTD0004 EXOFACTO Carbendazim CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Celastrol HIGHSTIT Natural Product DTD0004 EXOFACTO Celastrol DESCRIPT Celastrol inhibits the activity of ABCG2 DTD0004 EXOFACTO Celastrol MOACRIVE Inhibition DTD0004 EXOFACTO Celastrol CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Cerivastatin HIGHSTIT Approved Drug DTD0004 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 18.1 microM) DTD0004 EXOFACTO Cerivastatin MOACRIVE Inhibition DTD0004 EXOFACTO Cerivastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Chlordecone HIGHSTIT Natural Product DTD0004 EXOFACTO Chlordecone DESCRIPT Chlordecone inhibits the transportation of Hoechst 33342 by ABCG2 (IC50 = 90.4 microM) DTD0004 EXOFACTO Chlordecone MOACRIVE Inhibition DTD0004 EXOFACTO Chlordecone CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Chlormequate chloride HIGHSTIT Natural Product DTD0004 EXOFACTO Chlormequate chloride DESCRIPT Chlormequate chloride inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 1260 microM) DTD0004 EXOFACTO Chlormequate chloride MOACRIVE Inhibition DTD0004 EXOFACTO Chlormequate chloride CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Chlorpyrifos HIGHSTIT Natural Product DTD0004 EXOFACTO Chlorpyrifos DESCRIPT Chlorpyrifos inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 285 microM) DTD0004 EXOFACTO Chlorpyrifos MOACRIVE Inhibition DTD0004 EXOFACTO Chlorpyrifos CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Chlorpyrifos-methyl HIGHSTIT Natural Product DTD0004 EXOFACTO Chlorpyrifos-methyl DESCRIPT Chlorpyrifos-methyl inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 31 microM) DTD0004 EXOFACTO Chlorpyrifos-methyl MOACRIVE Inhibition DTD0004 EXOFACTO Chlorpyrifos-methyl CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Chrysoeriol HIGHSTIT Natural Product DTD0004 EXOFACTO Chrysoeriol DESCRIPT Chrysoeriol inhibits the activity of ABCG2 DTD0004 EXOFACTO Chrysoeriol MOACRIVE Inhibition DTD0004 EXOFACTO Chrysoeriol CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0004 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate induces the transportation of Hoechst 33342 by ABCG2 DTD0004 EXOFACTO Cigarette smoke condensate MOACRIVE Inducer DTD0004 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-BCRP DTD0004 EXOFACTO Cinnamic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Cinnamic acid DESCRIPT Cinnamic acid inhibits the transportation of Rosuvastatin by ABCG2 in a competitive manner DTD0004 EXOFACTO Cinnamic acid MOACRIVE Inhibition DTD0004 EXOFACTO Cinnamic acid CELLLINE Madin darby canine kidney strain cell line (MDCK)-BCRP DTD0004 EXOFACTO Clofibrate HIGHSTIT Approved Drug DTD0004 EXOFACTO Clofibrate DESCRIPT Clofibrate induces the activity of ABCG2 DTD0004 EXOFACTO Clofibrate MOACRIVE Inducer DTD0004 EXOFACTO Coumestrol HIGHSTIT Investigative Drug DTD0004 EXOFACTO Coumestrol DESCRIPT Coumestrol inhibits the transportation of Methotrexate by ABCG2 (IC50 = 0.063 microM) DTD0004 EXOFACTO Coumestrol MOACRIVE Inhibition DTD0004 EXOFACTO Curcumin HIGHSTIT Drug in Phase 3 Trial DTD0004 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Pheophorbide by ABCG2 DTD0004 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Resveratrol-3-O-glucuronide by ABCG2 DTD0004 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of Sulfasalazine by ABCG2 DTD0004 EXOFACTO Curcumin MOACRIVE Inhibition DTD0004 EXOFACTO Curcumin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Curcumin CELLLINE Model organism in vivo (mouse) DTD0004 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0004 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of ATPase by ABCG2 (Ki = 0.5 microM) DTD0004 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of ABCG2 DTD0004 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0004 EXOFACTO Cyclosporine CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Dacomitinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Dacomitinib DESCRIPT Dacomitinib inhibits the activity of ABCG2 DTD0004 EXOFACTO Dacomitinib MOACRIVE Inhibition DTD0004 EXOFACTO Daidzein HIGHSTIT Investigative Drug DTD0004 EXOFACTO Daidzein DESCRIPT Daidzein inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Daidzein MOACRIVE Inhibition DTD0004 EXOFACTO Daidzein CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Daunorubicin HIGHSTIT Approved Drug DTD0004 EXOFACTO Daunorubicin DESCRIPT Daunorubicin inhibits the transportation of Estrone sulfate by ABCG2 (IC50 = 59 microM) DTD0004 EXOFACTO Daunorubicin MOACRIVE Inhibition DTD0004 EXOFACTO Daunorubicin CELLLINE Mouse lymphoma (P388) cells-BCRP DTD0004 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0004 EXOFACTO Decitabine DESCRIPT Decitabine inhibits DNA methyltransferase, which then enhances Novobiocin's transportation via downregulating the hypermethylation in ABCG2's promoter DTD0004 EXOFACTO Decitabine MOACRIVE Inducer DTD0004 EXOFACTO Decitabine CELLLINE Human small cell lung cancer cells (PC-6) DTD0004 EXOFACTO Delavirdine HIGHSTIT Approved Drug DTD0004 EXOFACTO Delavirdine DESCRIPT Delavirdine inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 18.7 microM) DTD0004 EXOFACTO Delavirdine MOACRIVE Inhibition DTD0004 EXOFACTO Delavirdine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0004 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of ABCG2 DTD0004 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0004 EXOFACTO Diflufenican HIGHSTIT Natural Product DTD0004 EXOFACTO Diflufenican DESCRIPT Diflufenican inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 13 microM) DTD0004 EXOFACTO Diflufenican MOACRIVE Inhibition DTD0004 EXOFACTO Diflufenican CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Dimethoate HIGHSTIT Natural Product DTD0004 EXOFACTO Dimethoate DESCRIPT Dimethoate inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 22 microM) DTD0004 EXOFACTO Dimethoate MOACRIVE Inhibition DTD0004 EXOFACTO Dimethoate CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Dimethomorph HIGHSTIT Natural Product DTD0004 EXOFACTO Dimethomorph DESCRIPT Dimethomorph inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 26 microM) DTD0004 EXOFACTO Dimethomorph MOACRIVE Inhibition DTD0004 EXOFACTO Dimethomorph CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0004 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the activity of ABCG2 DTD0004 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0004 EXOFACTO Dithianon HIGHSTIT Natural Product DTD0004 EXOFACTO Dithianon DESCRIPT Dithianon inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 202 microM) DTD0004 EXOFACTO Dithianon MOACRIVE Inhibition DTD0004 EXOFACTO Dithianon CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Dolutegravir HIGHSTIT Approved Drug DTD0004 EXOFACTO Dolutegravir DESCRIPT Dolutegravir inhibits the transportation of Cimetidine by ABCG2 DTD0004 EXOFACTO Dolutegravir MOACRIVE Inhibition DTD0004 EXOFACTO Dolutegravir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Doxycycline HIGHSTIT Approved Drug DTD0004 EXOFACTO Doxycycline DESCRIPT Doxycycline induces the activity of ABCG2 DTD0004 EXOFACTO Doxycycline MOACRIVE Inducer DTD0004 EXOFACTO Eetuximab HIGHSTIT Approved Drug DTD0004 EXOFACTO Eetuximab DESCRIPT Eetuximab inhibits the activity of ABCG2 DTD0004 EXOFACTO Eetuximab MOACRIVE Inhibition DTD0004 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0004 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 20.6 microM) DTD0004 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0004 EXOFACTO Efavirenz CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Elacridar HIGHSTIT Discontinued Drug DTD0004 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Mitoxantrone by ABCG2 (IC50 = 0.31 microM) DTD0004 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Estrone sulfate by ABCG2 DTD0004 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Elacridar MOACRIVE Inhibition DTD0004 EXOFACTO Elacridar CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Elacridar CELLLINE Human enterocyte-like 2 cell (Caco-2)-BCRP DTD0004 EXOFACTO Ellagic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Ellagic acid DESCRIPT Ellagic acid inhibits the activity of ABCG2 DTD0004 EXOFACTO Ellagic acid MOACRIVE Inhibition DTD0004 EXOFACTO Ellagic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Endosulfan HIGHSTIT Natural Product DTD0004 EXOFACTO Endosulfan DESCRIPT Endosulfan inhibits the transportation of Hoechst 33342 by ABCG2 (IC50 = 24.8 microM) DTD0004 EXOFACTO Endosulfan MOACRIVE Inhibition DTD0004 EXOFACTO Endosulfan CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Epigallocatechin gallate HIGHSTIT Natural Product DTD0004 EXOFACTO Epigallocatechin gallate DESCRIPT Epigallocatechin gallate inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Epigallocatechin gallate MOACRIVE Inhibition DTD0004 EXOFACTO Epigallocatechin gallate CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Epoxiconazole HIGHSTIT Natural Product DTD0004 EXOFACTO Epoxiconazole DESCRIPT Epoxiconazole inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 455 microM) DTD0004 EXOFACTO Epoxiconazole MOACRIVE Inhibition DTD0004 EXOFACTO Epoxiconazole CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the transportation of Estrone sulfate by ABCG2 (IC50 = 0.13 microM; Ki = 0.15 microM) DTD0004 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0004 EXOFACTO Erlotinib CELLLINE Myelogenous leukemia cell line (K562)-BCRP DTD0004 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0004 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Topotecan by ABCG2 DTD0004 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of ABCG2 DTD0004 EXOFACTO Estradiol MOACRIVE Inhibition DTD0004 EXOFACTO Estradiol MOACRIVE Inducer DTD0004 EXOFACTO Estradiol CELLLINE Myelogenous leukemia cell line (K562)-BCRP DTD0004 EXOFACTO Etravirine HIGHSTIT Approved Drug DTD0004 EXOFACTO Etravirine DESCRIPT Etravirine inhibits the activity of ABCG2 DTD0004 EXOFACTO Etravirine MOACRIVE Inhibition DTD0004 EXOFACTO Febuxostat HIGHSTIT Approved Drug DTD0004 EXOFACTO Febuxostat DESCRIPT Febuxostat inhibits the activity of ABCG2 DTD0004 EXOFACTO Febuxostat MOACRIVE Inhibition DTD0004 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0004 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 5.43 microM) DTD0004 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0004 EXOFACTO Fluvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Folic acid HIGHSTIT Approved Drug DTD0004 EXOFACTO Folic acid DESCRIPT Folic acid induces the activity of ABCG2 DTD0004 EXOFACTO Folic acid MOACRIVE Inducer DTD0004 EXOFACTO Gallic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Gallic acid DESCRIPT Gallic acid inhibits the transportation of Rosuvastatin by ABCG2 in a competitive manner DTD0004 EXOFACTO Gallic acid MOACRIVE Inhibition DTD0004 EXOFACTO Gallic acid CELLLINE Madin darby canine kidney strain cell line (MDCK)-BCRP DTD0004 EXOFACTO Gefitinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Gefitinib DESCRIPT Gefitinib inhibits the transportation of Hoechst 33342 by ABCG2 (IC50 = 0.4 microM) DTD0004 EXOFACTO Gefitinib DESCRIPT Gefitinib inhibits the activity of ABCG2 DTD0004 EXOFACTO Gefitinib MOACRIVE Inhibition DTD0004 EXOFACTO Gefitinib CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0004 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Genistein MOACRIVE Inhibition DTD0004 EXOFACTO Genistein CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Glafenine HIGHSTIT Drug in Phase 4 Trial DTD0004 EXOFACTO Glafenine DESCRIPT Glafenine inhibits the activity of ABCG2 DTD0004 EXOFACTO Glafenine MOACRIVE Inhibition DTD0004 EXOFACTO Glecaprevir HIGHSTIT Approved Drug DTD0004 EXOFACTO Glecaprevir DESCRIPT Glecaprevir inhibits the activity of ABCG2 DTD0004 EXOFACTO Glecaprevir MOACRIVE Inhibition DTD0004 EXOFACTO Glyphosate HIGHSTIT Natural Product DTD0004 EXOFACTO Glyphosate DESCRIPT Glyphosate inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 148 microM) DTD0004 EXOFACTO Glyphosate MOACRIVE Inhibition DTD0004 EXOFACTO Glyphosate CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Gymnema sylvestre extract (1mg/ml) HIGHSTIT Natural Product DTD0004 EXOFACTO Gymnema sylvestre extract (1mg/ml) DESCRIPT Gymnema sylvestre extract (1mg/ml) inhibits the activity of ABCG2 DTD0004 EXOFACTO Gymnema sylvestre extract (1mg/ml) MOACRIVE Inhibition DTD0004 EXOFACTO Gymnema sylvestre extract (1mg/ml) CELLLINE Mammalian cells expressing human wild-type BCRP DTD0004 EXOFACTO Hesperetin HIGHSTIT Approved Drug DTD0004 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of mitoxantrone by ABCG2 DTD0004 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of SN-38 by ABCG2 DTD0004 EXOFACTO Hesperetin MOACRIVE Inhibition DTD0004 EXOFACTO Hesperetin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Hesperetin CELLLINE Myelogenous leukemia cell line (K562)-BCRP DTD0004 EXOFACTO Imatinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Imatinib DESCRIPT Imatinib induces the activity of ABCG2 DTD0004 EXOFACTO Imatinib DESCRIPT Imatinib inhibits the activity of ABCG2 DTD0004 EXOFACTO Imatinib MOACRIVE Inducer DTD0004 EXOFACTO Imatinib MOACRIVE Inhibition DTD0004 EXOFACTO Imazalil HIGHSTIT Natural Product DTD0004 EXOFACTO Imazalil DESCRIPT Imazalil inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 109 microM) DTD0004 EXOFACTO Imazalil MOACRIVE Inhibition DTD0004 EXOFACTO Imazalil CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Insulin HIGHSTIT Approved Drug DTD0004 EXOFACTO Insulin DESCRIPT Insulin induces the activity of ABCG2 DTD0004 EXOFACTO Insulin MOACRIVE Inducer DTD0004 EXOFACTO Ioxynil HIGHSTIT Natural Product DTD0004 EXOFACTO Ioxynil DESCRIPT Ioxynil inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 540 microM) DTD0004 EXOFACTO Ioxynil MOACRIVE Inhibition DTD0004 EXOFACTO Ioxynil CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Isoflavones HIGHSTIT Natural Product DTD0004 EXOFACTO Isoflavones DESCRIPT Isoflavones inhibits the transportation of Mitoxantrone by ABCG2 in a non-competitive manner (IC50 = 8.8 microM) DTD0004 EXOFACTO Isoflavones MOACRIVE Inhibition DTD0004 EXOFACTO Isoflavones CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0004 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of ABCG2 DTD0004 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0004 EXOFACTO Kaempferol HIGHSTIT Investigative Drug DTD0004 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Kaempferol MOACRIVE Inhibition DTD0004 EXOFACTO Kaempferol CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0004 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of ABCG2 DTD0004 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0004 EXOFACTO Laricitrin HIGHSTIT Natural Product DTD0004 EXOFACTO Laricitrin DESCRIPT Laricitrin inhibits the activity of ABCG2 DTD0004 EXOFACTO Laricitrin MOACRIVE Inhibition DTD0004 EXOFACTO Laricitrin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Leflunomide HIGHSTIT Approved Drug DTD0004 EXOFACTO Leflunomide DESCRIPT Leflunomide inhibits the activity of ABCG2 DTD0004 EXOFACTO Leflunomide MOACRIVE Inhibition DTD0004 EXOFACTO Limonin HIGHSTIT Natural Product DTD0004 EXOFACTO Limonin DESCRIPT Limonin inhibits the activity of ABCG2 DTD0004 EXOFACTO Limonin MOACRIVE Inhibition DTD0004 EXOFACTO Limonin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0004 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Estrone sulfate by ABCG2 DTD0004 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0004 EXOFACTO Linagliptin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 7.66 microM) DTD0004 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the activity of ABCG2 DTD0004 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0004 EXOFACTO Lopinavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Luteolin HIGHSTIT Natural Product DTD0004 EXOFACTO Luteolin DESCRIPT Luteolin inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Luteolin MOACRIVE Inhibition DTD0004 EXOFACTO Luteolin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Methiocarb HIGHSTIT Natural Product DTD0004 EXOFACTO Methiocarb DESCRIPT Methiocarb inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 440 microM) DTD0004 EXOFACTO Methiocarb MOACRIVE Inhibition DTD0004 EXOFACTO Methiocarb CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0004 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the activity of ABCG2 DTD0004 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0004 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0004 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCG2 DTD0004 EXOFACTO Micafungin MOACRIVE Inhibition DTD0004 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0004 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the activity of ABCG2 DTD0004 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0004 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0004 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Morin MOACRIVE Inhibition DTD0004 EXOFACTO Morin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0004 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Naringenin MOACRIVE Inhibition DTD0004 EXOFACTO Naringenin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 13.5 microM) DTD0004 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the activity of ABCG2 DTD0004 EXOFACTO Nelfinavir MOACRIVE Inhibition DTD0004 EXOFACTO Nelfinavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Nicardipine HIGHSTIT Approved Drug DTD0004 EXOFACTO Nicardipine DESCRIPT Nicardipine inhibits the activity of ABCG2 DTD0004 EXOFACTO Nicardipine MOACRIVE Inhibition DTD0004 EXOFACTO Nilotinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Nilotinib DESCRIPT Nilotinib inhibits the transportation of Methotrexate by ABCG2 (Ki = 0.69 microM) DTD0004 EXOFACTO Nilotinib MOACRIVE Inhibition DTD0004 EXOFACTO Nilotinib CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Nimodipine HIGHSTIT Approved Drug DTD0004 EXOFACTO Nimodipine DESCRIPT Nimodipine inhibits the activity of ABCG2 DTD0004 EXOFACTO Nimodipine MOACRIVE Inhibition DTD0004 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) HIGHSTIT Environmental toxicant DTD0004 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) DESCRIPT O,p'-DDT inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 10.4 microM) DTD0004 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) MOACRIVE Inhibition DTD0004 EXOFACTO o,p'-dichlorodiphenyltrichloroethane (DDT) CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Oleanolic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Oleanolic acid DESCRIPT Oleanolic acid inhibits the activity of ABCG2 DTD0004 EXOFACTO Oleanolic acid MOACRIVE Inhibition DTD0004 EXOFACTO Oleanolic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0004 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the transportation of Methotrexate by ABCG2 (IC50 = 10-50 microM) DTD0004 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the activity of ABCG2 DTD0004 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0004 EXOFACTO Omeprazole CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Osimertinib HIGHSTIT Approved Drug DTD0004 EXOFACTO Osimertinib DESCRIPT Osimertinib inhibits the activity of ABCG2 DTD0004 EXOFACTO Osimertinib MOACRIVE Inhibition DTD0004 EXOFACTO Oxycodone HIGHSTIT Approved Drug DTD0004 EXOFACTO Oxycodone DESCRIPT Oxycodone induces the activity of ABCG2 DTD0004 EXOFACTO Oxycodone MOACRIVE Inducer DTD0004 EXOFACTO Oxytetracycline HIGHSTIT Approved Drug DTD0004 EXOFACTO Oxytetracycline DESCRIPT Oxytetracycline induces the activity of ABCG2 DTD0004 EXOFACTO Oxytetracycline MOACRIVE Inducer DTD0004 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) HIGHSTIT Environmental toxicant DTD0004 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) DESCRIPT p,p'-DDE inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 4 microM) DTD0004 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) MOACRIVE Inhibition DTD0004 EXOFACTO p,p'-dichlorodiphenyldichloroethane (DDE) CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) HIGHSTIT Environmental toxicant DTD0004 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) DESCRIPT p,p'-DDT inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 5 microM) DTD0004 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) MOACRIVE Inhibition DTD0004 EXOFACTO p,p'-dichlorodiphenyltrichloroethane (DDT) CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) HIGHSTIT Environmental toxicant DTD0004 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) DESCRIPT p,p'-DDD inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 3 microM) DTD0004 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) MOACRIVE Inhibition DTD0004 EXOFACTO p,p'-tetrachlorodiphenylethane (DDD) CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Pantoprazole HIGHSTIT Approved Drug DTD0004 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the transportation of Methotrexate by ABCG2 (IC50 = 10 microM) DTD0004 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the activity of ABCG2 DTD0004 EXOFACTO Pantoprazole MOACRIVE Inhibition DTD0004 EXOFACTO Pantoprazole CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Passion flower extract (1mg/ml) HIGHSTIT Natural Product DTD0004 EXOFACTO Passion flower extract (1mg/ml) DESCRIPT Passion flower extract (1mg/ml) inhibits the activity of ABCG2 DTD0004 EXOFACTO Passion flower extract (1mg/ml) MOACRIVE Inhibition DTD0004 EXOFACTO Passion flower extract (1mg/ml) CELLLINE Mammalian cells expressing human wild-type BCRP DTD0004 EXOFACTO Permethrin HIGHSTIT Approved Drug DTD0004 EXOFACTO Permethrin DESCRIPT Permethrin inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 7 microM) DTD0004 EXOFACTO Permethrin MOACRIVE Inhibition DTD0004 EXOFACTO Permethrin CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Piperine HIGHSTIT Natural Product DTD0004 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Rosuvastatin by ABCG2 in a competitive manner DTD0004 EXOFACTO Piperine MOACRIVE Inhibition DTD0004 EXOFACTO Piperine CELLLINE Madin darby canine kidney strain cell line (MDCK)-BCRP DTD0004 EXOFACTO Pitavastatin calcium HIGHSTIT Approved Drug DTD0004 EXOFACTO Pitavastatin calcium DESCRIPT Pitavastatin calcium inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 2.92 microM) DTD0004 EXOFACTO Pitavastatin calcium MOACRIVE Inhibition DTD0004 EXOFACTO Pitavastatin calcium CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Plicamycin HIGHSTIT Approved Drug DTD0004 EXOFACTO Plicamycin DESCRIPT Plicamycin inhibits the activity of ABCG2 DTD0004 EXOFACTO Plicamycin MOACRIVE Inhibition DTD0004 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0004 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of Estrone sulfate by ABCG2 DTD0004 EXOFACTO Prazosin MOACRIVE Inhibition DTD0004 EXOFACTO Prazosin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0004 EXOFACTO Progesterone DESCRIPT Progesterone induces the activity of ABCG2 DTD0004 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the activity of ABCG2 DTD0004 EXOFACTO Progesterone MOACRIVE Inducer DTD0004 EXOFACTO Progesterone MOACRIVE Inhibition DTD0004 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0004 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of ABCG2 DTD0004 EXOFACTO Propafenone MOACRIVE Inhibition DTD0004 EXOFACTO Propyl gallate HIGHSTIT Natural Product DTD0004 EXOFACTO Propyl gallate DESCRIPT Propyl gallate inhibits the activity of ABCG2 DTD0004 EXOFACTO Propyl gallate MOACRIVE Inhibition DTD0004 EXOFACTO Propyl gallate CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Pyrethroids HIGHSTIT Natural Product DTD0004 EXOFACTO Pyrethroids DESCRIPT Pyrethroids inhibits the transportation of Fmitremorgin C by ABCG2 (IC50 = 42.5 microM) DTD0004 EXOFACTO Pyrethroids MOACRIVE Inhibition DTD0004 EXOFACTO Pyrethroids CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0004 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Mitoxantrone by ABCG2 DTD0004 EXOFACTO Quercetin MOACRIVE Inhibition DTD0004 EXOFACTO Quercetin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0004 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the activity of ABCG2 DTD0004 EXOFACTO Reserpine MOACRIVE Inhibition DTD0004 EXOFACTO Resmethrin HIGHSTIT Natural Product DTD0004 EXOFACTO Resmethrin DESCRIPT Resmethrin inhibits the transportation of Sulfasalazine by ABCG2 (IC50 = 5.6 microM) DTD0004 EXOFACTO Resmethrin MOACRIVE Inhibition DTD0004 EXOFACTO Resmethrin CELLLINE Spodoptera frugiperda (Sf9) cells-BCRP DTD0004 EXOFACTO Rimsulfuron HIGHSTIT Natural Product DTD0004 EXOFACTO Rimsulfuron DESCRIPT Rimsulfuron inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 12 microM) DTD0004 EXOFACTO Rimsulfuron MOACRIVE Inhibition DTD0004 EXOFACTO Rimsulfuron CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of ABCG2 DTD0004 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0004 EXOFACTO Rosiglitazone HIGHSTIT Approved Drug DTD0004 EXOFACTO Rosiglitazone DESCRIPT Rosiglitazone induces the activity of ABCG2 DTD0004 EXOFACTO Rosiglitazone MOACRIVE Inducer DTD0004 EXOFACTO Rosuvastatin HIGHSTIT Approved Drug DTD0004 EXOFACTO Rosuvastatin DESCRIPT Rosuvastatin inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 15.4 microM) DTD0004 EXOFACTO Rosuvastatin MOACRIVE Inhibition DTD0004 EXOFACTO Rosuvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Rutin HIGHSTIT Investigative Drug DTD0004 EXOFACTO Rutin DESCRIPT Rutin inhibits the activity of ABCG2 DTD0004 EXOFACTO Rutin MOACRIVE Inhibition DTD0004 EXOFACTO Rutin extract (1mg/ml) HIGHSTIT Natural Product DTD0004 EXOFACTO Rutin extract (1mg/ml) DESCRIPT Rutin extract (1mg/ml) inhibits the activity of ABCG2 DTD0004 EXOFACTO Rutin extract (1mg/ml) MOACRIVE Inhibition DTD0004 EXOFACTO Rutin extract (1mg/ml) CELLLINE Mammalian cells expressing human wild-type BCRP DTD0004 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0004 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Pheophorbide A by ABCG2 (IC50 = 27.4 microM) DTD0004 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0004 EXOFACTO Saquinavir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Selexipag HIGHSTIT Approved Drug DTD0004 EXOFACTO Selexipag DESCRIPT Selexipag inhibits the activity of ABCG2 DTD0004 EXOFACTO Selexipag MOACRIVE Inhibition DTD0004 EXOFACTO Simeprevir HIGHSTIT Approved Drug DTD0004 EXOFACTO Simeprevir DESCRIPT Simeprevir inhibits the transportation of Digoxin by ABCG2 DTD0004 EXOFACTO Simeprevir MOACRIVE Inhibition DTD0004 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0004 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estrone sulfate by ABCG2 (Ki = 18 microM) DTD0004 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0004 EXOFACTO Simvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Sinapic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Sinapic acid DESCRIPT Sinapic acid inhibits the activity of ABCG2 DTD0004 EXOFACTO Sinapic acid MOACRIVE Inhibition DTD0004 EXOFACTO Sinapic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Sirolimus HIGHSTIT Approved Drug DTD0004 EXOFACTO Sirolimus DESCRIPT Sirolimus inhibits the activity of ABCG2 DTD0004 EXOFACTO Sirolimus MOACRIVE Inhibition DTD0004 EXOFACTO SN-38 HIGHSTIT Drug in Phase 2 Trial DTD0004 EXOFACTO SN-38 DESCRIPT SN-38 inhibits the transportation of Estrone sulfate by ABCG2 (IC50 = 1.6 microM) DTD0004 EXOFACTO SN-38 MOACRIVE Inhibition DTD0004 EXOFACTO SN-38 CELLLINE Mouse lymphoma (P388) cells-BCRP DTD0004 EXOFACTO Soybean extract (1mg/ml) HIGHSTIT Natural Product DTD0004 EXOFACTO Soybean extract (1mg/ml) DESCRIPT Soybean extract (1mg/ml) inhibits the activity of ABCG2 (IC50 = 16.5 microM) DTD0004 EXOFACTO Soybean extract (1mg/ml) MOACRIVE Inhibition DTD0004 EXOFACTO Soybean extract (1mg/ml) CELLLINE Mammalian cells expressing human wild-type BCRP DTD0004 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0004 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Estrone sulfate by ABCG2 (IC50 = 0.73 microM) DTD0004 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the activity of ABCG2 DTD0004 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0004 EXOFACTO Sulfasalazine CELLLINE Oocytes-BCRP DTD0004 EXOFACTO Tacrolimus HIGHSTIT Approved Drug DTD0004 EXOFACTO Tacrolimus DESCRIPT Tacrolimus inhibits the activity of ABCG2 DTD0004 EXOFACTO Tacrolimus MOACRIVE Inhibition DTD0004 EXOFACTO Tamarixetin HIGHSTIT Natural Product DTD0004 EXOFACTO Tamarixetin DESCRIPT Tamarixetin inhibits the activity of ABCG2 DTD0004 EXOFACTO Tamarixetin MOACRIVE Inhibition DTD0004 EXOFACTO Tamarixetin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Tariquidar HIGHSTIT Discontinued Drug DTD0004 EXOFACTO Tariquidar DESCRIPT Tariquidar inhibits the transportation of Calcein AM by ABCG2 DTD0004 EXOFACTO Tariquidar MOACRIVE Inhibition DTD0004 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0004 EXOFACTO Telaprevir DESCRIPT Telaprevir induces the activity of ABCG2 DTD0004 EXOFACTO Telaprevir MOACRIVE Inducer DTD0004 EXOFACTO Tetrahydrocurcumin HIGHSTIT Natural Product DTD0004 EXOFACTO Tetrahydrocurcumin DESCRIPT Tetrahydrocurcumin inhibits the activity of ABCG2 DTD0004 EXOFACTO Tetrahydrocurcumin MOACRIVE Inhibition DTD0004 EXOFACTO Tetrahydrocurcumin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BCRP DTD0004 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0004 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Fmitremorgin C by ABCG2 (IC50 = 72.5 microM) DTD0004 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0004 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-BCRP DTD0004 EXOFACTO Thiacloprid HIGHSTIT Natural Product DTD0004 EXOFACTO Thiacloprid DESCRIPT Thiacloprid inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 396 microM) DTD0004 EXOFACTO Thiacloprid MOACRIVE Inhibition DTD0004 EXOFACTO Thiacloprid CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Tolcapone HIGHSTIT Approved Drug DTD0004 EXOFACTO Tolcapone DESCRIPT Tolcapone inhibits the activity of ABCG2 DTD0004 EXOFACTO Tolcapone MOACRIVE Inhibition DTD0004 EXOFACTO Tolclofos-methyl HIGHSTIT Natural Product DTD0004 EXOFACTO Tolclofos-methyl DESCRIPT Tolclofos-methyl inhibits the transportation of WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) by ABCG2 (IC50 = 17 microM) DTD0004 EXOFACTO Tolclofos-methyl MOACRIVE Inhibition DTD0004 EXOFACTO Tolclofos-methyl CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-BCRP DTD0004 EXOFACTO Topotecan HIGHSTIT Approved Drug DTD0004 EXOFACTO Topotecan DESCRIPT Topotecan induces the activity of ABCG2 DTD0004 EXOFACTO Topotecan MOACRIVE Inducer DTD0004 EXOFACTO Toremifene HIGHSTIT Approved Drug DTD0004 EXOFACTO Toremifene DESCRIPT Toremifene inhibits the activity of ABCG2 DTD0004 EXOFACTO Toremifene MOACRIVE Inhibition DTD0004 EXOFACTO Tricetin HIGHSTIT Natural Product DTD0004 EXOFACTO Tricetin DESCRIPT Tricetin inhibits the activity of ABCG2 DTD0004 EXOFACTO Tricetin MOACRIVE Inhibition DTD0004 EXOFACTO Tricetin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Tricetin 3',4',5'-trimethylether HIGHSTIT Natural Product DTD0004 EXOFACTO Tricetin 3',4',5'-trimethylether DESCRIPT Tricetin 3',4',5'-trimethylether inhibits the activity of ABCG2 DTD0004 EXOFACTO Tricetin 3',4',5'-trimethylether MOACRIVE Inhibition DTD0004 EXOFACTO Tricetin 3',4',5'-trimethylether CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Ursolic acid HIGHSTIT Natural Product DTD0004 EXOFACTO Ursolic acid DESCRIPT Ursolic acid inhibits the activity of ABCG2 DTD0004 EXOFACTO Ursolic acid MOACRIVE Inhibition DTD0004 EXOFACTO Ursolic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0004 EXOFACTO Venlafaxine HIGHSTIT Approved Drug DTD0004 EXOFACTO Venlafaxine DESCRIPT Venlafaxine induces the activity of ABCG2 DTD0004 EXOFACTO Venlafaxine MOACRIVE Inducer DTD0005 TRANSPID DTD0005 DTD0005 GENENAME SLC22A7 DTD0005 PROTNAME Organic anion transporter 2 DTD0005 GENEDBID 10864 DTD0005 UNIPROID Q9Y694 DTD0005 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0005 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A7 (IC50 = 1502 microM) DTD0005 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0005 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0005 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A7 (IC50 = 180 microM) DTD0005 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0005 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0005 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 77.5 microM) DTD0005 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0005 EXOFACTO Bumetanide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0005 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1570 microM) DTD0005 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0005 EXOFACTO Cefamandole CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0005 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1330 microM) DTD0005 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0005 EXOFACTO Cefoperazone CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0005 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 4680 microM) DTD0005 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0005 EXOFACTO Cefotaxime CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0005 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 4480 microM) DTD0005 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0005 EXOFACTO Cephaloridine CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0005 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1410 microM) DTD0005 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0005 EXOFACTO Cephalothin CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Chlorothiazide HIGHSTIT Approved Drug DTD0005 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 2205 microM) DTD0005 EXOFACTO Chlorothiazide MOACRIVE Inhibition DTD0005 EXOFACTO Chlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0005 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLC22A7 (IC50 = 16.9 microM) DTD0005 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0005 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-OAT2 DTD0005 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0005 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic anion by SLC22A7 (IC50 > 1000 microM) DTD0005 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0005 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0005 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A7 (IC50 = 126 microM) DTD0005 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0005 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Cyclothiazide HIGHSTIT Approved Drug DTD0005 EXOFACTO Cyclothiazide DESCRIPT Cyclothiazide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 39.2 microM) DTD0005 EXOFACTO Cyclothiazide MOACRIVE Inhibition DTD0005 EXOFACTO Cyclothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0005 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 14.3 microM) DTD0005 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0005 EXOFACTO Diclofenac CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0005 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the activity of SLC22A7 DTD0005 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0005 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0005 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of SLC22A7 DTD0005 EXOFACTO Estradiol MOACRIVE Inducer DTD0005 EXOFACTO Ethacrynic acid HIGHSTIT Approved Drug DTD0005 EXOFACTO Ethacrynic acid DESCRIPT Ethacrynic acid inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 121 microM) DTD0005 EXOFACTO Ethacrynic acid MOACRIVE Inhibition DTD0005 EXOFACTO Ethacrynic acid CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0005 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic anion by SLC22A7 DTD0005 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0005 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0005 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 603 microM) DTD0005 EXOFACTO Furosemide MOACRIVE Inhibition DTD0005 EXOFACTO Furosemide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0005 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic anion by SLC22A7 DTD0005 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0005 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Hydrochlorothiazide HIGHSTIT Approved Drug DTD0005 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1023 microM) DTD0005 EXOFACTO Hydrochlorothiazide MOACRIVE Inhibition DTD0005 EXOFACTO Hydrochlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0005 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 692 microM) DTD0005 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0005 EXOFACTO Ibuprofen CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0005 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 64.1 microM) DTD0005 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0005 EXOFACTO Indomethacin CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0005 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 400 microM) DTD0005 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Salicylate by SLC22A7 (IC50 = 400 microM) DTD0005 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0005 EXOFACTO Ketoprofen CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Mefenamic acid HIGHSTIT Approved Drug DTD0005 EXOFACTO Mefenamic acid DESCRIPT Mefenamic acid inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 21.7 microM) DTD0005 EXOFACTO Mefenamic acid MOACRIVE Inhibition DTD0005 EXOFACTO Mefenamic acid CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Minocycline HIGHSTIT Approved Drug DTD0005 EXOFACTO Minocycline DESCRIPT Minocycline inhibits the transportation of Prostaglandin F2alpha by SLC22A7 DTD0005 EXOFACTO Minocycline MOACRIVE Inhibition DTD0005 EXOFACTO Minocycline CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Naproxen HIGHSTIT Approved Drug DTD0005 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 486 microM) DTD0005 EXOFACTO Naproxen MOACRIVE Inhibition DTD0005 EXOFACTO Naproxen CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Oxytetracycline HIGHSTIT Approved Drug DTD0005 EXOFACTO Oxytetracycline DESCRIPT Oxytetracycline inhibits the transportation of Prostaglandin F2alpha by SLC22A7 DTD0005 EXOFACTO Oxytetracycline MOACRIVE Inhibition DTD0005 EXOFACTO Oxytetracycline CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0005 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic anion by SLC22A7 DTD0005 EXOFACTO Patulin MOACRIVE Inhibition DTD0005 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0005 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1878 microM) DTD0005 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0005 EXOFACTO Phenacetin CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0005 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 70.3 microM) DTD0005 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0005 EXOFACTO Piroxicam CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0005 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (Ki = 766 microM) DTD0005 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of SLC22A7 DTD0005 EXOFACTO Probenecid MOACRIVE Inhibition DTD0005 EXOFACTO Probenecid CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Salicylic acid HIGHSTIT Approved Drug DTD0005 EXOFACTO Salicylic acid DESCRIPT Salicylic acid inhibits the activity of SLC22A7 DTD0005 EXOFACTO Salicylic acid MOACRIVE Inhibition DTD0005 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0005 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 440 microM) DTD0005 EXOFACTO Sulindac MOACRIVE Inhibition DTD0005 EXOFACTO Sulindac CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Theophylline HIGHSTIT Approved Drug DTD0005 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the transportation of Erythromycin by SLC22A7 DTD0005 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the activity of SLC22A7 DTD0005 EXOFACTO Theophylline MOACRIVE Inhibition DTD0005 EXOFACTO Theophylline CELLLINE Oocytes-OAT2 DTD0005 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0005 EXOFACTO Trichlormethiazide DESCRIPT Trichloromethiazide inhibits the transportation of Prostaglandin F2alpha by SLC22A7 (IC50 = 1120 microM) DTD0005 EXOFACTO Trichlormethiazide MOACRIVE Inhibition DTD0005 EXOFACTO Trichlormethiazide CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0005 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic anion by SLC22A7 (IC50 = 149 microM) DTD0005 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0005 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0005 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0005 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Prostaglandin F2alpha by SLC22A7 DTD0005 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0005 EXOFACTO Zidovudine CELLLINE The Proximal Tubule (S2) Cells-OAT2 DTD0006 TRANSPID DTD0006 DTD0006 GENENAME SLC22A2 DTD0006 PROTNAME Organic cation transporter 2 DTD0006 GENEDBID 6582 DTD0006 UNIPROID O15244 DTD0006 EXOFACTO Acecainide HIGHSTIT Discontinued Drug DTD0006 EXOFACTO Acecainide DESCRIPT Acecainide inhibits the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Acecainide MOACRIVE Inhibition DTD0006 EXOFACTO Acecainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Aconitine HIGHSTIT Biotoxin DTD0006 EXOFACTO Aconitine DESCRIPT Aconitine inhibits the transportation of Tetraethylammonium by SLC22A2 (IC50 = 59.2 microM) DTD0006 EXOFACTO Aconitine MOACRIVE Inhibition DTD0006 EXOFACTO Aconitine CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0006 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic cation by SLC22A2 (IC50 = 121 microM) DTD0006 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0006 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0006 EXOFACTO Allethrin DESCRIPT Allethrin inhibits the transportation of Verapamil by SLC22A2 (IC50 = 42.6 microM) DTD0006 EXOFACTO Allethrin MOACRIVE Inhibition DTD0006 EXOFACTO Allethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0006 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic cation by SLC22A2 (IC50 = 34.3 microM) DTD0006 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0006 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0006 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of YM155 by SLC22A2 (IC50 = 45.9 microM) DTD0006 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 28.4 microM) DTD0006 EXOFACTO Amantadine MOACRIVE Inhibition DTD0006 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0006 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 14 microM) DTD0006 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0006 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Antiparasitics HIGHSTIT Discontinued Drug DTD0006 EXOFACTO Antiparasitics DESCRIPT Antiparasitics inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 182 microM) DTD0006 EXOFACTO Antiparasitics MOACRIVE Inhibition DTD0006 EXOFACTO Antiparasitics CELLLINE Chinese hamster ovary (CHO) cells-OCT2 DTD0006 EXOFACTO Atropine HIGHSTIT Approved Drug DTD0006 EXOFACTO Atropine DESCRIPT Atropine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 39 microM) DTD0006 EXOFACTO Atropine MOACRIVE Inhibition DTD0006 EXOFACTO Atropine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0006 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the activity of SLC22A2 DTD0006 EXOFACTO Budesonide MOACRIVE Inhibition DTD0006 EXOFACTO Butylscopolamine HIGHSTIT Approved Drug DTD0006 EXOFACTO Butylscopolamine DESCRIPT Butylscopolamine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 764 microM) DTD0006 EXOFACTO Butylscopolamine MOACRIVE Inhibition DTD0006 EXOFACTO Butylscopolamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Carvedilol HIGHSTIT Approved Drug DTD0006 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 63 microM) DTD0006 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the activity of SLC22A2 (IC50 = 3.6 microM) DTD0006 EXOFACTO Carvedilol MOACRIVE Inhibition DTD0006 EXOFACTO Carvedilol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0006 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0006 EXOFACTO Cetirizine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0006 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 1096 microM) DTD0006 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0006 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0006 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 14 microM) DTD0006 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0006 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Chlorpyrifos HIGHSTIT Natural Product DTD0006 EXOFACTO Chlorpyrifos DESCRIPT Chlorpyrifos inhibits the activity of SLC22A2 DTD0006 EXOFACTO Chlorpyrifos MOACRIVE Inhibition DTD0006 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0006 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLC22A2 (IC50 = 12.5 microM) DTD0006 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0006 EXOFACTO Cigarette smoke condensate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0006 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of YM155 by SLC22A2 (IC50 = 110 microM) DTD0006 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Tetraethylammonium by SLC22A2 (IC50 = 373 microM) DTD0006 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 120 microM) DTD0006 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A2 DTD0006 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of SLC22A2 DTD0006 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0006 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Cimetidine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0006 EXOFACTO Cisplatin DESCRIPT Cisplatin inhibits the activity of SLC22A2 DTD0006 EXOFACTO Cisplatin MOACRIVE Inhibition DTD0006 EXOFACTO Citreoverdine HIGHSTIT Natural Product DTD0006 EXOFACTO Citreoverdine DESCRIPT Citreoverdine inhibits the transportation of Organic cation by SLC22A2 (IC50 = 17.7 microM) DTD0006 EXOFACTO Citreoverdine MOACRIVE Inhibition DTD0006 EXOFACTO Citreoverdine CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0006 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic cation by SLC22A2 (IC50 = 17.7 microM) DTD0006 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0006 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Clonidine HIGHSTIT Approved Drug DTD0006 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 23 microM) DTD0006 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 16 microM) DTD0006 EXOFACTO Clonidine MOACRIVE Inhibition DTD0006 EXOFACTO Clonidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0006 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 113 microM) DTD0006 EXOFACTO Cocaine MOACRIVE Inhibition DTD0006 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Corticosterone HIGHSTIT Investigative Drug DTD0006 EXOFACTO Corticosterone DESCRIPT Corticosterone inhibits the transportation of YM155 by SLC22A2 (IC50 = 5.35 microM) DTD0006 EXOFACTO Corticosterone MOACRIVE Inhibition DTD0006 EXOFACTO Corticosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Crizotinib HIGHSTIT Approved Drug DTD0006 EXOFACTO Crizotinib DESCRIPT Crizotinib inhibits the transportation of Creatinine by SLC22A2 (IC50 = 1.58 +/- 0.24 microM) DTD0006 EXOFACTO Crizotinib MOACRIVE Inhibition DTD0006 EXOFACTO Crizotinib CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0006 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic cation by SLC22A2 (IC50 > 1000 microM) DTD0006 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0006 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0006 EXOFACTO Decitabine DESCRIPT Decitabine inhibits DNA methyltransferase, which then enhances Oxaliplatin's transportation via downregulating the hypermethylation in SLC22A2's promoter DTD0006 EXOFACTO Decitabine MOACRIVE Inducer DTD0006 EXOFACTO Decitabine CELLLINE Human renal cell carcinoma cells (RCC) DTD0006 EXOFACTO Decynium 22 HIGHSTIT Investigative Drug DTD0006 EXOFACTO Decynium 22 DESCRIPT Decynium 22 inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 0.1 microM) DTD0006 EXOFACTO Decynium 22 DESCRIPT Decynium 22 inhibits the transportation of Tetraethylammonium by SLC22A2 (IC50 = 13.8 microM) DTD0006 EXOFACTO Decynium 22 MOACRIVE Inhibition DTD0006 EXOFACTO Decynium 22 CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0006 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Tetraethylammonium by SLC22A2 (IC50 = 16 microM) DTD0006 EXOFACTO Desipramine MOACRIVE Inhibition DTD0006 EXOFACTO Desipramine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0006 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of SLC22A2 DTD0006 EXOFACTO Dexamethasone MOACRIVE Inhibition DTD0006 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0006 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 10.5 microM) DTD0006 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0006 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Diazepam HIGHSTIT Approved Drug DTD0006 EXOFACTO Diazepam DESCRIPT Diazepam inhibits the activity of SLC22A2 DTD0006 EXOFACTO Diazepam MOACRIVE Inhibition DTD0006 EXOFACTO Diphenhydramine HIGHSTIT Approved Drug DTD0006 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 21 microM) DTD0006 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 15 microM) DTD0006 EXOFACTO Diphenhydramine MOACRIVE Inhibition DTD0006 EXOFACTO Diphenhydramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0006 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 324 microM) DTD0006 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0006 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Dizocilpine HIGHSTIT Discontinued Drug DTD0006 EXOFACTO Dizocilpine DESCRIPT Dizocilpine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 21.5 microM) DTD0006 EXOFACTO Dizocilpine MOACRIVE Inhibition DTD0006 EXOFACTO Dizocilpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Dolutegravir HIGHSTIT Approved Drug DTD0006 EXOFACTO Dolutegravir DESCRIPT Dolutegravir inhibits the transportation of Metformin by SLC22A2 DTD0006 EXOFACTO Dolutegravir DESCRIPT Dolutegravir inhibits the activity of SLC22A2 DTD0006 EXOFACTO Dolutegravir MOACRIVE Inhibition DTD0006 EXOFACTO Dolutegravir CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OCT2 DTD0006 EXOFACTO Doxepin HIGHSTIT Approved Drug DTD0006 EXOFACTO Doxepin DESCRIPT Doxepin inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 13 microM) DTD0006 EXOFACTO Doxepin MOACRIVE Inhibition DTD0006 EXOFACTO Doxepin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO DX-619 HIGHSTIT Discontinued Drug DTD0006 EXOFACTO DX-619 DESCRIPT DX-619 inhibits the transportation of Creatinine by SLC22A2 (Ki = 0.94 microM) DTD0006 EXOFACTO DX-619 MOACRIVE Inhibition DTD0006 EXOFACTO DX-619 CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0006 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A2 (IC50 > 30 microM) DTD0006 EXOFACTO Estradiol MOACRIVE Inhibition DTD0006 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Etilefrine HIGHSTIT Drug Withdrawn DTD0006 EXOFACTO Etilefrine DESCRIPT Etilefrine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 4009 microM) DTD0006 EXOFACTO Etilefrine MOACRIVE Inhibition DTD0006 EXOFACTO Etilefrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Famotidine HIGHSTIT Approved Drug DTD0006 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 114 microM) DTD0006 EXOFACTO Famotidine MOACRIVE Inhibition DTD0006 EXOFACTO Famotidine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Fenamiphos HIGHSTIT Natural Product DTD0006 EXOFACTO Fenamiphos DESCRIPT Fenamiphos inhibits the transportation of Rhodamine 123 by SLC22A2 (IC50 = 6.9 microM) DTD0006 EXOFACTO Fenamiphos DESCRIPT Fenamiphos inhibits the transportation of Dopamine by SLC22A2 (IC50 = 2.8 microM) DTD0006 EXOFACTO Fenamiphos MOACRIVE Inhibition DTD0006 EXOFACTO Fenamiphos CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Fenfluramine HIGHSTIT Drug Withdrawn DTD0006 EXOFACTO Fenfluramine DESCRIPT Fenfluramine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 10 microM) DTD0006 EXOFACTO Fenfluramine MOACRIVE Inhibition DTD0006 EXOFACTO Fenfluramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Fenitrothion HIGHSTIT Environmental toxicant DTD0006 EXOFACTO Fenitrothion DESCRIPT Fenitrothion inhibits the activity of SLC22A2 DTD0006 EXOFACTO Fenitrothion MOACRIVE Inhibition DTD0006 EXOFACTO Flecainide HIGHSTIT Approved Drug DTD0006 EXOFACTO Flecainide DESCRIPT Flecainide inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 191 microM) DTD0006 EXOFACTO Flecainide MOACRIVE Inhibition DTD0006 EXOFACTO Flecainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Flurazepam HIGHSTIT Approved Drug DTD0006 EXOFACTO Flurazepam DESCRIPT Flurazepam inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 60 microM) DTD0006 EXOFACTO Flurazepam DESCRIPT Flurazepam inhibits the activity of SLC22A2 DTD0006 EXOFACTO Flurazepam MOACRIVE Inhibition DTD0006 EXOFACTO Flurazepam CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0006 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic cation by SLC22A2 DTD0006 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0006 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0006 EXOFACTO Genistein DESCRIPT Genistein induces the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Genistein MOACRIVE Inhibition DTD0006 EXOFACTO Genistein CELLLINE Human enterocyte-like 2 cell (Caco-2); LLC-PK1 vesicles DTD0006 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0006 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic cation by SLC22A2 (IC50 = 117 microM) DTD0006 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0006 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Green tea HIGHSTIT Natural Product DTD0006 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Metformin by SLC22A2 DTD0006 EXOFACTO Green tea MOACRIVE Inhibition DTD0006 EXOFACTO Green tea CELLLINE Human enterocyte-like 2 cell (Caco-2)-OCT2 DTD0006 EXOFACTO Grepafloxacin HIGHSTIT Approved Drug DTD0006 EXOFACTO Grepafloxacin DESCRIPT Grepafloxacin inhibits the transportation of Creatinine by SLC22A2 (Ki = 10.4 microM) DTD0006 EXOFACTO Grepafloxacin MOACRIVE Inhibition DTD0006 EXOFACTO Grepafloxacin CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0006 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the activity of SLC22A2 DTD0006 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0006 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0006 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 6 microM) DTD0006 EXOFACTO Imipramine MOACRIVE Inhibition DTD0006 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0006 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLC22A2 DTD0006 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0006 EXOFACTO Ketamine HIGHSTIT Approved Drug DTD0006 EXOFACTO Ketamine DESCRIPT Ketamine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 22.7 microM) DTD0006 EXOFACTO Ketamine MOACRIVE Inhibition DTD0006 EXOFACTO Ketamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0006 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of SLC22A2 DTD0006 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0006 EXOFACTO Lidocaine HIGHSTIT Approved Drug DTD0006 EXOFACTO Lidocaine DESCRIPT Lidocaine inhibits the activity of SLC22A2 DTD0006 EXOFACTO Lidocaine MOACRIVE Inhibition DTD0006 EXOFACTO Malathion HIGHSTIT Approved Drug DTD0006 EXOFACTO Malathion DESCRIPT Malathion inhibits the activity of SLC22A2 DTD0006 EXOFACTO Malathion MOACRIVE Inhibition DTD0006 EXOFACTO Mefloquine HIGHSTIT Approved Drug DTD0006 EXOFACTO Mefloquine DESCRIPT Mefloquine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 204 microM) DTD0006 EXOFACTO Mefloquine MOACRIVE Inhibition DTD0006 EXOFACTO Mefloquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Memantine HIGHSTIT Approved Drug DTD0006 EXOFACTO Memantine DESCRIPT Memantine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 7.3 microM) DTD0006 EXOFACTO Memantine MOACRIVE Inhibition DTD0006 EXOFACTO Memantine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0006 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 521 microM) DTD0006 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 398 microM) DTD0006 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 1380 microM) DTD0006 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 289 microM) DTD0006 EXOFACTO Metformin MOACRIVE Inhibition DTD0006 EXOFACTO Metformin CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0006 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of Cimetidine by SLC22A2 DTD0006 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0006 EXOFACTO Mexiletine HIGHSTIT Approved Drug DTD0006 EXOFACTO Mexiletine DESCRIPT Mexiletine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 55 microM) DTD0006 EXOFACTO Mexiletine DESCRIPT Mexiletine inhibits the activity of SLC22A2 DTD0006 EXOFACTO Mexiletine MOACRIVE Inhibition DTD0006 EXOFACTO Mexiletine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Mianserin HIGHSTIT Approved Drug DTD0006 EXOFACTO Mianserin DESCRIPT Mianserin inhibits the activity of SLC22A2 DTD0006 EXOFACTO Mianserin MOACRIVE Inhibition DTD0006 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0006 EXOFACTO Naringenin DESCRIPT Naringenin induces the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Naringenin MOACRIVE Inhibition DTD0006 EXOFACTO Naringenin CELLLINE Human enterocyte-like 2 cell (Caco-2); LLC-PK1 vesicles DTD0006 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0006 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Nicotine MOACRIVE Inhibition DTD0006 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO N-methylpyridinium HIGHSTIT Drug in Preclinical Test DTD0006 EXOFACTO N-methylpyridinium DESCRIPT N-methylpyridinium inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 2.4 microM) DTD0006 EXOFACTO N-methylpyridinium DESCRIPT N-methylpyridinium inhibits the transportation of YM155 by SLC22A2 (IC50 = 4.42 microM) DTD0006 EXOFACTO N-methylpyridinium MOACRIVE Inhibition DTD0006 EXOFACTO N-methylpyridinium CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO N-methylpyridinium CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Oxprenolol HIGHSTIT Approved Drug DTD0006 EXOFACTO Oxprenolol DESCRIPT Oxprenolol inhibits the transportation of Cimetidine by SLC22A2 DTD0006 EXOFACTO Oxprenolol MOACRIVE Inhibition DTD0006 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0006 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic cation by SLC22A2 (IC50 > 1000 microM) DTD0006 EXOFACTO Patulin MOACRIVE Inhibition DTD0006 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0006 EXOFACTO Pentamidine HIGHSTIT Approved Drug DTD0006 EXOFACTO Pentamidine DESCRIPT Pentamidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 10.6 microM) DTD0006 EXOFACTO Pentamidine MOACRIVE Inhibition DTD0006 EXOFACTO Pentamidine CELLLINE Chinese hamster ovary (CHO) cells-OCT2 DTD0006 EXOFACTO Phencyclidine HIGHSTIT Investigative Drug DTD0006 EXOFACTO Phencyclidine DESCRIPT Phencyclidine inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 24.9 microM) DTD0006 EXOFACTO Phencyclidine MOACRIVE Inhibition DTD0006 EXOFACTO Phencyclidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0006 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 111 microM) DTD0006 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of N-methylpyridinium by SLC22A2 (Ki = 54 microM) DTD0006 EXOFACTO Phenformin MOACRIVE Inhibition DTD0006 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Phenoxybenzamine HIGHSTIT Approved Drug DTD0006 EXOFACTO Phenoxybenzamine DESCRIPT Phenoxybenzamine inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A2 (IC50 = 4.9 microM) DTD0006 EXOFACTO Phenoxybenzamine MOACRIVE Inhibition DTD0006 EXOFACTO Phenoxybenzamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Phosmet HIGHSTIT Natural Product DTD0006 EXOFACTO Phosmet DESCRIPT Phosmet inhibits the transportation of Dopamine by SLC22A2 (IC50 = 3.6 microM) DTD0006 EXOFACTO Phosmet DESCRIPT Phosmet inhibits the transportation of Rhodamine 123 by SLC22A2 (IC50 = 7.9 microM) DTD0006 EXOFACTO Phosmet MOACRIVE Inhibition DTD0006 EXOFACTO Phosmet CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Pilsicainide HIGHSTIT Approved Drug DTD0006 EXOFACTO Pilsicainide DESCRIPT Pilsicainide inhibits the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Pilsicainide MOACRIVE Inhibition DTD0006 EXOFACTO Pilsicainide CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Piperine HIGHSTIT Natural Product DTD0006 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Metformin by SLC22A2 (IC50 = 3.727 microM) DTD0006 EXOFACTO Piperine DESCRIPT Piperine inhibits the transportation of Serotonin by SLC22A2 (IC50 = 5.4 microM) DTD0006 EXOFACTO Piperine MOACRIVE Inhibition DTD0006 EXOFACTO Piperine CELLLINE Madin darby canine kidney strain cell line (MDCK)-OCT2 DTD0006 EXOFACTO Plazomicin HIGHSTIT Approved Drug DTD0006 EXOFACTO Plazomicin DESCRIPT Plazomicin inhibits the activity of SLC22A2 DTD0006 EXOFACTO Plazomicin MOACRIVE Inhibition DTD0006 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0006 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of YM155 by SLC22A2 (IC50 = 80.4 microM) DTD0006 EXOFACTO Prazosin MOACRIVE Inhibition DTD0006 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0006 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of YM155 by SLC22A2 (IC50 = 91.9 microM) DTD0006 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 50 microM) DTD0006 EXOFACTO Procainamide MOACRIVE Inhibition DTD0006 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Procainamide CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0006 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A2 (IC50 = 26.7 microM) DTD0006 EXOFACTO Progesterone MOACRIVE Inhibition DTD0006 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0006 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 25 microM) DTD0006 EXOFACTO Propafenone MOACRIVE Inhibition DTD0006 EXOFACTO Propafenone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0006 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 229 microM) DTD0006 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the activity of SLC22A2 DTD0006 EXOFACTO Propranolol MOACRIVE Inhibition DTD0006 EXOFACTO Propranolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Pyridine HIGHSTIT Drug in Phase 4 Trial DTD0006 EXOFACTO Pyridine DESCRIPT Pyridine inhibits the transportation of Tetraethylammonium by SLC22A2 (IC50 = 790 microM) DTD0006 EXOFACTO Pyridine MOACRIVE Inhibition DTD0006 EXOFACTO Pyridine CELLLINE Chinese hamster ovary (CHO) cells-OCT2 DTD0006 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0006 EXOFACTO Quercetin DESCRIPT Quercetin induces the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Quercetin MOACRIVE Inhibition DTD0006 EXOFACTO Quercetin CELLLINE Human enterocyte-like 2 cell (Caco-2); LLC-PK1 vesicles DTD0006 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 13.3 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 8.7 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC22A2 (Ki = 3.4 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of YM155 by SLC22A2 (IC50 = 11 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 87 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 23 microM) DTD0006 EXOFACTO Quinine DESCRIPT Quinine inhibits the activity of SLC22A2 DTD0006 EXOFACTO Quinine MOACRIVE Inhibition DTD0006 EXOFACTO Quinine CELLLINE Chinese hamster ovary (CHO) cells-OCT2 DTD0006 EXOFACTO Quinine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Quinine CELLLINE Xenopus laevis oocytes-OCT2 DTD0006 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0006 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 1617 microM) DTD0006 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 76 microM) DTD0006 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Famotidine by SLC22A2 (Ki = 30.5 microM) DTD0006 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Cimetidine by SLC22A2 (Ki = 79 microM) DTD0006 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0006 EXOFACTO Ranitidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Ranitidine CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Sibutramine HIGHSTIT Approved Drug DTD0006 EXOFACTO Sibutramine DESCRIPT Sibutramine inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 29 microM) DTD0006 EXOFACTO Sibutramine MOACRIVE Inhibition DTD0006 EXOFACTO Sibutramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0006 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 87 microM) DTD0006 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0006 EXOFACTO Tamoxifen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0006 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of SLC22A2 (IC50 = 0.0064 microM) DTD0006 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of SLC22A2 DTD0006 EXOFACTO Telaprevir MOACRIVE Inhibition DTD0006 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0006 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the activity of SLC22A2 (IC50 = 3 microM) DTD0006 EXOFACTO Testosterone MOACRIVE Inhibition DTD0006 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0006 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 222 microM) DTD0006 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 189.2 microM) DTD0006 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0006 EXOFACTO Tetraethylammonium CELLLINE Oocytes-OCT2 DTD0006 EXOFACTO Tetraethylammonium CELLLINE Chinese hamster ovary (CHO) cells-OCT2 DTD0006 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0006 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Verapamil by SLC22A2 (IC50 = 11.2 microM) DTD0006 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0006 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Triazolam HIGHSTIT Approved Drug DTD0006 EXOFACTO Triazolam DESCRIPT Triazolam inhibits the activity of SLC22A2 DTD0006 EXOFACTO Triazolam MOACRIVE Inhibition DTD0006 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0006 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 1318 microM) DTD0006 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0006 EXOFACTO Trimethoprim CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0006 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of SLC22A2 DTD0006 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0006 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0006 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of YM155 by SLC22A2 (IC50 = 13.4 microM) DTD0006 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 85 microM) DTD0006 EXOFACTO Verapamil MOACRIVE Inhibition DTD0006 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Vitamin B1 HIGHSTIT Approved Drug DTD0006 EXOFACTO Vitamin B1 DESCRIPT Vitamin B1 inhibits the transportation of Tetraethylammonium by SLC22A2 DTD0006 EXOFACTO Vitamin B1 MOACRIVE Inhibition DTD0006 EXOFACTO Vitamin B1 CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Vorinostat HIGHSTIT Approved Drug DTD0006 EXOFACTO Vorinostat DESCRIPT Vorinostat inhibits histone deacetylase, which then enhances Oxaliplatin's transportation via increasing the histone acethylation level of SLC22A2 (IC50 = 4.69 microM) DTD0006 EXOFACTO Vorinostat MOACRIVE Inducer DTD0006 EXOFACTO Vorinostat CELLLINE Human renal cell carcinoma cells (RCC) DTD0006 EXOFACTO YM155 HIGHSTIT Drug in Phase 2 Trial DTD0006 EXOFACTO YM155 DESCRIPT YM155 inhibits the transportation of N-methylpyridinium by SLC22A2 (IC50 = 15.9 microM) DTD0006 EXOFACTO YM155 MOACRIVE Inhibition DTD0006 EXOFACTO YM155 CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT2 DTD0006 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0006 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic cation by SLC22A2 (IC50 = 24.8 microM) DTD0006 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0006 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OCT2 DTD0007 TRANSPID DTD0007 DTD0007 GENENAME SLC47A1 DTD0007 PROTNAME Multidrug and toxin extrusion protein 1 DTD0007 GENEDBID 55244 DTD0007 UNIPROID Q96FL8 DTD0007 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0007 EXOFACTO Allethrin DESCRIPT Allethrin inhibits the transportation of Verapamil by SLC47A1 (IC50 = 50.2 microM) DTD0007 EXOFACTO Allethrin MOACRIVE Inhibition DTD0007 EXOFACTO Allethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0007 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 111.8 microM) DTD0007 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Amantadine MOACRIVE Inhibition DTD0007 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0007 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Astemizole MOACRIVE Inhibition DTD0007 EXOFACTO Astemizole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Azacitidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Azacitidine DESCRIPT Azacitidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Azacitidine MOACRIVE Inhibition DTD0007 EXOFACTO Azacitidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Bithionol HIGHSTIT Drug Withdrawn DTD0007 EXOFACTO Bithionol DESCRIPT Bithionol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Bithionol MOACRIVE Inhibition DTD0007 EXOFACTO Bithionol CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0007 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Buspirone MOACRIVE Inhibition DTD0007 EXOFACTO Buspirone CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Camostat HIGHSTIT Drug in Phase 2 Trial DTD0007 EXOFACTO Camostat DESCRIPT Camostat inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Camostat MOACRIVE Inhibition DTD0007 EXOFACTO Camostat CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Carvedilol HIGHSTIT Approved Drug DTD0007 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the activity of SLC47A1 (IC50 = 103 microM) DTD0007 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Carvedilol MOACRIVE Inhibition DTD0007 EXOFACTO Carvedilol CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO CB3304 HIGHSTIT Drug in Phase 1/2 Trial DTD0007 EXOFACTO CB3304 DESCRIPT CB3304 inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO CB3304 MOACRIVE Inhibition DTD0007 EXOFACTO CB3304 CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0007 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 371.2 microM) DTD0007 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0007 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Chlorhexidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Chlorhexidine DESCRIPT Chlorhexidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Chlorhexidine MOACRIVE Inhibition DTD0007 EXOFACTO Chlorhexidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0007 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of Metformin by SLC47A1 (IC50 = 2.5 microM) DTD0007 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the activity of SLC47A1 DTD0007 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0007 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Chlorpheniramine HIGHSTIT Approved Drug DTD0007 EXOFACTO Chlorpheniramine DESCRIPT Chlorpheniramine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 87.6 microM) DTD0007 EXOFACTO Chlorpheniramine MOACRIVE Inhibition DTD0007 EXOFACTO Chlorpheniramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Ciclopirox HIGHSTIT Approved Drug DTD0007 EXOFACTO Ciclopirox DESCRIPT Ciclopirox inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Ciclopirox MOACRIVE Inhibition DTD0007 EXOFACTO Ciclopirox CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0007 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Verapamil by repressing mRNA expression of SLC47A1 (IC50 = 6.1 microM) DTD0007 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLC47A1 (IC50 = 6.1 microM) DTD0007 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0007 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-MATE1 DTD0007 EXOFACTO Cigarette smoke condensate CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 1.1 microM) DTD0007 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Metformin by SLC47A1 (Ki = 3.8 microM) DTD0007 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0007 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Clonidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Clonidine MOACRIVE Inhibition DTD0007 EXOFACTO Clonidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Cobicistat HIGHSTIT Approved Drug DTD0007 EXOFACTO Cobicistat DESCRIPT Cobicistat inhibits the activity of SLC47A1 (IC50 = 4.4 microM) DTD0007 EXOFACTO Cobicistat MOACRIVE Inhibition DTD0007 EXOFACTO Cortisone HIGHSTIT Approved Drug DTD0007 EXOFACTO Cortisone DESCRIPT Cortisone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Cortisone MOACRIVE Inhibition DTD0007 EXOFACTO Cortisone CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Crizotinib HIGHSTIT Approved Drug DTD0007 EXOFACTO Crizotinib DESCRIPT Crizotinib inhibits the transportation of Creatinine by SLC47A1 DTD0007 EXOFACTO Crizotinib MOACRIVE Inhibition DTD0007 EXOFACTO Crizotinib CELLLINE MATE1-overexpressing cells DTD0007 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0007 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 55.7 microM) DTD0007 EXOFACTO Desipramine MOACRIVE Inhibition DTD0007 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0007 EXOFACTO Dexamethasone DESCRIPT Dexamethasone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Dexamethasone MOACRIVE Inhibition DTD0007 EXOFACTO Dexamethasone CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0007 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0007 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Dihydroergotamine HIGHSTIT Approved Drug DTD0007 EXOFACTO Dihydroergotamine DESCRIPT Dihydroergotamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Dihydroergotamine MOACRIVE Inhibition DTD0007 EXOFACTO Dihydroergotamine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0007 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 12.5 microM) DTD0007 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0007 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Diphenhydramine HIGHSTIT Approved Drug DTD0007 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 87 microM) DTD0007 EXOFACTO Diphenhydramine MOACRIVE Inhibition DTD0007 EXOFACTO Diphenhydramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0007 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 83.8 microM) DTD0007 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0007 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Domperidone HIGHSTIT Approved Drug DTD0007 EXOFACTO Domperidone DESCRIPT Domperidone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Domperidone MOACRIVE Inhibition DTD0007 EXOFACTO Domperidone CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO DX-619 HIGHSTIT Discontinued Drug DTD0007 EXOFACTO DX-619 DESCRIPT DX-619 inhibits the transportation of Creatinine by SLC47A1 (Ki = 0.82 microM) DTD0007 EXOFACTO DX-619 MOACRIVE Inhibition DTD0007 EXOFACTO DX-619 CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0007 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Enalapril MOACRIVE Inhibition DTD0007 EXOFACTO Enalapril CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Epigallocatechin gallate HIGHSTIT Natural Product DTD0007 EXOFACTO Epigallocatechin gallate DESCRIPT Epigallocatechin gallate inhibits the transportation of Metformin by SLC47A1 DTD0007 EXOFACTO Epigallocatechin gallate MOACRIVE Inhibition DTD0007 EXOFACTO Epigallocatechin gallate CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Epinastine HIGHSTIT Approved Drug DTD0007 EXOFACTO Epinastine DESCRIPT Epinastine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Epinastine MOACRIVE Inhibition DTD0007 EXOFACTO Epinastine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0007 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0007 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Ethinyl estradiol HIGHSTIT Approved Drug DTD0007 EXOFACTO Ethinyl estradiol DESCRIPT Ethinyl estradiol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Ethinyl estradiol MOACRIVE Inhibition DTD0007 EXOFACTO Ethinyl estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Famotidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 0.6 microM) DTD0007 EXOFACTO Famotidine MOACRIVE Inhibition DTD0007 EXOFACTO Famotidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0007 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Furosemide MOACRIVE Inhibition DTD0007 EXOFACTO Furosemide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Gabexate HIGHSTIT Approved Drug DTD0007 EXOFACTO Gabexate DESCRIPT Gabexate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Gabexate MOACRIVE Inhibition DTD0007 EXOFACTO Gabexate CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Granisetron HIGHSTIT Approved Drug DTD0007 EXOFACTO Granisetron DESCRIPT Granisetron inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Granisetron MOACRIVE Inhibition DTD0007 EXOFACTO Granisetron CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Green tea HIGHSTIT Natural Product DTD0007 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Metformin by SLC47A1 DTD0007 EXOFACTO Green tea MOACRIVE Inhibition DTD0007 EXOFACTO Green tea CELLLINE Human enterocyte-like 2 cell (Caco-2)-MATE1 DTD0007 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0007 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 42 microM) DTD0007 EXOFACTO Imipramine MOACRIVE Inhibition DTD0007 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0007 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0007 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0007 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0007 EXOFACTO Irbesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Irinotecan HIGHSTIT Approved Drug DTD0007 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Irinotecan MOACRIVE Inhibition DTD0007 EXOFACTO Irinotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Isorhamnetin HIGHSTIT Natural Product DTD0007 EXOFACTO Isorhamnetin DESCRIPT Isorhamnetin inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 0.32 microM) DTD0007 EXOFACTO Isorhamnetin MOACRIVE Inhibition DTD0007 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0007 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLC47A1 DTD0007 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0007 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0007 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of SLC47A1 DTD0007 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0007 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0007 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0007 EXOFACTO Levofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Lidocaine HIGHSTIT Approved Drug DTD0007 EXOFACTO Lidocaine DESCRIPT Lidocaine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Lidocaine MOACRIVE Inhibition DTD0007 EXOFACTO Lidocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0007 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Losartan MOACRIVE Inhibition DTD0007 EXOFACTO Losartan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0007 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 666.9 microM) DTD0007 EXOFACTO Metformin DESCRIPT Metformin modulates the activity of SLC47A1 DTD0007 EXOFACTO Metformin MOACRIVE Inhibition DTD0007 EXOFACTO Metformin MOACRIVE Modulator DTD0007 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Methylergonovine HIGHSTIT Approved Drug DTD0007 EXOFACTO Methylergonovine DESCRIPT Methylergonovine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Methylergonovine MOACRIVE Inhibition DTD0007 EXOFACTO Methylergonovine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0007 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Tetraethylammonium by SLC47A1 (IC50 = 5.2 microM) DTD0007 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Metformin by SLC47A1 (IC50 = 4.4 microM) DTD0007 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0007 EXOFACTO Mitoxantrone CELLLINE Human cervical cancer cell line (Hela)-MATE1 DTD0007 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0007 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0007 EXOFACTO Phenacetin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Plazomicin HIGHSTIT Approved Drug DTD0007 EXOFACTO Plazomicin DESCRIPT Plazomicin inhibits the activity of SLC47A1 DTD0007 EXOFACTO Plazomicin MOACRIVE Inhibition DTD0007 EXOFACTO Pramipexole HIGHSTIT Approved Drug DTD0007 EXOFACTO Pramipexole DESCRIPT Pramipexole inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 141.4 microM) DTD0007 EXOFACTO Pramipexole MOACRIVE Inhibition DTD0007 EXOFACTO Pramipexole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0007 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Prazosin MOACRIVE Inhibition DTD0007 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0007 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 217 microM) DTD0007 EXOFACTO Procainamide MOACRIVE Inhibition DTD0007 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0007 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of 1-methyl-4-phenylpyridinium by SLC47A1 (IC50 = 1.9 microM) DTD0007 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 29.2 microM) DTD0007 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Quinine MOACRIVE Inhibition DTD0007 EXOFACTO Quinine CELLLINE Chinese hamster ovary (CHO) cells-MATE1 DTD0007 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0007 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Tetraethylammonium by SLC47A1 (IC50 = 17.5 microM) DTD0007 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Metformin by SLC47A1 (IC50 = 18.9 microM) DTD0007 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 25.4 microM) DTD0007 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0007 EXOFACTO Ranitidine CELLLINE Human cervical cancer cell line (Hela)-MATE1 DTD0007 EXOFACTO Ranitidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Rapamycin HIGHSTIT Approved Drug DTD0007 EXOFACTO Rapamycin DESCRIPT Rapamycin inhibits the transportation of Tetraethylammonium by SLC47A1 (IC50 = 3.51 microM) DTD0007 EXOFACTO Rapamycin DESCRIPT Rapamycin inhibits the transportation of Metformin by SLC47A1 (IC50 = 3.27 microM) DTD0007 EXOFACTO Rapamycin MOACRIVE Inhibition DTD0007 EXOFACTO Rapamycin CELLLINE Human cervical cancer cell line (Hela)-MATE1 DTD0007 EXOFACTO Rimantadine HIGHSTIT Approved Drug DTD0007 EXOFACTO Rimantadine DESCRIPT Rimantadine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Rimantadine MOACRIVE Inhibition DTD0007 EXOFACTO Rimantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0007 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Tetraethylammonium by SLC47A1 (IC50 = 13.9 microM) DTD0007 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Metformin by SLC47A1 (IC50 = 15.4 microM) DTD0007 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of SLC47A1 (IC50 = 3.1 microM) DTD0007 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0007 EXOFACTO Ritonavir CELLLINE Human cervical cancer cell line (Hela)-MATE1 DTD0007 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0007 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0007 EXOFACTO Spironolactone CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Sulfacetamide HIGHSTIT Approved Drug DTD0007 EXOFACTO Sulfacetamide DESCRIPT Sulfacetamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Sulfacetamide MOACRIVE Inhibition DTD0007 EXOFACTO Sulfacetamide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Sumatriptan HIGHSTIT Approved Drug DTD0007 EXOFACTO Sumatriptan DESCRIPT Sumatriptan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Sumatriptan MOACRIVE Inhibition DTD0007 EXOFACTO Sumatriptan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Talipexole HIGHSTIT Drug in Phase 4 Trial DTD0007 EXOFACTO Talipexole DESCRIPT Talipexole inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 66 microM) DTD0007 EXOFACTO Talipexole MOACRIVE Inhibition DTD0007 EXOFACTO Talipexole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0007 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of SLC47A1 (IC50 = 0.023 microM) DTD0007 EXOFACTO Telaprevir MOACRIVE Inhibition DTD0007 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0007 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0007 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0007 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Verapamil by SLC47A1 (IC50 = 47.5 microM) DTD0007 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0007 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Thiabendazole HIGHSTIT Approved Drug DTD0007 EXOFACTO Thiabendazole DESCRIPT Thiabendazole inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Thiabendazole MOACRIVE Inhibition DTD0007 EXOFACTO Thiabendazole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Topotecan HIGHSTIT Approved Drug DTD0007 EXOFACTO Topotecan DESCRIPT Topotecan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Topotecan MOACRIVE Inhibition DTD0007 EXOFACTO Topotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0007 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the activity of SLC47A1 DTD0007 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0007 EXOFACTO Tubocurarine HIGHSTIT Approved Drug DTD0007 EXOFACTO Tubocurarine DESCRIPT Tubocurarine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Tubocurarine MOACRIVE Inhibition DTD0007 EXOFACTO Tubocurarine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0007 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Tetraethylammonium by SLC47A1 (Ki = 27.5 microM) DTD0007 EXOFACTO Verapamil MOACRIVE Inhibition DTD0007 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0007 EXOFACTO Zafirlukast HIGHSTIT Approved Drug DTD0007 EXOFACTO Zafirlukast DESCRIPT Zafirlukast inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC47A1 DTD0007 EXOFACTO Zafirlukast MOACRIVE Inhibition DTD0007 EXOFACTO Zafirlukast CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE1 DTD0008 TRANSPID DTD0008 DTD0008 GENENAME SLCO1B1 DTD0008 PROTNAME Organic anion transporting polypeptide 1B1 DTD0008 GENEDBID 10599 DTD0008 UNIPROID Q9Y6L6 DTD0008 EXOFACTO (-)-epicatechin-3-gallate HIGHSTIT Natural Product DTD0008 EXOFACTO (-)-epicatechin-3-gallate DESCRIPT (-)-epicatechin-3-gallate inhibits the activity of SLCO1B1 in a substrate-dependent manner (IC50 = 59 microM) DTD0008 EXOFACTO (-)-epicatechin-3-gallate MOACRIVE Inhibition DTD0008 EXOFACTO (-)-epicatechin-3-gallate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO (-)-epigallocatechin-3-gallate HIGHSTIT Natural Product DTD0008 EXOFACTO (-)-epigallocatechin-3-gallate DESCRIPT (-)-epigallocatechin-3-gallate inhibits the activity of SLCO1B1 in a substrate-dependent manner (IC50 = 8 microM) DTD0008 EXOFACTO (-)-epigallocatechin-3-gallate MOACRIVE Inhibition DTD0008 EXOFACTO (-)-epigallocatechin-3-gallate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Acarbose HIGHSTIT Approved Drug DTD0008 EXOFACTO Acarbose DESCRIPT Acarbose inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Acarbose MOACRIVE Inhibition DTD0008 EXOFACTO Acarbose CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Acyclovir HIGHSTIT Approved Drug DTD0008 EXOFACTO Acyclovir DESCRIPT Acyclovir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Acyclovir MOACRIVE Inhibition DTD0008 EXOFACTO Acyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0008 EXOFACTO Allethrin DESCRIPT Allethrin inhibits the transportation of Fluorescein by SLCO1B1 (IC50 = 16.5 microM) DTD0008 EXOFACTO Allethrin MOACRIVE Inhibition DTD0008 EXOFACTO Allethrin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Allopurinol HIGHSTIT Approved Drug DTD0008 EXOFACTO Allopurinol DESCRIPT Allopurinol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Allopurinol MOACRIVE Inhibition DTD0008 EXOFACTO Allopurinol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0008 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Amantadine MOACRIVE Inhibition DTD0008 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0008 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0008 EXOFACTO Aminohippuric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Amiodarone HIGHSTIT Approved Drug DTD0008 EXOFACTO Amiodarone DESCRIPT Amiodarone inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Amiodarone MOACRIVE Inhibition DTD0008 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0008 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0008 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Amodiaquine HIGHSTIT Approved Drug DTD0008 EXOFACTO Amodiaquine DESCRIPT Amodiaquine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Amodiaquine MOACRIVE Inhibition DTD0008 EXOFACTO Amodiaquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Amprenavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 14.4 microM; Ki = 12.8 microM) DTD0008 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Amprenavir MOACRIVE Inhibition DTD0008 EXOFACTO Amprenavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Amprenavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0008 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Astemizole MOACRIVE Inhibition DTD0008 EXOFACTO Astemizole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Asunaprevir HIGHSTIT Drug in Phase 3 Trial DTD0008 EXOFACTO Asunaprevir DESCRIPT Asunaprevir inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Asunaprevir MOACRIVE Inhibition DTD0008 EXOFACTO Atazanavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 1.7 microM; Ki = 1.5 microM) DTD0008 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Atazanavir MOACRIVE Inhibition DTD0008 EXOFACTO Atazanavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Atazanavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Atenolol HIGHSTIT Approved Drug DTD0008 EXOFACTO Atenolol DESCRIPT Atenolol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Atenolol MOACRIVE Inhibition DTD0008 EXOFACTO Atenolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Atomoxetine HIGHSTIT Approved Drug DTD0008 EXOFACTO Atomoxetine DESCRIPT Atomoxetine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Atomoxetine MOACRIVE Inhibition DTD0008 EXOFACTO Atomoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Atorvastatin DESCRIPT Atorvastatin induces the activity of SLCO1B1 DTD0008 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0008 EXOFACTO Atorvastatin MOACRIVE Inducer DTD0008 EXOFACTO Atorvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Baicalin HIGHSTIT Discontinued Drug DTD0008 EXOFACTO Baicalin DESCRIPT Baicalin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Baicalin MOACRIVE Inhibition DTD0008 EXOFACTO Baicalin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0008 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0008 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0008 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0008 EXOFACTO Benzylpenicillin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Berberine HIGHSTIT Drug in Phase 4 Trial DTD0008 EXOFACTO Berberine DESCRIPT Berberine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Berberine MOACRIVE Inhibition DTD0008 EXOFACTO Berberine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Bestatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Bestatin DESCRIPT Bestatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Bestatin MOACRIVE Inhibition DTD0008 EXOFACTO Bestatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Bezafibrate HIGHSTIT Approved Drug DTD0008 EXOFACTO Bezafibrate DESCRIPT Bezafibrate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 45.2 microM) DTD0008 EXOFACTO Bezafibrate DESCRIPT Bezafibrate inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Bezafibrate MOACRIVE Inhibition DTD0008 EXOFACTO Bezafibrate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Biochanin A HIGHSTIT Natural Product DTD0008 EXOFACTO Biochanin A DESCRIPT Biochanin A inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 (IC50 = 11.3 microM; Ki = 10.2 microM) DTD0008 EXOFACTO Biochanin A MOACRIVE Inhibition DTD0008 EXOFACTO Biochanin A CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Boceprevir HIGHSTIT Approved Drug DTD0008 EXOFACTO Boceprevir DESCRIPT Boceprevir inhibits the activity of SLCO1B1 (IC50 = 18 microM) DTD0008 EXOFACTO Boceprevir MOACRIVE Inhibition DTD0008 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0008 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 0.7 microM; Ki = 0.6 microM) DTD0008 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO1B1 (IC50 = 1.7 microM) DTD0008 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.08 microM) DTD0008 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0008 EXOFACTO Bromsulphthalein CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Bromsulphthalein CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS1)-OATP2B1 DTD0008 EXOFACTO Bromsulphthalein CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Bucladesine HIGHSTIT Discontinued Drug DTD0008 EXOFACTO Bucladesine DESCRIPT Bucladesine induces the activity of SLCO1B1 DTD0008 EXOFACTO Bucladesine MOACRIVE Inducer DTD0008 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0008 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Budesonide MOACRIVE Inhibition DTD0008 EXOFACTO Budesonide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0008 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Bupropion MOACRIVE Inhibition DTD0008 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0008 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Buspirone MOACRIVE Inhibition DTD0008 EXOFACTO Buspirone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0008 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Caffeine MOACRIVE Inhibition DTD0008 EXOFACTO Caffeine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0008 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Candesartan MOACRIVE Inhibition DTD0008 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0008 EXOFACTO Captopril DESCRIPT Captopril inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Captopril MOACRIVE Inhibition DTD0008 EXOFACTO Captopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Carbamazepine HIGHSTIT Approved Drug DTD0008 EXOFACTO Carbamazepine DESCRIPT Carbamazepine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Carbamazepine MOACRIVE Inhibition DTD0008 EXOFACTO Carbamazepine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Caspofungin HIGHSTIT Approved Drug DTD0008 EXOFACTO Caspofungin DESCRIPT Caspofungin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B1 DTD0008 EXOFACTO Caspofungin MOACRIVE Inhibition DTD0008 EXOFACTO Caspofungin CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0008 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0008 EXOFACTO Cefadroxil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0008 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0008 EXOFACTO Cefamandole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0008 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0008 EXOFACTO Celecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cerivastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cerivastatin MOACRIVE Inhibition DTD0008 EXOFACTO Cerivastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0008 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0008 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Chelerythrine HIGHSTIT Investigative Drug DTD0008 EXOFACTO Chelerythrine DESCRIPT Chelerythrine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Chelerythrine MOACRIVE Inhibition DTD0008 EXOFACTO Chelerythrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0008 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 3.4 microM) DTD0008 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Chenodeoxycholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Chenodeoxycholic acid CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0008 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0008 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0008 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0008 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Chlorprothixene HIGHSTIT Approved Drug DTD0008 EXOFACTO Chlorprothixene DESCRIPT Chlorprothixene inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Chlorprothixene MOACRIVE Inhibition DTD0008 EXOFACTO Chlorprothixene CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Chlorzoxazone HIGHSTIT Approved Drug DTD0008 EXOFACTO Chlorzoxazone DESCRIPT Chlorzoxazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Chlorzoxazone MOACRIVE Inhibition DTD0008 EXOFACTO Chlorzoxazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cholic acid HIGHSTIT Approved Drug DTD0008 EXOFACTO Cholic acid DESCRIPT Cholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 25 microM) DTD0008 EXOFACTO Cholic acid DESCRIPT Cholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Cholic acid CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Cholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0008 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Estrone sulfate by by repressing mRNA expression of SLCO1B1 (IC50 = 7.2 microM) DTD0008 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLCO1B1 (IC50 = 7.2 microM) DTD0008 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0008 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-OATP1B1 DTD0008 EXOFACTO Cigarette smoke condensate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0008 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0008 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0008 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0008 EXOFACTO Clarithromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 9 microM) DTD0008 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 7.6 microM) DTD0008 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0008 EXOFACTO Clotrimazole CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Clotrimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Colchicine HIGHSTIT Approved Drug DTD0008 EXOFACTO Colchicine DESCRIPT Colchicine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Colchicine MOACRIVE Inhibition DTD0008 EXOFACTO Colchicine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Coumarin HIGHSTIT Investigative Drug DTD0008 EXOFACTO Coumarin DESCRIPT Coumarin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Coumarin MOACRIVE Inhibition DTD0008 EXOFACTO Coumarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Coumestrol HIGHSTIT Investigative Drug DTD0008 EXOFACTO Coumestrol DESCRIPT Coumestrol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Coumestrol MOACRIVE Inhibition DTD0008 EXOFACTO Coumestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rosuvastatin by SLCO1B1 (IC50 = 2.2 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rosuvastatin by SLCO1B1 (IC50 = 0.31 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.37 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 3.5 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.24 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Phalloidin by SLCO1B1 (Ki = 0.2 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bosentan by SLCO1B1 (IC50 = 0.3 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Cerivastatin by SLCO1B1 (Ki = 0.238 microM) DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Pitavastatin calcium by SLCO1B1 DTD0008 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0008 EXOFACTO Cyclosporine CELLLINE Oocytes-OATP1B1 DTD0008 EXOFACTO Cyclosporine CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Cyclosporine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Cyclosporine CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Daidzein HIGHSTIT Investigative Drug DTD0008 EXOFACTO Daidzein DESCRIPT Daidzein inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Daidzein MOACRIVE Inhibition DTD0008 EXOFACTO Daidzein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Darunavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Darunavir DESCRIPT Darunavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 3.5 microM; Ki = 3.1 microM) DTD0008 EXOFACTO Darunavir MOACRIVE Inhibition DTD0008 EXOFACTO Darunavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Dehydrocholic acid HIGHSTIT Approved Drug DTD0008 EXOFACTO Dehydrocholic acid DESCRIPT Dehydrocholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 29.7 microM) DTD0008 EXOFACTO Dehydrocholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Dehydrocholic acid CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0008 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Desipramine MOACRIVE Inhibition DTD0008 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0008 EXOFACTO Dexamethasone DESCRIPT Dexamethasone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Dexamethasone MOACRIVE Inhibition DTD0008 EXOFACTO Dexamethasone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Dextromethorphan HIGHSTIT Approved Drug DTD0008 EXOFACTO Dextromethorphan DESCRIPT Dextromethorphan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Dextromethorphan MOACRIVE Inhibition DTD0008 EXOFACTO Dextromethorphan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Diazepam HIGHSTIT Approved Drug DTD0008 EXOFACTO Diazepam DESCRIPT Diazepam inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Diazepam MOACRIVE Inhibition DTD0008 EXOFACTO Diazepam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0008 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0008 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Diethylstilbestrol HIGHSTIT Approved Drug DTD0008 EXOFACTO Diethylstilbestrol DESCRIPT Diethylstilbestrol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Diethylstilbestrol MOACRIVE Inhibition DTD0008 EXOFACTO Diethylstilbestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0008 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 7.9 microM; Ki = 7 microM) DTD0008 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Digoxin MOACRIVE Inhibition DTD0008 EXOFACTO Digoxin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Digoxin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0008 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0008 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0008 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0008 EXOFACTO Dipyridamole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0008 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0008 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Disulfiram HIGHSTIT Approved Drug DTD0008 EXOFACTO Disulfiram DESCRIPT Disulfiram inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Disulfiram MOACRIVE Inhibition DTD0008 EXOFACTO Disulfiram CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Dofetilide HIGHSTIT Approved Drug DTD0008 EXOFACTO Dofetilide DESCRIPT Dofetilide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Dofetilide MOACRIVE Inhibition DTD0008 EXOFACTO Dofetilide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Doxazosin HIGHSTIT Approved Drug DTD0008 EXOFACTO Doxazosin DESCRIPT Doxazosin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Doxazosin MOACRIVE Inhibition DTD0008 EXOFACTO Doxazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0008 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Doxorubicin MOACRIVE Inhibition DTD0008 EXOFACTO Doxorubicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0008 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0008 EXOFACTO Efavirenz CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Elacridar HIGHSTIT Discontinued Drug DTD0008 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Elacridar MOACRIVE Inhibition DTD0008 EXOFACTO Elacridar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Elagolix sodium HIGHSTIT Approved Drug DTD0008 EXOFACTO Elagolix sodium DESCRIPT Elagolix sodium inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Elagolix sodium MOACRIVE Inhibition DTD0008 EXOFACTO Eletriptan HIGHSTIT Approved Drug DTD0008 EXOFACTO Eletriptan DESCRIPT Eletriptan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Eletriptan MOACRIVE Inhibition DTD0008 EXOFACTO Eletriptan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Eltrombopag HIGHSTIT Approved Drug DTD0008 EXOFACTO Eltrombopag DESCRIPT Eltrombopag inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Eltrombopag MOACRIVE Inhibition DTD0008 EXOFACTO Emtricitabine HIGHSTIT Approved Drug DTD0008 EXOFACTO Emtricitabine DESCRIPT Emtricitabine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Emtricitabine MOACRIVE Inhibition DTD0008 EXOFACTO Emtricitabine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0008 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Enalapril MOACRIVE Inhibition DTD0008 EXOFACTO Enalapril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Epigallocatechin-4-gallate HIGHSTIT Natural Product DTD0008 EXOFACTO Epigallocatechin-4-gallate DESCRIPT Epigallocatechin-4-gallate inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 DTD0008 EXOFACTO Epigallocatechin-4-gallate MOACRIVE Inhibition DTD0008 EXOFACTO Epigallocatechin-4-gallate CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0008 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0008 EXOFACTO Erlotinib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0008 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0008 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0008 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 3.9 microM) DTD0008 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 3.3 microM) DTD0008 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Estradiol MOACRIVE Inhibition DTD0008 EXOFACTO Estradiol CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0008 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 0.2 microM) DTD0008 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.79 microM) DTD0008 EXOFACTO Estrone sulfate MOACRIVE Inhibition DTD0008 EXOFACTO Estrone sulfate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Estrone sulfate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0008 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Etoposide MOACRIVE Inhibition DTD0008 EXOFACTO Etoposide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ezetimibe HIGHSTIT Approved Drug DTD0008 EXOFACTO Ezetimibe DESCRIPT Ezetimibe inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ezetimibe MOACRIVE Inhibition DTD0008 EXOFACTO Ezetimibe CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Felodipine HIGHSTIT Approved Drug DTD0008 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Felodipine MOACRIVE Inhibition DTD0008 EXOFACTO Felodipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fendiline HIGHSTIT Drug Withdrawn DTD0008 EXOFACTO Fendiline DESCRIPT Fendiline inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fendiline MOACRIVE Inhibition DTD0008 EXOFACTO Fendiline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fenofibrate HIGHSTIT Approved Drug DTD0008 EXOFACTO Fenofibrate DESCRIPT Fenofibrate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 105.2 microM) DTD0008 EXOFACTO Fenofibrate DESCRIPT Fenofibrate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fenofibrate MOACRIVE Inhibition DTD0008 EXOFACTO Fenofibrate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Fenofibrate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fentanyl HIGHSTIT Approved Drug DTD0008 EXOFACTO Fentanyl DESCRIPT Fentanyl inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fentanyl MOACRIVE Inhibition DTD0008 EXOFACTO Fentanyl CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fexofenadine HIGHSTIT Approved Drug DTD0008 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the transportation of Estrone sulfate by SLCO1B1 (Ki = 257 microM) DTD0008 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fexofenadine MOACRIVE Inhibition DTD0008 EXOFACTO Fexofenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Flavonoids HIGHSTIT Natural Product DTD0008 EXOFACTO Flavonoids DESCRIPT Flavonoids inhibits the transportation of Fluvastatin and rosuvastatin by SLCO1B1 DTD0008 EXOFACTO Flavonoids MOACRIVE Inhibition DTD0008 EXOFACTO Flavonoids CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Fluconazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Fluconazole DESCRIPT Fluconazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fluconazole MOACRIVE Inhibition DTD0008 EXOFACTO Fluconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0008 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0008 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Flutamide HIGHSTIT Approved Drug DTD0008 EXOFACTO Flutamide DESCRIPT Flutamide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Flutamide MOACRIVE Inhibition DTD0008 EXOFACTO Flutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0008 EXOFACTO Fluvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Fluvoxamine HIGHSTIT Approved Drug DTD0008 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Fluvoxamine MOACRIVE Inhibition DTD0008 EXOFACTO Fluvoxamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0008 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Furosemide MOACRIVE Inhibition DTD0008 EXOFACTO Furosemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Gemfibrozil HIGHSTIT Approved Drug DTD0008 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Rosuvastatin by SLCO1B1 (IC50 = 25 microM) DTD0008 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 12.5 microM) DTD0008 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Gemfibrozil MOACRIVE Inhibition DTD0008 EXOFACTO Gemfibrozil CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Gemfibrozil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0008 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 DTD0008 EXOFACTO Genistein MOACRIVE Inhibition DTD0008 EXOFACTO Genistein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Genistein CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Glecaprevir HIGHSTIT Approved Drug DTD0008 EXOFACTO Glecaprevir DESCRIPT Glecaprevir inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Glecaprevir MOACRIVE Inhibition DTD0008 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0008 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.75 microM) DTD0008 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0008 EXOFACTO Glibenclamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Glipizide HIGHSTIT Approved Drug DTD0008 EXOFACTO Glipizide DESCRIPT Glipizide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glipizide MOACRIVE Inhibition DTD0008 EXOFACTO Glipizide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Glycochenodeoxycholic acid HIGHSTIT Investigative Drug DTD0008 EXOFACTO Glycochenodeoxycholic acid DESCRIPT Glycochenodeoxycholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glycochenodeoxycholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Glycochenodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Glycocholic acid HIGHSTIT Investigative Drug DTD0008 EXOFACTO Glycocholic acid DESCRIPT Glycocholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 22 microM) DTD0008 EXOFACTO Glycocholic acid DESCRIPT Glycocholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glycocholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Glycocholic acid CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Glycocholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Glycodeoxycholic acid HIGHSTIT Investigative Drug DTD0008 EXOFACTO Glycodeoxycholic acid DESCRIPT Glycodeoxycholic acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glycodeoxycholic acid MOACRIVE Inhibition DTD0008 EXOFACTO Glycodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Glycyrrhizin HIGHSTIT Drug in Phase 3 Trial DTD0008 EXOFACTO Glycyrrhizin DESCRIPT Glycyrrhizin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Glycyrrhizin MOACRIVE Inhibition DTD0008 EXOFACTO Glycyrrhizin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO GW1929 HIGHSTIT Investigative Drug DTD0008 EXOFACTO GW1929 DESCRIPT GW1929 inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 0.3 microM) DTD0008 EXOFACTO GW1929 MOACRIVE Inhibition DTD0008 EXOFACTO GW1929 CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO GW4064 HIGHSTIT Investigative Drug DTD0008 EXOFACTO GW4064 DESCRIPT Gw4064 inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 32.4 microM) DTD0008 EXOFACTO GW4064 MOACRIVE Inhibition DTD0008 EXOFACTO GW4064 CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Hyperforin HIGHSTIT Investigative Drug DTD0008 EXOFACTO Hyperforin DESCRIPT Hyperforin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.82 microM) DTD0008 EXOFACTO Hyperforin MOACRIVE Inhibition DTD0008 EXOFACTO Hyperforin CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0008 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ibuprofen DESCRIPT Ibuprofen induces the activity of SLCO1B1 DTD0008 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0008 EXOFACTO Ibuprofen MOACRIVE Inducer DTD0008 EXOFACTO Ibuprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0008 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Imipramine MOACRIVE Inhibition DTD0008 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 5.84 microM) DTD0008 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 12.2 microM; Ki = 10.8 microM) DTD0008 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Indinavir MOACRIVE Inhibition DTD0008 EXOFACTO Indinavir CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Indinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Indinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Indocyanine green HIGHSTIT Approved Drug DTD0008 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Indocyanine green MOACRIVE Inhibition DTD0008 EXOFACTO Indocyanine green CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0008 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0008 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Irinotecan HIGHSTIT Approved Drug DTD0008 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Irinotecan MOACRIVE Inhibition DTD0008 EXOFACTO Irinotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Isoniazid HIGHSTIT Approved Drug DTD0008 EXOFACTO Isoniazid DESCRIPT Isoniazid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Isoniazid MOACRIVE Inhibition DTD0008 EXOFACTO Isoniazid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Isradipine HIGHSTIT Approved Drug DTD0008 EXOFACTO Isradipine DESCRIPT Isradipine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Isradipine MOACRIVE Inhibition DTD0008 EXOFACTO Isradipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0008 EXOFACTO Ivermectin HIGHSTIT Approved Drug DTD0008 EXOFACTO Ivermectin DESCRIPT Ivermectin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ivermectin MOACRIVE Inhibition DTD0008 EXOFACTO Ivermectin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0008 EXOFACTO Ketoconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lamotrigine HIGHSTIT Approved Drug DTD0008 EXOFACTO Lamotrigine DESCRIPT Lamotrigine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Lamotrigine MOACRIVE Inhibition DTD0008 EXOFACTO Lamotrigine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lansoprazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Lansoprazole DESCRIPT Lansoprazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Lansoprazole MOACRIVE Inhibition DTD0008 EXOFACTO Lansoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO L-carnitine HIGHSTIT Approved Drug DTD0008 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO L-carnitine MOACRIVE Inhibition DTD0008 EXOFACTO L-carnitine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Letermovir HIGHSTIT Approved Drug DTD0008 EXOFACTO Letermovir DESCRIPT Letermovir inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Letermovir MOACRIVE Inhibition DTD0008 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0008 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0008 EXOFACTO Levofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Levothyroxine HIGHSTIT Approved Drug DTD0008 EXOFACTO Levothyroxine DESCRIPT Levothyroxine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Levothyroxine MOACRIVE Inhibition DTD0008 EXOFACTO Levothyroxine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0008 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B1 DTD0008 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0008 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lisinopril HIGHSTIT Approved Drug DTD0008 EXOFACTO Lisinopril DESCRIPT Lisinopril inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Lisinopril MOACRIVE Inhibition DTD0008 EXOFACTO Lisinopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lithocholate HIGHSTIT Investigative Drug DTD0008 EXOFACTO Lithocholate DESCRIPT Lithocholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 1.2 microM) DTD0008 EXOFACTO Lithocholate DESCRIPT Lithocholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.7 microM) DTD0008 EXOFACTO Lithocholate MOACRIVE Inhibition DTD0008 EXOFACTO Lithocholate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Loperamide HIGHSTIT Approved Drug DTD0008 EXOFACTO Loperamide DESCRIPT Loperamide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Loperamide MOACRIVE Inhibition DTD0008 EXOFACTO Loperamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 0.5 microM; Ki = 0.5 microM) DTD0008 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0008 EXOFACTO Lopinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Lopinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0008 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Loratadine MOACRIVE Inhibition DTD0008 EXOFACTO Loratadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 6.1 microM) DTD0008 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 12.7 microM) DTD0008 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Pravastatin by SLCO1B1 DTD0008 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Sodium taurocholate by SLCO1B1 DTD0008 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0008 EXOFACTO Lovastatin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Lovastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Mephenytoin HIGHSTIT Approved Drug DTD0008 EXOFACTO Mephenytoin DESCRIPT Mephenytoin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Mephenytoin MOACRIVE Inhibition DTD0008 EXOFACTO Mephenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Mesalazine HIGHSTIT Approved Drug DTD0008 EXOFACTO Mesalazine DESCRIPT Mesalazine inhibits the transportation of Bromsulphthalein by SLCO1B1 DTD0008 EXOFACTO Mesalazine MOACRIVE Inhibition DTD0008 EXOFACTO Mesalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0008 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Metformin MOACRIVE Inhibition DTD0008 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0008 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0008 EXOFACTO Methotrexate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Methoxsalen HIGHSTIT Approved Drug DTD0008 EXOFACTO Methoxsalen DESCRIPT Methoxsalen inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Methoxsalen MOACRIVE Inhibition DTD0008 EXOFACTO Methoxsalen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0008 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0008 EXOFACTO Metoprolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Midazolam HIGHSTIT Approved Drug DTD0008 EXOFACTO Midazolam DESCRIPT Midazolam inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Midazolam MOACRIVE Inhibition DTD0008 EXOFACTO Midazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Mifepristone HIGHSTIT Approved Drug DTD0008 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 3.3 microM) DTD0008 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 2.2 microM) DTD0008 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Mifepristone MOACRIVE Inhibition DTD0008 EXOFACTO Mifepristone CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Mifepristone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0008 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0008 EXOFACTO Mitoxantrone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Mix silybin A silybin B HIGHSTIT Natural Product DTD0008 EXOFACTO Mix silybin A silybin B DESCRIPT Mix silybin A silybin B inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Mix silybin A silybin B MOACRIVE Inhibition DTD0008 EXOFACTO Mix silybin A silybin B CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0008 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 5 microM) DTD0008 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.3 microM) DTD0008 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO MK-571 MOACRIVE Inhibition DTD0008 EXOFACTO MK-571 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Moclobemide HIGHSTIT Approved Drug DTD0008 EXOFACTO Moclobemide DESCRIPT Moclobemide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Moclobemide MOACRIVE Inhibition DTD0008 EXOFACTO Moclobemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Montelukast HIGHSTIT Approved Drug DTD0008 EXOFACTO Montelukast DESCRIPT Montelukast inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 10 microM) DTD0008 EXOFACTO Montelukast MOACRIVE Inhibition DTD0008 EXOFACTO Montelukast CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0008 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Morin MOACRIVE Inhibition DTD0008 EXOFACTO Morin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0008 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Naringenin MOACRIVE Inhibition DTD0008 EXOFACTO Naringenin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Naringin HIGHSTIT Investigative Drug DTD0008 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Naringin MOACRIVE Inhibition DTD0008 EXOFACTO Naringin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nefazodone HIGHSTIT Approved Drug DTD0008 EXOFACTO Nefazodone DESCRIPT Nefazodone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nefazodone MOACRIVE Inhibition DTD0008 EXOFACTO Nefazodone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.93 microM) DTD0008 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nelfinavir MOACRIVE Inhibition DTD0008 EXOFACTO Nelfinavir CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Nelfinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nicardipine HIGHSTIT Approved Drug DTD0008 EXOFACTO Nicardipine DESCRIPT Nicardipine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nicardipine MOACRIVE Inhibition DTD0008 EXOFACTO Nicardipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0008 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nicotine MOACRIVE Inhibition DTD0008 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nifedipine HIGHSTIT Approved Drug DTD0008 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nifedipine MOACRIVE Inhibition DTD0008 EXOFACTO Nifedipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nitrofurantoin HIGHSTIT Approved Drug DTD0008 EXOFACTO Nitrofurantoin DESCRIPT Nitrofurantoin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nitrofurantoin MOACRIVE Inhibition DTD0008 EXOFACTO Nitrofurantoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0008 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0008 EXOFACTO Novobiocin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Nystatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Nystatin DESCRIPT Nystatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Nystatin MOACRIVE Inhibition DTD0008 EXOFACTO Nystatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0008 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0008 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0008 EXOFACTO Omeprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ondansetron HIGHSTIT Approved Drug DTD0008 EXOFACTO Ondansetron DESCRIPT Ondansetron inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ondansetron MOACRIVE Inhibition DTD0008 EXOFACTO Ondansetron CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ouabain HIGHSTIT Approved Drug DTD0008 EXOFACTO Ouabain DESCRIPT Ouabain inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ouabain MOACRIVE Inhibition DTD0008 EXOFACTO Ouabain CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0008 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.03 microM) DTD0008 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 50 microM) DTD0008 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0008 EXOFACTO Paclitaxel CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Paclitaxel CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO Paclitaxel CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Pantoprazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Pantoprazole MOACRIVE Inhibition DTD0008 EXOFACTO Pantoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0008 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0008 EXOFACTO Paroxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phalloidin HIGHSTIT Investigative Drug DTD0008 EXOFACTO Phalloidin DESCRIPT Phalloidin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phalloidin MOACRIVE Inhibition DTD0008 EXOFACTO Phalloidin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0008 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0008 EXOFACTO Phenacetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0008 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phenformin MOACRIVE Inhibition DTD0008 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0008 EXOFACTO Phenobarbital DESCRIPT Phenobarbital inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of SLCO1B1 DTD0008 EXOFACTO Phenobarbital MOACRIVE Inhibition DTD0008 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0008 EXOFACTO Phenobarbital CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0008 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0008 EXOFACTO Phenylbutazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0008 EXOFACTO Phenytoin DESCRIPT Phenytoin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Phenytoin MOACRIVE Inhibition DTD0008 EXOFACTO Phenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Pilsicainide HIGHSTIT Approved Drug DTD0008 EXOFACTO Pilsicainide DESCRIPT Pilsicainide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Pilsicainide MOACRIVE Inhibition DTD0008 EXOFACTO Pilsicainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Pindolol HIGHSTIT Approved Drug DTD0008 EXOFACTO Pindolol DESCRIPT Pindolol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Pindolol MOACRIVE Inhibition DTD0008 EXOFACTO Pindolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0008 EXOFACTO Pioglitazone DESCRIPT Pioglitazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Pioglitazone MOACRIVE Inhibition DTD0008 EXOFACTO Pioglitazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0008 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0008 EXOFACTO Piroxicam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 21.8 microM) DTD0008 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0008 EXOFACTO Pravastatin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Pravastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0008 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Prazosin MOACRIVE Inhibition DTD0008 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Prednisolone HIGHSTIT Approved Drug DTD0008 EXOFACTO Prednisolone DESCRIPT Prednisolone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Prednisolone MOACRIVE Inhibition DTD0008 EXOFACTO Prednisolone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Prednisone HIGHSTIT Approved Drug DTD0008 EXOFACTO Prednisone DESCRIPT Prednisone inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Prednisone MOACRIVE Inhibition DTD0008 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0008 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transporation of ginkolide B by SLCO1B1 DTD0008 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Probenecid MOACRIVE Inhibition DTD0008 EXOFACTO Probenecid CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0008 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0008 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Procainamide MOACRIVE Inhibition DTD0008 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0008 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Progesterone MOACRIVE Inhibition DTD0008 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0008 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Propranolol MOACRIVE Inhibition DTD0008 EXOFACTO Propranolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO PRX-321 HIGHSTIT Drug in Phase 2 Trial DTD0008 EXOFACTO PRX-321 DESCRIPT PRX-321 inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO PRX-321 MOACRIVE Inhibition DTD0008 EXOFACTO PRX-321 CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0008 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Quercetin MOACRIVE Inhibition DTD0008 EXOFACTO Quercetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0008 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Quinine DESCRIPT Quinine inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Quinine MOACRIVE Inhibition DTD0008 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ranolazine HIGHSTIT Approved Drug DTD0008 EXOFACTO Ranolazine DESCRIPT Ranolazine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ranolazine MOACRIVE Inhibition DTD0008 EXOFACTO Ranolazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0008 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 2.2 microM) DTD0008 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Repaglinide MOACRIVE Inhibition DTD0008 EXOFACTO Repaglinide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0008 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Reserpine MOACRIVE Inhibition DTD0008 EXOFACTO Reserpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 1.5 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.94 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 1.8 microM; Ki = 1.6 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bromsulphthalein by SLCO1B1 (IC50 = 120 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Sulfobromophthalein by SLCO1B1 (Ki = 17 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.48 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bosentan by SLCO1B1 (IC50 = 3.2 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bromsulphthalein by SLCO1B1 (Ki = 17 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Atorvastatin by SLCO1B1 (IC50 = 3.25 microM; Ki = 3.08 microM) DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B1 DTD0008 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0008 EXOFACTO Rifampicin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Rifampicin CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Rifampicin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO Rifampicin CELLLINE Oocytes-OATP1B1 DTD0008 EXOFACTO Rifampicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Rifamycin SV HIGHSTIT Approved Drug DTD0008 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.17 microM) DTD0008 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Bromsulphthalein by SLCO1B1 (Ki = 2 microM) DTD0008 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Rifamycin SV MOACRIVE Inhibition DTD0008 EXOFACTO Rifamycin SV CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Rifamycin SV CELLLINE Oocytes-OATP1B1 DTD0008 EXOFACTO Rifapentine HIGHSTIT Approved Drug DTD0008 EXOFACTO Rifapentine DESCRIPT Rifapentine inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Rifapentine MOACRIVE Inhibition DTD0008 EXOFACTO Rifaximin HIGHSTIT Approved Drug DTD0008 EXOFACTO Rifaximin DESCRIPT Rifaximin inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Rifaximin MOACRIVE Inhibition DTD0008 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 1.6 microM; Ki = 1.4 microM) DTD0008 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 0.71 microM) DTD0008 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.78 microM) DTD0008 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0008 EXOFACTO Ritonavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Ritonavir CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Ritonavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Rosuvastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Rosuvastatin DESCRIPT Rosuvastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Rosuvastatin MOACRIVE Inhibition DTD0008 EXOFACTO Rosuvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sanguinarine HIGHSTIT Approved Drug DTD0008 EXOFACTO Sanguinarine DESCRIPT Sanguinarine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sanguinarine MOACRIVE Inhibition DTD0008 EXOFACTO Sanguinarine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 1.23 microM) DTD0008 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B1 (IC50 = 2.1 microM; Ki = 1.8 microM) DTD0008 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 1.59 microM) DTD0008 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0008 EXOFACTO Saquinavir CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Saquinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Saquinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Selexipag HIGHSTIT Approved Drug DTD0008 EXOFACTO Selexipag DESCRIPT Selexipag inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Selexipag MOACRIVE Inhibition DTD0008 EXOFACTO Sildenafil HIGHSTIT Approved Drug DTD0008 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Bosentan by SLCO1B1 (IC50 = 1.5 microM) DTD0008 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sildenafil MOACRIVE Inhibition DTD0008 EXOFACTO Sildenafil CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Silibinin HIGHSTIT Drug in Phase 2/3 Trial DTD0008 EXOFACTO Silibinin DESCRIPT Silibinin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Silibinin DESCRIPT Silibinin inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 DTD0008 EXOFACTO Silibinin MOACRIVE Inhibition DTD0008 EXOFACTO Silibinin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Silibinin CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Silibinin dihemisuccinate HIGHSTIT Natural Product DTD0008 EXOFACTO Silibinin dihemisuccinate DESCRIPT Silibinin dihemisuccinate inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 (IC50 = 10 microM) DTD0008 EXOFACTO Silibinin dihemisuccinate MOACRIVE Inhibition DTD0008 EXOFACTO Silibinin dihemisuccinate CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B1 DTD0008 EXOFACTO Silybin A HIGHSTIT Natural Product DTD0008 EXOFACTO Silybin A DESCRIPT Silybin A inhibits the transportation of Estradiol-17-glucuronide by SLCO1B1 (IC50 = 9.7 microM) DTD0008 EXOFACTO Silybin A MOACRIVE Inhibition DTD0008 EXOFACTO Silybin A CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Silybin B HIGHSTIT Natural Product DTD0008 EXOFACTO Silybin B DESCRIPT Silybin B inhibits the transportation of Estradiol-17-glucuronide by SLCO1B1 (IC50 = 8.5 microM) DTD0008 EXOFACTO Silybin B MOACRIVE Inhibition DTD0008 EXOFACTO Silybin B CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Silychristin HIGHSTIT Natural Product DTD0008 EXOFACTO Silychristin DESCRIPT Silychristin inhibits the transportation of Estradiol-17-glucuronide by SLCO1B1 (IC50 = 9 microM) DTD0008 EXOFACTO Silychristin MOACRIVE Inhibition DTD0008 EXOFACTO Silychristin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Silymarin HIGHSTIT Natural Product DTD0008 EXOFACTO Silymarin HIGHSTIT Drug in Phase 4 Trial DTD0008 EXOFACTO Silymarin DESCRIPT Silymarin inhibits the transportation of H-dehydroepiandrosterone sulfate by SLCO1B1 DTD0008 EXOFACTO Silymarin DESCRIPT Silymarin inhibits the activity of SLCO1B1 DTD0008 EXOFACTO Silymarin MOACRIVE Inhibition DTD0008 EXOFACTO Silymarin CELLLINE Human cervical cancer cell line (Hela)-OATP1B1 DTD0008 EXOFACTO Silymarin flavolignans HIGHSTIT Natural Product DTD0008 EXOFACTO Silymarin flavolignans DESCRIPT Silymarin flavolignans inhibits the transportation of Estradiol-17-glucuronide by SLCO1B1 DTD0008 EXOFACTO Silymarin flavolignans MOACRIVE Inhibition DTD0008 EXOFACTO Silymarin flavolignans CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Simeprevir HIGHSTIT Approved Drug DTD0008 EXOFACTO Simeprevir DESCRIPT Simeprevir inhibits the transportation of Digoxin by SLCO1B1 DTD0008 EXOFACTO Simeprevir MOACRIVE Inhibition DTD0008 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0008 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 9.7 +/- 0.2 microM) DTD0008 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0008 EXOFACTO Simvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sincalide HIGHSTIT Investigative Drug DTD0008 EXOFACTO Sincalide DESCRIPT Sincalide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sincalide MOACRIVE Inhibition DTD0008 EXOFACTO Sincalide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sodium taurocholate HIGHSTIT Drug in Phase 1/2 Trial DTD0008 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 11.4 microM) DTD0008 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sodium taurocholate MOACRIVE Inhibition DTD0008 EXOFACTO Sodium taurocholate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Sodium taurocholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sotalol HIGHSTIT Approved Drug DTD0008 EXOFACTO Sotalol DESCRIPT Sotalol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sotalol MOACRIVE Inhibition DTD0008 EXOFACTO Sotalol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0008 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0008 EXOFACTO Spironolactone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sulfaphenazole HIGHSTIT Approved Drug DTD0008 EXOFACTO Sulfaphenazole DESCRIPT Sulfaphenazole inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sulfaphenazole MOACRIVE Inhibition DTD0008 EXOFACTO Sulfaphenazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0008 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0008 EXOFACTO Sulfasalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tacrolimus HIGHSTIT Approved Drug DTD0008 EXOFACTO Tacrolimus DESCRIPT Tacrolimus inhibits the transportation of Phalloidin by SLCO1B1 (IC50 = 3.7 microM) DTD0008 EXOFACTO Tacrolimus DESCRIPT Tacrolimus inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.61 microM) DTD0008 EXOFACTO Tacrolimus MOACRIVE Inhibition DTD0008 EXOFACTO Tacrolimus CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0008 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0008 EXOFACTO Tamoxifen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Taurochenodeoxycholate HIGHSTIT Investigative Drug DTD0008 EXOFACTO Taurochenodeoxycholate DESCRIPT Taurochenodeoxycholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Taurochenodeoxycholate MOACRIVE Inhibition DTD0008 EXOFACTO Taurochenodeoxycholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0008 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of SLCO1B1 (IC50 = 0.0022 microM) DTD0008 EXOFACTO Telaprevir MOACRIVE Inhibition DTD0008 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0008 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 0.44 microM) DTD0008 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0008 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tenofovir HIGHSTIT Approved Drug DTD0008 EXOFACTO Tenofovir DESCRIPT Tenofovir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tenofovir MOACRIVE Inhibition DTD0008 EXOFACTO Tenofovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Terfenadine HIGHSTIT Drug Withdrawn DTD0008 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Terfenadine MOACRIVE Inhibition DTD0008 EXOFACTO Terfenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0008 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Testosterone MOACRIVE Inhibition DTD0008 EXOFACTO Testosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tetracycline HIGHSTIT Approved Drug DTD0008 EXOFACTO Tetracycline DESCRIPT Tetracycline inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tetracycline MOACRIVE Inhibition DTD0008 EXOFACTO Tetracycline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0008 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0008 EXOFACTO Tetraethylammonium CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0008 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Fluorescein by SLCO1B1 (IC50 = 5.7 microM) DTD0008 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0008 EXOFACTO Tetramethrin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Theophylline HIGHSTIT Approved Drug DTD0008 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Theophylline MOACRIVE Inhibition DTD0008 EXOFACTO Theophylline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Thioridazine HIGHSTIT Approved Drug DTD0008 EXOFACTO Thioridazine DESCRIPT Thioridazine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Thioridazine MOACRIVE Inhibition DTD0008 EXOFACTO Thioridazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Thiotepa HIGHSTIT Approved Drug DTD0008 EXOFACTO Thiotepa DESCRIPT Thiotepa inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Thiotepa MOACRIVE Inhibition DTD0008 EXOFACTO Thiotepa CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Ticlopidine HIGHSTIT Approved Drug DTD0008 EXOFACTO Ticlopidine DESCRIPT Ticlopidine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Ticlopidine MOACRIVE Inhibition DTD0008 EXOFACTO Ticlopidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tipranavir HIGHSTIT Approved Drug DTD0008 EXOFACTO Tipranavir DESCRIPT Tipranavir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tipranavir MOACRIVE Inhibition DTD0008 EXOFACTO Tipranavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Tolbutamide HIGHSTIT Approved Drug DTD0008 EXOFACTO Tolbutamide DESCRIPT Tolbutamide inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Tolbutamide MOACRIVE Inhibition DTD0008 EXOFACTO Tolbutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Topotecan HIGHSTIT Approved Drug DTD0008 EXOFACTO Topotecan DESCRIPT Topotecan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Topotecan MOACRIVE Inhibition DTD0008 EXOFACTO Topotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Triazolam HIGHSTIT Approved Drug DTD0008 EXOFACTO Triazolam DESCRIPT Triazolam inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Triazolam MOACRIVE Inhibition DTD0008 EXOFACTO Triazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0008 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0008 EXOFACTO Trimethoprim CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Triterpenoids HIGHSTIT Natural Product DTD0008 EXOFACTO Triterpenoids DESCRIPT Triterpenoids inhibits the transportation of Fluvastatin and rosuvastatin by SLCO1B1 DTD0008 EXOFACTO Triterpenoids MOACRIVE Inhibition DTD0008 EXOFACTO Triterpenoids CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0008 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (IC50 = 1.2 microM) DTD0008 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 (Ki = 1 microM) DTD0008 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0008 EXOFACTO Troglitazone CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0008 EXOFACTO Valacyclovir HIGHSTIT Approved Drug DTD0008 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Valacyclovir MOACRIVE Inhibition DTD0008 EXOFACTO Valacyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0008 EXOFACTO Valproic Acid DESCRIPT Valproic Acid inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Valproic Acid MOACRIVE Inhibition DTD0008 EXOFACTO Valproic Acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0008 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Pitavastatin by SLCO1B1 (Ki = 8.96 microM) DTD0008 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Valsartan MOACRIVE Inhibition DTD0008 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0008 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Valspodar MOACRIVE Inhibition DTD0008 EXOFACTO Valspodar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Varenicline HIGHSTIT Approved Drug DTD0008 EXOFACTO Varenicline DESCRIPT Varenicline inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Varenicline MOACRIVE Inhibition DTD0008 EXOFACTO Varenicline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0008 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Pitavastatin calcium by SLCO1B1 DTD0008 EXOFACTO Verapamil MOACRIVE Inhibition DTD0008 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0008 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0008 EXOFACTO Vinblastine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Vincristine HIGHSTIT Approved Drug DTD0008 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Estrone sulfate by SLCO1B1 DTD0008 EXOFACTO Vincristine MOACRIVE Inhibition DTD0008 EXOFACTO Vincristine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Warfarin HIGHSTIT Approved Drug DTD0008 EXOFACTO Warfarin DESCRIPT Warfarin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Warfarin MOACRIVE Inhibition DTD0008 EXOFACTO Warfarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0008 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0008 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B1 DTD0008 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0008 EXOFACTO Zidovudine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B1 DTD0009 TRANSPID DTD0009 DTD0009 GENENAME SLC22A3 DTD0009 PROTNAME Organic cation transporter 3 DTD0009 GENEDBID 6581 DTD0009 UNIPROID O75751 DTD0009 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0009 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki > 1000 microM) DTD0009 EXOFACTO Amantadine MOACRIVE Inhibition DTD0009 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Antiparasitics HIGHSTIT Discontinued Drug DTD0009 EXOFACTO Antiparasitics DESCRIPT Antiparasitics inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 20.4 microM) DTD0009 EXOFACTO Antiparasitics MOACRIVE Inhibition DTD0009 EXOFACTO Antiparasitics CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Atropine HIGHSTIT Approved Drug DTD0009 EXOFACTO Atropine DESCRIPT Atropine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 466 microM) DTD0009 EXOFACTO Atropine MOACRIVE Inhibition DTD0009 EXOFACTO Atropine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Clonidine HIGHSTIT Approved Drug DTD0009 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 373 microM) DTD0009 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 110 microM) DTD0009 EXOFACTO Clonidine MOACRIVE Inhibition DTD0009 EXOFACTO Clonidine CELLLINE Human retinal pigment epithelial (HRPE) cells-OCT3 DTD0009 EXOFACTO Clonidine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0009 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki > 1000 microM) DTD0009 EXOFACTO Cocaine MOACRIVE Inhibition DTD0009 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0009 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 14 microM) DTD0009 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the activity of SLC22A3 DTD0009 EXOFACTO Desipramine MOACRIVE Inhibition DTD0009 EXOFACTO Desipramine CELLLINE Human retinal pigment epithelial (HRPE) cells-OCT3 DTD0009 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0009 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 460 microM) DTD0009 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0009 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Diphenhydramine HIGHSTIT Approved Drug DTD0009 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 695 microM) DTD0009 EXOFACTO Diphenhydramine MOACRIVE Inhibition DTD0009 EXOFACTO Diphenhydramine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Dizocilpine HIGHSTIT Discontinued Drug DTD0009 EXOFACTO Dizocilpine DESCRIPT Dizocilpine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 224 microM) DTD0009 EXOFACTO Dizocilpine MOACRIVE Inhibition DTD0009 EXOFACTO Dizocilpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Ergotidine HIGHSTIT Approved Drug DTD0009 EXOFACTO Ergotidine DESCRIPT Ergotidine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 140 microM) DTD0009 EXOFACTO Ergotidine MOACRIVE Inhibition DTD0009 EXOFACTO Ergotidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0009 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A3 (IC50 = 2.88 microM) DTD0009 EXOFACTO Estradiol MOACRIVE Inhibition DTD0009 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Etilefrine HIGHSTIT Drug Withdrawn DTD0009 EXOFACTO Etilefrine DESCRIPT Etilefrine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 4448 microM) DTD0009 EXOFACTO Etilefrine MOACRIVE Inhibition DTD0009 EXOFACTO Etilefrine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Famotidine HIGHSTIT Approved Drug DTD0009 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 6.7 microM) DTD0009 EXOFACTO Famotidine MOACRIVE Inhibition DTD0009 EXOFACTO Famotidine CELLLINE Oocytes-OCT3 DTD0009 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0009 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 42 microM) DTD0009 EXOFACTO Imipramine MOACRIVE Inhibition DTD0009 EXOFACTO Imipramine CELLLINE Human retinal pigment epithelial (HRPE) cells-OCT3 DTD0009 EXOFACTO Ketamine HIGHSTIT Approved Drug DTD0009 EXOFACTO Ketamine DESCRIPT Ketamine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 225.7 microM) DTD0009 EXOFACTO Ketamine MOACRIVE Inhibition DTD0009 EXOFACTO Ketamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Memantine HIGHSTIT Approved Drug DTD0009 EXOFACTO Memantine DESCRIPT Memantine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 236 microM) DTD0009 EXOFACTO Memantine MOACRIVE Inhibition DTD0009 EXOFACTO Memantine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0009 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 904 microM) DTD0009 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 2332 microM) DTD0009 EXOFACTO Metformin MOACRIVE Inhibition DTD0009 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Metformin CELLLINE Oocytes-OCT3 DTD0009 EXOFACTO Pentamidine HIGHSTIT Approved Drug DTD0009 EXOFACTO Pentamidine DESCRIPT Pentamidine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 14.8 microM) DTD0009 EXOFACTO Pentamidine MOACRIVE Inhibition DTD0009 EXOFACTO Pentamidine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Phencyclidine HIGHSTIT Investigative Drug DTD0009 EXOFACTO Phencyclidine DESCRIPT Phencyclidine inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 333 microM) DTD0009 EXOFACTO Phencyclidine MOACRIVE Inhibition DTD0009 EXOFACTO Phencyclidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0009 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 134 microM) DTD0009 EXOFACTO Phenformin MOACRIVE Inhibition DTD0009 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Phenoxybenzamine HIGHSTIT Approved Drug DTD0009 EXOFACTO Phenoxybenzamine DESCRIPT Phenoxybenzamine inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A3 (IC50 = 6.13 microM) DTD0009 EXOFACTO Phenoxybenzamine MOACRIVE Inhibition DTD0009 EXOFACTO Phenoxybenzamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0009 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 12.6 microM) DTD0009 EXOFACTO Prazosin MOACRIVE Inhibition DTD0009 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0009 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 738 microM) DTD0009 EXOFACTO Procainamide MOACRIVE Inhibition DTD0009 EXOFACTO Procainamide CELLLINE Human retinal pigment epithelial (HRPE) cells-OCT3 DTD0009 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0009 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A3 (IC50 = 4.28 microM) DTD0009 EXOFACTO Progesterone MOACRIVE Inhibition DTD0009 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0009 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0009 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 22.7 microM) DTD0009 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 18.3 microM) DTD0009 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 37 microM) DTD0009 EXOFACTO Quinine DESCRIPT Quinine inhibits the activity of SLC22A3 DTD0009 EXOFACTO Quinine MOACRIVE Inhibition DTD0009 EXOFACTO Quinine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Quinine CELLLINE Oocytes-OCT3 DTD0009 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0009 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 372 microM) DTD0009 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 290 microM) DTD0009 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0009 EXOFACTO Ranitidine CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO Ranitidine CELLLINE Oocytes-OCT3 DTD0009 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0009 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A3 (Ki = 1372 microM) DTD0009 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 1237 microM) DTD0009 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 1476.6 microM) DTD0009 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0009 EXOFACTO Tetraethylammonium CELLLINE Human retinal pigment epithelial (HRPE) cells-OCT3 DTD0009 EXOFACTO Tetraethylammonium CELLLINE Oocytes-OCT3 DTD0009 EXOFACTO Tetraethylammonium CELLLINE Chinese hamster ovary (CHO) cells-OCT3 DTD0009 EXOFACTO YM155 HIGHSTIT Drug in Phase 2 Trial DTD0009 EXOFACTO YM155 DESCRIPT YM155 inhibits the transportation of N-methylpyridinium by SLC22A3 (IC50 = 108 microM) DTD0009 EXOFACTO YM155 MOACRIVE Inhibition DTD0009 EXOFACTO YM155 CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT3 DTD0010 TRANSPID DTD0010 DTD0010 GENENAME SLC22A1 DTD0010 PROTNAME Organic cation transporter 1 DTD0010 GENEDBID 6580 DTD0010 UNIPROID O15245 DTD0010 EXOFACTO 2-Methoxyestradiol HIGHSTIT Drug in Phase 2 Trial DTD0010 EXOFACTO 2-Methoxyestradiol DESCRIPT 2-Methoxyestradiol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO 2-Methoxyestradiol MOACRIVE Inhibition DTD0010 EXOFACTO 2-Methoxyestradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO 4-Androstene-3-17-Dione HIGHSTIT Investigative Drug DTD0010 EXOFACTO 4-Androstene-3-17-Dione DESCRIPT 4-Androstene-3-17-Dione inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO 4-Androstene-3-17-Dione MOACRIVE Inhibition DTD0010 EXOFACTO 4-Androstene-3-17-Dione CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acarbose HIGHSTIT Approved Drug DTD0010 EXOFACTO Acarbose DESCRIPT Acarbose inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acarbose MOACRIVE Inhibition DTD0010 EXOFACTO Acarbose CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acebutolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Acebutolol DESCRIPT Acebutolol inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 95.8 microM) DTD0010 EXOFACTO Acebutolol DESCRIPT Acebutolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acebutolol MOACRIVE Inhibition DTD0010 EXOFACTO Acebutolol CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Acebutolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acecainide HIGHSTIT Discontinued Drug DTD0010 EXOFACTO Acecainide DESCRIPT Acecainide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acecainide MOACRIVE Inhibition DTD0010 EXOFACTO Acecainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0010 EXOFACTO Acetaminophen DESCRIPT Acetaminophen inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acetaminophen MOACRIVE Inhibition DTD0010 EXOFACTO Acetaminophen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acetylcysteine HIGHSTIT Approved Drug DTD0010 EXOFACTO Acetylcysteine DESCRIPT Acetylcysteine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acetylcysteine MOACRIVE Inhibition DTD0010 EXOFACTO Acetylcysteine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Acyclovir HIGHSTIT Approved Drug DTD0010 EXOFACTO Acyclovir DESCRIPT Acyclovir inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Acyclovir MOACRIVE Inhibition DTD0010 EXOFACTO Acyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0010 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic cation by SLC22A1 (IC50 = 64.4 microM) DTD0010 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0010 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Agmatine HIGHSTIT Investigative Drug DTD0010 EXOFACTO Agmatine DESCRIPT Agmatine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Agmatine MOACRIVE Inhibition DTD0010 EXOFACTO Agmatine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0010 EXOFACTO Allethrin DESCRIPT Allethrin inhibits the transportation of Verapamil by SLC22A1 (IC50 = 2.6 microM) DTD0010 EXOFACTO Allethrin MOACRIVE Inhibition DTD0010 EXOFACTO Allethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Allopurinol HIGHSTIT Approved Drug DTD0010 EXOFACTO Allopurinol DESCRIPT Allopurinol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Allopurinol MOACRIVE Inhibition DTD0010 EXOFACTO Allopurinol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0010 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic cation by SLC22A1 (IC50 = 1.7 microM) DTD0010 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0010 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0010 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of YM155 by SLC22A1 (IC50 = 39.6 microM) DTD0010 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 236 microM) DTD0010 EXOFACTO Amantadine MOACRIVE Inhibition DTD0010 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Amiloride HIGHSTIT Approved Drug DTD0010 EXOFACTO Amiloride DESCRIPT Amiloride inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Amiloride DESCRIPT Amiloride inhibits the activity of SLC22A1 DTD0010 EXOFACTO Amiloride MOACRIVE Inhibition DTD0010 EXOFACTO Amiloride CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0010 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Metformin by SLC22A1 (IC50 = 6.99 microM) DTD0010 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0010 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ampicillin HIGHSTIT Approved Drug DTD0010 EXOFACTO Ampicillin DESCRIPT Ampicillin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ampicillin MOACRIVE Inhibition DTD0010 EXOFACTO Ampicillin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Amsacrine HIGHSTIT Approved Drug DTD0010 EXOFACTO Amsacrine DESCRIPT Amsacrine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Amsacrine MOACRIVE Inhibition DTD0010 EXOFACTO Amsacrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Antiparasitics HIGHSTIT Discontinued Drug DTD0010 EXOFACTO Antiparasitics DESCRIPT Antiparasitics inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 7.4 microM) DTD0010 EXOFACTO Antiparasitics MOACRIVE Inhibition DTD0010 EXOFACTO Antiparasitics CELLLINE Chinese hamster ovary (CHO) cells-OCT1 DTD0010 EXOFACTO Apomorphine HIGHSTIT Approved Drug DTD0010 EXOFACTO Apomorphine DESCRIPT Apomorphine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Apomorphine MOACRIVE Inhibition DTD0010 EXOFACTO Apomorphine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Arcaine HIGHSTIT Investigative Drug DTD0010 EXOFACTO Arcaine DESCRIPT Arcaine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Arcaine MOACRIVE Inhibition DTD0010 EXOFACTO Arcaine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Aspirin HIGHSTIT Approved Drug DTD0010 EXOFACTO Aspirin DESCRIPT Aspirin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Aspirin MOACRIVE Inhibition DTD0010 EXOFACTO Aspirin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Atenolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Atenolol DESCRIPT Atenolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Atenolol MOACRIVE Inhibition DTD0010 EXOFACTO Atenolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Atropine HIGHSTIT Approved Drug DTD0010 EXOFACTO Atropine DESCRIPT Atropine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 1.2 microM) DTD0010 EXOFACTO Atropine DESCRIPT Atropine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Atropine MOACRIVE Inhibition DTD0010 EXOFACTO Atropine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Azathioprine HIGHSTIT Approved Drug DTD0010 EXOFACTO Azathioprine DESCRIPT Azathioprine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Azathioprine MOACRIVE Inhibition DTD0010 EXOFACTO Azathioprine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Baclofen HIGHSTIT Approved Drug DTD0010 EXOFACTO Baclofen DESCRIPT Baclofen inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Baclofen MOACRIVE Inhibition DTD0010 EXOFACTO Baclofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Beclomethasone dipropionate HIGHSTIT Approved Drug DTD0010 EXOFACTO Beclomethasone dipropionate DESCRIPT Beclomethasone dipropionate inhibits the transportation of Agonist salbutamol by SLC22A1 DTD0010 EXOFACTO Beclomethasone dipropionate MOACRIVE Inhibition DTD0010 EXOFACTO Benzyl alcohol HIGHSTIT Approved Drug DTD0010 EXOFACTO Benzyl alcohol DESCRIPT Benzyl alcohol inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 0.018 microM) DTD0010 EXOFACTO Benzyl alcohol MOACRIVE Inhibition DTD0010 EXOFACTO Bucindolol HIGHSTIT Drug in Phase 2/3 Trial DTD0010 EXOFACTO Bucindolol DESCRIPT Bucindolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Bucindolol MOACRIVE Inhibition DTD0010 EXOFACTO Bucindolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0010 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Budesonide MOACRIVE Inhibition DTD0010 EXOFACTO Budesonide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0010 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Buspirone MOACRIVE Inhibition DTD0010 EXOFACTO Buspirone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Butylscopolamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Butylscopolamine DESCRIPT Butylscopolamine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 16 microM) DTD0010 EXOFACTO Butylscopolamine MOACRIVE Inhibition DTD0010 EXOFACTO Butylscopolamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0010 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Caffeine MOACRIVE Inhibition DTD0010 EXOFACTO Caffeine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0010 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Candesartan MOACRIVE Inhibition DTD0010 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0010 EXOFACTO Captopril DESCRIPT Captopril inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Captopril MOACRIVE Inhibition DTD0010 EXOFACTO Captopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Carbamazepine HIGHSTIT Approved Drug DTD0010 EXOFACTO Carbamazepine DESCRIPT Carbamazepine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Carbamazepine MOACRIVE Inhibition DTD0010 EXOFACTO Carbamazepine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Carisoprodol HIGHSTIT Approved Drug DTD0010 EXOFACTO Carisoprodol DESCRIPT Carisoprodol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Carisoprodol MOACRIVE Inhibition DTD0010 EXOFACTO Carisoprodol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Carvedilol HIGHSTIT Approved Drug DTD0010 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the activity of SLC22A1 DTD0010 EXOFACTO Carvedilol MOACRIVE Inhibition DTD0010 EXOFACTO Caspofungin HIGHSTIT Approved Drug DTD0010 EXOFACTO Caspofungin DESCRIPT Caspofungin inhibits the transportation of Tetraethyl by SLC22A1 DTD0010 EXOFACTO Caspofungin MOACRIVE Inhibition DTD0010 EXOFACTO Caspofungin CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0010 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0010 EXOFACTO Celecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0010 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0010 EXOFACTO Cephalexin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0010 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0010 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Chloramphenicol HIGHSTIT Approved Drug DTD0010 EXOFACTO Chloramphenicol DESCRIPT Chloramphenicol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Chloramphenicol MOACRIVE Inhibition DTD0010 EXOFACTO Chloramphenicol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0010 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0010 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0010 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Chlorprothixene HIGHSTIT Approved Drug DTD0010 EXOFACTO Chlorprothixene DESCRIPT Chlorprothixene inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Chlorprothixene MOACRIVE Inhibition DTD0010 EXOFACTO Chlorprothixene CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Chlorzoxazone HIGHSTIT Approved Drug DTD0010 EXOFACTO Chlorzoxazone DESCRIPT Chlorzoxazone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Chlorzoxazone MOACRIVE Inhibition DTD0010 EXOFACTO Chlorzoxazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Choline HIGHSTIT Investigative Drug DTD0010 EXOFACTO Choline DESCRIPT Choline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Choline MOACRIVE Inhibition DTD0010 EXOFACTO Choline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0010 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Verapamil by SLC22A1 (IC50 = 12.5 microM) DTD0010 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0010 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-OCT1 DTD0010 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of YM155 by SLC22A1 (IC50 = 149 microM) DTD0010 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of SLC22A1 DTD0010 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0010 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Citalopram HIGHSTIT Approved Drug DTD0010 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Citalopram MOACRIVE Inhibition DTD0010 EXOFACTO Citalopram CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Citreoverdine HIGHSTIT Natural Product DTD0010 EXOFACTO Citreoverdine DESCRIPT Citreoverdine inhibits the transportation of Organic cation by SLC22A1 (IC50 = 6.63 microM) DTD0010 EXOFACTO Citreoverdine MOACRIVE Inhibition DTD0010 EXOFACTO Citreoverdine CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0010 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic cation by SLC22A1 (IC50 = 6.63 microM) DTD0010 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0010 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Clemastine HIGHSTIT Approved Drug DTD0010 EXOFACTO Clemastine DESCRIPT Clemastine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clemastine MOACRIVE Inhibition DTD0010 EXOFACTO Clemastine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clindamycin HIGHSTIT Approved Drug DTD0010 EXOFACTO Clindamycin DESCRIPT Clindamycin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clindamycin MOACRIVE Inhibition DTD0010 EXOFACTO Clindamycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clodronate HIGHSTIT Approved Drug DTD0010 EXOFACTO Clodronate DESCRIPT Clodronate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clodronate MOACRIVE Inhibition DTD0010 EXOFACTO Clodronate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clomipramine HIGHSTIT Approved Drug DTD0010 EXOFACTO Clomipramine DESCRIPT Clomipramine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clomipramine MOACRIVE Inhibition DTD0010 EXOFACTO Clomipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clonidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 6.5 microM) DTD0010 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 0.55 microM) DTD0010 EXOFACTO Clonidine DESCRIPT Clonidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clonidine MOACRIVE Inhibition DTD0010 EXOFACTO Clonidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clonidine CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0010 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0010 EXOFACTO Clotrimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Clozapine HIGHSTIT Approved Drug DTD0010 EXOFACTO Clozapine DESCRIPT Clozapine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Clozapine MOACRIVE Inhibition DTD0010 EXOFACTO Clozapine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0010 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 85 microM) DTD0010 EXOFACTO Cocaine MOACRIVE Inhibition DTD0010 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Codeine HIGHSTIT Approved Drug DTD0010 EXOFACTO Codeine DESCRIPT Codeine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Codeine MOACRIVE Inhibition DTD0010 EXOFACTO Codeine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Colchicine HIGHSTIT Approved Drug DTD0010 EXOFACTO Colchicine DESCRIPT Colchicine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Colchicine MOACRIVE Inhibition DTD0010 EXOFACTO Colchicine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Corticosterone HIGHSTIT Investigative Drug DTD0010 EXOFACTO Corticosterone DESCRIPT Corticosterone inhibits the transportation of YM155 by SLC22A1 (IC50 = 8.89 microM) DTD0010 EXOFACTO Corticosterone DESCRIPT Corticosterone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Corticosterone MOACRIVE Inhibition DTD0010 EXOFACTO Corticosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Crizotinib HIGHSTIT Approved Drug DTD0010 EXOFACTO Crizotinib DESCRIPT Crizotinib inhibits the activity of SLC22A1 DTD0010 EXOFACTO Crizotinib MOACRIVE Inhibition DTD0010 EXOFACTO Cyclophosphamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Cyclophosphamide DESCRIPT Cyclophosphamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cyclophosphamide MOACRIVE Inhibition DTD0010 EXOFACTO Cyclophosphamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0010 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic cation by SLC22A1 (IC50 > 1000 microM) DTD0010 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0010 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0010 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0010 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cyproterone HIGHSTIT Approved Drug DTD0010 EXOFACTO Cyproterone DESCRIPT Cyproterone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cyproterone MOACRIVE Inhibition DTD0010 EXOFACTO Cyproterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Cysteamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Cysteamine DESCRIPT Cysteamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Cysteamine MOACRIVE Inhibition DTD0010 EXOFACTO Cysteamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0010 EXOFACTO Decitabine DESCRIPT Decitabine inhibits DNA methyltransferase, which then enhances Sorafenib's transportation via downregulating the hypermethylation in SLC22A1's promoter DTD0010 EXOFACTO Decitabine MOACRIVE Inducer DTD0010 EXOFACTO Decitabine CELLLINE Human embryonal rhabdomyosarcoma cells DTD0010 EXOFACTO Decynium 22 HIGHSTIT Investigative Drug DTD0010 EXOFACTO Decynium 22 DESCRIPT Decynium 22 inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 21.9 microM) DTD0010 EXOFACTO Decynium 22 DESCRIPT Decynium 22 inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 2.73 microM) DTD0010 EXOFACTO Decynium 22 MOACRIVE Inhibition DTD0010 EXOFACTO Decynium 22 CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Decynium 22 CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Denopamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Denopamine DESCRIPT Denopamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Denopamine MOACRIVE Inhibition DTD0010 EXOFACTO Denopamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0010 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Desipramine MOACRIVE Inhibition DTD0010 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0010 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of SLC22A1 DTD0010 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0010 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 202 microM) DTD0010 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0010 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Diazepam HIGHSTIT Approved Drug DTD0010 EXOFACTO Diazepam DESCRIPT Diazepam inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Diazepam MOACRIVE Inhibition DTD0010 EXOFACTO Diazepam CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0010 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0010 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Dieldrin HIGHSTIT Natural Product DTD0010 EXOFACTO Dieldrin DESCRIPT Dieldrin inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 0.9 microM) DTD0010 EXOFACTO Dieldrin MOACRIVE Inhibition DTD0010 EXOFACTO Dieldrin CELLLINE Human hepatoma HepaRG cells-OCT1 DTD0010 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0010 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Digoxin MOACRIVE Inhibition DTD0010 EXOFACTO Digoxin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0010 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0010 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Diphenhydramine HIGHSTIT Approved Drug DTD0010 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 3.4 microM) DTD0010 EXOFACTO Diphenhydramine MOACRIVE Inhibition DTD0010 EXOFACTO Diphenhydramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0010 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of 4-(4-Dimethylamino)styryl-N-methylpyridinium (ASP+) by SLC22A1 (IC50 = 81.7 microM) DTD0010 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0010 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Dizocilpine HIGHSTIT Discontinued Drug DTD0010 EXOFACTO Dizocilpine DESCRIPT Dizocilpine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 80.5 microM) DTD0010 EXOFACTO Dizocilpine MOACRIVE Inhibition DTD0010 EXOFACTO Dizocilpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Dolutegravir HIGHSTIT Approved Drug DTD0010 EXOFACTO Dolutegravir DESCRIPT Dolutegravir inhibits the transportation of Metformin by SLC22A1 DTD0010 EXOFACTO Dolutegravir MOACRIVE Inhibition DTD0010 EXOFACTO Dolutegravir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Dopamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Dopamine DESCRIPT Dopamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Dopamine MOACRIVE Inhibition DTD0010 EXOFACTO Dopamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Doxazosin HIGHSTIT Approved Drug DTD0010 EXOFACTO Doxazosin DESCRIPT Doxazosin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Doxazosin MOACRIVE Inhibition DTD0010 EXOFACTO Doxazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Doxycycline HIGHSTIT Approved Drug DTD0010 EXOFACTO Doxycycline DESCRIPT Doxycycline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Doxycycline MOACRIVE Inhibition DTD0010 EXOFACTO Doxycycline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0010 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0010 EXOFACTO Efavirenz CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Eflornithine HIGHSTIT Approved Drug DTD0010 EXOFACTO Eflornithine DESCRIPT Eflornithine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Eflornithine MOACRIVE Inhibition DTD0010 EXOFACTO Eflornithine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Eltrombopag HIGHSTIT Approved Drug DTD0010 EXOFACTO Eltrombopag DESCRIPT Eltrombopag inhibits the transportation of Tetraethylammonium by SLC22A1 DTD0010 EXOFACTO Eltrombopag MOACRIVE Inhibition DTD0010 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0010 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Enalapril MOACRIVE Inhibition DTD0010 EXOFACTO Enalapril CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Epinephrine HIGHSTIT Drug in Preclinical Test DTD0010 EXOFACTO Epinephrine DESCRIPT Epinephrine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Epinephrine MOACRIVE Inhibition DTD0010 EXOFACTO Epinephrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ergotamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Ergotamine DESCRIPT Ergotamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ergotamine MOACRIVE Inhibition DTD0010 EXOFACTO Ergotamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ergotidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Ergotidine DESCRIPT Ergotidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ergotidine MOACRIVE Inhibition DTD0010 EXOFACTO Ergotidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0010 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0010 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Esmolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Esmolol DESCRIPT Esmolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Esmolol MOACRIVE Inhibition DTD0010 EXOFACTO Esmolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0010 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A1 (IC50 = 5.73 microM) DTD0010 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the activity of SLC22A1 DTD0010 EXOFACTO Estradiol MOACRIVE Inhibition DTD0010 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ethopropazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Ethopropazine DESCRIPT Ethopropazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ethopropazine DESCRIPT Ethopropazine inhibits the transportation of Metformin by SLC22A1 DTD0010 EXOFACTO Ethopropazine MOACRIVE Inhibition DTD0010 EXOFACTO Ethopropazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Etilefrine HIGHSTIT Drug Withdrawn DTD0010 EXOFACTO Etilefrine DESCRIPT Etilefrine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 447 microM) DTD0010 EXOFACTO Etilefrine MOACRIVE Inhibition DTD0010 EXOFACTO Etilefrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0010 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Etoposide MOACRIVE Inhibition DTD0010 EXOFACTO Etoposide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Famotidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 28 microM) DTD0010 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Famotidine MOACRIVE Inhibition DTD0010 EXOFACTO Famotidine CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Famotidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Felodipine HIGHSTIT Approved Drug DTD0010 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Felodipine MOACRIVE Inhibition DTD0010 EXOFACTO Felodipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fenamiphos HIGHSTIT Natural Product DTD0010 EXOFACTO Fenamiphos DESCRIPT Fenamiphos inhibits the transportation of 4',6'-diamidino-2-phenylindole by SLC22A1 (IC50 = 27.5 microM) DTD0010 EXOFACTO Fenamiphos DESCRIPT Fenamiphos inhibits the transportation of Dopamine by SLC22A1 (IC50 = 9.2 microM) DTD0010 EXOFACTO Fenamiphos MOACRIVE Inhibition DTD0010 EXOFACTO Fenamiphos CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fenofibrate HIGHSTIT Approved Drug DTD0010 EXOFACTO Fenofibrate DESCRIPT Fenofibrate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Fenofibrate MOACRIVE Inhibition DTD0010 EXOFACTO Fenofibrate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fentanyl HIGHSTIT Approved Drug DTD0010 EXOFACTO Fentanyl DESCRIPT Fentanyl inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Fentanyl MOACRIVE Inhibition DTD0010 EXOFACTO Fentanyl CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fluorouracil HIGHSTIT Approved Drug DTD0010 EXOFACTO Fluorouracil DESCRIPT Fluorouracil inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Fluorouracil MOACRIVE Inhibition DTD0010 EXOFACTO Fluorouracil CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fluphenazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Fluphenazine DESCRIPT Fluphenazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Fluphenazine MOACRIVE Inhibition DTD0010 EXOFACTO Fluphenazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Flutamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Flutamide DESCRIPT Flutamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Flutamide MOACRIVE Inhibition DTD0010 EXOFACTO Flutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Folic acid HIGHSTIT Approved Drug DTD0010 EXOFACTO Folic acid DESCRIPT Folic acid inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Folic acid MOACRIVE Inhibition DTD0010 EXOFACTO Folic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0010 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic cation by SLC22A1 (IC50 > 1000 microM) DTD0010 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0010 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0010 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Furosemide MOACRIVE Inhibition DTD0010 EXOFACTO Furosemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Gabapentin HIGHSTIT Approved Drug DTD0010 EXOFACTO Gabapentin DESCRIPT Gabapentin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Gabapentin MOACRIVE Inhibition DTD0010 EXOFACTO Gabapentin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Gallopamil HIGHSTIT Drug in Phase 2 Trial DTD0010 EXOFACTO Gallopamil DESCRIPT Gallopamil inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Gallopamil MOACRIVE Inhibition DTD0010 EXOFACTO Gallopamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ganciclovir HIGHSTIT Approved Drug DTD0010 EXOFACTO Ganciclovir DESCRIPT Ganciclovir inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ganciclovir MOACRIVE Inhibition DTD0010 EXOFACTO Ganciclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Metformin by SLC22A1 (IC50 = 199 microM) DTD0010 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0010 EXOFACTO Glibenclamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0010 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic cation by SLC22A1 (IC50 = 584 microM) DTD0010 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0010 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Glipizide HIGHSTIT Approved Drug DTD0010 EXOFACTO Glipizide DESCRIPT Glipizide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Glipizide MOACRIVE Inhibition DTD0010 EXOFACTO Glipizide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Glucosamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Glucosamine DESCRIPT Glucosamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Glucosamine MOACRIVE Inhibition DTD0010 EXOFACTO Glucosamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Green tea HIGHSTIT Natural Product DTD0010 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Metformin by SLC22A1 DTD0010 EXOFACTO Green tea MOACRIVE Inhibition DTD0010 EXOFACTO Green tea CELLLINE Human enterocyte-like 2 cell (Caco-2)-OCT1 DTD0010 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0010 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0010 EXOFACTO Haloperidol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Hydralazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Hydralazine DESCRIPT Hydralazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Hydralazine MOACRIVE Inhibition DTD0010 EXOFACTO Hydralazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Hydrochlorothiazide HIGHSTIT Approved Drug DTD0010 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Hydrochlorothiazide MOACRIVE Inhibition DTD0010 EXOFACTO Hydrochlorothiazide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0010 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0010 EXOFACTO Ibuprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0010 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Imipramine MOACRIVE Inhibition DTD0010 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0010 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 61.7 microM) DTD0010 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Indinavir MOACRIVE Inhibition DTD0010 EXOFACTO Indinavir CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Indinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Insulin HIGHSTIT Approved Drug DTD0010 EXOFACTO Insulin DESCRIPT Insulin induces the activity of SLC22A1 DTD0010 EXOFACTO Insulin MOACRIVE Inducer DTD0010 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0010 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLC22A1 DTD0010 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0010 EXOFACTO Ketamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Ketamine DESCRIPT Ketamine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 114.5 microM) DTD0010 EXOFACTO Ketamine MOACRIVE Inhibition DTD0010 EXOFACTO Ketamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0010 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0010 EXOFACTO Ketoconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0010 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0010 EXOFACTO Ketoprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Levodopa HIGHSTIT Approved Drug DTD0010 EXOFACTO Levodopa DESCRIPT Levodopa inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Levodopa MOACRIVE Inhibition DTD0010 EXOFACTO Levodopa CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0010 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0010 EXOFACTO Levofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Levothyroxine HIGHSTIT Approved Drug DTD0010 EXOFACTO Levothyroxine DESCRIPT Levothyroxine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Levothyroxine MOACRIVE Inhibition DTD0010 EXOFACTO Levothyroxine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Lidocaine HIGHSTIT Approved Drug DTD0010 EXOFACTO Lidocaine DESCRIPT Lidocaine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Lidocaine MOACRIVE Inhibition DTD0010 EXOFACTO Lidocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Lindane HIGHSTIT Approved Drug DTD0010 EXOFACTO Lindane DESCRIPT Lindane inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 1.52 microM) DTD0010 EXOFACTO Lindane MOACRIVE Inhibition DTD0010 EXOFACTO Lindane CELLLINE Human hepatoma HepaRG cells-OCT1 DTD0010 EXOFACTO Loperamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Loperamide DESCRIPT Loperamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Loperamide MOACRIVE Inhibition DTD0010 EXOFACTO Loperamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0010 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Loratadine MOACRIVE Inhibition DTD0010 EXOFACTO Loratadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Mannitol HIGHSTIT Approved Drug DTD0010 EXOFACTO Mannitol DESCRIPT Mannitol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Mannitol MOACRIVE Inhibition DTD0010 EXOFACTO Mannitol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Meclizine HIGHSTIT Approved Drug DTD0010 EXOFACTO Meclizine DESCRIPT Meclizine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Meclizine MOACRIVE Inhibition DTD0010 EXOFACTO Meclizine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Melagatran HIGHSTIT Drug in Phase 3 Trial DTD0010 EXOFACTO Melagatran DESCRIPT Melagatran inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Melagatran MOACRIVE Inhibition DTD0010 EXOFACTO Melagatran CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Memantine HIGHSTIT Approved Drug DTD0010 EXOFACTO Memantine DESCRIPT Memantine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 3.7 microM) DTD0010 EXOFACTO Memantine DESCRIPT Memantine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Memantine MOACRIVE Inhibition DTD0010 EXOFACTO Memantine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Mepenzolate HIGHSTIT Approved Drug DTD0010 EXOFACTO Mepenzolate DESCRIPT Mepenzolate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Mepenzolate MOACRIVE Inhibition DTD0010 EXOFACTO Mepenzolate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0010 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 2820 microM) DTD0010 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 493 microM) DTD0010 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 1231 microM) DTD0010 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Metformin MOACRIVE Inhibition DTD0010 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Metformin CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Methimazole HIGHSTIT Approved Drug DTD0010 EXOFACTO Methimazole DESCRIPT Methimazole inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Methimazole MOACRIVE Inhibition DTD0010 EXOFACTO Methimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0010 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0010 EXOFACTO Methotrexate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Methyldopa HIGHSTIT Approved Drug DTD0010 EXOFACTO Methyldopa DESCRIPT Methyldopa inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Methyldopa MOACRIVE Inhibition DTD0010 EXOFACTO Methyldopa CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Metoclopramide HIGHSTIT Approved Drug DTD0010 EXOFACTO Metoclopramide DESCRIPT Metoclopramide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Metoclopramide MOACRIVE Inhibition DTD0010 EXOFACTO Metoclopramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0010 EXOFACTO Metoprolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Mianserin HIGHSTIT Approved Drug DTD0010 EXOFACTO Mianserin DESCRIPT Mianserin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Mianserin MOACRIVE Inhibition DTD0010 EXOFACTO Mianserin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Midazolam HIGHSTIT Approved Drug DTD0010 EXOFACTO Midazolam DESCRIPT Midazolam inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 3.7 microM) DTD0010 EXOFACTO Midazolam MOACRIVE Inhibition DTD0010 EXOFACTO Midazolam CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Morphine HIGHSTIT Approved Drug DTD0010 EXOFACTO Morphine DESCRIPT Morphine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Morphine MOACRIVE Inhibition DTD0010 EXOFACTO Morphine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Naltrexone HIGHSTIT Approved Drug DTD0010 EXOFACTO Naltrexone DESCRIPT Naltrexone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Naltrexone MOACRIVE Inhibition DTD0010 EXOFACTO Naltrexone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Nandrolone HIGHSTIT Approved Drug DTD0010 EXOFACTO Nandrolone DESCRIPT Nandrolone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Nandrolone MOACRIVE Inhibition DTD0010 EXOFACTO Nandrolone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0010 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 21.8 microM) DTD0010 EXOFACTO Nelfinavir MOACRIVE Inhibition DTD0010 EXOFACTO Nelfinavir CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0010 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Tetraethylammonium by SLC22A1 DTD0010 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the activity of SLC22A1 DTD0010 EXOFACTO Nicotine MOACRIVE Inhibition DTD0010 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Nicotine CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO N-methylpyridinium HIGHSTIT Drug in Preclinical Test DTD0010 EXOFACTO N-methylpyridinium DESCRIPT N-methylpyridinium inhibits the transportation of YM155 by SLC22A1 (IC50 = 30.4 microM) DTD0010 EXOFACTO N-methylpyridinium MOACRIVE Inhibition DTD0010 EXOFACTO N-methylpyridinium CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Normetanephrine HIGHSTIT Investigative Drug DTD0010 EXOFACTO Normetanephrine DESCRIPT Normetanephrine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Normetanephrine MOACRIVE Inhibition DTD0010 EXOFACTO Normetanephrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ondansetron HIGHSTIT Approved Drug DTD0010 EXOFACTO Ondansetron DESCRIPT Ondansetron inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ondansetron MOACRIVE Inhibition DTD0010 EXOFACTO Ondansetron CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Orciprenaline HIGHSTIT Approved Drug DTD0010 EXOFACTO Orciprenaline DESCRIPT Orciprenaline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Orciprenaline MOACRIVE Inhibition DTD0010 EXOFACTO Orciprenaline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Orphenadrine HIGHSTIT Approved Drug DTD0010 EXOFACTO Orphenadrine DESCRIPT Orphenadrine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Orphenadrine MOACRIVE Inhibition DTD0010 EXOFACTO Orphenadrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Oxprenolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Oxprenolol DESCRIPT Oxprenolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Oxprenolol MOACRIVE Inhibition DTD0010 EXOFACTO Oxprenolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0010 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0010 EXOFACTO Paclitaxel CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Pancuronium HIGHSTIT Approved Drug DTD0010 EXOFACTO Pancuronium DESCRIPT Pancuronium inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A1 DTD0010 EXOFACTO Pancuronium DESCRIPT Pancuronium inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Pancuronium MOACRIVE Inhibition DTD0010 EXOFACTO Pancuronium CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Pancuronium CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Papaverine HIGHSTIT Approved Drug DTD0010 EXOFACTO Papaverine DESCRIPT Papaverine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Papaverine MOACRIVE Inhibition DTD0010 EXOFACTO Papaverine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0010 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic cation by SLC22A1 DTD0010 EXOFACTO Patulin MOACRIVE Inhibition DTD0010 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Pentamidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Pentamidine DESCRIPT Pentamidine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 16.4 microM) DTD0010 EXOFACTO Pentamidine MOACRIVE Inhibition DTD0010 EXOFACTO Pentamidine CELLLINE Chinese hamster ovary (CHO) cells-OCT1 DTD0010 EXOFACTO Phenazone HIGHSTIT Investigative Drug DTD0010 EXOFACTO Phenazone DESCRIPT Phenazone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Phenazone MOACRIVE Inhibition DTD0010 EXOFACTO Phenazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phencyclidine HIGHSTIT Investigative Drug DTD0010 EXOFACTO Phencyclidine DESCRIPT Phencyclidine inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 4.4 microM) DTD0010 EXOFACTO Phencyclidine MOACRIVE Inhibition DTD0010 EXOFACTO Phencyclidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0010 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 23 microM) DTD0010 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 13 microM) DTD0010 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the activity of SLC22A1 DTD0010 EXOFACTO Phenformin MOACRIVE Inhibition DTD0010 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0010 EXOFACTO Phenobarbital DESCRIPT Phenobarbital inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Phenobarbital MOACRIVE Inhibition DTD0010 EXOFACTO Phenobarbital CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phenoxybenzamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Phenoxybenzamine DESCRIPT Phenoxybenzamine inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A1 (IC50 = 2.72 microM) DTD0010 EXOFACTO Phenoxybenzamine DESCRIPT Phenoxybenzamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Phenoxybenzamine MOACRIVE Inhibition DTD0010 EXOFACTO Phenoxybenzamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0010 EXOFACTO Phenytoin DESCRIPT Phenytoin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Phenytoin MOACRIVE Inhibition DTD0010 EXOFACTO Phenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Phosmet HIGHSTIT Natural Product DTD0010 EXOFACTO Phosmet DESCRIPT Phosmet inhibits the transportation of 4',6'-diamidino-2-phenylindole by SLC22A1 (IC50 = 10.4 microM) DTD0010 EXOFACTO Phosmet DESCRIPT Phosmet inhibits the transportation of Dopamine by SLC22A1 (IC50 = 7.1 microM) DTD0010 EXOFACTO Phosmet MOACRIVE Inhibition DTD0010 EXOFACTO Phosmet CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Pilocarpine HIGHSTIT Approved Drug DTD0010 EXOFACTO Pilocarpine DESCRIPT Pilocarpine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Pilocarpine MOACRIVE Inhibition DTD0010 EXOFACTO Pilocarpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Pindolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Pindolol DESCRIPT Pindolol inhibits the transportation of Tetraethylammonium by SLC22A1 DTD0010 EXOFACTO Pindolol MOACRIVE Inhibition DTD0010 EXOFACTO Pindolol CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0010 EXOFACTO Pioglitazone DESCRIPT Pioglitazone inhibits the transportation of Metformin by SLC22A1 (IC50 = 185 microM) DTD0010 EXOFACTO Pioglitazone MOACRIVE Inhibition DTD0010 EXOFACTO Pioglitazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0010 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0010 EXOFACTO Pravastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0010 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of YM155 by SLC22A1 (IC50 = 1.56 microM) DTD0010 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the activity of SLC22A1 DTD0010 EXOFACTO Prazosin MOACRIVE Inhibition DTD0010 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Prednisone HIGHSTIT Approved Drug DTD0010 EXOFACTO Prednisone DESCRIPT Prednisone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Prednisone MOACRIVE Inhibition DTD0010 EXOFACTO Prednisone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0010 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Probenecid MOACRIVE Inhibition DTD0010 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of YM155 by SLC22A1 (IC50 = 51.3 microM) DTD0010 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Procainamide MOACRIVE Inhibition DTD0010 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Prochlorperazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Prochlorperazine DESCRIPT Prochlorperazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Prochlorperazine MOACRIVE Inhibition DTD0010 EXOFACTO Prochlorperazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0010 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A1 (IC50 = 3.05 microM) DTD0010 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Progesterone MOACRIVE Inhibition DTD0010 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Promazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Promazine DESCRIPT Promazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Promazine MOACRIVE Inhibition DTD0010 EXOFACTO Promazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Promethazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Promethazine DESCRIPT Promethazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Promethazine MOACRIVE Inhibition DTD0010 EXOFACTO Promethazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0010 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Propafenone MOACRIVE Inhibition DTD0010 EXOFACTO Propafenone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Propofol HIGHSTIT Approved Drug DTD0010 EXOFACTO Propofol DESCRIPT Propofol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Propofol MOACRIVE Inhibition DTD0010 EXOFACTO Propofol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Propranolol MOACRIVE Inhibition DTD0010 EXOFACTO Propranolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Pyrazinamide HIGHSTIT Approved Drug DTD0010 EXOFACTO Pyrazinamide DESCRIPT Pyrazinamide inhibits the activity of SLC22A1 DTD0010 EXOFACTO Pyrazinamide MOACRIVE Inhibition DTD0010 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of YM155 by SLC22A1 (IC50 = 7.11 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 6.7 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 5.7 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 22.9 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 17.5 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 13 microM) DTD0010 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Quinine MOACRIVE Inhibition DTD0010 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Quinine CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Quinine CELLLINE Chinese hamster ovary (CHO) cells-OCT1 DTD0010 EXOFACTO Quinine CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0010 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 33 microM) DTD0010 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 28 microM) DTD0010 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0010 EXOFACTO Ranitidine CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Ranitidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0010 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 1.8 microM) DTD0010 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Metformin by SLC22A1 (IC50 = 1.6 microM) DTD0010 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Repaglinide MOACRIVE Inhibition DTD0010 EXOFACTO Repaglinide CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OCT1 DTD0010 EXOFACTO Repaglinide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0010 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0010 EXOFACTO Rifampicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Rifampin HIGHSTIT Approved Drug DTD0010 EXOFACTO Rifampin DESCRIPT Rifampicin induces the activity of SLC22A1 DTD0010 EXOFACTO Rifampin MOACRIVE Inducer DTD0010 EXOFACTO Risperidone HIGHSTIT Approved Drug DTD0010 EXOFACTO Risperidone DESCRIPT Risperidone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Risperidone MOACRIVE Inhibition DTD0010 EXOFACTO Risperidone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0010 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 5.18 microM) DTD0010 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 14 microM) DTD0010 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0010 EXOFACTO Ritonavir CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Ritonavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Rocuronium HIGHSTIT Approved Drug DTD0010 EXOFACTO Rocuronium DESCRIPT Rocuronium inhibits the transportation of Tributylmethylammonium by SLC22A1 DTD0010 EXOFACTO Rocuronium MOACRIVE Inhibition DTD0010 EXOFACTO Rocuronium CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0010 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 8.26 microM) DTD0010 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0010 EXOFACTO Saquinavir CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Scopolamine HIGHSTIT Approved Drug DTD0010 EXOFACTO Scopolamine DESCRIPT Scopolamine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Scopolamine MOACRIVE Inhibition DTD0010 EXOFACTO Scopolamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0010 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Metformin by SLC22A1 (IC50 = 89 microM) DTD0010 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0010 EXOFACTO Simvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Sodium butyrate HIGHSTIT Drug in Phase 2/3 Trial DTD0010 EXOFACTO Sodium butyrate DESCRIPT Butyrate inhibits histone deacetylase, which then enhances Sorafenib's transportation via increasing the histone acethylation level of SLC22A1 DTD0010 EXOFACTO Sodium butyrate MOACRIVE Inducer DTD0010 EXOFACTO Sodium butyrate CELLLINE Human embryonal rhabdomyosarcoma cells DTD0010 EXOFACTO Sodium taurocholate HIGHSTIT Drug in Phase 1/2 Trial DTD0010 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Sodium taurocholate MOACRIVE Inhibition DTD0010 EXOFACTO Sodium taurocholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Sotalol HIGHSTIT Approved Drug DTD0010 EXOFACTO Sotalol DESCRIPT Sotalol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Sotalol MOACRIVE Inhibition DTD0010 EXOFACTO Sotalol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Sparfloxacin HIGHSTIT Approved Drug DTD0010 EXOFACTO Sparfloxacin DESCRIPT Sparfloxacin inhibits the activity of SLC22A1 DTD0010 EXOFACTO Sparfloxacin MOACRIVE Inhibition DTD0010 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0010 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0010 EXOFACTO Spironolactone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0010 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0010 EXOFACTO Sulfasalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0010 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Sulindac MOACRIVE Inhibition DTD0010 EXOFACTO Sulindac CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tacrine HIGHSTIT Approved Drug DTD0010 EXOFACTO Tacrine DESCRIPT Tacrine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Tacrine DESCRIPT Tacrine inhibits the transportation of Metformin by SLC22A1 DTD0010 EXOFACTO Tacrine MOACRIVE Inhibition DTD0010 EXOFACTO Tacrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0010 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0010 EXOFACTO Tamoxifen CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Terazosin HIGHSTIT Approved Drug DTD0010 EXOFACTO Terazosin DESCRIPT Terazosin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Terazosin MOACRIVE Inhibition DTD0010 EXOFACTO Terazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Terbutaline HIGHSTIT Approved Drug DTD0010 EXOFACTO Terbutaline DESCRIPT Terbutaline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Terbutaline MOACRIVE Inhibition DTD0010 EXOFACTO Terbutaline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Terfenadine HIGHSTIT Drug Withdrawn DTD0010 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Terfenadine MOACRIVE Inhibition DTD0010 EXOFACTO Terfenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tetracycline HIGHSTIT Approved Drug DTD0010 EXOFACTO Tetracycline DESCRIPT Tetracycline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Tetracycline MOACRIVE Inhibition DTD0010 EXOFACTO Tetracycline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0010 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of Tetraethylammonium by SLC22A1 (IC50 = 167 microM) DTD0010 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 469.7 microM) DTD0010 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 216 microM) DTD0010 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of N-methylpyridinium by SLC22A1 (Ki = 158 microM) DTD0010 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of Tetraethylammonium by SLC22A1 DTD0010 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0010 EXOFACTO Tetraethylammonium CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Tetraethylammonium CELLLINE Chinese hamster ovary (CHO) cells-OCT1 DTD0010 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0010 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Verapamil by SLC22A1 (IC50 = 4.9 microM) DTD0010 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0010 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Theophylline HIGHSTIT Approved Drug DTD0010 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Theophylline MOACRIVE Inhibition DTD0010 EXOFACTO Theophylline CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Timolol HIGHSTIT Approved Drug DTD0010 EXOFACTO Timolol DESCRIPT Timolol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Timolol MOACRIVE Inhibition DTD0010 EXOFACTO Timolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tramadol HIGHSTIT Approved Drug DTD0010 EXOFACTO Tramadol DESCRIPT Tramadol inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Tramadol MOACRIVE Inhibition DTD0010 EXOFACTO Tramadol CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Trihexyphenidyl HIGHSTIT Approved Drug DTD0010 EXOFACTO Trihexyphenidyl DESCRIPT Trihexyphenidyl inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Trihexyphenidyl MOACRIVE Inhibition DTD0010 EXOFACTO Trihexyphenidyl CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0010 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0010 EXOFACTO Trimethoprim CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Trimipramine HIGHSTIT Approved Drug DTD0010 EXOFACTO Trimipramine DESCRIPT Trimipramine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Trimipramine MOACRIVE Inhibition DTD0010 EXOFACTO Trimipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0010 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0010 EXOFACTO Troglitazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Tubocurarine HIGHSTIT Approved Drug DTD0010 EXOFACTO Tubocurarine DESCRIPT Tubocurarine inhibits the transportation of YM155 by SLC22A1 (IC50 = 62.4 microM) DTD0010 EXOFACTO Tubocurarine DESCRIPT Tubocurarine inhibits the activity of SLC22A1 DTD0010 EXOFACTO Tubocurarine MOACRIVE Inhibition DTD0010 EXOFACTO Tubocurarine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0010 EXOFACTO Valproic Acid DESCRIPT Valproic Acid inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Valproic Acid MOACRIVE Inhibition DTD0010 EXOFACTO Valproic Acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0010 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0010 EXOFACTO Vancomycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Vecuronium HIGHSTIT Approved Drug DTD0010 EXOFACTO Vecuronium DESCRIPT Vecuronium inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 232 microM) DTD0010 EXOFACTO Vecuronium DESCRIPT Vecuronium inhibits the transportation of 1-Methyl-4-phenylpyridinium by SLC22A1 (Ki = 120 microM) DTD0010 EXOFACTO Vecuronium MOACRIVE Inhibition DTD0010 EXOFACTO Vecuronium CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Vecuronium CELLLINE Oocytes-OCT1 DTD0010 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0010 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of YM155 by SLC22A1 (IC50 = 1.23 microM) DTD0010 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Metformin by SLC22A1 (IC50 = 0.62 microM) DTD0010 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Tetraethylammonium by SLC22A1 (Ki = 2.9 microM) DTD0010 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Verapamil MOACRIVE Inhibition DTD0010 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Verapamil CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0010 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0010 EXOFACTO Vinblastine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Vitamin B1 HIGHSTIT Approved Drug DTD0010 EXOFACTO Vitamin B1 DESCRIPT Vitamin B1 inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Vitamin B1 DESCRIPT Vitamin B1 inhibits the transportation of Tetraethylammonium by SLC22A1 DTD0010 EXOFACTO Vitamin B1 MOACRIVE Inhibition DTD0010 EXOFACTO Vitamin B1 CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Vitamin B1 CELLLINE Human cervical cancer cell line (Hela)-OCT1 DTD0010 EXOFACTO Warfarin HIGHSTIT Approved Drug DTD0010 EXOFACTO Warfarin DESCRIPT Warfarin inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Warfarin MOACRIVE Inhibition DTD0010 EXOFACTO Warfarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO YM155 HIGHSTIT Drug in Phase 2 Trial DTD0010 EXOFACTO YM155 DESCRIPT YM155 inhibits the transportation of N-methylpyridinium by SLC22A1 (IC50 = 23.8 microM) DTD0010 EXOFACTO YM155 MOACRIVE Inhibition DTD0010 EXOFACTO YM155 CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Zanamivir HIGHSTIT Approved Drug DTD0010 EXOFACTO Zanamivir DESCRIPT Zanamivir inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Zanamivir MOACRIVE Inhibition DTD0010 EXOFACTO Zanamivir CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0010 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0010 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic cation by SLC22A1 (IC50 = 0.62 microM) DTD0010 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0010 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OCT1 DTD0010 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0010 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of 4-(4-(dimethylamino)styryl)-N-methylpyridinium by SLC22A1 DTD0010 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0010 EXOFACTO Zidovudine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCT1 DTD0012 TRANSPID DTD0012 DTD0012 GENENAME ABCC3 DTD0012 PROTNAME Multidrug resistance-associated protein 3 DTD0012 GENEDBID 8714 DTD0012 UNIPROID O15438 DTD0012 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0012 EXOFACTO Acetaminophen DESCRIPT Acetaminophen induces the activity of ABCC3 DTD0012 EXOFACTO Acetaminophen MOACRIVE Inducer DTD0012 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0012 EXOFACTO Cefaclor CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0012 EXOFACTO Cefadroxil CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0012 EXOFACTO Cefamandole CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefmetazole HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefmetazole MOACRIVE Inhibition DTD0012 EXOFACTO Cefmetazole CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0012 EXOFACTO Cefoperazone CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefoxitin HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefoxitin DESCRIPT Cefoxitin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefoxitin MOACRIVE Inhibition DTD0012 EXOFACTO Cefoxitin CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0012 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0012 EXOFACTO Ceftriaxone CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cefuroxime HIGHSTIT Approved Drug DTD0012 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cefuroxime MOACRIVE Inhibition DTD0012 EXOFACTO Cefuroxime CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0012 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0012 EXOFACTO Cephalexin CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Cephradine HIGHSTIT Approved Drug DTD0012 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 DTD0012 EXOFACTO Cephradine MOACRIVE Inhibition DTD0012 EXOFACTO Cephradine CELLLINE Spodoptera frugiperda 21-MRP3 DTD0012 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0012 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid induces the activity of ABCC3 DTD0012 EXOFACTO Chenodeoxycholic acid MOACRIVE Inducer DTD0012 EXOFACTO Delavirdine HIGHSTIT Approved Drug DTD0012 EXOFACTO Delavirdine DESCRIPT Delavirdine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC3 DTD0012 EXOFACTO Delavirdine MOACRIVE Inhibition DTD0012 EXOFACTO Delavirdine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP3 DTD0012 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0012 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the activity of ABCC3 DTD0012 EXOFACTO Doxorubicin MOACRIVE Inhibition DTD0012 EXOFACTO Doxorubicin CELLLINE Human colon cancer cells (HT-29)-MRP3 DTD0012 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0012 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC3 DTD0012 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0012 EXOFACTO Efavirenz CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP3 DTD0012 EXOFACTO Emtricitabine HIGHSTIT Approved Drug DTD0012 EXOFACTO Emtricitabine DESCRIPT Emtricitabine inhibits the transportation of 5-Chloromethylfluorescein diacetate by ABCC3 DTD0012 EXOFACTO Emtricitabine MOACRIVE Inhibition DTD0012 EXOFACTO Emtricitabine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-MRP3 DTD0012 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0012 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the activity of ABCC3 DTD0012 EXOFACTO Etoposide MOACRIVE Inhibition DTD0012 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0012 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the activity of ABCC3 DTD0012 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0012 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0012 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCC3 DTD0012 EXOFACTO Micafungin MOACRIVE Inhibition DTD0012 EXOFACTO Oxypertine HIGHSTIT Drug in Preclinical Test DTD0012 EXOFACTO Oxypertine DESCRIPT Oxypertine induces the activity of ABCC3 DTD0012 EXOFACTO Oxypertine MOACRIVE Inducer DTD0012 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0012 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of ABCC3 DTD0012 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0012 EXOFACTO Prasterone HIGHSTIT Approved Drug DTD0012 EXOFACTO Prasterone DESCRIPT Prasterone induces the activity of ABCC3 DTD0012 EXOFACTO Prasterone MOACRIVE Inducer DTD0012 EXOFACTO Rimonabant HIGHSTIT Drug Withdrawn DTD0012 EXOFACTO Rimonabant DESCRIPT Rimonabant inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC3 DTD0012 EXOFACTO Rimonabant MOACRIVE Inhibition DTD0012 EXOFACTO Rimonabant CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP3 DTD0012 EXOFACTO Sodium taurocholate HIGHSTIT Drug in Phase 1/2 Trial DTD0012 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of Estradiol-17beta-glucuronide by ABCC3 (IC50 = 40 microM) DTD0012 EXOFACTO Sodium taurocholate MOACRIVE Inhibition DTD0012 EXOFACTO Sodium taurocholate CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP3 DTD0013 TRANSPID DTD0013 DTD0013 GENENAME ABCB4 DTD0013 PROTNAME Multidrug resistance protein 3 DTD0013 GENEDBID 5244 DTD0013 UNIPROID P21439 DTD0013 EXOFACTO Bezafibrate HIGHSTIT Approved Drug DTD0013 EXOFACTO Bezafibrate DESCRIPT Bezafibrate induces the activity of ABCB4 DTD0013 EXOFACTO Bezafibrate MOACRIVE Inducer DTD0013 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0013 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of ABCB4 DTD0013 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0013 EXOFACTO Cyclosporine CELLLINE Spodoptera frugiperda (Sf9) cells-MDR3 DTD0013 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0013 EXOFACTO Doxorubicin DESCRIPT Doxorubicin induces the activity of ABCB4 DTD0013 EXOFACTO Doxorubicin MOACRIVE Inducer DTD0013 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0013 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the activity of ABCB4 DTD0013 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0013 EXOFACTO Paclitaxel CELLLINE Spodoptera frugiperda (Sf9) cells-MDR3 DTD0013 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0013 EXOFACTO Phenobarbital DESCRIPT Phenobarbital induces the activity of ABCB4 DTD0013 EXOFACTO Phenobarbital MOACRIVE Inducer DTD0013 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0013 EXOFACTO Simvastatin DESCRIPT Simvastatin induces the activity of ABCB4 DTD0013 EXOFACTO Simvastatin MOACRIVE Inducer DTD0013 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0013 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the activity of ABCB4 DTD0013 EXOFACTO Verapamil MOACRIVE Inhibition DTD0013 EXOFACTO Verapamil CELLLINE Spodoptera frugiperda (Sf9) cells-MDR3 DTD0013 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0013 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the activity of ABCB4 DTD0013 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0013 EXOFACTO Vinblastine CELLLINE Spodoptera frugiperda (Sf9) cells-MDR3 DTD0014 TRANSPID DTD0014 DTD0014 GENENAME ABCB11 DTD0014 PROTNAME Bile salt export pump DTD0014 GENEDBID 8647 DTD0014 UNIPROID O95342 DTD0014 EXOFACTO Atenolol HIGHSTIT Approved Drug DTD0014 EXOFACTO Atenolol DESCRIPT Atenolol inhibits the activity of ABCB11 DTD0014 EXOFACTO Atenolol MOACRIVE Inhibition DTD0014 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0014 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 9.12 microM) DTD0014 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0014 EXOFACTO Atorvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0014 EXOFACTO Boldine HIGHSTIT Natural Product DTD0014 EXOFACTO Boldine DESCRIPT Boldine induces the activity of ABCB11 DTD0014 EXOFACTO Boldine MOACRIVE Inducer DTD0014 EXOFACTO Boldine CELLLINE Model organism in vivo (rat) DTD0014 EXOFACTO Bosentan HIGHSTIT Approved Drug DTD0014 EXOFACTO Bosentan DESCRIPT Bosentan inhibits the activity of ABCB11 DTD0014 EXOFACTO Bosentan MOACRIVE Inhibition DTD0014 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0014 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the activity of ABCB11 DTD0014 EXOFACTO Budesonide MOACRIVE Inhibition DTD0014 EXOFACTO Candesartan cilexetil HIGHSTIT Approved Drug DTD0014 EXOFACTO Candesartan cilexetil DESCRIPT Candesartan cilexetil inhibits the activity of ABCB11 (IC50 = 6.2 microM) DTD0014 EXOFACTO Candesartan cilexetil MOACRIVE Inhibition DTD0014 EXOFACTO Candesartan cilexetil CELLLINE Human hepatocytes-BSEP DTD0014 EXOFACTO Cerivastatin HIGHSTIT Approved Drug DTD0014 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 11.4 microM) DTD0014 EXOFACTO Cerivastatin MOACRIVE Inhibition DTD0014 EXOFACTO Cerivastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-BSEP DTD0014 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0014 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid induces the activity of ABCB11 DTD0014 EXOFACTO Chenodeoxycholic acid MOACRIVE Inducer DTD0014 EXOFACTO Chenodiol HIGHSTIT Approved Drug DTD0014 EXOFACTO Chenodiol DESCRIPT Chenodiol induces the activity of ABCB11 DTD0014 EXOFACTO Chenodiol MOACRIVE Inducer DTD0014 EXOFACTO Chenodiol CELLLINE Hepatocyte-BSEP DTD0014 EXOFACTO Clofazimine HIGHSTIT Approved Drug DTD0014 EXOFACTO Clofazimine DESCRIPT Clofazimine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 2.3 microM) DTD0014 EXOFACTO Clofazimine MOACRIVE Inhibition DTD0014 EXOFACTO Clofazimine CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Cloxacillin HIGHSTIT Approved Drug DTD0014 EXOFACTO Cloxacillin DESCRIPT Cloxacillin inhibits the activity of ABCB11 DTD0014 EXOFACTO Cloxacillin MOACRIVE Inhibition DTD0014 EXOFACTO Colchicine HIGHSTIT Approved Drug DTD0014 EXOFACTO Colchicine DESCRIPT Colchicine induces the activity of ABCB11 DTD0014 EXOFACTO Colchicine MOACRIVE Inducer DTD0014 EXOFACTO Conjugated estrogens HIGHSTIT Approved Drug DTD0014 EXOFACTO Conjugated estrogens DESCRIPT Conjugated estrogens inhibits the activity of ABCB11 DTD0014 EXOFACTO Conjugated estrogens MOACRIVE Inhibition DTD0014 EXOFACTO Cyanidin HIGHSTIT Natural Product DTD0014 EXOFACTO Cyanidin DESCRIPT Cyanidin inhibits the activity of ABCB11 (IC50 = 7.6 microM) DTD0014 EXOFACTO Cyanidin MOACRIVE Inhibition DTD0014 EXOFACTO Cyanidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Cyanidin-3,5-diglucoside HIGHSTIT Natural Product DTD0014 EXOFACTO Cyanidin-3,5-diglucoside DESCRIPT Cyanidin-3,5-diglucoside inhibits the activity of ABCB11 (IC50 = 43 microM) DTD0014 EXOFACTO Cyanidin-3,5-diglucoside MOACRIVE Inhibition DTD0014 EXOFACTO Cyanidin-3,5-diglucoside CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 0.94 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 18.9 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 8.4 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Glycocholate by ABCB11 (IC50 = 0.93 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Taurochenodeoxycholate by ABCB11 (Ki = 9.5 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 7.8 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bodipy by ABCB11 (IC50 = 7.5 microM) DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Sodium taurocholate by ABCB11 DTD0014 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of ABCB11 DTD0014 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0014 EXOFACTO Cyclosporine CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Cyclosporine CELLLINE High Five cells-BSEP DTD0014 EXOFACTO Cyclosporine CELLLINE Hepatocyte-BSEP DTD0014 EXOFACTO Delphinidin HIGHSTIT Natural Product DTD0014 EXOFACTO Delphinidin DESCRIPT Delphinidin inhibits the activity of ABCB11 (IC50 = 87 microM) DTD0014 EXOFACTO Delphinidin MOACRIVE Inhibition DTD0014 EXOFACTO Delphinidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Disulfiram HIGHSTIT Approved Drug DTD0014 EXOFACTO Disulfiram DESCRIPT Disulfiram inhibits the activity of ABCB11 DTD0014 EXOFACTO Disulfiram MOACRIVE Inhibition DTD0014 EXOFACTO Epigalocatechin gallate HIGHSTIT Investigative Drug DTD0014 EXOFACTO Epigalocatechin gallate DESCRIPT Epigalocatechin gallate inhibits the transportation of Bodipy by ABCB11 (IC50 = 214 microM) DTD0014 EXOFACTO Epigalocatechin gallate MOACRIVE Inhibition DTD0014 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0014 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the activity of ABCB11 DTD0014 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0014 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 15.8 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 14.7 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 11.3 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Glycocholate by ABCB11 (IC50 = 18.8 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Sodium taurocholate by ABCB11 (Ki = 27.5 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 146.5 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Bodipy by ABCB11 (IC50 = 260.1 microM) DTD0014 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of ABCB11 DTD0014 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0014 EXOFACTO Glibenclamide CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Glibenclamide CELLLINE High Five cells-BSEP DTD0014 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0014 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of ABCB11 DTD0014 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0014 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0014 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of ABCB11 DTD0014 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0014 EXOFACTO Malvidin HIGHSTIT Natural Product DTD0014 EXOFACTO Malvidin DESCRIPT Malvidin inhibits the activity of ABCB11 (IC50 = 49 microM) DTD0014 EXOFACTO Malvidin MOACRIVE Inhibition DTD0014 EXOFACTO Malvidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0014 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCB11 DTD0014 EXOFACTO Micafungin MOACRIVE Inhibition DTD0014 EXOFACTO Midecamycin HIGHSTIT Approved Drug DTD0014 EXOFACTO Midecamycin DESCRIPT Midecamycin inhibits the activity of ABCB11 DTD0014 EXOFACTO Midecamycin MOACRIVE Inhibition DTD0014 EXOFACTO Pelargonidin HIGHSTIT Natural Product DTD0014 EXOFACTO Pelargonidin DESCRIPT Pelargonidin inhibits the activity of ABCB11 (IC50 = 76 microM) DTD0014 EXOFACTO Pelargonidin MOACRIVE Inhibition DTD0014 EXOFACTO Pelargonidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Peonidin HIGHSTIT Natural Product DTD0014 EXOFACTO Peonidin DESCRIPT Peonidin inhibits the activity of ABCB11 (IC50 = 30 microM) DTD0014 EXOFACTO Peonidin MOACRIVE Inhibition DTD0014 EXOFACTO Peonidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Petunidin HIGHSTIT Natural Product DTD0014 EXOFACTO Petunidin DESCRIPT Petunidin inhibits the activity of ABCB11 (IC50 = 193 microM) DTD0014 EXOFACTO Petunidin MOACRIVE Inhibition DTD0014 EXOFACTO Petunidin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-BSEP DTD0014 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0014 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the activity of ABCB11 DTD0014 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0014 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0014 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Dihydrofluorescein by ABCB11 (IC50 = 17.3 microM) DTD0014 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Bodipy by ABCB11 (IC50 = 224.6 microM) DTD0014 EXOFACTO Progesterone MOACRIVE Inhibition DTD0014 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0014 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 2.8 microM) DTD0014 EXOFACTO Reserpine MOACRIVE Inhibition DTD0014 EXOFACTO Reserpine CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0014 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 10.5 microM) DTD0014 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0014 EXOFACTO Rifampicin CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Rifamycin SV HIGHSTIT Approved Drug DTD0014 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the activity of ABCB11 DTD0014 EXOFACTO Rifamycin SV MOACRIVE Inhibition DTD0014 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0014 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Taurochenodeoxycholate by ABCB11 (IC50 = 27.6 microM) DTD0014 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 9.5 microM) DTD0014 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Glycocholate by ABCB11 (IC50 = 16 microM) DTD0014 EXOFACTO Troglitazone DESCRIPT Troglitazone induces the activity of ABCB11 DTD0014 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0014 EXOFACTO Troglitazone MOACRIVE Inducer DTD0014 EXOFACTO Troglitazone CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0014 EXOFACTO Valinomycin HIGHSTIT Investigative Drug DTD0014 EXOFACTO Valinomycin DESCRIPT Valinomycin inhibits the transportation of Sodium taurocholate by ABCB11 (IC50 = 0.7 microM) DTD0014 EXOFACTO Valinomycin MOACRIVE Inhibition DTD0014 EXOFACTO Valinomycin CELLLINE Spodoptera frugiperda (Sf9) cells-BSEP DTD0015 TRANSPID DTD0015 DTD0015 GENENAME ABCC4 DTD0015 PROTNAME Multidrug resistance-associated protein 4 DTD0015 GENEDBID 10257 DTD0015 UNIPROID O15439 DTD0015 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0015 EXOFACTO Acetaminophen DESCRIPT Acetaminophen induces the activity of ABCC4 DTD0015 EXOFACTO Acetaminophen MOACRIVE Inducer DTD0015 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0015 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 150 microM) DTD0015 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0015 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0015 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 16 microM) DTD0015 EXOFACTO Candesartan MOACRIVE Inhibition DTD0015 EXOFACTO Candesartan CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0015 EXOFACTO Cefaclor CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0015 EXOFACTO Cefadroxil CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0015 EXOFACTO Cefamandole CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefmetazole HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the activity of ABCC4 DTD0015 EXOFACTO Cefmetazole MOACRIVE Inhibition DTD0015 EXOFACTO Cefmetazole CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0015 EXOFACTO Cefoperazone CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefoxitin HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefoxitin DESCRIPT Cefoxitin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefoxitin MOACRIVE Inhibition DTD0015 EXOFACTO Cefoxitin CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0015 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0015 EXOFACTO Ceftriaxone CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cefuroxime HIGHSTIT Approved Drug DTD0015 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cefuroxime MOACRIVE Inhibition DTD0015 EXOFACTO Cefuroxime CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0015 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the transportation of Methotrexate by ABCC4 (IC50 = 35 microM) DTD0015 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the activity of ABCC4 DTD0015 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0015 EXOFACTO Celecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0015 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0015 EXOFACTO Cephalexin CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Cephradine HIGHSTIT Approved Drug DTD0015 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 DTD0015 EXOFACTO Cephradine MOACRIVE Inhibition DTD0015 EXOFACTO Cephradine CELLLINE Spodoptera frugiperda 21-MRP4 DTD0015 EXOFACTO Chlorothiazide HIGHSTIT Approved Drug DTD0015 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the activity of ABCC4 DTD0015 EXOFACTO Chlorothiazide MOACRIVE Inhibition DTD0015 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0015 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Methotrexate by ABCC4 (IC50 = 0.006 microM) DTD0015 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the activity of ABCC4 DTD0015 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0015 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Dihydrotestosterone HIGHSTIT Drug in Phase 4 Trial DTD0015 EXOFACTO Dihydrotestosterone DESCRIPT Dihydrotestosterone induces the activity of ABCC4 DTD0015 EXOFACTO Dihydrotestosterone MOACRIVE Inducer DTD0015 EXOFACTO Dilazep HIGHSTIT Investigative Drug DTD0015 EXOFACTO Dilazep DESCRIPT Dilazep inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 20 microM) DTD0015 EXOFACTO Dilazep MOACRIVE Inhibition DTD0015 EXOFACTO Dilazep CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0015 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Cholyltaurine by ABCC4 (IC50 < 20 microM) DTD0015 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 2 microM) DTD0015 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0015 EXOFACTO Dipyridamole CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP4 DTD0015 EXOFACTO Dipyridamole CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Eetuximab HIGHSTIT Approved Drug DTD0015 EXOFACTO Eetuximab DESCRIPT Eetuximab induces the activity of ABCC4 DTD0015 EXOFACTO Eetuximab MOACRIVE Inducer DTD0015 EXOFACTO Etodolac HIGHSTIT Approved Drug DTD0015 EXOFACTO Etodolac DESCRIPT Etodolac inhibits the activity of ABCC4 DTD0015 EXOFACTO Etodolac MOACRIVE Inhibition DTD0015 EXOFACTO Flutamide HIGHSTIT Approved Drug DTD0015 EXOFACTO Flutamide DESCRIPT Flutamide induces the activity of ABCC4 DTD0015 EXOFACTO Flutamide MOACRIVE Inducer DTD0015 EXOFACTO Folic acid HIGHSTIT Approved Drug DTD0015 EXOFACTO Folic acid DESCRIPT Folic acid inhibits the transportation of Methotrexate by ABCC4 DTD0015 EXOFACTO Folic acid DESCRIPT Folic acid inhibits the transportation of Sodium taurocholate by ABCC4 DTD0015 EXOFACTO Folic acid MOACRIVE Inhibition DTD0015 EXOFACTO Folic acid CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO Folic acid CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP4 DTD0015 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0015 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the activity of ABCC4 DTD0015 EXOFACTO Furosemide MOACRIVE Inhibition DTD0015 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0015 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Methotrexate by ABCC4 (IC50 = 6.1 microM) DTD0015 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the activity of ABCC4 DTD0015 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0015 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0015 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Methotrexate by ABCC4 (IC50 = 11.9 microM) DTD0015 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the activity of ABCC4 DTD0015 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0015 EXOFACTO Ketoprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0015 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 1.5 microM) DTD0015 EXOFACTO Losartan MOACRIVE Inhibition DTD0015 EXOFACTO Losartan CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0015 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Cholyltaurine by ABCC4 (IC50 = 2 microM) DTD0015 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 10 microM) DTD0015 EXOFACTO MK-571 MOACRIVE Inhibition DTD0015 EXOFACTO MK-571 CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP4 DTD0015 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Plant polyphenols HIGHSTIT Natural Product DTD0015 EXOFACTO Plant polyphenols DESCRIPT Plant polyphenols inhibits the transportation of [3H]-dinitrophenyl S-glutathione by ABCC4 DTD0015 EXOFACTO Plant polyphenols MOACRIVE Inhibition DTD0015 EXOFACTO Plant polyphenols CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0015 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 (IC50 < 100 microM) DTD0015 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Cholyltaurine by ABCC4 (IC50 = 100 microM) DTD0015 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 2300 microM) DTD0015 EXOFACTO Probenecid MOACRIVE Inhibition DTD0015 EXOFACTO Probenecid CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO Probenecid CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP4 DTD0015 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0015 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 DTD0015 EXOFACTO Quercetin MOACRIVE Inhibition DTD0015 EXOFACTO Quercetin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Rimonabant HIGHSTIT Drug Withdrawn DTD0015 EXOFACTO Rimonabant DESCRIPT Rimonabant inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC4 DTD0015 EXOFACTO Rimonabant MOACRIVE Inhibition DTD0015 EXOFACTO Rimonabant CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Sildenafil HIGHSTIT Approved Drug DTD0015 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 20 microM) DTD0015 EXOFACTO Sildenafil MOACRIVE Inhibition DTD0015 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Silymarin HIGHSTIT Natural Product DTD0015 EXOFACTO Silymarin DESCRIPT Silymarin inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 DTD0015 EXOFACTO Silymarin MOACRIVE Inhibition DTD0015 EXOFACTO Silymarin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0015 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 420 microM) DTD0015 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0015 EXOFACTO Sulfinpyrazone CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0015 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of Methotrexate by ABCC4 (IC50 = 2.11 microM) DTD0015 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the activity of ABCC4 DTD0015 EXOFACTO Sulindac MOACRIVE Inhibition DTD0015 EXOFACTO Sulindac CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0015 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 11 microM) DTD0015 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the activity of ABCC4 DTD0015 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0015 EXOFACTO Telmisartan CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO Thioguanine HIGHSTIT Approved Drug DTD0015 EXOFACTO Thioguanine DESCRIPT Thioguanine inhibits the transportation of Bimane-glutathione by ABCC4 DTD0015 EXOFACTO Thioguanine MOACRIVE Inhibition DTD0015 EXOFACTO Thioguanine CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP4 DTD0015 EXOFACTO Trequinsin HIGHSTIT Discontinued Drug DTD0015 EXOFACTO Trequinsin DESCRIPT Trequinsin inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 10 microM) DTD0015 EXOFACTO Trequinsin MOACRIVE Inhibition DTD0015 EXOFACTO Trequinsin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0015 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0015 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Methotrexate by ABCC4 DTD0015 EXOFACTO Valspodar MOACRIVE Inhibition DTD0015 EXOFACTO Valspodar CELLLINE Spodoptera frugiperda (Sf9) cells-MRP4 DTD0015 EXOFACTO Zaprinast HIGHSTIT Discontinued Drug DTD0015 EXOFACTO Zaprinast DESCRIPT Zaprinast inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 250 microM) DTD0015 EXOFACTO Zaprinast MOACRIVE Inhibition DTD0015 EXOFACTO Zaprinast CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 TRANSPID DTD0016 DTD0016 GENENAME ABCC5 DTD0016 PROTNAME Multidrug resistance-associated protein 5 DTD0016 GENEDBID 10057 DTD0016 UNIPROID O15440 DTD0016 EXOFACTO 4-(2-Aminoethyl) benzenesulfonyl fluoride HIGHSTIT Investigative Drug DTD0016 EXOFACTO 4-(2-Aminoethyl) benzenesulfonyl fluoride DESCRIPT 4-(2-Aminoethyl) benzenesulfonyl fluoride inhibits the activity of ABCC5 DTD0016 EXOFACTO 4-(2-Aminoethyl) benzenesulfonyl fluoride MOACRIVE Inhibition DTD0016 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0016 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 150 microM) DTD0016 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0016 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0016 EXOFACTO Cisplatin DESCRIPT Cisplatin induces the activity of ABCC5 DTD0016 EXOFACTO Cisplatin MOACRIVE Inducer DTD0016 EXOFACTO Cisplatin CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP5 DTD0016 EXOFACTO Curcumin HIGHSTIT Drug in Phase 3 Trial DTD0016 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 0.5 +/- 0.1 microM) DTD0016 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 0.7 +/- 0.1 microM) DTD0016 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of 5-Fluorouracil by ABCC5 (IC50 = 20.1 +/- 2.2 microM) DTD0016 EXOFACTO Curcumin DESCRIPT Curcumin inhibits the transportation of 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein by ABCC5 DTD0016 EXOFACTO Curcumin MOACRIVE Inhibition DTD0016 EXOFACTO Curcumin CELLLINE Human pancreatic cancer cell lines (PANC-1)-MRP5 DTD0016 EXOFACTO Curcumin CELLLINE MiaPaCa-2 pancreatic cancer cells DTD0016 EXOFACTO Curcumin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Cyclic adenosine monophosphate HIGHSTIT Investigative Drug DTD0016 EXOFACTO Cyclic adenosine monophosphate DESCRIPT Cyclic adenosine monophosphate inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 DTD0016 EXOFACTO Cyclic adenosine monophosphate MOACRIVE Inhibition DTD0016 EXOFACTO Cyclic adenosine monophosphate CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP5 DTD0016 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0016 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 30 microM) DTD0016 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 DTD0016 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0016 EXOFACTO Dipyridamole CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Floxuridine HIGHSTIT Approved Drug DTD0016 EXOFACTO Floxuridine DESCRIPT Floxuridine inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 1163 microM) DTD0016 EXOFACTO Floxuridine MOACRIVE Inhibition DTD0016 EXOFACTO Floxuridine CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Fluorouracil HIGHSTIT Approved Drug DTD0016 EXOFACTO Fluorouracil DESCRIPT Fluorouracil induces the activity of ABCC5 DTD0016 EXOFACTO Fluorouracil MOACRIVE Inducer DTD0016 EXOFACTO Gemcitabine HIGHSTIT Approved Drug DTD0016 EXOFACTO Gemcitabine DESCRIPT Gemcitabine induces the activity of ABCC5 DTD0016 EXOFACTO Gemcitabine MOACRIVE Inducer DTD0016 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0016 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 15 microM) DTD0016 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0016 EXOFACTO Glibenclamide CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0016 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 780 microM) DTD0016 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 1059 microM) DTD0016 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0016 EXOFACTO Methotrexate CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0016 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCC5 DTD0016 EXOFACTO Micafungin MOACRIVE Inhibition DTD0016 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0016 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 200 microM) DTD0016 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 17 microM) DTD0016 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 15.9 microM) DTD0016 EXOFACTO MK-571 MOACRIVE Inhibition DTD0016 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Pemetrexed HIGHSTIT Approved Drug DTD0016 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 442 microM) DTD0016 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 2110 microM) DTD0016 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (Ki = 300 microM) DTD0016 EXOFACTO Pemetrexed MOACRIVE Inhibition DTD0016 EXOFACTO Pemetrexed CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Plant polyphenols HIGHSTIT Natural Product DTD0016 EXOFACTO Plant polyphenols DESCRIPT Plant polyphenols inhibits the activity of ABCC5 DTD0016 EXOFACTO Plant polyphenols MOACRIVE Inhibition DTD0016 EXOFACTO Plant polyphenols CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0016 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 34 microM) DTD0016 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 200 microM) DTD0016 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 70 microM) DTD0016 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of ABCC5 DTD0016 EXOFACTO Probenecid MOACRIVE Inhibition DTD0016 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0016 EXOFACTO Rifampicin DESCRIPT Rifampicin induces the activity of ABCC5 DTD0016 EXOFACTO Rifampicin MOACRIVE Inducer DTD0016 EXOFACTO Rifampicin CELLLINE Human hepatocellular carcinoma cell line (HepG2)-MRP5 DTD0016 EXOFACTO Sildenafil HIGHSTIT Approved Drug DTD0016 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 80 microM) DTD0016 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 580 microM) DTD0016 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 (Ki = 0.267 microM) DTD0016 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 DTD0016 EXOFACTO Sildenafil MOACRIVE Inhibition DTD0016 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Sildenafil CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP5 DTD0016 EXOFACTO Silymarin HIGHSTIT Natural Product DTD0016 EXOFACTO Silymarin DESCRIPT Silymarin inhibits the activity of ABCC5 DTD0016 EXOFACTO Silymarin MOACRIVE Inhibition DTD0016 EXOFACTO Silymarin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0016 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 103.2 microM) DTD0016 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 300 microM) DTD0016 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0016 EXOFACTO Sulfinpyrazone CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Sulfinpyrazone CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Trequinsin HIGHSTIT Discontinued Drug DTD0016 EXOFACTO Trequinsin DESCRIPT Trequinsin inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 218 microM) DTD0016 EXOFACTO Trequinsin DESCRIPT Trequinsin inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 30 microM) DTD0016 EXOFACTO Trequinsin DESCRIPT Trequinsin inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 580 microM) DTD0016 EXOFACTO Trequinsin DESCRIPT Trequinsin inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 (Ki = 0.24 microM) DTD0016 EXOFACTO Trequinsin MOACRIVE Inhibition DTD0016 EXOFACTO Trequinsin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0016 EXOFACTO Trequinsin CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Trequinsin CELLLINE Chinese hamster lung fibroblasts V79 cells (V79)-MRP5 DTD0016 EXOFACTO Zaprinast HIGHSTIT Discontinued Drug DTD0016 EXOFACTO Zaprinast DESCRIPT Zaprinast inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC5 (IC50 = 250 microM) DTD0016 EXOFACTO Zaprinast DESCRIPT Zaprinast inhibits the transportation of 5-Fluorodeoxyuridine monophosphate by ABCC5 (IC50 = 20 microM) DTD0016 EXOFACTO Zaprinast DESCRIPT Zaprinast inhibits the transportation of Carboxydichlorofluorescein by ABCC5 (IC50 = 32.3 microM) DTD0016 EXOFACTO Zaprinast DESCRIPT Zaprinast inhibits the transportation of Cyclic guanosine monophosphate by ABCC5 DTD0016 EXOFACTO Zaprinast MOACRIVE Inhibition DTD0016 EXOFACTO Zaprinast CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP4 DTD0016 EXOFACTO Zaprinast CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP5 DTD0017 TRANSPID DTD0017 DTD0017 GENENAME ABCC6 DTD0017 PROTNAME Multidrug resistance-associated protein 6 DTD0017 GENEDBID 368 DTD0017 UNIPROID O95255 DTD0017 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0017 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of N-ethylmaleimide S-glutathione by ABCC6 DTD0017 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0017 EXOFACTO Benzbromarone CELLLINE Spodoptera frugiperda (Sf9) cells-MRP6 DTD0017 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0017 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of N-ethylmaleimide S-glutathione by ABCC6 DTD0017 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0017 EXOFACTO Indomethacin CELLLINE Spodoptera frugiperda (Sf9) cells-MRP6 DTD0017 EXOFACTO Micafungin HIGHSTIT Approved Drug DTD0017 EXOFACTO Micafungin DESCRIPT Micafungin inhibits the activity of ABCC6 DTD0017 EXOFACTO Micafungin MOACRIVE Inhibition DTD0017 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0017 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of N-ethylmaleimide S-glutathione by ABCC6 DTD0017 EXOFACTO Probenecid MOACRIVE Inhibition DTD0017 EXOFACTO Probenecid CELLLINE Spodoptera frugiperda (Sf9) cells-MRP6 DTD0019 TRANSPID DTD0019 DTD0019 GENENAME SLC10A1 DTD0019 PROTNAME Sodium/taurocholate cotransporting polypeptide DTD0019 GENEDBID 6554 DTD0019 UNIPROID Q14973 DTD0019 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0019 EXOFACTO Adenosine DESCRIPT Adenosine induces the activity of SLC10A1 DTD0019 EXOFACTO Adenosine MOACRIVE Inducer DTD0019 EXOFACTO Apple juice HIGHSTIT Dietary Constituent DTD0019 EXOFACTO Apple juice DESCRIPT Apple juice inhibits the transportation of Sodium taurocholate by SLC10A1 DTD0019 EXOFACTO Apple juice DESCRIPT Apple juices inhibits the transportation of Fexofenadine by SLC10A1 DTD0019 EXOFACTO Apple juice MOACRIVE Inhibition DTD0019 EXOFACTO Apple juice CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Boldine HIGHSTIT Natural Product DTD0019 EXOFACTO Boldine DESCRIPT Boldine induces the activity of SLC10A1 DTD0019 EXOFACTO Boldine MOACRIVE Inducer DTD0019 EXOFACTO Boldine CELLLINE Model organism in vivo (rat) DTD0019 EXOFACTO Bosentan HIGHSTIT Approved Drug DTD0019 EXOFACTO Bosentan DESCRIPT Bosentan inhibits the transportation of Sodium taurocholate by SLC10A1 (Ki = 18 microM) DTD0019 EXOFACTO Bosentan DESCRIPT Bosentan inhibits the activity of SLC10A1 DTD0019 EXOFACTO Bosentan MOACRIVE Inhibition DTD0019 EXOFACTO Bosentan CELLLINE Human embryonic kidney 293 cells (HEK293)-NTCP DTD0019 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0019 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 7.3 microM) DTD0019 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0019 EXOFACTO Bromsulphthalein CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Caspofungin HIGHSTIT Approved Drug DTD0019 EXOFACTO Caspofungin DESCRIPT Caspofungin inhibits the transportation of Sodium taurocholate by SLC10A1 DTD0019 EXOFACTO Caspofungin MOACRIVE Inhibition DTD0019 EXOFACTO Caspofungin CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0019 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 3.6 microM) DTD0019 EXOFACTO Chenodeoxycholic acid MOACRIVE Inhibition DTD0019 EXOFACTO Chenodeoxycholic acid CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Chlorpropamide HIGHSTIT Approved Drug DTD0019 EXOFACTO Chlorpropamide DESCRIPT Chlorpropamide inhibits the transportation of Sodium taurocholate by SLC10A1 DTD0019 EXOFACTO Chlorpropamide MOACRIVE Inhibition DTD0019 EXOFACTO Chlorpropamide CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0019 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Taurocholate by by repressing mRNA expression of SLC10A1 (IC50 = 140 microM) DTD0019 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0019 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-NTCP DTD0019 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0019 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 1 microM) DTD0019 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rosuvastatin by SLC10A1 (IC50 = 0.37 microM) DTD0019 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0019 EXOFACTO Cyclosporine CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0019 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of SLC10A1 DTD0019 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0019 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0019 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 15 microM) DTD0019 EXOFACTO Furosemide MOACRIVE Inhibition DTD0019 EXOFACTO Furosemide CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Gemfibrozil HIGHSTIT Approved Drug DTD0019 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Rosuvastatin by SLC10A1 (IC50 = 23 microM) DTD0019 EXOFACTO Gemfibrozil MOACRIVE Inhibition DTD0019 EXOFACTO Gemfibrozil CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0019 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the activity of SLC10A1 DTD0019 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0019 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0019 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 264 microM) DTD0019 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0019 EXOFACTO Ketoconazole CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO LUM001 HIGHSTIT Drug in Phase 2 Trial DTD0019 EXOFACTO LUM001 DESCRIPT LUM001 inhibits the activity of SLC10A1 DTD0019 EXOFACTO LUM001 MOACRIVE Inhibition DTD0019 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0019 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Sodium taurocholate by SLC10A1 DTD0019 EXOFACTO Progesterone MOACRIVE Inhibition DTD0019 EXOFACTO Progesterone CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0019 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of Sodium taurocholate by SLC10A1 (IC50 = 5.5 microM) DTD0019 EXOFACTO Propranolol MOACRIVE Inhibition DTD0019 EXOFACTO Propranolol CELLLINE Human cervical cancer cell line (Hela)-NTCP DTD0019 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0019 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the activity of SLC10A1 DTD0019 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0019 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0019 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of SLC10A1 DTD0019 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0020 TRANSPID DTD0020 DTD0020 GENENAME SLC10A2 DTD0020 PROTNAME Apical sodium-dependent bile acid transporter DTD0020 GENEDBID 6555 DTD0020 UNIPROID Q12908 DTD0020 EXOFACTO 264W94 HIGHSTIT Drug in Phase 2 Trial DTD0020 EXOFACTO 264W94 DESCRIPT 264W94 modulates the activity of SLC10A2 DTD0020 EXOFACTO 264W94 MOACRIVE Modulator DTD0020 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0020 EXOFACTO Budesonide DESCRIPT Budesonide induces the activity of SLC10A2 DTD0020 EXOFACTO Budesonide MOACRIVE Inducer DTD0020 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0020 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid inhibits the transportation of Sodium taurocholate by SLC10A2 (Ki = 75 microM) DTD0020 EXOFACTO Chenodeoxycholic acid MOACRIVE Inhibition DTD0020 EXOFACTO Chenodeoxycholic acid CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-ASBT DTD0020 EXOFACTO Chenodiol HIGHSTIT Approved Drug DTD0020 EXOFACTO Chenodiol DESCRIPT Chenodiol inhibits the transportation of Sodium taurocholate by SLC10A2 (Ki = 3.3 microM) DTD0020 EXOFACTO Chenodiol MOACRIVE Inhibition DTD0020 EXOFACTO Chenodiol CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-ASBT DTD0020 EXOFACTO Ciprofibrate HIGHSTIT Approved Drug DTD0020 EXOFACTO Ciprofibrate DESCRIPT Ciprofibrate induces the activity of SLC10A2 DTD0020 EXOFACTO Ciprofibrate MOACRIVE Inducer DTD0020 EXOFACTO Colestyramine HIGHSTIT Drug in Phase 2 Trial DTD0020 EXOFACTO Colestyramine DESCRIPT Colestyramine induces the activity of SLC10A2 DTD0020 EXOFACTO Colestyramine MOACRIVE Inducer DTD0020 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0020 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Sodium taurocholate by SLC10A2 (Ki = 24 microM) DTD0020 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0020 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0020 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of SLC10A2 DTD0020 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0020 EXOFACTO Elobixibat HIGHSTIT Drug in Phase 3 Trial DTD0020 EXOFACTO Elobixibat DESCRIPT Elobixibat inhibits the activity of SLC10A2 DTD0020 EXOFACTO Elobixibat MOACRIVE Inhibition DTD0020 EXOFACTO GSK1614235 + GSK2330672 HIGHSTIT Drug in Phase 1 Trial DTD0020 EXOFACTO GSK1614235 + GSK2330672 DESCRIPT GSK1614235 + GSK2330672 modulates the activity of SLC10A2 DTD0020 EXOFACTO GSK1614235 + GSK2330672 MOACRIVE Modulator DTD0020 EXOFACTO GSK2330672 HIGHSTIT Drug in Phase 2 Trial DTD0020 EXOFACTO GSK2330672 DESCRIPT GSK2330672 modulates the activity of SLC10A2 DTD0020 EXOFACTO GSK2330672 MOACRIVE Modulator DTD0020 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0020 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the activity of SLC10A2 DTD0020 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0020 EXOFACTO LUM001 HIGHSTIT Drug in Phase 2 Trial DTD0020 EXOFACTO LUM001 DESCRIPT LUM001 inhibits the activity of SLC10A2 DTD0020 EXOFACTO LUM001 MOACRIVE Inhibition DTD0020 EXOFACTO S-8921 HIGHSTIT Drug in Phase 2 Trial DTD0020 EXOFACTO S-8921 DESCRIPT S-8921 inhibits the activity of SLC10A2 DTD0020 EXOFACTO S-8921 MOACRIVE Inhibition DTD0020 EXOFACTO Secretin HIGHSTIT Approved Drug DTD0020 EXOFACTO Secretin DESCRIPT Secretin induces the activity of SLC10A2 DTD0020 EXOFACTO Secretin MOACRIVE Inducer DTD0020 EXOFACTO Taurochenodeoxycholate HIGHSTIT Investigative Drug DTD0020 EXOFACTO Taurochenodeoxycholate DESCRIPT Taurochenodeoxycholate inhibits the transportation of Sodium taurocholate by SLC10A2 (Ki = 6.1 microM) DTD0020 EXOFACTO Taurochenodeoxycholate MOACRIVE Inhibition DTD0020 EXOFACTO Taurochenodeoxycholate CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-ASBT DTD0020 EXOFACTO Taurocholic acid HIGHSTIT Drug in Phase 1/2 Trial DTD0020 EXOFACTO Taurocholic acid DESCRIPT Taurocholic acid modulates the activity of SLC10A2 DTD0020 EXOFACTO Taurocholic acid MOACRIVE Modulator DTD0020 EXOFACTO Tauroursodeoxycholate HIGHSTIT Investigative Drug DTD0020 EXOFACTO Tauroursodeoxycholate DESCRIPT Tauroursodeoxycholate inhibits the transportation of Sodium taurocholate by SLC10A2 (Ki = 28 microM) DTD0020 EXOFACTO Tauroursodeoxycholate MOACRIVE Inhibition DTD0020 EXOFACTO Tauroursodeoxycholate CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-ASBT DTD0021 TRANSPID DTD0021 DTD0021 GENENAME SLC15A1 DTD0021 PROTNAME Peptide transporter 1 DTD0021 GENEDBID 6564 DTD0021 UNIPROID P46059 DTD0021 EXOFACTO [11C]GlySar HIGHSTIT Investigative Drug DTD0021 EXOFACTO [11C]GlySar DESCRIPT [11C]GlySar modulates the activity of SLC15A1 DTD0021 EXOFACTO [11C]GlySar MOACRIVE Modulator DTD0021 EXOFACTO [14C]GlySar HIGHSTIT Investigative Drug DTD0021 EXOFACTO [14C]GlySar DESCRIPT [14C]GlySar modulates the activity of SLC15A1 DTD0021 EXOFACTO [14C]GlySar MOACRIVE Modulator DTD0021 EXOFACTO [3H]GlySar HIGHSTIT Investigative Drug DTD0021 EXOFACTO [3H]GlySar DESCRIPT [3H]GlySar modulates the activity of SLC15A1 DTD0021 EXOFACTO [3H]GlySar MOACRIVE Modulator DTD0021 EXOFACTO 4-AMBA HIGHSTIT Investigative Drug DTD0021 EXOFACTO 4-AMBA DESCRIPT 4-AMBA inhibits the activity of SLC15A1 DTD0021 EXOFACTO 4-AMBA MOACRIVE Inhibition DTD0021 EXOFACTO Ampicillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Ampicillin DESCRIPT Ampicillin inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 10000 microM) DTD0021 EXOFACTO Ampicillin DESCRIPT Ampicillin inhibits the transportation of Valacyclovir by SLC15A1 DTD0021 EXOFACTO Ampicillin DESCRIPT Ampicillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Ampicillin MOACRIVE Inhibition DTD0021 EXOFACTO Ampicillin CELLLINE Chinese hamster ovary (CHO) cells-PEPT1 DTD0021 EXOFACTO Ampicillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0021 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 30000 microM) DTD0021 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0021 EXOFACTO Benzylpenicillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Bestatin HIGHSTIT Approved Drug DTD0021 EXOFACTO Bestatin DESCRIPT Bestatin inhibits the transporation of melatonin by SLC15A1 (IC50 = 1000 microM) DTD0021 EXOFACTO Bestatin MOACRIVE Inhibition DTD0021 EXOFACTO Bestatin CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0021 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0021 EXOFACTO Captopril DESCRIPT Captopril inhibits the transportation of Sulpiride by SLC15A1 DTD0021 EXOFACTO Captopril MOACRIVE Inhibition DTD0021 EXOFACTO Captopril CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0021 EXOFACTO Cefaclor CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Glycylsarcosine by SLC15A1 DTD0021 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0021 EXOFACTO Cefadroxil CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Cefadroxil CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 8100 microM) DTD0021 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0021 EXOFACTO Cefamandole CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefazolin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefazolin DESCRIPT Cefazolin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefazolin MOACRIVE Inhibition DTD0021 EXOFACTO Cefazolin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefdinir HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefdinir DESCRIPT Cefdinir inhibits the transportation of Glycylsarcosine by SLC15A1 DTD0021 EXOFACTO Cefdinir MOACRIVE Inhibition DTD0021 EXOFACTO Cefdinir CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Cefepime HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefepime DESCRIPT Cefepime inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefepime MOACRIVE Inhibition DTD0021 EXOFACTO Cefepime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefixime HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 10000 microM) DTD0021 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 12000 microM) DTD0021 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the transportation of Cefadroxil by SLC15A1 (Ki = 1310 microM) DTD0021 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefixime MOACRIVE Inhibition DTD0021 EXOFACTO Cefixime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefmetazole HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 28000 microM) DTD0021 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefmetazole MOACRIVE Inhibition DTD0021 EXOFACTO Cefmetazole CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0021 EXOFACTO Cefotaxime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefoxitin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefoxitin DESCRIPT Cefoxitin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefoxitin MOACRIVE Inhibition DTD0021 EXOFACTO Cefoxitin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefpodoxime HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefpodoxime DESCRIPT Cefpodoxime inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefpodoxime MOACRIVE Inhibition DTD0021 EXOFACTO Cefpodoxime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefsulodin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefsulodin DESCRIPT Cefsulodin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki > 30000 microM) DTD0021 EXOFACTO Cefsulodin MOACRIVE Inhibition DTD0021 EXOFACTO Cefsulodin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Ceftazidime HIGHSTIT Approved Drug DTD0021 EXOFACTO Ceftazidime DESCRIPT Ceftazidime inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki > 10000 microM) DTD0021 EXOFACTO Ceftazidime MOACRIVE Inhibition DTD0021 EXOFACTO Ceftazidime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Ceftibuten HIGHSTIT Approved Drug DTD0021 EXOFACTO Ceftibuten DESCRIPT Ceftibuten inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 870 microM) DTD0021 EXOFACTO Ceftibuten DESCRIPT Ceftibuten inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 710 microM) DTD0021 EXOFACTO Ceftibuten DESCRIPT Ceftibuten inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 340 microM) DTD0021 EXOFACTO Ceftibuten DESCRIPT Ceftibuten inhibits the activity of SLC15A1 DTD0021 EXOFACTO Ceftibuten MOACRIVE Inhibition DTD0021 EXOFACTO Ceftibuten CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Ceftibuten CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0021 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the activity of SLC15A1 DTD0021 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0021 EXOFACTO Ceftriaxone CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cefuroxime HIGHSTIT Approved Drug DTD0021 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 26000 microM) DTD0021 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki > 5000 microM) DTD0021 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cefuroxime MOACRIVE Inhibition DTD0021 EXOFACTO Cefuroxime CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0021 EXOFACTO Cephalexin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0021 EXOFACTO Cephalothin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cephapirin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cephapirin DESCRIPT Cephapirin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki > 10000 microM) DTD0021 EXOFACTO Cephapirin DESCRIPT Cephapirin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cephapirin MOACRIVE Inhibition DTD0021 EXOFACTO Cephapirin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cephradine HIGHSTIT Approved Drug DTD0021 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 9.8 microM) DTD0021 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cephradine MOACRIVE Inhibition DTD0021 EXOFACTO Cephradine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cisplatin DESCRIPT Cisplatin induces the activity of SLC15A1 DTD0021 EXOFACTO Cisplatin MOACRIVE Inducer DTD0021 EXOFACTO Cloxacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cloxacillin DESCRIPT Cloxacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 3000 microM) DTD0021 EXOFACTO Cloxacillin DESCRIPT Cloxacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cloxacillin MOACRIVE Inhibition DTD0021 EXOFACTO Cloxacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cyclacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 600 microM) DTD0021 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 350 microM) DTD0021 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 500 microM) DTD0021 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Cyclacillin MOACRIVE Inhibition DTD0021 EXOFACTO Cyclacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Cyclacillin CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Dicloxacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Dicloxacillin DESCRIPT Dicloxacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 7200 microM) DTD0021 EXOFACTO Dicloxacillin DESCRIPT Dicloxacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Dicloxacillin MOACRIVE Inhibition DTD0021 EXOFACTO Dicloxacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0021 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the activity of SLC15A1 DTD0021 EXOFACTO Enalapril MOACRIVE Inhibition DTD0021 EXOFACTO Flucloxacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Flucloxacillin DESCRIPT Flucloxacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Flucloxacillin MOACRIVE Inhibition DTD0021 EXOFACTO Flucloxacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Fosinopril HIGHSTIT Approved Drug DTD0021 EXOFACTO Fosinopril DESCRIPT Fosinopril inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 35.5 microM) DTD0021 EXOFACTO Fosinopril MOACRIVE Inhibition DTD0021 EXOFACTO Fosinopril CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Insulin HIGHSTIT Approved Drug DTD0021 EXOFACTO Insulin DESCRIPT Insulin induces the activity of SLC15A1 DTD0021 EXOFACTO Insulin MOACRIVE Inducer DTD0021 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0021 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 230 microM) DTD0021 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0021 EXOFACTO Irbesartan CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Levodopa HIGHSTIT Approved Drug DTD0021 EXOFACTO Levodopa DESCRIPT Levodopa inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 141200 microM) DTD0021 EXOFACTO Levodopa MOACRIVE Inhibition DTD0021 EXOFACTO Levodopa CELLLINE Chinese hamster ovary (CHO) cells-PEPT1 DTD0021 EXOFACTO Loracarbef HIGHSTIT Approved Drug DTD0021 EXOFACTO Loracarbef DESCRIPT Loracarbef inhibits the transportation of Cefadroxil by SLC15A1 DTD0021 EXOFACTO Loracarbef MOACRIVE Inhibition DTD0021 EXOFACTO Loracarbef CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0021 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 52 microM) DTD0021 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 24 microM) DTD0021 EXOFACTO Losartan MOACRIVE Inhibition DTD0021 EXOFACTO Losartan CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Losartan CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO MDL-28170 HIGHSTIT Discontinued Drug DTD0021 EXOFACTO MDL-28170 DESCRIPT MDL-28170 inhibits the activity of SLC15A1 DTD0021 EXOFACTO MDL-28170 MOACRIVE Inhibition DTD0021 EXOFACTO MDL-28170 CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Methyldopa HIGHSTIT Approved Drug DTD0021 EXOFACTO Methyldopa DESCRIPT Methyldopa inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 151600 microM) DTD0021 EXOFACTO Methyldopa MOACRIVE Inhibition DTD0021 EXOFACTO Methyldopa CELLLINE Chinese hamster ovary (CHO) cells-PEPT1 DTD0021 EXOFACTO Moxalactam HIGHSTIT Approved Drug DTD0021 EXOFACTO Moxalactam DESCRIPT Moxalactam inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 12300 microM) DTD0021 EXOFACTO Moxalactam DESCRIPT Moxalactam inhibits the activity of SLC15A1 DTD0021 EXOFACTO Moxalactam MOACRIVE Inhibition DTD0021 EXOFACTO Moxalactam CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Oxacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Oxacillin DESCRIPT Oxacillin inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 12000 microM) DTD0021 EXOFACTO Oxacillin DESCRIPT Oxacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Oxacillin MOACRIVE Inhibition DTD0021 EXOFACTO Oxacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Penicillin V HIGHSTIT Approved Drug DTD0021 EXOFACTO Penicillin V DESCRIPT Penicillin V inhibits the activity of SLC15A1 DTD0021 EXOFACTO Penicillin V MOACRIVE Inhibition DTD0021 EXOFACTO Penicillin V CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Piperacillin HIGHSTIT Approved Drug DTD0021 EXOFACTO Piperacillin DESCRIPT Piperacillin inhibits the activity of SLC15A1 DTD0021 EXOFACTO Piperacillin MOACRIVE Inhibition DTD0021 EXOFACTO Piperacillin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0021 EXOFACTO Quinapril HIGHSTIT Approved Drug DTD0021 EXOFACTO Quinapril DESCRIPT Quinapril inhibits the activity of SLC15A1 DTD0021 EXOFACTO Quinapril MOACRIVE Inhibition DTD0021 EXOFACTO Valacyclovir HIGHSTIT Approved Drug DTD0021 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Glycylsarcosine by SLC15A1 (IC50 = 400 microM) DTD0021 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 4080 microM) DTD0021 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 1280 microM) DTD0021 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Cefadroxil by SLC15A1 (Ki = 910 microM) DTD0021 EXOFACTO Valacyclovir MOACRIVE Inhibition DTD0021 EXOFACTO Valacyclovir CELLLINE Chinese hamster ovary (CHO) cells-PEPT1 DTD0021 EXOFACTO Valacyclovir CELLLINE Oocytes-PEPT1 DTD0021 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0021 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 560 microM) DTD0021 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Glycylsarcosine by SLC15A1 (Ki = 390 microM) DTD0021 EXOFACTO Valsartan MOACRIVE Inhibition DTD0021 EXOFACTO Valsartan CELLLINE Human cervical cancer cell line (Hela)-PEPT1 DTD0021 EXOFACTO Valsartan CELLLINE Human enterocyte-like 2 cell (Caco-2)-PEPT1 DTD0022 TRANSPID DTD0022 DTD0022 GENENAME SLC15A2 DTD0022 PROTNAME Peptide transporter 2 DTD0022 GENEDBID 6565 DTD0022 UNIPROID Q16348 DTD0022 EXOFACTO Amoxicillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Amoxicillin DESCRIPT Amoxicillin inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 733 microM) DTD0022 EXOFACTO Amoxicillin DESCRIPT Amoxicillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Amoxicillin MOACRIVE Inhibition DTD0022 EXOFACTO Amoxicillin CELLLINE Madin-Darby Canine Kidney (MDCK) cells-PEPT2 DTD0022 EXOFACTO Ampicillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Ampicillin DESCRIPT Ampicillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Ampicillin MOACRIVE Inhibition DTD0022 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0022 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0022 EXOFACTO Bestatin HIGHSTIT Approved Drug DTD0022 EXOFACTO Bestatin DESCRIPT Bestatin inhibits the transporation of melatonin by SLC15A2 (IC50 = 1000 microM) DTD0022 EXOFACTO Bestatin MOACRIVE Inhibition DTD0022 EXOFACTO Bestatin CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0022 EXOFACTO Carnosine HIGHSTIT Investigative Drug DTD0022 EXOFACTO Carnosine DESCRIPT Carnosine inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 60 microM) DTD0022 EXOFACTO Carnosine MOACRIVE Inhibition DTD0022 EXOFACTO Carnosine CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 65 microM) DTD0022 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0022 EXOFACTO Cefaclor CELLLINE Madin-Darby Canine Kidney (MDCK) cells-PEPT2 DTD0022 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Glycylsarcosine by SLC15A2 DTD0022 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0022 EXOFACTO Cefadroxil CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0022 EXOFACTO Cefdinir HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefdinir DESCRIPT Cefdinir inhibits the transportation of Glycylsarcosine by SLC15A2 DTD0022 EXOFACTO Cefdinir MOACRIVE Inhibition DTD0022 EXOFACTO Cefdinir CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Cefepime HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefepime DESCRIPT Cefepime inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefepime MOACRIVE Inhibition DTD0022 EXOFACTO Cefixime HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the transportation of Glycylsarcosine by SLC15A2 DTD0022 EXOFACTO Cefixime DESCRIPT Cefixime inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefixime MOACRIVE Inhibition DTD0022 EXOFACTO Cefixime CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Cefmetazole HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefmetazole DESCRIPT Cefmetazole inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefmetazole MOACRIVE Inhibition DTD0022 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0022 EXOFACTO Cefpodoxime HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefpodoxime DESCRIPT Cefpodoxime inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefpodoxime MOACRIVE Inhibition DTD0022 EXOFACTO Ceftibuten HIGHSTIT Approved Drug DTD0022 EXOFACTO Ceftibuten DESCRIPT Ceftibuten inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 90 microM) DTD0022 EXOFACTO Ceftibuten MOACRIVE Inhibition DTD0022 EXOFACTO Ceftibuten CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Cefuroxime HIGHSTIT Approved Drug DTD0022 EXOFACTO Cefuroxime DESCRIPT Cefuroxime inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cefuroxime MOACRIVE Inhibition DTD0022 EXOFACTO Cephalexin HIGHSTIT Approved Drug DTD0022 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 98 microM) DTD0022 EXOFACTO Cephalexin DESCRIPT Cephalexin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cephalexin MOACRIVE Inhibition DTD0022 EXOFACTO Cephalexin CELLLINE Chinese hamster ovary (CHO) cells-PEPT2 DTD0022 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0022 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0022 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0022 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0022 EXOFACTO Cephapirin HIGHSTIT Approved Drug DTD0022 EXOFACTO Cephapirin DESCRIPT Cephapirin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cephapirin MOACRIVE Inhibition DTD0022 EXOFACTO Cloxacillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Cloxacillin DESCRIPT Cloxacillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cloxacillin MOACRIVE Inhibition DTD0022 EXOFACTO Cyclacillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Glycylsarcosine by SLC15A2 (IC50 = 610 microM) DTD0022 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 39.1 microM) DTD0022 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the transportation of Chephalexin by SLC15A2 (Ki = 36.8 microM) DTD0022 EXOFACTO Cyclacillin DESCRIPT Cyclacillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Cyclacillin MOACRIVE Inhibition DTD0022 EXOFACTO Cyclacillin CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO Dicloxacillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Dicloxacillin DESCRIPT Dicloxacillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Dicloxacillin MOACRIVE Inhibition DTD0022 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0022 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of SLC15A2 DTD0022 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0022 EXOFACTO Laevulinic acid HIGHSTIT Investigative Drug DTD0022 EXOFACTO Laevulinic acid DESCRIPT Laevulinic acid inhibits the activity of SLC15A2 DTD0022 EXOFACTO Laevulinic acid MOACRIVE Inhibition DTD0022 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0022 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 2.4 microM) DTD0022 EXOFACTO Losartan MOACRIVE Inhibition DTD0022 EXOFACTO Losartan CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0022 EXOFACTO MDL-28170 HIGHSTIT Discontinued Drug DTD0022 EXOFACTO MDL-28170 DESCRIPT MDL-28170 inhibits the activity of SLC15A2 DTD0022 EXOFACTO MDL-28170 MOACRIVE Inhibition DTD0022 EXOFACTO Oxacillin HIGHSTIT Approved Drug DTD0022 EXOFACTO Oxacillin DESCRIPT Oxacillin inhibits the activity of SLC15A2 DTD0022 EXOFACTO Oxacillin MOACRIVE Inhibition DTD0022 EXOFACTO Quinapril HIGHSTIT Approved Drug DTD0022 EXOFACTO Quinapril DESCRIPT Quinapril inhibits the activity of SLC15A2 DTD0022 EXOFACTO Quinapril MOACRIVE Inhibition DTD0022 EXOFACTO Valganciclovir HIGHSTIT Approved Drug DTD0022 EXOFACTO Valganciclovir DESCRIPT Valganciclovir inhibits the activity of SLC15A2 DTD0022 EXOFACTO Valganciclovir MOACRIVE Inhibition DTD0022 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0022 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Glycylsarcosine by SLC15A2 (Ki = 110 microM) DTD0022 EXOFACTO Valsartan MOACRIVE Inhibition DTD0022 EXOFACTO Valsartan CELLLINE Human cervical cancer cell line (Hela)-PEPT2 DTD0023 TRANSPID DTD0023 DTD0023 GENENAME SLC22A5 DTD0023 PROTNAME Organic cation/carnitine transporter 2 DTD0023 GENEDBID 6584 DTD0023 UNIPROID O76082 DTD0023 EXOFACTO Aldosterone HIGHSTIT Approved Drug DTD0023 EXOFACTO Aldosterone DESCRIPT Aldosterone inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Aldosterone MOACRIVE Inhibition DTD0023 EXOFACTO Aldosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Cefepime HIGHSTIT Approved Drug DTD0023 EXOFACTO Cefepime DESCRIPT Cefepime inhibits the transportation of L-carnitine by SLC22A5 (IC50 = 1700 microM) DTD0023 EXOFACTO Cefepime DESCRIPT Cefepime inhibits the activity of SLC22A5 DTD0023 EXOFACTO Cefepime MOACRIVE Inhibition DTD0023 EXOFACTO Cefepime CELLLINE Human cervical cancer cell line (Hela)-OCTN2 DTD0023 EXOFACTO Cefoselis HIGHSTIT Approved Drug DTD0023 EXOFACTO Cefoselis DESCRIPT Cefoselis inhibits the transportation of L-carnitine by SLC22A5 (IC50 = 6400 microM) DTD0023 EXOFACTO Cefoselis MOACRIVE Inhibition DTD0023 EXOFACTO Cefoselis CELLLINE Human cervical cancer cell line (Hela)-OCTN2 DTD0023 EXOFACTO Cefsulodin HIGHSTIT Approved Drug DTD0023 EXOFACTO Cefsulodin DESCRIPT Cefsulodin inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Cefsulodin MOACRIVE Inhibition DTD0023 EXOFACTO Cefsulodin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0023 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of L-carnitine by SLC22A5 (IC50 = 230 microM) DTD0023 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0023 EXOFACTO Cephaloridine CELLLINE Human cervical cancer cell line (Hela)-OCTN2 DTD0023 EXOFACTO Emetine HIGHSTIT Approved Drug DTD0023 EXOFACTO Emetine DESCRIPT Emetine inhibits the transportation of L-carnitine by SLC22A5 (IC50 = 4.2 microM) DTD0023 EXOFACTO Emetine MOACRIVE Inhibition DTD0023 EXOFACTO Emetine CELLLINE Oocytes-OCTN2 DTD0023 EXOFACTO L-carnitine HIGHSTIT Approved Drug DTD0023 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of Carnitine by SLC22A5 DTD0023 EXOFACTO L-carnitine MOACRIVE Inhibition DTD0023 EXOFACTO L-carnitine CELLLINE Oocytes-OCTN2 DTD0023 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0023 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Ergothioneine by SLC22A5 DTD0023 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0023 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Lomefloxacin HIGHSTIT Approved Drug DTD0023 EXOFACTO Lomefloxacin DESCRIPT Lomefloxacin inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Lomefloxacin MOACRIVE Inhibition DTD0023 EXOFACTO Lomefloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Methamphetamine HIGHSTIT Approved Drug DTD0023 EXOFACTO Methamphetamine DESCRIPT Methamphetamine inhibits the transportation of Tetraethylammonium by SLC22A5 DTD0023 EXOFACTO Methamphetamine MOACRIVE Inhibition DTD0023 EXOFACTO Methamphetamine CELLLINE Human cervical cancer cell line (Hela)-OCTN2 DTD0023 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0023 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Tetraethylammonium by SLC22A5 DTD0023 EXOFACTO Nicotine MOACRIVE Inhibition DTD0023 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Nicotine CELLLINE Human cervical cancer cell line (Hela)-OCTN2 DTD0023 EXOFACTO Ofloxacin HIGHSTIT Approved Drug DTD0023 EXOFACTO Ofloxacin DESCRIPT Ofloxacin inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Ofloxacin MOACRIVE Inhibition DTD0023 EXOFACTO Ofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0023 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the activity of SLC22A5 DTD0023 EXOFACTO Progesterone MOACRIVE Inhibition DTD0023 EXOFACTO Pyrilamide HIGHSTIT Approved Drug DTD0023 EXOFACTO Pyrilamide DESCRIPT Pyrilamide inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Pyrilamide MOACRIVE Inhibition DTD0023 EXOFACTO Pyrilamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0023 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Ergothioneine by SLC22A5 DTD0023 EXOFACTO Quinine MOACRIVE Inhibition DTD0023 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0023 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0023 EXOFACTO Valproic Acid DESCRIPT Valproic Acid inhibits the transportation of L-Carnitine by SLC22A5 DTD0023 EXOFACTO Valproic Acid MOACRIVE Inhibition DTD0023 EXOFACTO Valproic Acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN2 DTD0024 TRANSPID DTD0024 DTD0024 GENENAME SLC22A6 DTD0024 PROTNAME Organic anion transporter 1 DTD0024 GENEDBID 9356 DTD0024 UNIPROID Q4U2R8 DTD0024 EXOFACTO Acetazolamide HIGHSTIT Approved Drug DTD0024 EXOFACTO Acetazolamide DESCRIPT Acetazolamide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 75 microM) DTD0024 EXOFACTO Acetazolamide MOACRIVE Inhibition DTD0024 EXOFACTO Acetazolamide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Adefovir HIGHSTIT Approved Drug DTD0024 EXOFACTO Adefovir DESCRIPT Adefovir inhibits the transportation of Naproxen by SLC22A6 (IC50 = 1.8 microM) DTD0024 EXOFACTO Adefovir DESCRIPT Adefovir inhibits the transportation of Ketoprofen by SLC22A6 (IC50 = 0.9 microM) DTD0024 EXOFACTO Adefovir DESCRIPT Adefovir inhibits the transportation of Ibuprofen by SLC22A6 (IC50 = 1.5 microM) DTD0024 EXOFACTO Adefovir MOACRIVE Inhibition DTD0024 EXOFACTO Adefovir CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Adipate HIGHSTIT Investigative Drug DTD0024 EXOFACTO Adipate DESCRIPT Adipate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 6.2 microM) DTD0024 EXOFACTO Adipate MOACRIVE Inhibition DTD0024 EXOFACTO Adipate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0024 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A6 (IC50 = 12.3 microM) DTD0024 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0024 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Alpha-ketoglutaric acid HIGHSTIT Investigative Drug DTD0024 EXOFACTO Alpha-ketoglutaric acid DESCRIPT Alpha-ketoglutaric acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.7 microM) DTD0024 EXOFACTO Alpha-ketoglutaric acid MOACRIVE Inhibition DTD0024 EXOFACTO Alpha-ketoglutaric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0024 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A6 (IC50 = 28.4 microM) DTD0024 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0024 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0024 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 8.8 microM) DTD0024 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Bestatin by SLC22A6 (IC50 = 106 microM; Ki = 92 microM) DTD0024 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 6.02 microM) DTD0024 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Uric acid by SLC22A6 (IC50 = 127 microM) DTD0024 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the activity of SLC22A6 DTD0024 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0024 EXOFACTO Aminohippuric acid CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Aminohippuric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Aminohippuric acid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Amoxicillin HIGHSTIT Approved Drug DTD0024 EXOFACTO Amoxicillin DESCRIPT Amoxicillin inhibits the activity of SLC22A6 DTD0024 EXOFACTO Amoxicillin MOACRIVE Inhibition DTD0024 EXOFACTO Aspirin HIGHSTIT Approved Drug DTD0024 EXOFACTO Aspirin DESCRIPT Aspirin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 769 microM) DTD0024 EXOFACTO Aspirin MOACRIVE Inhibition DTD0024 EXOFACTO Aspirin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Bendroflumethiazide HIGHSTIT Approved Drug DTD0024 EXOFACTO Bendroflumethiazide DESCRIPT Bendroflumethiazide inhibits the transportation of Polycyclic aromatic hydrocarbons by SLC22A6 DTD0024 EXOFACTO Bendroflumethiazide MOACRIVE Inhibition DTD0024 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0024 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Ochratoxin A by SLC22A6 DTD0024 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0024 EXOFACTO Benzylpenicillin CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Benzylpenicillin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Betamipron HIGHSTIT Approved Drug DTD0024 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 16.2 microM) DTD0024 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 23.6 microM) DTD0024 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the transportation of Adefovir by SLC22A6 (IC50 = 6 microM) DTD0024 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the activity of SLC22A6 DTD0024 EXOFACTO Betamipron MOACRIVE Inhibition DTD0024 EXOFACTO Betamipron CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Betamipron CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0024 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 7.6 microM) DTD0024 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0024 EXOFACTO Bumetanide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0024 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 17 microM) DTD0024 EXOFACTO Candesartan MOACRIVE Inhibition DTD0024 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Caspofungin HIGHSTIT Approved Drug DTD0024 EXOFACTO Caspofungin DESCRIPT Caspofungin inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Caspofungin MOACRIVE Inhibition DTD0024 EXOFACTO Caspofungin CELLLINE Human cervical cancer cell line (Hela)-OAT1 DTD0024 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the activity of SLC22A6 DTD0024 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0024 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 6140 microM) DTD0024 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0024 EXOFACTO Cefadroxil CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 30 microM) DTD0024 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0024 EXOFACTO Cefamandole CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cefazolin HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefazolin DESCRIPT Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 180 microM) DTD0024 EXOFACTO Cefazolin MOACRIVE Inhibition DTD0024 EXOFACTO Cefazolin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 210 microM) DTD0024 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0024 EXOFACTO Cefoperazone CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0024 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 3130 microM) DTD0024 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0024 EXOFACTO Cefotaxime CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0024 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 230 microM) DTD0024 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0024 EXOFACTO Ceftriaxone CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0024 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1250 microM) DTD0024 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 740 microM) DTD0024 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0024 EXOFACTO Cephaloridine CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Cephaloridine CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0024 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A6 (Ki = 220 microM) DTD0024 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0024 EXOFACTO Cephalothin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cephradine HIGHSTIT Approved Drug DTD0024 EXOFACTO Cephradine DESCRIPT Cephradine inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1600 microM) DTD0024 EXOFACTO Cephradine MOACRIVE Inhibition DTD0024 EXOFACTO Cephradine CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Chlorothiazide HIGHSTIT Approved Drug DTD0024 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.78 microM) DTD0024 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the activity of SLC22A6 DTD0024 EXOFACTO Chlorothiazide MOACRIVE Inhibition DTD0024 EXOFACTO Chlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cidofovir HIGHSTIT Approved Drug DTD0024 EXOFACTO Cidofovir DESCRIPT Cidofovir inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 60 microM) DTD0024 EXOFACTO Cidofovir MOACRIVE Inhibition DTD0024 EXOFACTO Cidofovir CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Cigarette smoke condensate (0.08mg/ml) HIGHSTIT Natural Product DTD0024 EXOFACTO Cigarette smoke condensate (0.08mg/ml) DESCRIPT Cigarette smoke condensate (0.08mg/ml) inhibits the activity of SLC22A6 DTD0024 EXOFACTO Cigarette smoke condensate (0.08mg/ml) MOACRIVE Inhibition DTD0024 EXOFACTO Cigarette smoke condensate (0.08mg/ml) CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Cigarette smoke condensate (0.32mg/ml) HIGHSTIT Natural Product DTD0024 EXOFACTO Cigarette smoke condensate (0.32mg/ml) DESCRIPT Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A6 DTD0024 EXOFACTO Cigarette smoke condensate (0.32mg/ml) MOACRIVE Inhibition DTD0024 EXOFACTO Cigarette smoke condensate (0.32mg/ml) CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Cilastatin HIGHSTIT Approved Drug DTD0024 EXOFACTO Cilastatin DESCRIPT Cilastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 1470 microM) DTD0024 EXOFACTO Cilastatin MOACRIVE Inhibition DTD0024 EXOFACTO Cilastatin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0024 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of SLC22A6 DTD0024 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0024 EXOFACTO Cinoxacin HIGHSTIT Approved Drug DTD0024 EXOFACTO Cinoxacin DESCRIPT Cinoxacin inhibits the transportation of P-aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Cinoxacin MOACRIVE Inhibition DTD0024 EXOFACTO Citreoverdine HIGHSTIT Natural Product DTD0024 EXOFACTO Citreoverdine DESCRIPT Citreoverdine inhibits the transportation of Organic anion by SLC22A6 (IC50 = 16.9 microM) DTD0024 EXOFACTO Citreoverdine MOACRIVE Inhibition DTD0024 EXOFACTO Citreoverdine CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0024 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic anion by SLC22A6 (IC50 = 16.9 microM) DTD0024 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0024 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cyclic cidofovir HIGHSTIT Discontinued Drug DTD0024 EXOFACTO Cyclic cidofovir DESCRIPT Cyclic cidofovir inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1100 microM) DTD0024 EXOFACTO Cyclic cidofovir MOACRIVE Inhibition DTD0024 EXOFACTO Cyclic cidofovir CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Cyclopiazonic acid HIGHSTIT Natural Product DTD0024 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0024 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A6 (IC50 = 6.59 microM) DTD0024 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0024 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Cyclothiazide HIGHSTIT Approved Drug DTD0024 EXOFACTO Cyclothiazide DESCRIPT Cyclothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 84.3 microM) DTD0024 EXOFACTO Cyclothiazide DESCRIPT Cyclothiazide inhibits the activity of SLC22A6 DTD0024 EXOFACTO Cyclothiazide MOACRIVE Inhibition DTD0024 EXOFACTO Cyclothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Danshen HIGHSTIT Dietary Constituent DTD0024 EXOFACTO Danshen DESCRIPT Danshen inhibits the transportation of P-aminohippuric acid by SLC22A6 (Ki = 40.4 microM) DTD0024 EXOFACTO Danshen MOACRIVE Inhibition DTD0024 EXOFACTO Danshen CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0024 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.46 microM) DTD0024 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Adefovir by SLC22A6 (IC50 = 4 microM) DTD0024 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0024 EXOFACTO Diclofenac CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Diclofenac CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Diflunisal HIGHSTIT Approved Drug DTD0024 EXOFACTO Diflunisal DESCRIPT Diflunisal inhibits the transportation of Adefovir by SLC22A6 (IC50 = 0.85 microM) DTD0024 EXOFACTO Diflunisal MOACRIVE Inhibition DTD0024 EXOFACTO Diflunisal CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Doxycycline HIGHSTIT Approved Drug DTD0024 EXOFACTO Doxycycline DESCRIPT Doxycycline inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Doxycycline MOACRIVE Inhibition DTD0024 EXOFACTO Doxycycline CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Eetuximab HIGHSTIT Approved Drug DTD0024 EXOFACTO Eetuximab DESCRIPT Eetuximab inhibits the activity of SLC22A6 DTD0024 EXOFACTO Eetuximab MOACRIVE Inhibition DTD0024 EXOFACTO Ellagic acid HIGHSTIT Natural Product DTD0024 EXOFACTO Ellagic acid DESCRIPT Ellagic acid inhibits the transportation of Para-aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Ellagic acid MOACRIVE Inhibition DTD0024 EXOFACTO Ellagic acid CELLLINE Xenopus laevis oocytes-OAT1 DTD0024 EXOFACTO Ethacrynic acid HIGHSTIT Approved Drug DTD0024 EXOFACTO Ethacrynic acid DESCRIPT Ethacrynic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 29.6 microM) DTD0024 EXOFACTO Ethacrynic acid MOACRIVE Inhibition DTD0024 EXOFACTO Ethacrynic acid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Etodolac HIGHSTIT Approved Drug DTD0024 EXOFACTO Etodolac DESCRIPT Etodolac inhibits the transportation of Adefovir by SLC22A6 (IC50 = 50 microM) DTD0024 EXOFACTO Etodolac MOACRIVE Inhibition DTD0024 EXOFACTO Etodolac CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Fisetin HIGHSTIT Natural Product DTD0024 EXOFACTO Fisetin DESCRIPT Fisetin inhibits the transportation of Para-aminohippuric acid by SLC22A6 through competitive inhibition DTD0024 EXOFACTO Fisetin MOACRIVE Inhibition DTD0024 EXOFACTO Fluorescein HIGHSTIT Approved Drug DTD0024 EXOFACTO Fluorescein DESCRIPT Fluorescein inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Fluorescein MOACRIVE Inhibition DTD0024 EXOFACTO Fluorescein CELLLINE Human cervical cancer cell line (Hela)-OAT1 DTD0024 EXOFACTO Flurbiprofen HIGHSTIT Approved Drug DTD0024 EXOFACTO Flurbiprofen DESCRIPT Flurbiprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 1.5 microM) DTD0024 EXOFACTO Flurbiprofen MOACRIVE Inhibition DTD0024 EXOFACTO Flurbiprofen CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0024 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 26.3 microM) DTD0024 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0024 EXOFACTO Fluvastatin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Fumarate HIGHSTIT Investigative Drug DTD0024 EXOFACTO Fumarate DESCRIPT Fumarate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 1733 microM) DTD0024 EXOFACTO Fumarate MOACRIVE Inhibition DTD0024 EXOFACTO Fumarate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Fumonisin B1 HIGHSTIT Natural Product DTD0024 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0024 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic anion by SLC22A6 (IC50 = 768 microM) DTD0024 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0024 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0024 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 18 microM) DTD0024 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the activity of SLC22A6 DTD0024 EXOFACTO Furosemide MOACRIVE Inhibition DTD0024 EXOFACTO Furosemide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Gallic acid HIGHSTIT Natural Product DTD0024 EXOFACTO Gallic acid DESCRIPT Gallic acid inhibits the transportation of P-aminohippuric acid by SLC22A6 (IC50 = 1.2 microM) DTD0024 EXOFACTO Gallic acid MOACRIVE Inhibition DTD0024 EXOFACTO Gallic acid CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Genistein-4-O-sulfate HIGHSTIT Natural Product DTD0024 EXOFACTO Genistein-4-O-sulfate DESCRIPT Genistein-4-O-sulfate inhibits the transportation of Para-aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Genistein-4-O-sulfate MOACRIVE Inhibition DTD0024 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0024 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic anion by SLC22A6 (IC50 = 117 microM) DTD0024 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0024 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Glutarate HIGHSTIT Investigative Drug DTD0024 EXOFACTO Glutarate DESCRIPT Glutarate inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.3 microM) DTD0024 EXOFACTO Glutarate DESCRIPT Glutarate inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 4.9 microM) DTD0024 EXOFACTO Glutarate MOACRIVE Inhibition DTD0024 EXOFACTO Glutarate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Glutarate CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Hydrochlorothiazide HIGHSTIT Approved Drug DTD0024 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 67.3 microM) DTD0024 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide inhibits the activity of SLC22A6 (Ki = 150 microM) DTD0024 EXOFACTO Hydrochlorothiazide MOACRIVE Inhibition DTD0024 EXOFACTO Hydrochlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0024 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 55.6 microM) DTD0024 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 8 microM) DTD0024 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0024 EXOFACTO Ibuprofen CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Ibuprofen CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0024 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 3.83 microM) DTD0024 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Adefovir by SLC22A6 (IC50 = 3 microM) DTD0024 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the activity of SLC22A6 DTD0024 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0024 EXOFACTO Indomethacin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Indomethacin CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0024 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 319 microM) DTD0024 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0024 EXOFACTO Ketoconazole CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0024 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 4.34 microM) DTD0024 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 1.3 microM) DTD0024 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 1.4 microM) DTD0024 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0024 EXOFACTO Ketoprofen CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Ketoprofen CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0024 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0024 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0024 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 12 microM) DTD0024 EXOFACTO Losartan MOACRIVE Inhibition DTD0024 EXOFACTO Losartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Lumiracoxib HIGHSTIT Approved Drug DTD0024 EXOFACTO Lumiracoxib DESCRIPT Lumiracoxib inhibits the activity of SLC22A6 DTD0024 EXOFACTO Lumiracoxib MOACRIVE Inhibition DTD0024 EXOFACTO Luteolin HIGHSTIT Natural Product DTD0024 EXOFACTO Luteolin DESCRIPT Luteolin inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 0.47 microM) DTD0024 EXOFACTO Luteolin MOACRIVE Inhibition DTD0024 EXOFACTO Mefenamic acid HIGHSTIT Approved Drug DTD0024 EXOFACTO Mefenamic acid DESCRIPT Mefenamic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 0.83 microM) DTD0024 EXOFACTO Mefenamic acid MOACRIVE Inhibition DTD0024 EXOFACTO Mefenamic acid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Methazolamide HIGHSTIT Approved Drug DTD0024 EXOFACTO Methazolamide DESCRIPT Methazolamide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 438 microM) DTD0024 EXOFACTO Methazolamide MOACRIVE Inhibition DTD0024 EXOFACTO Methazolamide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Minocycline HIGHSTIT Approved Drug DTD0024 EXOFACTO Minocycline DESCRIPT Minocycline inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Minocycline MOACRIVE Inhibition DTD0024 EXOFACTO Minocycline CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0024 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 0.3 microM) DTD0024 EXOFACTO Morin MOACRIVE Inhibition DTD0024 EXOFACTO Naproxen HIGHSTIT Approved Drug DTD0024 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 5.67 microM) DTD0024 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the transportation of Adefovir by SLC22A6 (IC50 = 5.8 microM) DTD0024 EXOFACTO Naproxen MOACRIVE Inhibition DTD0024 EXOFACTO Naproxen CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Naproxen CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0024 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 34.8 microM; Ki = 14.9 microM) DTD0024 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0024 EXOFACTO Novobiocin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT1 DTD0024 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0024 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A6 (IC50 = 0.28 microM) DTD0024 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0024 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Oxytetracycline HIGHSTIT Approved Drug DTD0024 EXOFACTO Oxytetracycline DESCRIPT Oxytetracycline inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Oxytetracycline MOACRIVE Inhibition DTD0024 EXOFACTO Oxytetracycline CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Patulin HIGHSTIT Natural Product DTD0024 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0024 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic anion by SLC22A6 (IC50 = 44.8 microM) DTD0024 EXOFACTO Patulin MOACRIVE Inhibition DTD0024 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0024 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 275 microM) DTD0024 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Adefovir by SLC22A6 (IC50 = 200 microM) DTD0024 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0024 EXOFACTO Phenacetin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Phenacetin CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0024 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Methotrexate by SLC22A6 DTD0024 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0024 EXOFACTO Phenylbutazone CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Piperacillin HIGHSTIT Approved Drug DTD0024 EXOFACTO Piperacillin DESCRIPT Piperacillin inhibits the transporation of tazobactam by SLC22A6 (IC50 = 54.32 microM; Ki = 37 microM) DTD0024 EXOFACTO Piperacillin MOACRIVE Inhibition DTD0024 EXOFACTO Piperacillin CELLLINE Human embryonic kidney 293 cells (HEK293) DTD0024 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0024 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 19.8 microM) DTD0024 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 62.8 microM) DTD0024 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Adefovir by SLC22A6 (IC50 = 20.5 microM) DTD0024 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the activity of SLC22A6 DTD0024 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0024 EXOFACTO Piroxicam CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Piroxicam CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Pratosartan HIGHSTIT Drug in Phase 3 Trial DTD0024 EXOFACTO Pratosartan DESCRIPT Pratosartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 1.5 microM) DTD0024 EXOFACTO Pratosartan MOACRIVE Inhibition DTD0024 EXOFACTO Pratosartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0024 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 408 microM) DTD0024 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0024 EXOFACTO Pravastatin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Ochratoxin A by SLC22A6 (Ki = 4.29 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Dimesna by SLC22A6 (Ki = 26 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Cidofovir by SLC22A6 (IC50 = 3.9 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 6.5 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (Ki = 12.1 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Methotrexate by SLC22A6 (IC50 = 17 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 17 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Adefovir by SLC22A6 (IC50 = 7.4 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 6.3 microM) DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of SLC22A6 DTD0024 EXOFACTO Probenecid MOACRIVE Inhibition DTD0024 EXOFACTO Probenecid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Probenecid CELLLINE Human cervical cancer cell line (Hela)-OAT1 DTD0024 EXOFACTO Probenecid CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Probenecid CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0024 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Para-aminohippuric acid by SLC22A6 DTD0024 EXOFACTO Quercetin MOACRIVE Inhibition DTD0024 EXOFACTO Quercetin-3-O-sulfate HIGHSTIT Natural Product DTD0024 EXOFACTO Quercetin-3-O-sulfate DESCRIPT Quercetin-3-O-sulfate inhibits the transportation of Para-aminohippuric acid by SLC22A6 (IC50 = 1.22 microM) DTD0024 EXOFACTO Quercetin-3-O-sulfate MOACRIVE Inhibition DTD0024 EXOFACTO Rhein HIGHSTIT Natural Product DTD0024 EXOFACTO Rhein DESCRIPT Rhubarb inhibits the transportation of P-aminohippuric acid by SLC22A6 in a competitive manner (IC50 = 0.072 microM) DTD0024 EXOFACTO Rhein MOACRIVE Inhibition DTD0024 EXOFACTO Rhein CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0024 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Olmesartan medoxomil by SLC22A6 (Ki = 62.2 microM) DTD0024 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 79.1 microM) DTD0024 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0024 EXOFACTO Rifampicin CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Rosmarinic acid HIGHSTIT Natural Product DTD0024 EXOFACTO Rosmarinic acid DESCRIPT Rosmarinic acid inhibits the transportation of P-aminohippuric acid by SLC22A6 (Ki = 0.35 microM) DTD0024 EXOFACTO Rosmarinic acid MOACRIVE Inhibition DTD0024 EXOFACTO Rosmarinic acid CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Salicylic acid HIGHSTIT Approved Drug DTD0024 EXOFACTO Salicylic acid DESCRIPT Salicylic acid inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 325 microM) DTD0024 EXOFACTO Salicylic acid DESCRIPT Salicylic acid inhibits the transportation of 6-Carboxyfluorescein by SLC22A6 (IC50 = 280 microM) DTD0024 EXOFACTO Salicylic acid MOACRIVE Inhibition DTD0024 EXOFACTO Salicylic acid CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Salicylic acid CELLLINE Chinese hamster ovary (CHO) cells-OAT1 DTD0024 EXOFACTO Selexipag HIGHSTIT Approved Drug DTD0024 EXOFACTO Selexipag DESCRIPT Selexipag inhibits the activity of SLC22A6 DTD0024 EXOFACTO Selexipag MOACRIVE Inhibition DTD0024 EXOFACTO Silybin HIGHSTIT Natural Product DTD0024 EXOFACTO Silybin DESCRIPT Silybin inhibits the transportation of Para-aminohippuric acid by SLC22A6 in a competitive manner DTD0024 EXOFACTO Silybin MOACRIVE Inhibition DTD0024 EXOFACTO Silybin CELLLINE Madin darby canine kidney strain cell line (MDCK)-OAT1 DTD0024 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0024 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 73.6 microM) DTD0024 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 41.5 microM) DTD0024 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the activity of SLC22A6 DTD0024 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0024 EXOFACTO Simvastatin CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Simvastatin CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0024 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Methotrexate by SLC22A6 (IC50 = 4.6 microM) DTD0024 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0024 EXOFACTO Sulfasalazine CELLLINE Oocytes-OAT1 DTD0024 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0024 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 36.2 microM) DTD0024 EXOFACTO Sulindac MOACRIVE Inhibition DTD0024 EXOFACTO Sulindac CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0024 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 0.46 microM) DTD0024 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0024 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0024 EXOFACTO Trichlormethiazide DESCRIPT Trichloromethiazide inhibits the transportation of Aminohippuric acid by SLC22A6 (IC50 = 19.2 microM) DTD0024 EXOFACTO Trichlormethiazide MOACRIVE Inhibition DTD0024 EXOFACTO Trichlormethiazide CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0024 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0024 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Uric acid by SLC22A6 (IC50 = 16 microM) DTD0024 EXOFACTO Valsartan MOACRIVE Inhibition DTD0024 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT1 DTD0024 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0024 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of SLC22A6 DTD0024 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0024 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0024 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic anion by SLC22A6 (IC50 = 147 microM) DTD0024 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0024 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OAT1 DTD0025 TRANSPID DTD0025 DTD0025 GENENAME SLC22A8 DTD0025 PROTNAME Organic anion transporter 3 DTD0025 GENEDBID 9376 DTD0025 UNIPROID Q8TCC7 DTD0025 EXOFACTO Acetazolamide HIGHSTIT Approved Drug DTD0025 EXOFACTO Acetazolamide DESCRIPT Acetazolamide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 816 microM) DTD0025 EXOFACTO Acetazolamide MOACRIVE Inhibition DTD0025 EXOFACTO Acetazolamide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Adipate HIGHSTIT Investigative Drug DTD0025 EXOFACTO Adipate DESCRIPT Adipate inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 136 microM) DTD0025 EXOFACTO Adipate MOACRIVE Inhibition DTD0025 EXOFACTO Adipate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0025 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A8 (IC50 = 13.1 microM) DTD0025 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0025 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0025 EXOFACTO Allethrin DESCRIPT Allethrin inhibits the transportation of Fluorescein by SLC22A8 (IC50 = 69.4 microM) DTD0025 EXOFACTO Allethrin MOACRIVE Inhibition DTD0025 EXOFACTO Allethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Alpha-ketoglutaric acid HIGHSTIT Investigative Drug DTD0025 EXOFACTO Alpha-ketoglutaric acid DESCRIPT Alpha-ketoglutaric acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 92.8 microM) DTD0025 EXOFACTO Alpha-ketoglutaric acid MOACRIVE Inhibition DTD0025 EXOFACTO Alpha-ketoglutaric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0025 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A8 (IC50 = 4.55 microM) DTD0025 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0025 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0025 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 19.6 microM) DTD0025 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0025 EXOFACTO Aminohippuric acid CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Angiotensinamide HIGHSTIT Investigative Drug DTD0025 EXOFACTO Angiotensinamide DESCRIPT Angiotensinamide inhibits the activity of SLC22A8 DTD0025 EXOFACTO Angiotensinamide MOACRIVE Inhibition DTD0025 EXOFACTO Aspirin HIGHSTIT Approved Drug DTD0025 EXOFACTO Aspirin DESCRIPT Aspirin inhibits the transportation of Cilostazol by SLC22A8 DTD0025 EXOFACTO Aspirin MOACRIVE Inhibition DTD0025 EXOFACTO Bendroflumethiazide HIGHSTIT Approved Drug DTD0025 EXOFACTO Bendroflumethiazide DESCRIPT Bendroflumethiazide inhibits the transportation of Polycyclic aromatic hydrocarbons by SLC22A8 DTD0025 EXOFACTO Bendroflumethiazide MOACRIVE Inhibition DTD0025 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0025 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Methotrexate by SLC22A8 (Ki = 97.6 microM) DTD0025 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0025 EXOFACTO Benzylpenicillin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Benzylpenicillin CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Betamipron HIGHSTIT Approved Drug DTD0025 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 48.3 microM) DTD0025 EXOFACTO Betamipron MOACRIVE Inhibition DTD0025 EXOFACTO Betamipron CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0025 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Methotrexate by SLC22A8 (IC50 = 5.4 microM) DTD0025 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.8 microM) DTD0025 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.75 microM) DTD0025 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0025 EXOFACTO Bumetanide CELLLINE Oocytes-OAT3 DTD0025 EXOFACTO Bumetanide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0025 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.3 microM) DTD0025 EXOFACTO Candesartan MOACRIVE Inhibition DTD0025 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Carbenicillin HIGHSTIT Approved Drug DTD0025 EXOFACTO Carbenicillin DESCRIPT Carbenicillin inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Carbenicillin MOACRIVE Inhibition DTD0025 EXOFACTO Carbenicillin CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Cefaclor HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefaclor DESCRIPT Cefaclor inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Cefaclor MOACRIVE Inhibition DTD0025 EXOFACTO Cefaclor CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 8620 microM) DTD0025 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estrone sulfate by SLC22A8 DTD0025 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0025 EXOFACTO Cefadroxil CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cefadroxil CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 50 microM) DTD0025 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0025 EXOFACTO Cefamandole CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cefazolin HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefazolin DESCRIPT Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 550 microM) DTD0025 EXOFACTO Cefazolin MOACRIVE Inhibition DTD0025 EXOFACTO Cefazolin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 1890 microM) DTD0025 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0025 EXOFACTO Cefoperazone CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0025 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 290 microM) DTD0025 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0025 EXOFACTO Cefotaxime CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0025 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 4390 microM) DTD0025 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0025 EXOFACTO Ceftriaxone CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0025 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the activity of SLC22A8 DTD0025 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0025 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0025 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 2460 microM) DTD0025 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0025 EXOFACTO Cephaloridine CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0025 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A8 (Ki = 40 microM) DTD0025 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0025 EXOFACTO Cephalothin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Chlorothiazide HIGHSTIT Approved Drug DTD0025 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 65.3 microM) DTD0025 EXOFACTO Chlorothiazide MOACRIVE Inhibition DTD0025 EXOFACTO Chlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cigarette smoke condensate (0.08mg/ml) HIGHSTIT Natural Product DTD0025 EXOFACTO Cigarette smoke condensate (0.08mg/ml) DESCRIPT Cigarette smoke condensate (0.08mg/ml) inhibits the activity of SLC22A8 DTD0025 EXOFACTO Cigarette smoke condensate (0.08mg/ml) MOACRIVE Inhibition DTD0025 EXOFACTO Cigarette smoke condensate (0.08mg/ml) CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Cigarette smoke condensate (0.32mg/ml) HIGHSTIT Natural Product DTD0025 EXOFACTO Cigarette smoke condensate (0.32mg/ml) DESCRIPT Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A8 DTD0025 EXOFACTO Cigarette smoke condensate (0.32mg/ml) MOACRIVE Inhibition DTD0025 EXOFACTO Cigarette smoke condensate (0.32mg/ml) CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Cilastatin HIGHSTIT Approved Drug DTD0025 EXOFACTO Cilastatin DESCRIPT Cilastatin inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 231 microM) DTD0025 EXOFACTO Cilastatin MOACRIVE Inhibition DTD0025 EXOFACTO Cilastatin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0025 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 79 microM) DTD0025 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0025 EXOFACTO Cimetidine CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Ciprofloxacin HIGHSTIT Approved Drug DTD0025 EXOFACTO Ciprofloxacin DESCRIPT Ciprofloxacin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Ciprofloxacin MOACRIVE Inhibition DTD0025 EXOFACTO Citreoverdine HIGHSTIT Natural Product DTD0025 EXOFACTO Citreoverdine DESCRIPT Citreoverdine inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.63 microM) DTD0025 EXOFACTO Citreoverdine MOACRIVE Inhibition DTD0025 EXOFACTO Citreoverdine CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0025 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.63 microM) DTD0025 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0025 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cyclopiazonic acid HIGHSTIT Natural Product DTD0025 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0025 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A8 (IC50 = 1.9 microM) DTD0025 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0025 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Cyclothiazide HIGHSTIT Approved Drug DTD0025 EXOFACTO Cyclothiazide DESCRIPT Cyclothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 27.9 microM) DTD0025 EXOFACTO Cyclothiazide MOACRIVE Inhibition DTD0025 EXOFACTO Cyclothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Daidzein-7-O-Glucuronide HIGHSTIT Natural Product DTD0025 EXOFACTO Daidzein-7-O-Glucuronide DESCRIPT Daidzein-7-O-Glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 DTD0025 EXOFACTO Daidzein-7-O-Glucuronide MOACRIVE Inhibition DTD0025 EXOFACTO Daidzein-7-O-Glucuronide CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Danshen HIGHSTIT Dietary Constituent DTD0025 EXOFACTO Danshen DESCRIPT Danshen inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 8.6 microM) DTD0025 EXOFACTO Danshen MOACRIVE Inhibition DTD0025 EXOFACTO Danshen CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0025 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.78 microM) DTD0025 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0025 EXOFACTO Diclofenac CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Dicloxacillin HIGHSTIT Approved Drug DTD0025 EXOFACTO Dicloxacillin DESCRIPT Dicloxacillin inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Dicloxacillin MOACRIVE Inhibition DTD0025 EXOFACTO Dicloxacillin CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Dihydrotestosterone HIGHSTIT Drug in Phase 4 Trial DTD0025 EXOFACTO Dihydrotestosterone DESCRIPT Dihydrotestosterone induces the activity of SLC22A8 DTD0025 EXOFACTO Dihydrotestosterone MOACRIVE Inducer DTD0025 EXOFACTO Esomeprazole HIGHSTIT Approved Drug DTD0025 EXOFACTO Esomeprazole DESCRIPT Esomeprazole inhibits the activity of SLC22A8 DTD0025 EXOFACTO Esomeprazole MOACRIVE Inhibition DTD0025 EXOFACTO Ethacrynic acid HIGHSTIT Approved Drug DTD0025 EXOFACTO Ethacrynic acid DESCRIPT Ethacrynic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.58 microM) DTD0025 EXOFACTO Ethacrynic acid MOACRIVE Inhibition DTD0025 EXOFACTO Ethacrynic acid CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Etoricoxib HIGHSTIT Approved Drug DTD0025 EXOFACTO Etoricoxib DESCRIPT Etoricoxib inhibits the activity of SLC22A8 DTD0025 EXOFACTO Etoricoxib MOACRIVE Inhibition DTD0025 EXOFACTO Ezogabine HIGHSTIT Drug Withdrawn DTD0025 EXOFACTO Ezogabine DESCRIPT Ezogabine inhibits the activity of SLC22A8 DTD0025 EXOFACTO Ezogabine MOACRIVE Inhibition DTD0025 EXOFACTO Fenofibric acid HIGHSTIT Approved Drug DTD0025 EXOFACTO Fenofibric acid DESCRIPT Fenofibric acid inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 2.2 microM) DTD0025 EXOFACTO Fenofibric acid MOACRIVE Inhibition DTD0025 EXOFACTO Fenofibric acid CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Fluorescein HIGHSTIT Approved Drug DTD0025 EXOFACTO Fluorescein DESCRIPT Fluorescein inhibits the activity of SLC22A8 DTD0025 EXOFACTO Fluorescein MOACRIVE Inhibition DTD0025 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0025 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 5.79 microM) DTD0025 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0025 EXOFACTO Fluvastatin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Fumonisin B1 HIGHSTIT Natural Product DTD0025 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0025 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic anion by SLC22A8 (IC50 = 181 microM) DTD0025 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0025 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0025 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 1.7 microM) DTD0025 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 7.31 microM) DTD0025 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the activity of SLC22A8 DTD0025 EXOFACTO Furosemide MOACRIVE Inhibition DTD0025 EXOFACTO Furosemide CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Furosemide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Gallic acid HIGHSTIT Natural Product DTD0025 EXOFACTO Gallic acid DESCRIPT Gallic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 9 microM) DTD0025 EXOFACTO Gallic acid MOACRIVE Inhibition DTD0025 EXOFACTO Gallic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Gatifloxacin HIGHSTIT Approved Drug DTD0025 EXOFACTO Gatifloxacin DESCRIPT Gatifloxacin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Gatifloxacin MOACRIVE Inhibition DTD0025 EXOFACTO Gemfibrozil HIGHSTIT Approved Drug DTD0025 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Pravastatin by SLC22A8 (IC50 = 6.8 microM) DTD0025 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the activity of SLC22A8 DTD0025 EXOFACTO Gemfibrozil MOACRIVE Inhibition DTD0025 EXOFACTO Gemfibrozil CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Genistein-7-O-glucuronide HIGHSTIT Natural Product DTD0025 EXOFACTO Genistein-7-O-glucuronide DESCRIPT Genistein-7-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 DTD0025 EXOFACTO Genistein-7-O-glucuronide MOACRIVE Inhibition DTD0025 EXOFACTO Genistein-7-O-glucuronide CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0025 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic anion by SLC22A8 (IC50 = 73.9 microM) DTD0025 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0025 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Glutarate HIGHSTIT Investigative Drug DTD0025 EXOFACTO Glutarate DESCRIPT Glutarate inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 78.5 microM) DTD0025 EXOFACTO Glutarate MOACRIVE Inhibition DTD0025 EXOFACTO Glutarate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Glycitein-7-O-glucuronide HIGHSTIT Natural Product DTD0025 EXOFACTO Glycitein-7-O-glucuronide DESCRIPT Glycitein-7-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 DTD0025 EXOFACTO Glycitein-7-O-glucuronide MOACRIVE Inhibition DTD0025 EXOFACTO Glycitein-7-O-glucuronide CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Hydrochlorothiazide HIGHSTIT Approved Drug DTD0025 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 942 microM) DTD0025 EXOFACTO Hydrochlorothiazide MOACRIVE Inhibition DTD0025 EXOFACTO Hydrochlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0025 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 3.7 microM) DTD0025 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 6 microM) DTD0025 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the activity of SLC22A8 DTD0025 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0025 EXOFACTO Ibuprofen CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Ibuprofen CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Indapamide HIGHSTIT Approved Drug DTD0025 EXOFACTO Indapamide DESCRIPT Indapamide inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 11 microM) DTD0025 EXOFACTO Indapamide MOACRIVE Inhibition DTD0025 EXOFACTO Indapamide CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0025 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.61 microM) DTD0025 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0025 EXOFACTO Indomethacin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0025 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLC22A8 DTD0025 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0025 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0025 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of SLC22A8 DTD0025 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0025 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0025 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 5.98 microM) DTD0025 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0025 EXOFACTO Ketoprofen CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Lansoprazole HIGHSTIT Approved Drug DTD0025 EXOFACTO Lansoprazole DESCRIPT Lansoprazole inhibits the activity of SLC22A8 DTD0025 EXOFACTO Lansoprazole MOACRIVE Inhibition DTD0025 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0025 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Estrone sulfate by SLC22A8 DTD0025 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0025 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0025 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 1.6 microM) DTD0025 EXOFACTO Losartan MOACRIVE Inhibition DTD0025 EXOFACTO Losartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Mefenamic acid HIGHSTIT Approved Drug DTD0025 EXOFACTO Mefenamic acid DESCRIPT Mefenamic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 0.78 microM) DTD0025 EXOFACTO Mefenamic acid MOACRIVE Inhibition DTD0025 EXOFACTO Mefenamic acid CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Methazolamide HIGHSTIT Approved Drug DTD0025 EXOFACTO Methazolamide DESCRIPT Methazolamide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 97.5 microM) DTD0025 EXOFACTO Methazolamide MOACRIVE Inhibition DTD0025 EXOFACTO Methazolamide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Metronidazole HIGHSTIT Approved Drug DTD0025 EXOFACTO Metronidazole DESCRIPT Metronidazole inhibits the activity of SLC22A8 DTD0025 EXOFACTO Metronidazole MOACRIVE Inhibition DTD0025 EXOFACTO Naproxen HIGHSTIT Approved Drug DTD0025 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 4.67 microM) DTD0025 EXOFACTO Naproxen MOACRIVE Inhibition DTD0025 EXOFACTO Naproxen CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Nitrofurantoin HIGHSTIT Approved Drug DTD0025 EXOFACTO Nitrofurantoin DESCRIPT Nitrofurantoin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Nitrofurantoin MOACRIVE Inhibition DTD0025 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0025 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 4.99 microM; Ki = 4.77 microM) DTD0025 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0025 EXOFACTO Novobiocin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT3 DTD0025 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0025 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.027 microM) DTD0025 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0025 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Oxacillin HIGHSTIT Approved Drug DTD0025 EXOFACTO Oxacillin DESCRIPT Oxacillin inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Oxacillin MOACRIVE Inhibition DTD0025 EXOFACTO Oxacillin CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0025 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic anion by SLC22A8 (IC50 > 1000 microM) DTD0025 EXOFACTO Patulin MOACRIVE Inhibition DTD0025 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0025 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 19.4 microM) DTD0025 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0025 EXOFACTO Phenacetin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0025 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Methotrexate by SLC22A8 (Ki = 34.7 microM) DTD0025 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0025 EXOFACTO Phenylbutazone CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Piperacillin HIGHSTIT Approved Drug DTD0025 EXOFACTO Piperacillin DESCRIPT Piperacillin inhibits the transporation of tazobactam by SLC22A8 (IC50 = 89.04 microM; Ki = 172 microM) DTD0025 EXOFACTO Piperacillin MOACRIVE Inhibition DTD0025 EXOFACTO Piperacillin CELLLINE Human embryonic kidney 293 cells (HEK293) DTD0025 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0025 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 2.52 microM) DTD0025 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 4.88 microM) DTD0025 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0025 EXOFACTO Piroxicam CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Pratosartan HIGHSTIT Drug in Phase 3 Trial DTD0025 EXOFACTO Pratosartan DESCRIPT Pratosartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.095 microM) DTD0025 EXOFACTO Pratosartan MOACRIVE Inhibition DTD0025 EXOFACTO Pratosartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0025 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 13.7 microM) DTD0025 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0025 EXOFACTO Pravastatin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 5.6 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Ochratoxin A by SLC22A8 (Ki = 4.41 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Cimetidine by SLC22A8 (IC50 = 3.1 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Fexofenadine by SLC22A8 (Ki = 1.3 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estrone sulfate by SLC22A8 (Ki = 9 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Dimesna by SLC22A8 (Ki = 32 microM) DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estrone sulfate by SLC22A8 DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Fluorescein by SLC22A8 DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid blocks the activity of SLC22A8 DTD0025 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the activity of SLC22A8 DTD0025 EXOFACTO Probenecid MOACRIVE Inhibition DTD0025 EXOFACTO Probenecid MOACRIVE Blocker DTD0025 EXOFACTO Probenecid CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Probenecid CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Probenecid CELLLINE Human cervical cancer cell line (Hela)-OAT3 DTD0025 EXOFACTO Quercetin-3-O-glucuronide HIGHSTIT Natural Product DTD0025 EXOFACTO Quercetin-3-O-glucuronide DESCRIPT Quercetin-3-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 1.31 microM) DTD0025 EXOFACTO Quercetin-3-O-glucuronide DESCRIPT Quercetin-3-O-glucuronide inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 0.43 microM) DTD0025 EXOFACTO Quercetin-3-O-glucuronide MOACRIVE Inhibition DTD0025 EXOFACTO Quercetin-3-O-glucuronide CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Quercetin-3-O-sulfate HIGHSTIT Natural Product DTD0025 EXOFACTO Quercetin-3-O-sulfate DESCRIPT Quercetin-3-O-sulfate inhibits the transportation of 5-carboxyfluorescein by SLC22A8 (IC50 = 0.75 microM) DTD0025 EXOFACTO Quercetin-3-O-sulfate MOACRIVE Inhibition DTD0025 EXOFACTO Quercetin-3-O-sulfate CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Quinapril HIGHSTIT Approved Drug DTD0025 EXOFACTO Quinapril DESCRIPT Quinapril inhibits the transportation of Sitagliptin by SLC22A8 (IC50 = 6.2 microM) DTD0025 EXOFACTO Quinapril MOACRIVE Inhibition DTD0025 EXOFACTO Quinapril CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Rhein HIGHSTIT Natural Product DTD0025 EXOFACTO Rhein DESCRIPT Rhubarb inhibits the transportation of Estrone sulfate by SLC22A8 in a competitive manner (IC50 = 0.008 microM) DTD0025 EXOFACTO Rhein MOACRIVE Inhibition DTD0025 EXOFACTO Rhein CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Rofecoxib HIGHSTIT Approved Drug DTD0025 EXOFACTO Rofecoxib DESCRIPT Rofecoxib inhibits the activity of SLC22A8 DTD0025 EXOFACTO Rofecoxib MOACRIVE Inhibition DTD0025 EXOFACTO Rosmarinic acid HIGHSTIT Natural Product DTD0025 EXOFACTO Rosmarinic acid DESCRIPT Rosmarinic acid inhibits the transportation of Estrone sulfate by SLC22A8 (Ki= 0.55 microM) DTD0025 EXOFACTO Rosmarinic acid MOACRIVE Inhibition DTD0025 EXOFACTO Rosmarinic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Selexipag HIGHSTIT Approved Drug DTD0025 EXOFACTO Selexipag DESCRIPT Selexipag inhibits the activity of SLC22A8 DTD0025 EXOFACTO Selexipag MOACRIVE Inhibition DTD0025 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0025 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 32.3 microM) DTD0025 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0025 EXOFACTO Simvastatin CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Sitagliptin HIGHSTIT Approved Drug DTD0025 EXOFACTO Sitagliptin DESCRIPT Sitagliptin inhibits the transportation of Cimetidine by SLC22A8 (IC50 = 160 microM) DTD0025 EXOFACTO Sitagliptin MOACRIVE Inhibition DTD0025 EXOFACTO Sitagliptin CELLLINE Chinese hamster ovary (CHO) cells-OAT3 DTD0025 EXOFACTO Sulfadiazine HIGHSTIT Approved Drug DTD0025 EXOFACTO Sulfadiazine DESCRIPT Sulfadiazine inhibits the activity of SLC22A8 DTD0025 EXOFACTO Sulfadiazine MOACRIVE Inhibition DTD0025 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0025 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Methotrexate by SLC22A8 (IC50 = 3 microM) DTD0025 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the activity of SLC22A8 DTD0025 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0025 EXOFACTO Sulfasalazine CELLLINE Oocytes-OAT3 DTD0025 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0025 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 3.62 microM) DTD0025 EXOFACTO Sulindac MOACRIVE Inhibition DTD0025 EXOFACTO Sulindac CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0025 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 1.6 microM) DTD0025 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0025 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0025 EXOFACTO Tetramethrin DESCRIPT Tetramethrin inhibits the transportation of Fluorescein by SLC22A8 (IC50 = 77.6 microM) DTD0025 EXOFACTO Tetramethrin MOACRIVE Inhibition DTD0025 EXOFACTO Tetramethrin CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Torsemide HIGHSTIT Approved Drug DTD0025 EXOFACTO Torsemide DESCRIPT Torsemide inhibits the activity of SLC22A8 DTD0025 EXOFACTO Torsemide MOACRIVE Inhibition DTD0025 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0025 EXOFACTO Trichlormethiazide DESCRIPT Trichloromethiazide inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 71.2 microM) DTD0025 EXOFACTO Trichlormethiazide MOACRIVE Inhibition DTD0025 EXOFACTO Trichlormethiazide CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Ursolic acid HIGHSTIT Natural Product DTD0025 EXOFACTO Ursolic acid DESCRIPT Ursolic acid inhibits the transportation of Estrone sulfate by SLC22A8 (IC50 = 19 microM) DTD0025 EXOFACTO Ursolic acid MOACRIVE Inhibition DTD0025 EXOFACTO Ursolic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Valdecoxib HIGHSTIT Approved Drug DTD0025 EXOFACTO Valdecoxib DESCRIPT Valdecoxib inhibits the activity of SLC22A8 DTD0025 EXOFACTO Valdecoxib MOACRIVE Inhibition DTD0025 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0025 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Uric acid by SLC22A8 (IC50 = 0.2 microM) DTD0025 EXOFACTO Valsartan MOACRIVE Inhibition DTD0025 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT3 DTD0025 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0025 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of SLC22A8 DTD0025 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0025 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0025 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic anion by SLC22A8 (IC50 = 6.71 microM) DTD0025 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0025 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0025 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0025 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Estrone sulfate by SLC22A8 DTD0025 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0025 EXOFACTO Zidovudine CELLLINE The Proximal Tubule (S2) Cells-OAT3 DTD0026 TRANSPID DTD0026 DTD0026 GENENAME SLC22A11 DTD0026 PROTNAME Organic anion transporter 4 DTD0026 GENEDBID 55867 DTD0026 UNIPROID Q9NSA0 DTD0026 EXOFACTO Acetazolamide HIGHSTIT Approved Drug DTD0026 EXOFACTO Acetazolamide DESCRIPT Acetazolamide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 425 microM) DTD0026 EXOFACTO Acetazolamide MOACRIVE Inhibition DTD0026 EXOFACTO Acetazolamide CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Aflatoxin B1 HIGHSTIT Mycotoxins DTD0026 EXOFACTO Aflatoxin B1 DESCRIPT Aflatoxin B1 inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) DTD0026 EXOFACTO Aflatoxin B1 MOACRIVE Inhibition DTD0026 EXOFACTO Aflatoxin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Alpha-zearalenol HIGHSTIT Mycotoxins DTD0026 EXOFACTO Alpha-zearalenol DESCRIPT Alpha-zearalenol inhibits the transportation of Organic anion by SLC22A11 (IC50 = 130 microM) DTD0026 EXOFACTO Alpha-zearalenol MOACRIVE Inhibition DTD0026 EXOFACTO Alpha-zearalenol CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0026 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Methotrexate by SLC22A11 DTD0026 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0026 EXOFACTO Benzylpenicillin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Betamipron HIGHSTIT Approved Drug DTD0026 EXOFACTO Betamipron DESCRIPT Betamipron inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 502 microM) DTD0026 EXOFACTO Betamipron MOACRIVE Inhibition DTD0026 EXOFACTO Betamipron CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0026 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 348 microM) DTD0026 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0026 EXOFACTO Bumetanide CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cabazitaxel HIGHSTIT Approved Drug DTD0026 EXOFACTO Cabazitaxel DESCRIPT Cabazitaxel inhibits the activity of SLC22A11 DTD0026 EXOFACTO Cabazitaxel MOACRIVE Inhibition DTD0026 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0026 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 60 microM) DTD0026 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the activity of SLC22A11 (Ki = 88.9 microM) DTD0026 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the activity of SLC22A11 DTD0026 EXOFACTO Candesartan MOACRIVE Inhibition DTD0026 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Candesartan cilexetil HIGHSTIT Approved Drug DTD0026 EXOFACTO Candesartan cilexetil DESCRIPT Candesartan cilexetil inhibits the activity of SLC22A11 (Ki = 135.2 microM) DTD0026 EXOFACTO Candesartan cilexetil MOACRIVE Inhibition DTD0026 EXOFACTO Candesartan cilexetil CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0026 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 1140 microM) DTD0026 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0026 EXOFACTO Cefamandole CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cefazolin HIGHSTIT Approved Drug DTD0026 EXOFACTO Cefazolin DESCRIPT Cefazolin inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 1740 microM) DTD0026 EXOFACTO Cefazolin MOACRIVE Inhibition DTD0026 EXOFACTO Cefazolin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cefoperazone HIGHSTIT Approved Drug DTD0026 EXOFACTO Cefoperazone DESCRIPT Cefoperazone inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 2800 microM) DTD0026 EXOFACTO Cefoperazone MOACRIVE Inhibition DTD0026 EXOFACTO Cefoperazone CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cefotaxime HIGHSTIT Approved Drug DTD0026 EXOFACTO Cefotaxime DESCRIPT Cefotaxime inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 6150 microM) DTD0026 EXOFACTO Cefotaxime MOACRIVE Inhibition DTD0026 EXOFACTO Cefotaxime CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Ceftriaxone HIGHSTIT Approved Drug DTD0026 EXOFACTO Ceftriaxone DESCRIPT Ceftriaxone inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 2380 microM) DTD0026 EXOFACTO Ceftriaxone MOACRIVE Inhibition DTD0026 EXOFACTO Ceftriaxone CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cephaloridine HIGHSTIT Drug Withdrawn DTD0026 EXOFACTO Cephaloridine DESCRIPT Cephaloridine inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 3630 microM) DTD0026 EXOFACTO Cephaloridine MOACRIVE Inhibition DTD0026 EXOFACTO Cephaloridine CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cephalothin HIGHSTIT Approved Drug DTD0026 EXOFACTO Cephalothin DESCRIPT Cephalothin inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 200 microM) DTD0026 EXOFACTO Cephalothin MOACRIVE Inhibition DTD0026 EXOFACTO Cephalothin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Chlorothiazide HIGHSTIT Approved Drug DTD0026 EXOFACTO Chlorothiazide DESCRIPT Chlorothiazide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 2632 microM) DTD0026 EXOFACTO Chlorothiazide MOACRIVE Inhibition DTD0026 EXOFACTO Chlorothiazide CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cigarette smoke condensate (0.32mg/ml) HIGHSTIT Natural Product DTD0026 EXOFACTO Cigarette smoke condensate (0.32mg/ml) DESCRIPT Cigarette smoke condensate (0.32mg/ml) inhibits the activity of SLC22A11 DTD0026 EXOFACTO Cigarette smoke condensate (0.32mg/ml) MOACRIVE Inhibition DTD0026 EXOFACTO Cigarette smoke condensate (0.32mg/ml) CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Citrioveridine HIGHSTIT Mycotoxins DTD0026 EXOFACTO Citrioveridine DESCRIPT Citrioveridine inhibits the transportation of Organic anion by SLC22A11 (IC50 = 823 microM) DTD0026 EXOFACTO Citrioveridine MOACRIVE Inhibition DTD0026 EXOFACTO Citrioveridine CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Cyclopiazonic acid HIGHSTIT Mycotoxins DTD0026 EXOFACTO Cyclopiazonic acid DESCRIPT Cyclopiazonic acid inhibits the transportation of Organic anion by SLC22A11 (IC50 = 86.6 microM) DTD0026 EXOFACTO Cyclopiazonic acid MOACRIVE Inhibition DTD0026 EXOFACTO Cyclopiazonic acid CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0026 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 34.5 microM) DTD0026 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0026 EXOFACTO Diclofenac CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Ethacrynic acid HIGHSTIT Approved Drug DTD0026 EXOFACTO Ethacrynic acid DESCRIPT Ethacrynic acid inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 8.76 microM) DTD0026 EXOFACTO Ethacrynic acid MOACRIVE Inhibition DTD0026 EXOFACTO Ethacrynic acid CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Fumonisin B1 HIGHSTIT Mycotoxins DTD0026 EXOFACTO Fumonisin B1 DESCRIPT Fumonisin B1 inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) DTD0026 EXOFACTO Fumonisin B1 MOACRIVE Inhibition DTD0026 EXOFACTO Fumonisin B1 CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0026 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 44.5 microM) DTD0026 EXOFACTO Furosemide MOACRIVE Inhibition DTD0026 EXOFACTO Furosemide CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Gliotoxin HIGHSTIT Mycotoxins DTD0026 EXOFACTO Gliotoxin DESCRIPT Gliotoxin inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) DTD0026 EXOFACTO Gliotoxin MOACRIVE Inhibition DTD0026 EXOFACTO Gliotoxin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0026 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 103 microM) DTD0026 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0026 EXOFACTO Ibuprofen CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0026 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 10.1 microM) DTD0026 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0026 EXOFACTO Indomethacin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Ketoprofen HIGHSTIT Approved Drug DTD0026 EXOFACTO Ketoprofen DESCRIPT Ketoprofen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 70.3 microM) DTD0026 EXOFACTO Ketoprofen MOACRIVE Inhibition DTD0026 EXOFACTO Ketoprofen CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO KW-3902 HIGHSTIT Drug in Phase 3 Trial DTD0026 EXOFACTO KW-3902 DESCRIPT KW-3902 inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 20.7 microM) DTD0026 EXOFACTO KW-3902 MOACRIVE Inhibition DTD0026 EXOFACTO KW-3902 CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Lesinurad HIGHSTIT Approved Drug DTD0026 EXOFACTO Lesinurad DESCRIPT Lesinurad inhibits the activity of SLC22A11 DTD0026 EXOFACTO Lesinurad MOACRIVE Inhibition DTD0026 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0026 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Estrone sulfate by SLC22A11 DTD0026 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0026 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0026 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 18 microM) DTD0026 EXOFACTO Losartan DESCRIPT Losartan inhibits the activity of SLC22A11 (Ki = 24.8 microM) DTD0026 EXOFACTO Losartan MOACRIVE Inhibition DTD0026 EXOFACTO Losartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Mefenamic acid HIGHSTIT Approved Drug DTD0026 EXOFACTO Mefenamic acid DESCRIPT Mefenamic acid inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 61.7 microM) DTD0026 EXOFACTO Mefenamic acid MOACRIVE Inhibition DTD0026 EXOFACTO Mefenamic acid CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Naproxen HIGHSTIT Approved Drug DTD0026 EXOFACTO Naproxen DESCRIPT Naproxen inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 85.4 microM) DTD0026 EXOFACTO Naproxen MOACRIVE Inhibition DTD0026 EXOFACTO Naproxen CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0026 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 92.68 microM; Ki = 90.5 microM) DTD0026 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0026 EXOFACTO Novobiocin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-OAT4 DTD0026 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0026 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Uric acid by SLC22A11 (IC50 = 4.4 microM) DTD0026 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0026 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Patulin HIGHSTIT Mycotoxins DTD0026 EXOFACTO Patulin DESCRIPT Patulin inhibits the transportation of Organic anion by SLC22A11 (IC50 > 1000 microM) DTD0026 EXOFACTO Patulin MOACRIVE Inhibition DTD0026 EXOFACTO Patulin CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0026 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Methotrexate by SLC22A11 DTD0026 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0026 EXOFACTO Phenylbutazone CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0026 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 84.9 microM) DTD0026 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Ochratoxin A by SLC22A11 (Ki = 107.8 microM) DTD0026 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0026 EXOFACTO Piroxicam CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Pranlukast HIGHSTIT Approved Drug DTD0026 EXOFACTO Pranlukast DESCRIPT Pranlukast inhibits the activity of SLC22A11 DTD0026 EXOFACTO Pranlukast MOACRIVE Inhibition DTD0026 EXOFACTO Pratosartan HIGHSTIT Drug in Phase 3 Trial DTD0026 EXOFACTO Pratosartan DESCRIPT Pratosartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 31 microM) DTD0026 EXOFACTO Pratosartan MOACRIVE Inhibition DTD0026 EXOFACTO Pratosartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0026 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Prostaglandin F2alpha by SLC22A11 (Ki = 54.9 microM) DTD0026 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Ochratoxin A by SLC22A11 (Ki = 44.4 microM) DTD0026 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estrone sulfate by SLC22A11 DTD0026 EXOFACTO Probenecid MOACRIVE Inhibition DTD0026 EXOFACTO Probenecid CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0026 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 617 microM) DTD0026 EXOFACTO Sulindac MOACRIVE Inhibition DTD0026 EXOFACTO Sulindac CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0026 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 1.2 microM) DTD0026 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0026 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0026 EXOFACTO Trichlormethiazide DESCRIPT Trichloromethiazide inhibits the transportation of Estrone sulfate by SLC22A11 (IC50 = 1505 microM) DTD0026 EXOFACTO Trichlormethiazide MOACRIVE Inhibition DTD0026 EXOFACTO Trichlormethiazide CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0026 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Uric acid by SLC22A11 (IC50 = 26 microM) DTD0026 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the activity of SLC22A11 (Ki = 19.6 microM) DTD0026 EXOFACTO Valsartan MOACRIVE Inhibition DTD0026 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OAT4 DTD0026 EXOFACTO Zearalenone HIGHSTIT Mycotoxins DTD0026 EXOFACTO Zearalenone DESCRIPT Zearalenone inhibits the transportation of Organic anion by SLC22A11 (IC50 = 103 microM) DTD0026 EXOFACTO Zearalenone MOACRIVE Inhibition DTD0026 EXOFACTO Zearalenone CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0026 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0026 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Estrone sulfate by SLC22A11 DTD0026 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0026 EXOFACTO Zidovudine CELLLINE The Proximal Tubule (S2) Cells-OAT4 DTD0027 TRANSPID DTD0027 DTD0027 GENENAME SLC22A12 DTD0027 PROTNAME Urate anion exchanger 1 DTD0027 GENEDBID 116085 DTD0027 UNIPROID Q96S37 DTD0027 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0027 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of Uric acid by SLC22A12 (IC50 = 0.13 microM) DTD0027 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of Uric acid by SLC22A12 DTD0027 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0027 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Fenofibric acid HIGHSTIT Approved Drug DTD0027 EXOFACTO Fenofibric acid DESCRIPT Fenofibric acid inhibits the transportation of Uric acid by SLC22A12 (IC50 = 35.68 microM) DTD0027 EXOFACTO Fenofibric acid MOACRIVE Inhibition DTD0027 EXOFACTO Fenofibric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0027 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the activity of SLC22A12 DTD0027 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0027 EXOFACTO Lesinurad HIGHSTIT Approved Drug DTD0027 EXOFACTO Lesinurad DESCRIPT Lesinurad inhibits the activity of SLC22A12 DTD0027 EXOFACTO Lesinurad DESCRIPT Lesinurad modulates the activity of SLC22A12 DTD0027 EXOFACTO Lesinurad MOACRIVE Inhibition DTD0027 EXOFACTO Lesinurad MOACRIVE Modulator DTD0027 EXOFACTO Losartan HIGHSTIT Approved Drug DTD0027 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by SLC22A12 (IC50 = 570.5 microM) DTD0027 EXOFACTO Losartan DESCRIPT Losartan inhibits the transportation of Uric acid by SLC22A12 (Ki = 0.0077 microM) DTD0027 EXOFACTO Losartan MOACRIVE Inhibition DTD0027 EXOFACTO Losartan CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Losartan CELLLINE Oocytes-URAT1 DTD0027 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0027 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Uric acid by SLC22A12 (IC50 = 2 microM) DTD0027 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Uric acid by SLC22A12 (Ki = 5.74 microM) DTD0027 EXOFACTO Morin MOACRIVE Inhibition DTD0027 EXOFACTO Morin CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Pratosartan HIGHSTIT Drug in Phase 3 Trial DTD0027 EXOFACTO Pratosartan DESCRIPT Pratosartan inhibits the transportation of Uric acid by SLC22A12 (Ki = 0.0067 microM) DTD0027 EXOFACTO Pratosartan MOACRIVE Inhibition DTD0027 EXOFACTO Pratosartan CELLLINE Oocytes-URAT1 DTD0027 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0027 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Uric acid by SLC22A12 (IC50 = 50 microM) DTD0027 EXOFACTO Probenecid MOACRIVE Inhibition DTD0027 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0027 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the transportation of Uric acid by SLC22A12 (IC50 = 100 microM) DTD0027 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0027 EXOFACTO Sulfinpyrazone CELLLINE Human embryonic kidney 293 cells (HEK293)-URAT1 DTD0027 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0027 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Uric acid by SLC22A12 (Ki = 0.0182 microM) DTD0027 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0027 EXOFACTO Telmisartan CELLLINE Oocytes-URAT1 DTD0027 EXOFACTO Uric acid HIGHSTIT Investigative Drug DTD0027 EXOFACTO Uric acid DESCRIPT Uric acid inhibits the transportation of Oxypurinol by SLC22A12 (IC50 = 170 microM) DTD0027 EXOFACTO Uric acid MOACRIVE Inhibition DTD0027 EXOFACTO Uric acid CELLLINE Oocytes-URAT1 DTD0028 TRANSPID DTD0028 DTD0028 GENENAME SLC47A2 DTD0028 PROTNAME Multidrug and toxin extrusion protein 2 DTD0028 GENEDBID 146802 DTD0028 UNIPROID Q86VL8 DTD0028 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0028 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 1167 microM) DTD0028 EXOFACTO Amantadine MOACRIVE Inhibition DTD0028 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Carvedilol HIGHSTIT Approved Drug DTD0028 EXOFACTO Carvedilol DESCRIPT Carvedilol inhibits the activity of SLC47A2 (IC50 = 202 microM) DTD0028 EXOFACTO Carvedilol MOACRIVE Inhibition DTD0028 EXOFACTO Carvedilol CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0028 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 817.6 microM) DTD0028 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0028 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Chlorpheniramine HIGHSTIT Approved Drug DTD0028 EXOFACTO Chlorpheniramine DESCRIPT Chlorpheniramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 191.2 microM) DTD0028 EXOFACTO Chlorpheniramine MOACRIVE Inhibition DTD0028 EXOFACTO Chlorpheniramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0028 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLC47A2 (IC50 = 61.4 microM) DTD0028 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0028 EXOFACTO Cigarette smoke condensate CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0028 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 7.3 microM) DTD0028 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 2.1 microM) DTD0028 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0028 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Cobicistat HIGHSTIT Approved Drug DTD0028 EXOFACTO Cobicistat DESCRIPT Cobicistat inhibits the activity of SLC47A2 (IC50 = 3.2 microM) DTD0028 EXOFACTO Cobicistat MOACRIVE Inhibition DTD0028 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0028 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 283 microM) DTD0028 EXOFACTO Desipramine MOACRIVE Inhibition DTD0028 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0028 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 117 microM) DTD0028 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0028 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Diphenhydramine HIGHSTIT Approved Drug DTD0028 EXOFACTO Diphenhydramine DESCRIPT Diphenhydramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 266.5 microM) DTD0028 EXOFACTO Diphenhydramine MOACRIVE Inhibition DTD0028 EXOFACTO Diphenhydramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0028 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 291.6 microM) DTD0028 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0028 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO DX-619 HIGHSTIT Discontinued Drug DTD0028 EXOFACTO DX-619 DESCRIPT DX-619 inhibits the transportation of Creatinine by SLC47A2 (Ki = 0.1 microM) DTD0028 EXOFACTO DX-619 MOACRIVE Inhibition DTD0028 EXOFACTO DX-619 CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Famotidine HIGHSTIT Approved Drug DTD0028 EXOFACTO Famotidine DESCRIPT Famotidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 9.7 microM) DTD0028 EXOFACTO Famotidine MOACRIVE Inhibition DTD0028 EXOFACTO Famotidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Green tea HIGHSTIT Natural Product DTD0028 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Metformin by SLC47A2 DTD0028 EXOFACTO Green tea MOACRIVE Inhibition DTD0028 EXOFACTO Green tea CELLLINE Human enterocyte-like 2 cell (Caco-2)-MATE2 DTD0028 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0028 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 182.9 microM) DTD0028 EXOFACTO Imipramine MOACRIVE Inhibition DTD0028 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0028 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLC47A2 DTD0028 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0028 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0028 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the activity of SLC47A2 DTD0028 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0028 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0028 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 6515.7 microM) DTD0028 EXOFACTO Metformin MOACRIVE Inhibition DTD0028 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Plazomicin HIGHSTIT Approved Drug DTD0028 EXOFACTO Plazomicin DESCRIPT Plazomicin inhibits the activity of SLC47A2 DTD0028 EXOFACTO Plazomicin MOACRIVE Inhibition DTD0028 EXOFACTO Pramipexole HIGHSTIT Approved Drug DTD0028 EXOFACTO Pramipexole DESCRIPT Pramipexole inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 24.1 microM) DTD0028 EXOFACTO Pramipexole MOACRIVE Inhibition DTD0028 EXOFACTO Pramipexole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0028 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 178.1 microM) DTD0028 EXOFACTO Procainamide MOACRIVE Inhibition DTD0028 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0028 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of 1-methyl-4-phenylpyridinium by SLC47A2 (IC50 = 6.4 microM) DTD0028 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 23.1 microM) DTD0028 EXOFACTO Quinine MOACRIVE Inhibition DTD0028 EXOFACTO Quinine CELLLINE Chinese hamster ovary (CHO) cells-MATE2 DTD0028 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0028 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 25 microM) DTD0028 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0028 EXOFACTO Ranitidine CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0028 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of SLC47A2 (IC50 = 90 microM) DTD0028 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0028 EXOFACTO Talipexole HIGHSTIT Drug in Phase 4 Trial DTD0028 EXOFACTO Talipexole DESCRIPT Talipexole inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 119.5 microM) DTD0028 EXOFACTO Talipexole MOACRIVE Inhibition DTD0028 EXOFACTO Talipexole CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0028 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0028 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium modulates the activity of SLC47A2 DTD0028 EXOFACTO Tetraethylammonium MOACRIVE Modulator DTD0028 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0028 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 32.1 microM) DTD0028 EXOFACTO Verapamil MOACRIVE Inhibition DTD0028 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-MATE2 DTD0029 TRANSPID DTD0029 DTD0029 GENENAME SLCO1A2 DTD0029 PROTNAME Organic anion transporting polypeptide 1A2 DTD0029 GENEDBID 6579 DTD0029 UNIPROID P46721 DTD0029 EXOFACTO (-)-epicatechin-3-gallate HIGHSTIT Natural Product DTD0029 EXOFACTO (-)-epicatechin-3-gallate DESCRIPT (-)-epicatechin-3-gallate inhibits the activity of SLCO1A2 in a substrate-dependent manner (IC50 = 10 microM) DTD0029 EXOFACTO (-)-epicatechin-3-gallate MOACRIVE Inhibition DTD0029 EXOFACTO (-)-epicatechin-3-gallate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO (-)-epigallocatechin-3-gallate HIGHSTIT Natural Product DTD0029 EXOFACTO (-)-epigallocatechin-3-gallate DESCRIPT (-)-epigallocatechin-3-gallate inhibits the activity of SLCO1A2 in a substrate-dependent manner (IC50 = 55 microM) DTD0029 EXOFACTO (-)-epigallocatechin-3-gallate MOACRIVE Inhibition DTD0029 EXOFACTO (-)-epigallocatechin-3-gallate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Apigenin HIGHSTIT Investigative Drug DTD0029 EXOFACTO Apigenin DESCRIPT Apigenin inhibits the transportation of Atorvastatin by SLCO1A2 (IC50 = 9.3 microM; Ki = 22 microM) DTD0029 EXOFACTO Apigenin MOACRIVE Inhibition DTD0029 EXOFACTO Apigenin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0029 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO1A2 (IC50 = 3.75 microM) DTD0029 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0029 EXOFACTO Bromsulphthalein CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS1)-OATP1A2 DTD0029 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0029 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0029 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0029 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0029 EXOFACTO Grapefruit juice HIGHSTIT Dietary Constituent DTD0029 EXOFACTO Grapefruit juice DESCRIPT Grapefruit inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juice inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Grapefruit juice MOACRIVE Inhibition DTD0029 EXOFACTO Grapefruit juice CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP1A2 DTD0029 EXOFACTO Grapefruit juice CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Green tea HIGHSTIT Natural Product DTD0029 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Nadolol by SLCO1A2 DTD0029 EXOFACTO Green tea MOACRIVE Inhibition DTD0029 EXOFACTO Green tea CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Hesperetin HIGHSTIT Approved Drug DTD0029 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Hesperetin MOACRIVE Inhibition DTD0029 EXOFACTO Hesperetin CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Hesperidin HIGHSTIT Approved Drug DTD0029 EXOFACTO Hesperidin DESCRIPT Hesperidin inhibits the transportation of Fexofenadine by SLCO1A2 (IC50 = 2.7 microM) DTD0029 EXOFACTO Hesperidin MOACRIVE Inhibition DTD0029 EXOFACTO Hesperidin CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Indocyanine green HIGHSTIT Approved Drug DTD0029 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Sodium taurocholate by SLCO1A2 DTD0029 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Sulfobromophthalein by SLCO1A2 DTD0029 EXOFACTO Indocyanine green MOACRIVE Inhibition DTD0029 EXOFACTO Indocyanine green CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Kaempferol HIGHSTIT Investigative Drug DTD0029 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Atorvastatin by SLCO1A2 (IC50 = 37.3 microM; Ki = 25.2 microM) DTD0029 EXOFACTO Kaempferol MOACRIVE Inhibition DTD0029 EXOFACTO Kaempferol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0029 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0029 EXOFACTO Lovastatin CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Mesalazine HIGHSTIT Approved Drug DTD0029 EXOFACTO Mesalazine DESCRIPT Mesalazine inhibits the transportation of Bromsulphthalein by SLCO1A2 DTD0029 EXOFACTO Mesalazine MOACRIVE Inhibition DTD0029 EXOFACTO Mesalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Mifepristone HIGHSTIT Approved Drug DTD0029 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Mifepristone MOACRIVE Inhibition DTD0029 EXOFACTO Naloxone HIGHSTIT Approved Drug DTD0029 EXOFACTO Naloxone DESCRIPT Naloxone inhibits the transportation of Deltorphin by SLCO1A2 DTD0029 EXOFACTO Naloxone MOACRIVE Inhibition DTD0029 EXOFACTO Naloxone CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Naringin HIGHSTIT Investigative Drug DTD0029 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Fexofenadine by SLCO1A2 (IC50 = 3.6 microM) DTD0029 EXOFACTO Naringin DESCRIPT Naringin inhibits the activity of SLCO1A2 (IC50 = 343 microM) DTD0029 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Naringin MOACRIVE Inhibition DTD0029 EXOFACTO Naringin CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Naringin CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Orange juice HIGHSTIT Dietary Constituent DTD0029 EXOFACTO Orange juice DESCRIPT Orange juice inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Orange juice DESCRIPT Orange juice inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Orange juice MOACRIVE Inhibition DTD0029 EXOFACTO Orange juice CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP1A2 DTD0029 EXOFACTO Orange juice CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0029 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0029 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0029 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transporation of ginkolide B by SLCO1A2 DTD0029 EXOFACTO Probenecid MOACRIVE Inhibition DTD0029 EXOFACTO Probenecid CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0029 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0029 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Atorvastatin by SLCO1A2 (IC50 = 13.5 microM; Ki = 32.4 microM) DTD0029 EXOFACTO Quercetin MOACRIVE Inhibition DTD0029 EXOFACTO Quercetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1A2 DTD0029 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0029 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Sulfobromophthalein by SLCO1A2 (Ki = 51 microM) DTD0029 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bromsulphthalein by SLCO1A2 (Ki = 51 microM) DTD0029 EXOFACTO Rifampicin DESCRIPT Rifampicin induces the activity of SLCO1A2 DTD0029 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0029 EXOFACTO Rifampicin CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Rifamycin SV HIGHSTIT Approved Drug DTD0029 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Bromsulphthalein by SLCO1A2 (Ki = 11 microM) DTD0029 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Rifamycin SV MOACRIVE Inhibition DTD0029 EXOFACTO Rifamycin SV CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Rifaximin HIGHSTIT Approved Drug DTD0029 EXOFACTO Rifaximin DESCRIPT Rifaximin inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Rifaximin MOACRIVE Inhibition DTD0029 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0029 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Fexofenadine by SLCO1A2 (IC50 < 10 microM) DTD0029 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of SLCO1A2 DTD0029 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0029 EXOFACTO Ritonavir CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0029 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Fexofenadine by SLCO1A2 (IC50 < 10 microM) DTD0029 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0029 EXOFACTO Saquinavir CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0029 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0029 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Fexofenadine by SLCO1A2 DTD0029 EXOFACTO Valspodar MOACRIVE Inhibition DTD0029 EXOFACTO Valspodar CELLLINE Oocytes-OATP1A2 DTD0029 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0029 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Fexofenadine by SLCO1A2 (IC50 = 2.6 microM) DTD0029 EXOFACTO Verapamil MOACRIVE Inhibition DTD0029 EXOFACTO Verapamil CELLLINE Human cervical cancer cell line (Hela)-OATP1A2 DTD0030 TRANSPID DTD0030 DTD0030 GENENAME SLCO1B3 DTD0030 PROTNAME Organic anion transporting polypeptide 1B3 DTD0030 GENEDBID 28234 DTD0030 UNIPROID Q9NPD5 DTD0030 EXOFACTO (-)-epicatechin-3-gallate HIGHSTIT Natural Product DTD0030 EXOFACTO (-)-epicatechin-3-gallate DESCRIPT (-)-epicatechin-3-gallate inhibits the activity of SLCO1B3 in a concentration-dependent way DTD0030 EXOFACTO (-)-epicatechin-3-gallate MOACRIVE Inhibition DTD0030 EXOFACTO (-)-epicatechin-3-gallate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Acarbose HIGHSTIT Approved Drug DTD0030 EXOFACTO Acarbose DESCRIPT Acarbose inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Acarbose MOACRIVE Inhibition DTD0030 EXOFACTO Acarbose CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Acyclovir HIGHSTIT Approved Drug DTD0030 EXOFACTO Acyclovir DESCRIPT Acyclovir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Acyclovir MOACRIVE Inhibition DTD0030 EXOFACTO Acyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Allopurinol HIGHSTIT Approved Drug DTD0030 EXOFACTO Allopurinol DESCRIPT Allopurinol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Allopurinol MOACRIVE Inhibition DTD0030 EXOFACTO Allopurinol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0030 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Amantadine MOACRIVE Inhibition DTD0030 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0030 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0030 EXOFACTO Aminohippuric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0030 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0030 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Amodiaquine HIGHSTIT Approved Drug DTD0030 EXOFACTO Amodiaquine DESCRIPT Amodiaquine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Amodiaquine MOACRIVE Inhibition DTD0030 EXOFACTO Amodiaquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Amprenavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 19.1 microM; Ki = 13.1 microM) DTD0030 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Amprenavir MOACRIVE Inhibition DTD0030 EXOFACTO Amprenavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Amprenavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0030 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Astemizole MOACRIVE Inhibition DTD0030 EXOFACTO Astemizole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Asunaprevir HIGHSTIT Drug in Phase 3 Trial DTD0030 EXOFACTO Asunaprevir DESCRIPT Asunaprevir inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Asunaprevir MOACRIVE Inhibition DTD0030 EXOFACTO Atazanavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 3 microM; Ki = 2 microM) DTD0030 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Atazanavir MOACRIVE Inhibition DTD0030 EXOFACTO Atazanavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Atazanavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Atenolol HIGHSTIT Approved Drug DTD0030 EXOFACTO Atenolol DESCRIPT Atenolol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Atenolol MOACRIVE Inhibition DTD0030 EXOFACTO Atenolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Atomoxetine HIGHSTIT Approved Drug DTD0030 EXOFACTO Atomoxetine DESCRIPT Atomoxetine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Atomoxetine MOACRIVE Inhibition DTD0030 EXOFACTO Atomoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0030 EXOFACTO Atorvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Baicalin HIGHSTIT Discontinued Drug DTD0030 EXOFACTO Baicalin DESCRIPT Baicalin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Baicalin MOACRIVE Inhibition DTD0030 EXOFACTO Baicalin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0030 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0030 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0030 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0030 EXOFACTO Benzylpenicillin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Berberine HIGHSTIT Drug in Phase 4 Trial DTD0030 EXOFACTO Berberine DESCRIPT Berberine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Berberine MOACRIVE Inhibition DTD0030 EXOFACTO Berberine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Bestatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Bestatin DESCRIPT Bestatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Bestatin MOACRIVE Inhibition DTD0030 EXOFACTO Bestatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Boceprevir HIGHSTIT Approved Drug DTD0030 EXOFACTO Boceprevir DESCRIPT Boceprevir inhibits the activity of SLCO1B3 (IC50 = 4.9 microM) DTD0030 EXOFACTO Boceprevir MOACRIVE Inhibition DTD0030 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0030 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 1.4 microM; Ki = 1 microM) DTD0030 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 3 microM) DTD0030 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 DTD0030 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0030 EXOFACTO Bromsulphthalein CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Bromsulphthalein CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0030 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Budesonide MOACRIVE Inhibition DTD0030 EXOFACTO Budesonide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0030 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Bupropion MOACRIVE Inhibition DTD0030 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0030 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Buspirone MOACRIVE Inhibition DTD0030 EXOFACTO Buspirone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0030 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Caffeine MOACRIVE Inhibition DTD0030 EXOFACTO Caffeine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0030 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Candesartan MOACRIVE Inhibition DTD0030 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0030 EXOFACTO Captopril DESCRIPT Captopril inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Captopril MOACRIVE Inhibition DTD0030 EXOFACTO Captopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Carbamazepine HIGHSTIT Approved Drug DTD0030 EXOFACTO Carbamazepine DESCRIPT Carbamazepine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Carbamazepine MOACRIVE Inhibition DTD0030 EXOFACTO Carbamazepine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Carfilzomib HIGHSTIT Approved Drug DTD0030 EXOFACTO Carfilzomib DESCRIPT Carfilzomib inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Carfilzomib MOACRIVE Inhibition DTD0030 EXOFACTO Carfilzomib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0030 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0030 EXOFACTO Cefadroxil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0030 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0030 EXOFACTO Cefamandole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0030 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0030 EXOFACTO Celecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cerivastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cerivastatin MOACRIVE Inhibition DTD0030 EXOFACTO Cerivastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0030 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0030 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Chelerythrine HIGHSTIT Investigative Drug DTD0030 EXOFACTO Chelerythrine DESCRIPT Chelerythrine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Chelerythrine MOACRIVE Inhibition DTD0030 EXOFACTO Chelerythrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Chlorambucil HIGHSTIT Approved Drug DTD0030 EXOFACTO Chlorambucil DESCRIPT Chlorambucil inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Chlorambucil MOACRIVE Inhibition DTD0030 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0030 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0030 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0030 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0030 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Chlorprothixene HIGHSTIT Approved Drug DTD0030 EXOFACTO Chlorprothixene DESCRIPT Chlorprothixene inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Chlorprothixene MOACRIVE Inhibition DTD0030 EXOFACTO Chlorprothixene CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Chlorzoxazone HIGHSTIT Approved Drug DTD0030 EXOFACTO Chlorzoxazone DESCRIPT Chlorzoxazone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Chlorzoxazone MOACRIVE Inhibition DTD0030 EXOFACTO Chlorzoxazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cholic acid HIGHSTIT Approved Drug DTD0030 EXOFACTO Cholic acid DESCRIPT Cholic acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cholic acid MOACRIVE Inhibition DTD0030 EXOFACTO Cholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0030 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Cholecystokinin octapeptide sulphated by SLCO1B3 (IC50 = 7.6 microM) DTD0030 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the activity of SLCO1B3 (IC50 = 7.6 microM) DTD0030 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0030 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-OATP1B3 DTD0030 EXOFACTO Cigarette smoke condensate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0030 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0030 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0030 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0030 EXOFACTO Clarithromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0030 EXOFACTO Clotrimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Colchicine HIGHSTIT Approved Drug DTD0030 EXOFACTO Colchicine DESCRIPT Colchicine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Colchicine MOACRIVE Inhibition DTD0030 EXOFACTO Colchicine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Coumarin HIGHSTIT Investigative Drug DTD0030 EXOFACTO Coumarin DESCRIPT Coumarin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Coumarin MOACRIVE Inhibition DTD0030 EXOFACTO Coumarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Coumestrol HIGHSTIT Investigative Drug DTD0030 EXOFACTO Coumestrol DESCRIPT Coumestrol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Coumestrol MOACRIVE Inhibition DTD0030 EXOFACTO Coumestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0030 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rosuvastatin by SLCO1B3 (IC50 = 0.06 microM) DTD0030 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 0.3 microM) DTD0030 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bosentan by SLCO1B3 (IC50 = 0.8 microM) DTD0030 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 0.3 microM) DTD0030 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0030 EXOFACTO Cyclosporine CELLLINE Human cervical cancer cell line (Hela)-OATP1B3 DTD0030 EXOFACTO Cyclosporine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Cyclosporine CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0030 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Dactinomycin HIGHSTIT Approved Drug DTD0030 EXOFACTO Dactinomycin DESCRIPT Dactinomycin inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Dactinomycin MOACRIVE Inhibition DTD0030 EXOFACTO Daidzein HIGHSTIT Investigative Drug DTD0030 EXOFACTO Daidzein DESCRIPT Daidzein inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Daidzein MOACRIVE Inhibition DTD0030 EXOFACTO Daidzein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Darunavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Darunavir DESCRIPT Darunavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 4.8 microM; Ki = 3.3 microM) DTD0030 EXOFACTO Darunavir MOACRIVE Inhibition DTD0030 EXOFACTO Darunavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0030 EXOFACTO Decitabine DESCRIPT Decitabine inhibits DNA methyltransferase, which then enhances the expression of SLCO1B3 via downregulating the promoter hypermethylation level DTD0030 EXOFACTO Decitabine MOACRIVE Inducer DTD0030 EXOFACTO Decitabine CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0030 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0030 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Desipramine MOACRIVE Inhibition DTD0030 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0030 EXOFACTO Dexamethasone DESCRIPT Dexamethasone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Dexamethasone MOACRIVE Inhibition DTD0030 EXOFACTO Dexamethasone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Dextromethorphan HIGHSTIT Approved Drug DTD0030 EXOFACTO Dextromethorphan DESCRIPT Dextromethorphan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Dextromethorphan MOACRIVE Inhibition DTD0030 EXOFACTO Dextromethorphan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Diazepam HIGHSTIT Approved Drug DTD0030 EXOFACTO Diazepam DESCRIPT Diazepam inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Diazepam MOACRIVE Inhibition DTD0030 EXOFACTO Diazepam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0030 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0030 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Diethylstilbestrol HIGHSTIT Approved Drug DTD0030 EXOFACTO Diethylstilbestrol DESCRIPT Diethylstilbestrol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Diethylstilbestrol MOACRIVE Inhibition DTD0030 EXOFACTO Diethylstilbestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0030 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 1 microM; Ki = 0.7 microM) DTD0030 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Digoxin MOACRIVE Inhibition DTD0030 EXOFACTO Digoxin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Digoxin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0030 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0030 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Dioscin HIGHSTIT Investigative Drug DTD0030 EXOFACTO Dioscin DESCRIPT Dioscin inhibits the transportation of Cyclosporine by SLCO1B3 DTD0030 EXOFACTO Dioscin DESCRIPT Dioscin inhibits the transportation of Epigalocatechin gallate by SLCO1B3 DTD0030 EXOFACTO Dioscin DESCRIPT Dioscin inhibits the transportation of Rifampicin by SLCO1B3 DTD0030 EXOFACTO Dioscin DESCRIPT Dioscin inhibits the transportation of Telmisartan by SLCO1B3 DTD0030 EXOFACTO Dioscin MOACRIVE Inhibition DTD0030 EXOFACTO Dioscin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0030 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0030 EXOFACTO Dipyridamole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0030 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0030 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Disulfiram HIGHSTIT Approved Drug DTD0030 EXOFACTO Disulfiram DESCRIPT Disulfiram inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Disulfiram MOACRIVE Inhibition DTD0030 EXOFACTO Disulfiram CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Docetaxel HIGHSTIT Approved Drug DTD0030 EXOFACTO Docetaxel DESCRIPT Docetaxel inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Docetaxel MOACRIVE Inhibition DTD0030 EXOFACTO Dofetilide HIGHSTIT Approved Drug DTD0030 EXOFACTO Dofetilide DESCRIPT Dofetilide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Dofetilide MOACRIVE Inhibition DTD0030 EXOFACTO Dofetilide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Doxazosin HIGHSTIT Approved Drug DTD0030 EXOFACTO Doxazosin DESCRIPT Doxazosin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Doxazosin MOACRIVE Inhibition DTD0030 EXOFACTO Doxazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0030 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Doxorubicin MOACRIVE Inhibition DTD0030 EXOFACTO Doxorubicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0030 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0030 EXOFACTO Efavirenz CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Elacridar HIGHSTIT Discontinued Drug DTD0030 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Elacridar MOACRIVE Inhibition DTD0030 EXOFACTO Elacridar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Eletriptan HIGHSTIT Approved Drug DTD0030 EXOFACTO Eletriptan DESCRIPT Eletriptan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Eletriptan MOACRIVE Inhibition DTD0030 EXOFACTO Eletriptan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Eltrombopag HIGHSTIT Approved Drug DTD0030 EXOFACTO Eltrombopag DESCRIPT Eltrombopag inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 DTD0030 EXOFACTO Eltrombopag MOACRIVE Inhibition DTD0030 EXOFACTO Emtricitabine HIGHSTIT Approved Drug DTD0030 EXOFACTO Emtricitabine DESCRIPT Emtricitabine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Emtricitabine MOACRIVE Inhibition DTD0030 EXOFACTO Emtricitabine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0030 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Enalapril MOACRIVE Inhibition DTD0030 EXOFACTO Enalapril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0030 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0030 EXOFACTO Erlotinib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0030 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0030 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0030 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 12.9 microM) DTD0030 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Estradiol MOACRIVE Inhibition DTD0030 EXOFACTO Estradiol CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Estradiol-17beta-glucuronide HIGHSTIT Investigative Drug DTD0030 EXOFACTO Estradiol-17beta-glucuronide DESCRIPT Estradiol-17beta-glucuronide modulates the activity of SLCO1B3 DTD0030 EXOFACTO Estradiol-17beta-glucuronide MOACRIVE Modulator DTD0030 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0030 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate inhibits the transportation of Sincalide by SLCO1B3 (IC50 = 97.1 microM) DTD0030 EXOFACTO Estrone sulfate MOACRIVE Inhibition DTD0030 EXOFACTO Estrone sulfate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0030 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Etoposide MOACRIVE Inhibition DTD0030 EXOFACTO Etoposide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ezetimibe HIGHSTIT Approved Drug DTD0030 EXOFACTO Ezetimibe DESCRIPT Ezetimibe inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ezetimibe MOACRIVE Inhibition DTD0030 EXOFACTO Ezetimibe CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Felodipine HIGHSTIT Approved Drug DTD0030 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Felodipine MOACRIVE Inhibition DTD0030 EXOFACTO Felodipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fendiline HIGHSTIT Drug Withdrawn DTD0030 EXOFACTO Fendiline DESCRIPT Fendiline inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fendiline MOACRIVE Inhibition DTD0030 EXOFACTO Fendiline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fenofibrate HIGHSTIT Approved Drug DTD0030 EXOFACTO Fenofibrate DESCRIPT Fenofibrate inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fenofibrate MOACRIVE Inhibition DTD0030 EXOFACTO Fenofibrate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fentanyl HIGHSTIT Approved Drug DTD0030 EXOFACTO Fentanyl DESCRIPT Fentanyl inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fentanyl MOACRIVE Inhibition DTD0030 EXOFACTO Fentanyl CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fexofenadine HIGHSTIT Approved Drug DTD0030 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the transportation of Estrone sulfate by SLCO1B3 (Ki = 205 microM) DTD0030 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fexofenadine MOACRIVE Inhibition DTD0030 EXOFACTO Fexofenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fluconazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Fluconazole DESCRIPT Fluconazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fluconazole MOACRIVE Inhibition DTD0030 EXOFACTO Fluconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0030 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0030 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Flutamide HIGHSTIT Approved Drug DTD0030 EXOFACTO Flutamide DESCRIPT Flutamide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Flutamide MOACRIVE Inhibition DTD0030 EXOFACTO Flutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0030 EXOFACTO Fluvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Fluvoxamine HIGHSTIT Approved Drug DTD0030 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Fluvoxamine MOACRIVE Inhibition DTD0030 EXOFACTO Fluvoxamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0030 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Furosemide MOACRIVE Inhibition DTD0030 EXOFACTO Furosemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Gemfibrozil HIGHSTIT Approved Drug DTD0030 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Gemfibrozil MOACRIVE Inhibition DTD0030 EXOFACTO Gemfibrozil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0030 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Genistein MOACRIVE Inhibition DTD0030 EXOFACTO Genistein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glecaprevir HIGHSTIT Approved Drug DTD0030 EXOFACTO Glecaprevir DESCRIPT Glecaprevir inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Glecaprevir MOACRIVE Inhibition DTD0030 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0030 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0030 EXOFACTO Glibenclamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glipizide HIGHSTIT Approved Drug DTD0030 EXOFACTO Glipizide DESCRIPT Glipizide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glipizide MOACRIVE Inhibition DTD0030 EXOFACTO Glipizide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glycochenodeoxycholic acid HIGHSTIT Investigative Drug DTD0030 EXOFACTO Glycochenodeoxycholic acid DESCRIPT Glycochenodeoxycholic acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glycochenodeoxycholic acid MOACRIVE Inhibition DTD0030 EXOFACTO Glycochenodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glycocholic acid HIGHSTIT Investigative Drug DTD0030 EXOFACTO Glycocholic acid DESCRIPT Glycocholic acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glycocholic acid MOACRIVE Inhibition DTD0030 EXOFACTO Glycocholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glycodeoxycholic acid HIGHSTIT Investigative Drug DTD0030 EXOFACTO Glycodeoxycholic acid DESCRIPT Glycodeoxycholic acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glycodeoxycholic acid MOACRIVE Inhibition DTD0030 EXOFACTO Glycodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Glycyrrhizin HIGHSTIT Drug in Phase 3 Trial DTD0030 EXOFACTO Glycyrrhizin DESCRIPT Glycyrrhizin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Glycyrrhizin MOACRIVE Inhibition DTD0030 EXOFACTO Glycyrrhizin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Green tea HIGHSTIT Natural Product DTD0030 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Bromosulfophtalein by SLCO1B3 DTD0030 EXOFACTO Green tea DESCRIPT Green tea inhibits the transportation of Atorvastatin by SLCO1B3 DTD0030 EXOFACTO Green tea MOACRIVE Inhibition DTD0030 EXOFACTO Green tea CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP1B3 DTD0030 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0030 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0030 EXOFACTO Ibuprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0030 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Imipramine MOACRIVE Inhibition DTD0030 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 12.3 microM; Ki = 8.5 microM) DTD0030 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Indinavir MOACRIVE Inhibition DTD0030 EXOFACTO Indinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Indinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Indocyanine green HIGHSTIT Approved Drug DTD0030 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Indocyanine green MOACRIVE Inhibition DTD0030 EXOFACTO Indocyanine green CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0030 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0030 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Irinotecan HIGHSTIT Approved Drug DTD0030 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Irinotecan MOACRIVE Inhibition DTD0030 EXOFACTO Irinotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Isoniazid HIGHSTIT Approved Drug DTD0030 EXOFACTO Isoniazid DESCRIPT Isoniazid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Isoniazid MOACRIVE Inhibition DTD0030 EXOFACTO Isoniazid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Isradipine HIGHSTIT Approved Drug DTD0030 EXOFACTO Isradipine DESCRIPT Isradipine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Isradipine MOACRIVE Inhibition DTD0030 EXOFACTO Isradipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Itraconazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Itraconazole DESCRIPT Itraconazole inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Itraconazole MOACRIVE Inhibition DTD0030 EXOFACTO Ivermectin HIGHSTIT Approved Drug DTD0030 EXOFACTO Ivermectin DESCRIPT Ivermectin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ivermectin MOACRIVE Inhibition DTD0030 EXOFACTO Ivermectin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0030 EXOFACTO Ketoconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lamotrigine HIGHSTIT Approved Drug DTD0030 EXOFACTO Lamotrigine DESCRIPT Lamotrigine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Lamotrigine MOACRIVE Inhibition DTD0030 EXOFACTO Lamotrigine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lansoprazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Lansoprazole DESCRIPT Lansoprazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Lansoprazole MOACRIVE Inhibition DTD0030 EXOFACTO Lansoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO L-carnitine HIGHSTIT Approved Drug DTD0030 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO L-carnitine MOACRIVE Inhibition DTD0030 EXOFACTO L-carnitine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Letermovir HIGHSTIT Approved Drug DTD0030 EXOFACTO Letermovir DESCRIPT Letermovir inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Letermovir MOACRIVE Inhibition DTD0030 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0030 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0030 EXOFACTO Levofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Levothyroxine HIGHSTIT Approved Drug DTD0030 EXOFACTO Levothyroxine DESCRIPT Levothyroxine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Levothyroxine MOACRIVE Inhibition DTD0030 EXOFACTO Levothyroxine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0030 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0030 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lisinopril HIGHSTIT Approved Drug DTD0030 EXOFACTO Lisinopril DESCRIPT Lisinopril inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Lisinopril MOACRIVE Inhibition DTD0030 EXOFACTO Lisinopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lithocholate HIGHSTIT Investigative Drug DTD0030 EXOFACTO Lithocholate DESCRIPT Lithocholate inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 6.8 microM) DTD0030 EXOFACTO Lithocholate MOACRIVE Inhibition DTD0030 EXOFACTO Lithocholate CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Loperamide HIGHSTIT Approved Drug DTD0030 EXOFACTO Loperamide DESCRIPT Loperamide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Loperamide MOACRIVE Inhibition DTD0030 EXOFACTO Loperamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 2 microM; Ki = 1.4 microM) DTD0030 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0030 EXOFACTO Lopinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Lopinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0030 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Loratadine MOACRIVE Inhibition DTD0030 EXOFACTO Loratadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0030 EXOFACTO Lovastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Mephenytoin HIGHSTIT Approved Drug DTD0030 EXOFACTO Mephenytoin DESCRIPT Mephenytoin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Mephenytoin MOACRIVE Inhibition DTD0030 EXOFACTO Mephenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Mesalazine HIGHSTIT Approved Drug DTD0030 EXOFACTO Mesalazine DESCRIPT Mesalazine inhibits the transportation of Bromsulphthalein by SLCO1B3 DTD0030 EXOFACTO Mesalazine MOACRIVE Inhibition DTD0030 EXOFACTO Mesalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0030 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Metformin MOACRIVE Inhibition DTD0030 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0030 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0030 EXOFACTO Methotrexate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Methoxsalen HIGHSTIT Approved Drug DTD0030 EXOFACTO Methoxsalen DESCRIPT Methoxsalen inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Methoxsalen MOACRIVE Inhibition DTD0030 EXOFACTO Methoxsalen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0030 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0030 EXOFACTO Metoprolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Midazolam HIGHSTIT Approved Drug DTD0030 EXOFACTO Midazolam DESCRIPT Midazolam inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Midazolam MOACRIVE Inhibition DTD0030 EXOFACTO Midazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Mifepristone HIGHSTIT Approved Drug DTD0030 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 5.3 microM) DTD0030 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Mifepristone MOACRIVE Inhibition DTD0030 EXOFACTO Mifepristone CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Mifepristone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0030 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0030 EXOFACTO Mitoxantrone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Mix silybin A silybin B HIGHSTIT Natural Product DTD0030 EXOFACTO Mix silybin A silybin B DESCRIPT Mix silybin A silybin B inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Mix silybin A silybin B MOACRIVE Inhibition DTD0030 EXOFACTO Mix silybin A silybin B CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0030 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 0.5 microM; Ki = 0.2 microM) DTD0030 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 0.3 microM) DTD0030 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO MK-571 MOACRIVE Inhibition DTD0030 EXOFACTO MK-571 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Moclobemide HIGHSTIT Approved Drug DTD0030 EXOFACTO Moclobemide DESCRIPT Moclobemide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Moclobemide MOACRIVE Inhibition DTD0030 EXOFACTO Moclobemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Montelukast HIGHSTIT Approved Drug DTD0030 EXOFACTO Montelukast DESCRIPT Montelukast inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 0.5 microM) DTD0030 EXOFACTO Montelukast DESCRIPT Montelukast inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 15 microM) DTD0030 EXOFACTO Montelukast MOACRIVE Inhibition DTD0030 EXOFACTO Montelukast CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0030 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Morin MOACRIVE Inhibition DTD0030 EXOFACTO Morin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0030 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Naringenin MOACRIVE Inhibition DTD0030 EXOFACTO Naringenin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Naringin HIGHSTIT Investigative Drug DTD0030 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Naringin MOACRIVE Inhibition DTD0030 EXOFACTO Naringin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nefazodone HIGHSTIT Approved Drug DTD0030 EXOFACTO Nefazodone DESCRIPT Nefazodone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nefazodone MOACRIVE Inhibition DTD0030 EXOFACTO Nefazodone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nelfinavir MOACRIVE Inhibition DTD0030 EXOFACTO Nelfinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nicardipine HIGHSTIT Approved Drug DTD0030 EXOFACTO Nicardipine DESCRIPT Nicardipine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nicardipine MOACRIVE Inhibition DTD0030 EXOFACTO Nicardipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0030 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nicotine MOACRIVE Inhibition DTD0030 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nifedipine HIGHSTIT Approved Drug DTD0030 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nifedipine MOACRIVE Inhibition DTD0030 EXOFACTO Nifedipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nitrofurantoin HIGHSTIT Approved Drug DTD0030 EXOFACTO Nitrofurantoin DESCRIPT Nitrofurantoin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nitrofurantoin MOACRIVE Inhibition DTD0030 EXOFACTO Nitrofurantoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0030 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0030 EXOFACTO Novobiocin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Nystatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Nystatin DESCRIPT Nystatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Nystatin MOACRIVE Inhibition DTD0030 EXOFACTO Nystatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0030 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0030 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0030 EXOFACTO Omeprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ondansetron HIGHSTIT Approved Drug DTD0030 EXOFACTO Ondansetron DESCRIPT Ondansetron inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ondansetron MOACRIVE Inhibition DTD0030 EXOFACTO Ondansetron CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ouabain HIGHSTIT Approved Drug DTD0030 EXOFACTO Ouabain DESCRIPT Ouabain inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ouabain MOACRIVE Inhibition DTD0030 EXOFACTO Ouabain CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 0.5 microM) DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 4 microM) DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 2 microM) DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Fluorescein by SLCO1B3 DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0030 EXOFACTO Paclitaxel CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Paclitaxel CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Paclitaxel CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Paclitaxel CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0030 EXOFACTO Pantoprazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Pantoprazole MOACRIVE Inhibition DTD0030 EXOFACTO Pantoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0030 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0030 EXOFACTO Paroxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phalloidin HIGHSTIT Investigative Drug DTD0030 EXOFACTO Phalloidin DESCRIPT Phalloidin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phalloidin MOACRIVE Inhibition DTD0030 EXOFACTO Phalloidin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0030 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0030 EXOFACTO Phenacetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0030 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phenformin MOACRIVE Inhibition DTD0030 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0030 EXOFACTO Phenobarbital DESCRIPT Phenobarbital inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phenobarbital MOACRIVE Inhibition DTD0030 EXOFACTO Phenobarbital CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0030 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0030 EXOFACTO Phenylbutazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0030 EXOFACTO Phenytoin DESCRIPT Phenytoin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Phenytoin MOACRIVE Inhibition DTD0030 EXOFACTO Phenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Pilsicainide HIGHSTIT Approved Drug DTD0030 EXOFACTO Pilsicainide DESCRIPT Pilsicainide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Pilsicainide MOACRIVE Inhibition DTD0030 EXOFACTO Pilsicainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Pindolol HIGHSTIT Approved Drug DTD0030 EXOFACTO Pindolol DESCRIPT Pindolol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Pindolol MOACRIVE Inhibition DTD0030 EXOFACTO Pindolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0030 EXOFACTO Pioglitazone DESCRIPT Pioglitazone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Pioglitazone MOACRIVE Inhibition DTD0030 EXOFACTO Pioglitazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0030 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0030 EXOFACTO Piroxicam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0030 EXOFACTO Pravastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0030 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Prazosin MOACRIVE Inhibition DTD0030 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Prednisolone HIGHSTIT Approved Drug DTD0030 EXOFACTO Prednisolone DESCRIPT Prednisolone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Prednisolone MOACRIVE Inhibition DTD0030 EXOFACTO Prednisolone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Prednisone HIGHSTIT Approved Drug DTD0030 EXOFACTO Prednisone DESCRIPT Prednisone inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Prednisone MOACRIVE Inhibition DTD0030 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0030 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Fexofenadine by SLCO1B3 (Ki = 130 microM) DTD0030 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transporation of ginkolide B by SLCO1B3 DTD0030 EXOFACTO Probenecid MOACRIVE Inhibition DTD0030 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Probenecid CELLLINE Human enterocyte-like 2 cell (Caco-2) DTD0030 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0030 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Procainamide MOACRIVE Inhibition DTD0030 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0030 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Progesterone MOACRIVE Inhibition DTD0030 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0030 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Propranolol MOACRIVE Inhibition DTD0030 EXOFACTO Propranolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0030 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Quercetin MOACRIVE Inhibition DTD0030 EXOFACTO Quercetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0030 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Quinine MOACRIVE Inhibition DTD0030 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ranolazine HIGHSTIT Approved Drug DTD0030 EXOFACTO Ranolazine DESCRIPT Ranolazine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ranolazine MOACRIVE Inhibition DTD0030 EXOFACTO Ranolazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0030 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 5.6 microM) DTD0030 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Repaglinide MOACRIVE Inhibition DTD0030 EXOFACTO Repaglinide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0030 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Reserpine MOACRIVE Inhibition DTD0030 EXOFACTO Reserpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 2.6 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bromsulphthalein by SLCO1B3 (IC50 = 1.5 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bosentan by SLCO1B3 (IC50 = 1.6 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 1.3 microM; Ki = 0.9 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Sulfobromophthalein by SLCO1B3 (Ki = 5 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 0.8 microM) DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0030 EXOFACTO Rifampicin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Rifampicin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Rifampicin CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0030 EXOFACTO Rifampicin CELLLINE Oocytes-OATP1B3 DTD0030 EXOFACTO Rifampicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Rifamycin SV HIGHSTIT Approved Drug DTD0030 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Bromsulphthalein by SLCO1B3 (Ki = 3 microM) DTD0030 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Rifamycin SV MOACRIVE Inhibition DTD0030 EXOFACTO Rifamycin SV CELLLINE Oocytes-OATP1B3 DTD0030 EXOFACTO Rifamycin SV CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Rifaximin HIGHSTIT Approved Drug DTD0030 EXOFACTO Rifaximin DESCRIPT Rifaximin inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Rifaximin MOACRIVE Inhibition DTD0030 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 3.6 microM; Ki = 2.5 microM) DTD0030 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0030 EXOFACTO Ritonavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Ritonavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Rosuvastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Rosuvastatin DESCRIPT Rosuvastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Rosuvastatin MOACRIVE Inhibition DTD0030 EXOFACTO Rosuvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sanguinarine HIGHSTIT Approved Drug DTD0030 EXOFACTO Sanguinarine DESCRIPT Sanguinarine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sanguinarine MOACRIVE Inhibition DTD0030 EXOFACTO Sanguinarine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Cholyl-glycylamido-fluorescein by SLCO1B3 (IC50 = 4.1 microM; Ki = 2.8 microM) DTD0030 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0030 EXOFACTO Saquinavir CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Saquinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Selexipag HIGHSTIT Approved Drug DTD0030 EXOFACTO Selexipag DESCRIPT Selexipag inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Selexipag MOACRIVE Inhibition DTD0030 EXOFACTO Sildenafil HIGHSTIT Approved Drug DTD0030 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Bosentan by SLCO1B3 (IC50 = 4 microM) DTD0030 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sildenafil MOACRIVE Inhibition DTD0030 EXOFACTO Sildenafil CELLLINE Chinese hamster ovary (CHO) cells-OATP1B1 DTD0030 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Silibinin HIGHSTIT Drug in Phase 2/3 Trial DTD0030 EXOFACTO Silibinin DESCRIPT Silibinin inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 DTD0030 EXOFACTO Silibinin MOACRIVE Inhibition DTD0030 EXOFACTO Silibinin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Silibinin dihemisuccinate HIGHSTIT Natural Product DTD0030 EXOFACTO Silibinin dihemisuccinate DESCRIPT Silibinin dihemisuccinate inhibits the transportation of H-amanitin by SLCO1B3 (IC50 = 1 microM; Ki = 2.1 microM) DTD0030 EXOFACTO Silibinin dihemisuccinate MOACRIVE Inhibition DTD0030 EXOFACTO Silibinin dihemisuccinate CELLLINE Madin darby canine kidney strain II cell line (MDCKII)-OATP1B3 DTD0030 EXOFACTO Silybin A HIGHSTIT Natural Product DTD0030 EXOFACTO Silybin A DESCRIPT Silybin A inhibits the transportation of Estradiol-17-glucuronide by SLCO1B3 (IC50 = 2.7 microM) DTD0030 EXOFACTO Silybin A MOACRIVE Inhibition DTD0030 EXOFACTO Silybin A CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Silybin B HIGHSTIT Natural Product DTD0030 EXOFACTO Silybin B DESCRIPT Silybin B inhibits the transportation of Estradiol-17-glucuronide by SLCO1B3 (IC50 = 5 microM) DTD0030 EXOFACTO Silybin B MOACRIVE Inhibition DTD0030 EXOFACTO Silybin B CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Silychristin HIGHSTIT Natural Product DTD0030 EXOFACTO Silychristin DESCRIPT Silychristin inhibits the transportation of Estradiol-17-glucuronide by SLCO1B3 (IC50 = 36.4 microM) DTD0030 EXOFACTO Silychristin MOACRIVE Inhibition DTD0030 EXOFACTO Silychristin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Silymarin flavolignans HIGHSTIT Natural Product DTD0030 EXOFACTO Silymarin flavolignans DESCRIPT Silymarin flavolignans inhibits the transportation of Estradiol-17-glucuronide by SLCO1B3 DTD0030 EXOFACTO Silymarin flavolignans MOACRIVE Inhibition DTD0030 EXOFACTO Silymarin flavolignans CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0030 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0030 EXOFACTO Simvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sincalide HIGHSTIT Investigative Drug DTD0030 EXOFACTO Sincalide DESCRIPT Sincalide inhibits the transportation of Amantinin by SLCO1B3 (IC50 = 10 microM) DTD0030 EXOFACTO Sincalide DESCRIPT Sincalide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sincalide MOACRIVE Inhibition DTD0030 EXOFACTO Sincalide CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP1B3 DTD0030 EXOFACTO Sincalide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sodium taurocholate HIGHSTIT Drug in Phase 1/2 Trial DTD0030 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sodium taurocholate MOACRIVE Inhibition DTD0030 EXOFACTO Sodium taurocholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sotalol HIGHSTIT Approved Drug DTD0030 EXOFACTO Sotalol DESCRIPT Sotalol inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sotalol MOACRIVE Inhibition DTD0030 EXOFACTO Sotalol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0030 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0030 EXOFACTO Spironolactone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sulfaphenazole HIGHSTIT Approved Drug DTD0030 EXOFACTO Sulfaphenazole DESCRIPT Sulfaphenazole inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sulfaphenazole MOACRIVE Inhibition DTD0030 EXOFACTO Sulfaphenazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0030 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0030 EXOFACTO Sulfasalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0030 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0030 EXOFACTO Tamoxifen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Taurochenodeoxycholate HIGHSTIT Investigative Drug DTD0030 EXOFACTO Taurochenodeoxycholate DESCRIPT Taurochenodeoxycholate inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Taurochenodeoxycholate MOACRIVE Inhibition DTD0030 EXOFACTO Taurochenodeoxycholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Telaprevir HIGHSTIT Approved Drug DTD0030 EXOFACTO Telaprevir DESCRIPT Telaprevir inhibits the activity of SLCO1B3 (IC50 = 0.0068 microM) DTD0030 EXOFACTO Telaprevir MOACRIVE Inhibition DTD0030 EXOFACTO Telithromycin HIGHSTIT Approved Drug DTD0030 EXOFACTO Telithromycin DESCRIPT Telithromycin inhibits the activity of SLCO1B3 DTD0030 EXOFACTO Telithromycin MOACRIVE Inhibition DTD0030 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0030 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0030 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tenofovir HIGHSTIT Approved Drug DTD0030 EXOFACTO Tenofovir DESCRIPT Tenofovir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tenofovir MOACRIVE Inhibition DTD0030 EXOFACTO Tenofovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Terfenadine HIGHSTIT Drug Withdrawn DTD0030 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Terfenadine MOACRIVE Inhibition DTD0030 EXOFACTO Terfenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0030 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Testosterone MOACRIVE Inhibition DTD0030 EXOFACTO Testosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tetracycline HIGHSTIT Approved Drug DTD0030 EXOFACTO Tetracycline DESCRIPT Tetracycline inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tetracycline MOACRIVE Inhibition DTD0030 EXOFACTO Tetracycline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0030 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0030 EXOFACTO Tetraethylammonium CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Theophylline HIGHSTIT Approved Drug DTD0030 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Theophylline MOACRIVE Inhibition DTD0030 EXOFACTO Theophylline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Thioridazine HIGHSTIT Approved Drug DTD0030 EXOFACTO Thioridazine DESCRIPT Thioridazine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Thioridazine MOACRIVE Inhibition DTD0030 EXOFACTO Thioridazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Thiotepa HIGHSTIT Approved Drug DTD0030 EXOFACTO Thiotepa DESCRIPT Thiotepa inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Thiotepa MOACRIVE Inhibition DTD0030 EXOFACTO Thiotepa CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Ticlopidine HIGHSTIT Approved Drug DTD0030 EXOFACTO Ticlopidine DESCRIPT Ticlopidine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Ticlopidine MOACRIVE Inhibition DTD0030 EXOFACTO Ticlopidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tipranavir HIGHSTIT Approved Drug DTD0030 EXOFACTO Tipranavir DESCRIPT Tipranavir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tipranavir MOACRIVE Inhibition DTD0030 EXOFACTO Tipranavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Tolbutamide HIGHSTIT Approved Drug DTD0030 EXOFACTO Tolbutamide DESCRIPT Tolbutamide inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Tolbutamide MOACRIVE Inhibition DTD0030 EXOFACTO Tolbutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Topotecan HIGHSTIT Approved Drug DTD0030 EXOFACTO Topotecan DESCRIPT Topotecan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Topotecan MOACRIVE Inhibition DTD0030 EXOFACTO Topotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Triazolam HIGHSTIT Approved Drug DTD0030 EXOFACTO Triazolam DESCRIPT Triazolam inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Triazolam MOACRIVE Inhibition DTD0030 EXOFACTO Triazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0030 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0030 EXOFACTO Trimethoprim CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0030 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Estradiol-17beta-glucuronide by SLCO1B3 (IC50 = 15.7 microM) DTD0030 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0030 EXOFACTO Troglitazone CELLLINE Chinese hamster ovary (CHO) cells-OATP1B3 DTD0030 EXOFACTO Valacyclovir HIGHSTIT Approved Drug DTD0030 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Valacyclovir MOACRIVE Inhibition DTD0030 EXOFACTO Valacyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0030 EXOFACTO Valproic Acid DESCRIPT Valproic Acid inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Valproic Acid MOACRIVE Inhibition DTD0030 EXOFACTO Valproic Acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0030 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Valsartan MOACRIVE Inhibition DTD0030 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0030 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Valspodar MOACRIVE Inhibition DTD0030 EXOFACTO Valspodar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Varenicline HIGHSTIT Approved Drug DTD0030 EXOFACTO Varenicline DESCRIPT Varenicline inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Varenicline MOACRIVE Inhibition DTD0030 EXOFACTO Varenicline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0030 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Verapamil MOACRIVE Inhibition DTD0030 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0030 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0030 EXOFACTO Vinblastine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Vincristine HIGHSTIT Approved Drug DTD0030 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Sincalide by SLCO1B3 DTD0030 EXOFACTO Vincristine MOACRIVE Inhibition DTD0030 EXOFACTO Vincristine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Warfarin HIGHSTIT Approved Drug DTD0030 EXOFACTO Warfarin DESCRIPT Warfarin inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Warfarin MOACRIVE Inhibition DTD0030 EXOFACTO Warfarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0030 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0030 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Estradiol 17b-D-glucuronide by SLCO1B3 DTD0030 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0030 EXOFACTO Zidovudine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP1B3 DTD0031 TRANSPID DTD0031 DTD0031 GENENAME SLCO2B1 DTD0031 PROTNAME Organic anion transporting polypeptide 2B1 DTD0031 GENEDBID 11309 DTD0031 UNIPROID O94956 DTD0031 EXOFACTO (-)-epicatechin-3-gallate HIGHSTIT Natural Product DTD0031 EXOFACTO (-)-epicatechin-3-gallate DESCRIPT (-)-epicatechin-3-gallate inhibits the activity of SLCO2B1 in a substrate-dependent manner (IC50 = 36 microM) DTD0031 EXOFACTO (-)-epicatechin-3-gallate MOACRIVE Inhibition DTD0031 EXOFACTO (-)-epicatechin-3-gallate CELLLINE Chinese hamster ovary (CHO) cells-OATP2B1 DTD0031 EXOFACTO (-)-epigallocatechin-3-gallate HIGHSTIT Natural Product DTD0031 EXOFACTO (-)-epigallocatechin-3-gallate DESCRIPT (-)-epigallocatechin-3-gallate inhibits the activity of SLCO2B1 in a substrate-dependent manner (IC50 = 101 microM) DTD0031 EXOFACTO (-)-epigallocatechin-3-gallate MOACRIVE Inhibition DTD0031 EXOFACTO (-)-epigallocatechin-3-gallate CELLLINE Chinese hamster ovary (CHO) cells-OATP2B1 DTD0031 EXOFACTO Acarbose HIGHSTIT Approved Drug DTD0031 EXOFACTO Acarbose DESCRIPT Acarbose inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Acarbose MOACRIVE Inhibition DTD0031 EXOFACTO Acarbose CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Acyclovir HIGHSTIT Approved Drug DTD0031 EXOFACTO Acyclovir DESCRIPT Acyclovir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Acyclovir MOACRIVE Inhibition DTD0031 EXOFACTO Acyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Allethrin HIGHSTIT Natural Product DTD0031 EXOFACTO Allethrin DESCRIPT Allethrin induces the transportation of Fluorescein by SLCO2B1 DTD0031 EXOFACTO Allethrin MOACRIVE Inducer DTD0031 EXOFACTO Allethrin CELLLINE Chinese hamster ovary (CHO) cells-OATP2B1 DTD0031 EXOFACTO Allopurinol HIGHSTIT Approved Drug DTD0031 EXOFACTO Allopurinol DESCRIPT Allopurinol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Allopurinol MOACRIVE Inhibition DTD0031 EXOFACTO Allopurinol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Amantadine HIGHSTIT Approved Drug DTD0031 EXOFACTO Amantadine DESCRIPT Amantadine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Amantadine MOACRIVE Inhibition DTD0031 EXOFACTO Amantadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0031 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0031 EXOFACTO Aminohippuric acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0031 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0031 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Amodiaquine HIGHSTIT Approved Drug DTD0031 EXOFACTO Amodiaquine DESCRIPT Amodiaquine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Amodiaquine MOACRIVE Inhibition DTD0031 EXOFACTO Amodiaquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Amprenavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Amprenavir DESCRIPT Amprenavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Amprenavir MOACRIVE Inhibition DTD0031 EXOFACTO Amprenavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Apigenin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Apigenin DESCRIPT Apigenin inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 13.9 microM; Ki = 8.7 microM) DTD0031 EXOFACTO Apigenin MOACRIVE Inhibition DTD0031 EXOFACTO Apigenin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Apple juice HIGHSTIT Dietary Constituent DTD0031 EXOFACTO Apple juice DESCRIPT Apple juice inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Apple juice DESCRIPT Apple juice inhibits the transportation of Atenolol by SLCO2B1 DTD0031 EXOFACTO Apple juice DESCRIPT Apple juice inhibits the activity of SLCO2B1 DTD0031 EXOFACTO Apple juice MOACRIVE Inhibition DTD0031 EXOFACTO Apple juice CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Apple juice CELLLINE Healthy people DTD0031 EXOFACTO Apple juice CELLLINE Patient samples DTD0031 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0031 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Astemizole MOACRIVE Inhibition DTD0031 EXOFACTO Astemizole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Atazanavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Atazanavir DESCRIPT Atazanavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Atazanavir MOACRIVE Inhibition DTD0031 EXOFACTO Atazanavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Atenolol HIGHSTIT Approved Drug DTD0031 EXOFACTO Atenolol DESCRIPT Atenolol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Atenolol MOACRIVE Inhibition DTD0031 EXOFACTO Atenolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Atomoxetine HIGHSTIT Approved Drug DTD0031 EXOFACTO Atomoxetine DESCRIPT Atomoxetine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Atomoxetine MOACRIVE Inhibition DTD0031 EXOFACTO Atomoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Atorvastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 0.4 microM) DTD0031 EXOFACTO Atorvastatin DESCRIPT Atorvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Atorvastatin MOACRIVE Inhibition DTD0031 EXOFACTO Atorvastatin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Atorvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Baicalin HIGHSTIT Discontinued Drug DTD0031 EXOFACTO Baicalin DESCRIPT Baicalin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Baicalin MOACRIVE Inhibition DTD0031 EXOFACTO Baicalin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Benzbromarone HIGHSTIT Approved Drug DTD0031 EXOFACTO Benzbromarone DESCRIPT Benzbromarone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Benzbromarone MOACRIVE Inhibition DTD0031 EXOFACTO Benzbromarone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Benzoic acid HIGHSTIT Approved Drug DTD0031 EXOFACTO Benzoic acid DESCRIPT Benzoic acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Benzoic acid MOACRIVE Inhibition DTD0031 EXOFACTO Benzoic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Benzylpenicillin HIGHSTIT Drug in Phase 3 Trial DTD0031 EXOFACTO Benzylpenicillin DESCRIPT Benzylpenicillin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Benzylpenicillin MOACRIVE Inhibition DTD0031 EXOFACTO Benzylpenicillin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Berberine HIGHSTIT Drug in Phase 4 Trial DTD0031 EXOFACTO Berberine DESCRIPT Berberine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Berberine MOACRIVE Inhibition DTD0031 EXOFACTO Berberine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Bestatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Bestatin DESCRIPT Bestatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Bestatin MOACRIVE Inhibition DTD0031 EXOFACTO Bestatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Bilberry extract HIGHSTIT Natural Product DTD0031 EXOFACTO Bilberry extract DESCRIPT Bilberry extract inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Bilberry extract MOACRIVE Inhibition DTD0031 EXOFACTO Bilberry extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Black cohosh extract HIGHSTIT Natural Product DTD0031 EXOFACTO Black cohosh extract DESCRIPT Black cohosh extract inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Black cohosh extract MOACRIVE Inhibition DTD0031 EXOFACTO Black cohosh extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0031 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2 microM; Ki = 1.5 microM) DTD0031 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.7 microM) DTD0031 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein modulates the activity of SLCO2B1 DTD0031 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0031 EXOFACTO Bromsulphthalein MOACRIVE Modulator DTD0031 EXOFACTO Bromsulphthalein CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Bromsulphthalein CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS1)-OATP2B1 DTD0031 EXOFACTO Budesonide HIGHSTIT Approved Drug DTD0031 EXOFACTO Budesonide DESCRIPT Budesonide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Budesonide MOACRIVE Inhibition DTD0031 EXOFACTO Budesonide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0031 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Bupropion MOACRIVE Inhibition DTD0031 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Buspirone HIGHSTIT Approved Drug DTD0031 EXOFACTO Buspirone DESCRIPT Buspirone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Buspirone MOACRIVE Inhibition DTD0031 EXOFACTO Buspirone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0031 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Caffeine MOACRIVE Inhibition DTD0031 EXOFACTO Caffeine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Candesartan HIGHSTIT Approved Drug DTD0031 EXOFACTO Candesartan DESCRIPT Candesartan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Candesartan MOACRIVE Inhibition DTD0031 EXOFACTO Candesartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Captopril HIGHSTIT Approved Drug DTD0031 EXOFACTO Captopril DESCRIPT Captopril inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Captopril MOACRIVE Inhibition DTD0031 EXOFACTO Captopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Carbamazepine HIGHSTIT Approved Drug DTD0031 EXOFACTO Carbamazepine DESCRIPT Carbamazepine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Carbamazepine MOACRIVE Inhibition DTD0031 EXOFACTO Carbamazepine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cefadroxil HIGHSTIT Approved Drug DTD0031 EXOFACTO Cefadroxil DESCRIPT Cefadroxil inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cefadroxil MOACRIVE Inhibition DTD0031 EXOFACTO Cefadroxil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cefamandole HIGHSTIT Approved Drug DTD0031 EXOFACTO Cefamandole DESCRIPT Cefamandole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cefamandole MOACRIVE Inhibition DTD0031 EXOFACTO Cefamandole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0031 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0031 EXOFACTO Celecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cerivastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 66.2 microM) DTD0031 EXOFACTO Cerivastatin DESCRIPT Cerivastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cerivastatin MOACRIVE Inhibition DTD0031 EXOFACTO Cerivastatin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Cerivastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cetirizine HIGHSTIT Approved Drug DTD0031 EXOFACTO Cetirizine DESCRIPT Cetirizine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cetirizine MOACRIVE Inhibition DTD0031 EXOFACTO Cetirizine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Chelerythrine HIGHSTIT Investigative Drug DTD0031 EXOFACTO Chelerythrine DESCRIPT Chelerythrine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Chelerythrine MOACRIVE Inhibition DTD0031 EXOFACTO Chelerythrine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0031 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0031 EXOFACTO Chloroquine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0031 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0031 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Chlorprothixene HIGHSTIT Approved Drug DTD0031 EXOFACTO Chlorprothixene DESCRIPT Chlorprothixene inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Chlorprothixene MOACRIVE Inhibition DTD0031 EXOFACTO Chlorprothixene CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Chlorzoxazone HIGHSTIT Approved Drug DTD0031 EXOFACTO Chlorzoxazone DESCRIPT Chlorzoxazone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Chlorzoxazone MOACRIVE Inhibition DTD0031 EXOFACTO Chlorzoxazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cholic acid HIGHSTIT Approved Drug DTD0031 EXOFACTO Cholic acid DESCRIPT Cholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cholic acid MOACRIVE Inhibition DTD0031 EXOFACTO Cholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cigarette smoke condensate HIGHSTIT Natural Product DTD0031 EXOFACTO Cigarette smoke condensate DESCRIPT Cigarette smoke condensate inhibits the transportation of Bromosulfophtalein by by repressing mRNA expression of SLCO2B1 (IC50 = 39.5 microM) DTD0031 EXOFACTO Cigarette smoke condensate MOACRIVE Inhibition DTD0031 EXOFACTO Cigarette smoke condensate CELLLINE Human hepatoma HepaRG cells-OATP2B1 DTD0031 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0031 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0031 EXOFACTO Cimetidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Citrus juice HIGHSTIT Dietary Constituent DTD0031 EXOFACTO Citrus juice DESCRIPT Citrus juice inhibits the transportation of Montelukast by SLCO2B1 DTD0031 EXOFACTO Citrus juice MOACRIVE Inhibition DTD0031 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0031 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0031 EXOFACTO Clarithromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0031 EXOFACTO Clotrimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Colchicine HIGHSTIT Approved Drug DTD0031 EXOFACTO Colchicine DESCRIPT Colchicine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Colchicine MOACRIVE Inhibition DTD0031 EXOFACTO Colchicine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Coumarin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Coumarin DESCRIPT Coumarin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Coumarin MOACRIVE Inhibition DTD0031 EXOFACTO Coumarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Coumestrol HIGHSTIT Investigative Drug DTD0031 EXOFACTO Coumestrol DESCRIPT Coumestrol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Coumestrol MOACRIVE Inhibition DTD0031 EXOFACTO Coumestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0031 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Rosuvastatin by SLCO2B1 (IC50 = 0.07 microM) DTD0031 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 20 microM) DTD0031 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0031 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Cyclosporine CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Daidzein HIGHSTIT Investigative Drug DTD0031 EXOFACTO Daidzein DESCRIPT Daidzein inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Daidzein MOACRIVE Inhibition DTD0031 EXOFACTO Daidzein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0031 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Desipramine MOACRIVE Inhibition DTD0031 EXOFACTO Desipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0031 EXOFACTO Dexamethasone DESCRIPT Dexamethasone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Dexamethasone MOACRIVE Inhibition DTD0031 EXOFACTO Dexamethasone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Dextromethorphan HIGHSTIT Approved Drug DTD0031 EXOFACTO Dextromethorphan DESCRIPT Dextromethorphan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Dextromethorphan MOACRIVE Inhibition DTD0031 EXOFACTO Dextromethorphan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Diazepam HIGHSTIT Approved Drug DTD0031 EXOFACTO Diazepam DESCRIPT Diazepam inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Diazepam MOACRIVE Inhibition DTD0031 EXOFACTO Diazepam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0031 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0031 EXOFACTO Diclofenac CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Diethylstilbestrol HIGHSTIT Approved Drug DTD0031 EXOFACTO Diethylstilbestrol DESCRIPT Diethylstilbestrol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Diethylstilbestrol MOACRIVE Inhibition DTD0031 EXOFACTO Diethylstilbestrol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0031 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Digoxin MOACRIVE Inhibition DTD0031 EXOFACTO Digoxin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Diltiazem HIGHSTIT Approved Drug DTD0031 EXOFACTO Diltiazem DESCRIPT Diltiazem inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Diltiazem MOACRIVE Inhibition DTD0031 EXOFACTO Diltiazem CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0031 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0031 EXOFACTO Dipyridamole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Disopyramide HIGHSTIT Approved Drug DTD0031 EXOFACTO Disopyramide DESCRIPT Disopyramide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Disopyramide MOACRIVE Inhibition DTD0031 EXOFACTO Disopyramide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Disulfiram HIGHSTIT Approved Drug DTD0031 EXOFACTO Disulfiram DESCRIPT Disulfiram inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Disulfiram MOACRIVE Inhibition DTD0031 EXOFACTO Disulfiram CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Dofetilide HIGHSTIT Approved Drug DTD0031 EXOFACTO Dofetilide DESCRIPT Dofetilide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Dofetilide MOACRIVE Inhibition DTD0031 EXOFACTO Dofetilide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Doxazosin HIGHSTIT Approved Drug DTD0031 EXOFACTO Doxazosin DESCRIPT Doxazosin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Doxazosin MOACRIVE Inhibition DTD0031 EXOFACTO Doxazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0031 EXOFACTO Doxorubicin DESCRIPT Doxorubicin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Doxorubicin MOACRIVE Inhibition DTD0031 EXOFACTO Doxorubicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Echinacea extract HIGHSTIT Natural Product DTD0031 EXOFACTO Echinacea extract DESCRIPT Echinacea extract inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Echinacea extract MOACRIVE Inhibition DTD0031 EXOFACTO Echinacea extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Efavirenz HIGHSTIT Approved Drug DTD0031 EXOFACTO Efavirenz DESCRIPT Efavirenz inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Efavirenz MOACRIVE Inhibition DTD0031 EXOFACTO Efavirenz CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Elacridar HIGHSTIT Discontinued Drug DTD0031 EXOFACTO Elacridar DESCRIPT Elacridar inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Elacridar MOACRIVE Inhibition DTD0031 EXOFACTO Elacridar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Eletriptan HIGHSTIT Approved Drug DTD0031 EXOFACTO Eletriptan DESCRIPT Eletriptan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Eletriptan MOACRIVE Inhibition DTD0031 EXOFACTO Eletriptan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Eltrombopag HIGHSTIT Approved Drug DTD0031 EXOFACTO Eltrombopag DESCRIPT Eltrombopag inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Eltrombopag MOACRIVE Inhibition DTD0031 EXOFACTO Emtricitabine HIGHSTIT Approved Drug DTD0031 EXOFACTO Emtricitabine DESCRIPT Emtricitabine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Emtricitabine MOACRIVE Inhibition DTD0031 EXOFACTO Emtricitabine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Enalapril HIGHSTIT Approved Drug DTD0031 EXOFACTO Enalapril DESCRIPT Enalapril inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Enalapril MOACRIVE Inhibition DTD0031 EXOFACTO Enalapril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ergoloid mesylates HIGHSTIT Approved Drug DTD0031 EXOFACTO Ergoloid mesylates DESCRIPT Ergoloid mesylates inhibits the activity of SLCO2B1 DTD0031 EXOFACTO Ergoloid mesylates MOACRIVE Inhibition DTD0031 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0031 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0031 EXOFACTO Erlotinib CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0031 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0031 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0031 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Estradiol MOACRIVE Inhibition DTD0031 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Estrone HIGHSTIT Approved Drug DTD0031 EXOFACTO Estrone DESCRIPT Estrone inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2.5 microM; Ki = 1.9 microM) DTD0031 EXOFACTO Estrone MOACRIVE Inhibition DTD0031 EXOFACTO Estrone CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0031 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate modulates the activity of SLCO2B1 DTD0031 EXOFACTO Estrone sulfate MOACRIVE Modulator DTD0031 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0031 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Etoposide MOACRIVE Inhibition DTD0031 EXOFACTO Etoposide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ezetimibe HIGHSTIT Approved Drug DTD0031 EXOFACTO Ezetimibe DESCRIPT Ezetimibe inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ezetimibe MOACRIVE Inhibition DTD0031 EXOFACTO Ezetimibe CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Felodipine HIGHSTIT Approved Drug DTD0031 EXOFACTO Felodipine DESCRIPT Felodipine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Felodipine MOACRIVE Inhibition DTD0031 EXOFACTO Felodipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fendiline HIGHSTIT Drug Withdrawn DTD0031 EXOFACTO Fendiline DESCRIPT Fendiline inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fendiline MOACRIVE Inhibition DTD0031 EXOFACTO Fendiline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fenofibrate HIGHSTIT Approved Drug DTD0031 EXOFACTO Fenofibrate DESCRIPT Fenofibrate inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fenofibrate MOACRIVE Inhibition DTD0031 EXOFACTO Fenofibrate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fentanyl HIGHSTIT Approved Drug DTD0031 EXOFACTO Fentanyl DESCRIPT Fentanyl inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fentanyl MOACRIVE Inhibition DTD0031 EXOFACTO Fentanyl CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fexofenadine HIGHSTIT Approved Drug DTD0031 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fexofenadine MOACRIVE Inhibition DTD0031 EXOFACTO Fexofenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fluconazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Fluconazole DESCRIPT Fluconazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fluconazole MOACRIVE Inhibition DTD0031 EXOFACTO Fluconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0031 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0031 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Flutamide HIGHSTIT Approved Drug DTD0031 EXOFACTO Flutamide DESCRIPT Flutamide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Flutamide MOACRIVE Inhibition DTD0031 EXOFACTO Flutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0031 EXOFACTO Fluvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Fluvoxamine HIGHSTIT Approved Drug DTD0031 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Fluvoxamine MOACRIVE Inhibition DTD0031 EXOFACTO Fluvoxamine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0031 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Furosemide MOACRIVE Inhibition DTD0031 EXOFACTO Furosemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Gemfibrozil HIGHSTIT Approved Drug DTD0031 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Rosuvastatin by SLCO2B1 (IC50 = 8 microM) DTD0031 EXOFACTO Gemfibrozil DESCRIPT Gemfibrozil inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Gemfibrozil MOACRIVE Inhibition DTD0031 EXOFACTO Gemfibrozil CELLLINE Human cervical cancer cell line (Hela)-OATP2B1 DTD0031 EXOFACTO Gemfibrozil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Genistein HIGHSTIT Drug in Phase 2 Trial DTD0031 EXOFACTO Genistein DESCRIPT Genistein inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Genistein MOACRIVE Inhibition DTD0031 EXOFACTO Genistein CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ginkgo biloba HIGHSTIT Natural Product DTD0031 EXOFACTO Ginkgo biloba DESCRIPT Ginkgo biloba inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 11.2 +/- 3.3 microM) DTD0031 EXOFACTO Ginkgo biloba MOACRIVE Inhibition DTD0031 EXOFACTO Ginkgo biloba CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ginkgo leaf extract HIGHSTIT Natural Product DTD0031 EXOFACTO Ginkgo leaf extract DESCRIPT Ginkgo leaf extract inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 11.2 microM) DTD0031 EXOFACTO Ginkgo leaf extract MOACRIVE Inhibition DTD0031 EXOFACTO Ginkgo leaf extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0031 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0031 EXOFACTO Glibenclamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glipizide HIGHSTIT Approved Drug DTD0031 EXOFACTO Glipizide DESCRIPT Glipizide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glipizide MOACRIVE Inhibition DTD0031 EXOFACTO Glipizide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glycochenodeoxycholic acid HIGHSTIT Investigative Drug DTD0031 EXOFACTO Glycochenodeoxycholic acid DESCRIPT Glycochenodeoxycholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glycochenodeoxycholic acid MOACRIVE Inhibition DTD0031 EXOFACTO Glycochenodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glycocholic acid HIGHSTIT Investigative Drug DTD0031 EXOFACTO Glycocholic acid DESCRIPT Glycocholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glycocholic acid MOACRIVE Inhibition DTD0031 EXOFACTO Glycocholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glycodeoxycholic acid HIGHSTIT Investigative Drug DTD0031 EXOFACTO Glycodeoxycholic acid DESCRIPT Glycodeoxycholic acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glycodeoxycholic acid MOACRIVE Inhibition DTD0031 EXOFACTO Glycodeoxycholic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Glycyrrhizin HIGHSTIT Drug in Phase 3 Trial DTD0031 EXOFACTO Glycyrrhizin DESCRIPT Glycyrrhizin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Glycyrrhizin MOACRIVE Inhibition DTD0031 EXOFACTO Glycyrrhizin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Grapefruit juice HIGHSTIT Dietary Constituent DTD0031 EXOFACTO Grapefruit juice DESCRIPT Grapefruit juice inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Grapefruit juice MOACRIVE Inhibition DTD0031 EXOFACTO Grapefruit juice CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Green tea extract HIGHSTIT Natural Product DTD0031 EXOFACTO Green tea extract DESCRIPT Green tea extract inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 22.1 microM) DTD0031 EXOFACTO Green tea extract MOACRIVE Inhibition DTD0031 EXOFACTO Green tea extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Herbal extract HIGHSTIT Natural Product DTD0031 EXOFACTO Herbal extract DESCRIPT Herbal extracts inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Herbal extract MOACRIVE Inhibition DTD0031 EXOFACTO Herbal extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Hesperetin HIGHSTIT Approved Drug DTD0031 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 67.6 microM) DTD0031 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.92 microM) DTD0031 EXOFACTO Hesperetin DESCRIPT Hesperetin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Hesperetin MOACRIVE Inhibition DTD0031 EXOFACTO Hesperetin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Ibuprofen HIGHSTIT Approved Drug DTD0031 EXOFACTO Ibuprofen DESCRIPT Ibuprofen inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ibuprofen MOACRIVE Inhibition DTD0031 EXOFACTO Ibuprofen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0031 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Imipramine MOACRIVE Inhibition DTD0031 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Indinavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3.9 microM; Ki = 3 microM) DTD0031 EXOFACTO Indinavir DESCRIPT Indinavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Indinavir MOACRIVE Inhibition DTD0031 EXOFACTO Indinavir CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Indinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Indocyanine green HIGHSTIT Approved Drug DTD0031 EXOFACTO Indocyanine green DESCRIPT Indocyanine green inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Indocyanine green MOACRIVE Inhibition DTD0031 EXOFACTO Indocyanine green CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0031 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0031 EXOFACTO Indomethacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Irinotecan HIGHSTIT Approved Drug DTD0031 EXOFACTO Irinotecan DESCRIPT Irinotecan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Irinotecan MOACRIVE Inhibition DTD0031 EXOFACTO Irinotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Isoniazid HIGHSTIT Approved Drug DTD0031 EXOFACTO Isoniazid DESCRIPT Isoniazid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Isoniazid MOACRIVE Inhibition DTD0031 EXOFACTO Isoniazid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Isorhamnetin HIGHSTIT Natural Product DTD0031 EXOFACTO Isorhamnetin DESCRIPT Isorhamnetin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Isorhamnetin MOACRIVE Inhibition DTD0031 EXOFACTO Isorhamnetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Isradipine HIGHSTIT Approved Drug DTD0031 EXOFACTO Isradipine DESCRIPT Isradipine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Isradipine MOACRIVE Inhibition DTD0031 EXOFACTO Isradipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ivermectin HIGHSTIT Approved Drug DTD0031 EXOFACTO Ivermectin DESCRIPT Ivermectin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ivermectin MOACRIVE Inhibition DTD0031 EXOFACTO Ivermectin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Kaempferol HIGHSTIT Investigative Drug DTD0031 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 20.7 microM; Ki = 15.1 microM) DTD0031 EXOFACTO Kaempferol DESCRIPT Kaempferol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Kaempferol MOACRIVE Inhibition DTD0031 EXOFACTO Kaempferol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ketoconazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Ketoconazole DESCRIPT Ketoconazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ketoconazole MOACRIVE Inhibition DTD0031 EXOFACTO Ketoconazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Lamotrigine HIGHSTIT Approved Drug DTD0031 EXOFACTO Lamotrigine DESCRIPT Lamotrigine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Lamotrigine MOACRIVE Inhibition DTD0031 EXOFACTO Lamotrigine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Lansoprazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Lansoprazole DESCRIPT Lansoprazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Lansoprazole MOACRIVE Inhibition DTD0031 EXOFACTO Lansoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO L-carnitine HIGHSTIT Approved Drug DTD0031 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO L-carnitine MOACRIVE Inhibition DTD0031 EXOFACTO L-carnitine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0031 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0031 EXOFACTO Levofloxacin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Levothyroxine HIGHSTIT Approved Drug DTD0031 EXOFACTO Levothyroxine DESCRIPT Levothyroxine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Levothyroxine MOACRIVE Inhibition DTD0031 EXOFACTO Levothyroxine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Lisinopril HIGHSTIT Approved Drug DTD0031 EXOFACTO Lisinopril DESCRIPT Lisinopril inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Lisinopril MOACRIVE Inhibition DTD0031 EXOFACTO Lisinopril CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Loperamide HIGHSTIT Approved Drug DTD0031 EXOFACTO Loperamide DESCRIPT Loperamide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Loperamide MOACRIVE Inhibition DTD0031 EXOFACTO Loperamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Lopinavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Lopinavir DESCRIPT Lopinavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Lopinavir MOACRIVE Inhibition DTD0031 EXOFACTO Lopinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0031 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Loratadine MOACRIVE Inhibition DTD0031 EXOFACTO Loratadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Lovastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Lovastatin DESCRIPT Lovastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Lovastatin MOACRIVE Inhibition DTD0031 EXOFACTO Lovastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Mephenytoin HIGHSTIT Approved Drug DTD0031 EXOFACTO Mephenytoin DESCRIPT Mephenytoin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Mephenytoin MOACRIVE Inhibition DTD0031 EXOFACTO Mephenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Mesalazine HIGHSTIT Approved Drug DTD0031 EXOFACTO Mesalazine DESCRIPT Mesalazine inhibits the transportation of Bromsulphthalein by SLCO2B1 DTD0031 EXOFACTO Mesalazine MOACRIVE Inhibition DTD0031 EXOFACTO Mesalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0031 EXOFACTO Metformin DESCRIPT Metformin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Metformin MOACRIVE Inhibition DTD0031 EXOFACTO Metformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0031 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0031 EXOFACTO Methotrexate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Methoxsalen HIGHSTIT Approved Drug DTD0031 EXOFACTO Methoxsalen DESCRIPT Methoxsalen inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Methoxsalen MOACRIVE Inhibition DTD0031 EXOFACTO Methoxsalen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Metoprolol HIGHSTIT Approved Drug DTD0031 EXOFACTO Metoprolol DESCRIPT Metoprolol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Metoprolol MOACRIVE Inhibition DTD0031 EXOFACTO Metoprolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Midazolam HIGHSTIT Approved Drug DTD0031 EXOFACTO Midazolam DESCRIPT Midazolam inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Midazolam MOACRIVE Inhibition DTD0031 EXOFACTO Midazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Mifepristone HIGHSTIT Approved Drug DTD0031 EXOFACTO Mifepristone DESCRIPT Mifepristone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Mifepristone MOACRIVE Inhibition DTD0031 EXOFACTO Mifepristone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Mitoxantrone HIGHSTIT Approved Drug DTD0031 EXOFACTO Mitoxantrone DESCRIPT Mitoxantrone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Mitoxantrone MOACRIVE Inhibition DTD0031 EXOFACTO Mitoxantrone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Mix silybin A silybin B HIGHSTIT Natural Product DTD0031 EXOFACTO Mix silybin A silybin B DESCRIPT Mix silybin A silybin B inhibits the activity of SLCO2B1 DTD0031 EXOFACTO Mix silybin A silybin B MOACRIVE Inhibition DTD0031 EXOFACTO Mix silybin A silybin B CELLLINE Chinese hamster ovary (CHO) cells-OATP2B1 DTD0031 EXOFACTO MK-571 HIGHSTIT Discontinued Drug DTD0031 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 0.2 microM) DTD0031 EXOFACTO MK-571 DESCRIPT MK-571 inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO MK-571 MOACRIVE Inhibition DTD0031 EXOFACTO MK-571 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO MK-571 CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Moclobemide HIGHSTIT Approved Drug DTD0031 EXOFACTO Moclobemide DESCRIPT Moclobemide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Moclobemide MOACRIVE Inhibition DTD0031 EXOFACTO Moclobemide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Montelukast HIGHSTIT Approved Drug DTD0031 EXOFACTO Montelukast DESCRIPT Montelukast inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 1 microM) DTD0031 EXOFACTO Montelukast MOACRIVE Inhibition DTD0031 EXOFACTO Montelukast CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Morin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Morin DESCRIPT Morin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Morin MOACRIVE Inhibition DTD0031 EXOFACTO Morin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Naringenin HIGHSTIT Drug in Phase 1 Trial DTD0031 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 49.2 microM) DTD0031 EXOFACTO Naringenin DESCRIPT Naringenin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Naringenin MOACRIVE Inhibition DTD0031 EXOFACTO Naringenin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Naringenin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Naringin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 4.63 microM) DTD0031 EXOFACTO Naringin DESCRIPT Naringin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Naringin MOACRIVE Inhibition DTD0031 EXOFACTO Naringin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Naringin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nefazodone HIGHSTIT Approved Drug DTD0031 EXOFACTO Nefazodone DESCRIPT Nefazodone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nefazodone MOACRIVE Inhibition DTD0031 EXOFACTO Nefazodone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nelfinavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Nelfinavir DESCRIPT Nelfinavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nelfinavir MOACRIVE Inhibition DTD0031 EXOFACTO Nelfinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nicardipine HIGHSTIT Approved Drug DTD0031 EXOFACTO Nicardipine DESCRIPT Nicardipine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nicardipine MOACRIVE Inhibition DTD0031 EXOFACTO Nicardipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0031 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nicotine MOACRIVE Inhibition DTD0031 EXOFACTO Nicotine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nifedipine HIGHSTIT Approved Drug DTD0031 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nifedipine MOACRIVE Inhibition DTD0031 EXOFACTO Nifedipine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nitrofurantoin HIGHSTIT Approved Drug DTD0031 EXOFACTO Nitrofurantoin DESCRIPT Nitrofurantoin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nitrofurantoin MOACRIVE Inhibition DTD0031 EXOFACTO Nitrofurantoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Novobiocin HIGHSTIT Approved Drug DTD0031 EXOFACTO Novobiocin DESCRIPT Novobiocin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Novobiocin MOACRIVE Inhibition DTD0031 EXOFACTO Novobiocin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Nystatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Nystatin DESCRIPT Nystatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Nystatin MOACRIVE Inhibition DTD0031 EXOFACTO Nystatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Olmesartan medoxomil HIGHSTIT Approved Drug DTD0031 EXOFACTO Olmesartan medoxomil DESCRIPT Olmesartan medoxomil inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Olmesartan medoxomil MOACRIVE Inhibition DTD0031 EXOFACTO Olmesartan medoxomil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0031 EXOFACTO Omeprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ondansetron HIGHSTIT Approved Drug DTD0031 EXOFACTO Ondansetron DESCRIPT Ondansetron inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ondansetron MOACRIVE Inhibition DTD0031 EXOFACTO Ondansetron CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Orange juice HIGHSTIT Dietary Constituent DTD0031 EXOFACTO Orange juice DESCRIPT Orange juice inhibits the transportation of Aliskiren by SLCO2B1 (IC50 = 2.7 microM) DTD0031 EXOFACTO Orange juice DESCRIPT Orange juice inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Orange juice MOACRIVE Inhibition DTD0031 EXOFACTO Orange juice CELLLINE Healthy people DTD0031 EXOFACTO Orange juice CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Ouabain HIGHSTIT Approved Drug DTD0031 EXOFACTO Ouabain DESCRIPT Ouabain inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ouabain MOACRIVE Inhibition DTD0031 EXOFACTO Ouabain CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0031 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 25 microM) DTD0031 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0031 EXOFACTO Paclitaxel CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Paclitaxel CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Pantoprazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Pantoprazole DESCRIPT Pantoprazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Pantoprazole MOACRIVE Inhibition DTD0031 EXOFACTO Pantoprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0031 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0031 EXOFACTO Paroxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phalloidin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Phalloidin DESCRIPT Phalloidin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phalloidin MOACRIVE Inhibition DTD0031 EXOFACTO Phalloidin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phenacetin HIGHSTIT Drug Withdrawn DTD0031 EXOFACTO Phenacetin DESCRIPT Phenacetin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phenacetin MOACRIVE Inhibition DTD0031 EXOFACTO Phenacetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phenformin HIGHSTIT Drug Withdrawn DTD0031 EXOFACTO Phenformin DESCRIPT Phenformin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phenformin MOACRIVE Inhibition DTD0031 EXOFACTO Phenformin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phenobarbital HIGHSTIT Approved Drug DTD0031 EXOFACTO Phenobarbital DESCRIPT Phenobarbital inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phenobarbital MOACRIVE Inhibition DTD0031 EXOFACTO Phenobarbital CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0031 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0031 EXOFACTO Phenylbutazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0031 EXOFACTO Phenytoin DESCRIPT Phenytoin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Phenytoin MOACRIVE Inhibition DTD0031 EXOFACTO Phenytoin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Phloretin HIGHSTIT Investigative Drug DTD0031 EXOFACTO Phloretin DESCRIPT Phloretin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 1.31 microM) DTD0031 EXOFACTO Phloretin MOACRIVE Inhibition DTD0031 EXOFACTO Phloretin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Phloridzin HIGHSTIT Natural Product DTD0031 EXOFACTO Phloridzin DESCRIPT Phloridzin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 23.2 microM) DTD0031 EXOFACTO Phloridzin MOACRIVE Inhibition DTD0031 EXOFACTO Phloridzin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Pilsicainide HIGHSTIT Approved Drug DTD0031 EXOFACTO Pilsicainide DESCRIPT Pilsicainide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Pilsicainide MOACRIVE Inhibition DTD0031 EXOFACTO Pilsicainide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Pindolol HIGHSTIT Approved Drug DTD0031 EXOFACTO Pindolol DESCRIPT Pindolol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Pindolol MOACRIVE Inhibition DTD0031 EXOFACTO Pindolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0031 EXOFACTO Pioglitazone DESCRIPT Pioglitazone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Pioglitazone MOACRIVE Inhibition DTD0031 EXOFACTO Pioglitazone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Piroxicam HIGHSTIT Approved Drug DTD0031 EXOFACTO Piroxicam DESCRIPT Piroxicam inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Piroxicam MOACRIVE Inhibition DTD0031 EXOFACTO Piroxicam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Pravastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Pravastatin DESCRIPT Pravastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Pravastatin MOACRIVE Inhibition DTD0031 EXOFACTO Pravastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Prazosin HIGHSTIT Approved Drug DTD0031 EXOFACTO Prazosin DESCRIPT Prazosin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Prazosin MOACRIVE Inhibition DTD0031 EXOFACTO Prazosin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Prednisolone HIGHSTIT Approved Drug DTD0031 EXOFACTO Prednisolone DESCRIPT Prednisolone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Prednisolone MOACRIVE Inhibition DTD0031 EXOFACTO Prednisolone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Probenecid HIGHSTIT Approved Drug DTD0031 EXOFACTO Probenecid DESCRIPT Probenecid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Probenecid MOACRIVE Inhibition DTD0031 EXOFACTO Probenecid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0031 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Procainamide MOACRIVE Inhibition DTD0031 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Progesterone HIGHSTIT Approved Drug DTD0031 EXOFACTO Progesterone DESCRIPT Progesterone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Progesterone MOACRIVE Inhibition DTD0031 EXOFACTO Progesterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Propranolol HIGHSTIT Approved Drug DTD0031 EXOFACTO Propranolol DESCRIPT Propranolol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Propranolol MOACRIVE Inhibition DTD0031 EXOFACTO Propranolol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO PRX-321 HIGHSTIT Drug in Phase 2 Trial DTD0031 EXOFACTO PRX-321 DESCRIPT PRX-321 inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO PRX-321 MOACRIVE Inhibition DTD0031 EXOFACTO PRX-321 CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Quercetin HIGHSTIT Approved Drug DTD0031 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 9.47 microM) DTD0031 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Atorvastatin by SLCO2B1 (IC50 = 14.1 microM; Ki = 20.8 microM) DTD0031 EXOFACTO Quercetin DESCRIPT Quercetin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Quercetin MOACRIVE Inhibition DTD0031 EXOFACTO Quercetin CELLLINE Xenopus laevis oocytes-OATP2B1 DTD0031 EXOFACTO Quercetin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0031 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Quinine MOACRIVE Inhibition DTD0031 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ranolazine HIGHSTIT Approved Drug DTD0031 EXOFACTO Ranolazine DESCRIPT Ranolazine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ranolazine MOACRIVE Inhibition DTD0031 EXOFACTO Ranolazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0031 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 5.2 microM) DTD0031 EXOFACTO Repaglinide DESCRIPT Repaglinide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Repaglinide MOACRIVE Inhibition DTD0031 EXOFACTO Repaglinide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0031 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Reserpine MOACRIVE Inhibition DTD0031 EXOFACTO Reserpine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0031 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 2.1 microM; Ki = 1.6 microM) DTD0031 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Bromsulphthalein by SLCO2B1 (IC50 = 90 microM) DTD0031 EXOFACTO Rifampicin DESCRIPT Rifampicin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Rifampicin MOACRIVE Inhibition DTD0031 EXOFACTO Rifampicin CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Rifampicin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Rifampicin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Rifamycin SV HIGHSTIT Approved Drug DTD0031 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3 microM; Ki = 2.3 microM) DTD0031 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Bromsulphthalein by SLCO2B1 (Ki = 3 microM) DTD0031 EXOFACTO Rifamycin SV DESCRIPT Rifamycin SV inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Rifamycin SV MOACRIVE Inhibition DTD0031 EXOFACTO Rifamycin SV CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Rifamycin SV CELLLINE Oocytes-OATP2B1 DTD0031 EXOFACTO Rifamycin SV CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 6.3 microM; Ki = 4.8 microM) DTD0031 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0031 EXOFACTO Ritonavir CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Ritonavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Rosuvastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Rosuvastatin DESCRIPT Rosuvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Rosuvastatin MOACRIVE Inhibition DTD0031 EXOFACTO Rosuvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sanguinarine HIGHSTIT Approved Drug DTD0031 EXOFACTO Sanguinarine DESCRIPT Sanguinarine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sanguinarine MOACRIVE Inhibition DTD0031 EXOFACTO Sanguinarine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 5.3 microM; Ki = 4 microM) DTD0031 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0031 EXOFACTO Saquinavir CELLLINE Human enterocyte-like 2 cell (Caco-2)-OATP2B1 DTD0031 EXOFACTO Saquinavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sildenafil HIGHSTIT Approved Drug DTD0031 EXOFACTO Sildenafil DESCRIPT Sildenafil inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sildenafil MOACRIVE Inhibition DTD0031 EXOFACTO Sildenafil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Silibinin HIGHSTIT Drug in Phase 2/3 Trial DTD0031 EXOFACTO Silibinin DESCRIPT Silibinin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Silibinin MOACRIVE Inhibition DTD0031 EXOFACTO Silibinin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Silibinin dihemisuccinate HIGHSTIT Natural Product DTD0031 EXOFACTO Silibinin dihemisuccinate DESCRIPT Silibinin dihemisuccinate inhibits the transportation of Bromosulfophthalein by SLCO2B1 (IC50 = 1 microM) DTD0031 EXOFACTO Silibinin dihemisuccinate MOACRIVE Inhibition DTD0031 EXOFACTO Silibinin dihemisuccinate CELLLINE Madin darby canine kidney strain II cell line (MDCKII)-OATP2B1 DTD0031 EXOFACTO Silybin A HIGHSTIT Natural Product DTD0031 EXOFACTO Silybin A DESCRIPT Silybin A inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 4.5 microM) DTD0031 EXOFACTO Silybin A MOACRIVE Inhibition DTD0031 EXOFACTO Silybin A CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Silybin B HIGHSTIT Natural Product DTD0031 EXOFACTO Silybin B DESCRIPT Silybin B inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 0.8 microM) DTD0031 EXOFACTO Silybin B MOACRIVE Inhibition DTD0031 EXOFACTO Silybin B CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Silychristin HIGHSTIT Natural Product DTD0031 EXOFACTO Silychristin DESCRIPT Silychristin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 3.6 microM) DTD0031 EXOFACTO Silychristin MOACRIVE Inhibition DTD0031 EXOFACTO Silychristin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Silymarin flavolignans HIGHSTIT Natural Product DTD0031 EXOFACTO Silymarin flavolignans DESCRIPT Silymarin flavolignans inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Silymarin flavolignans MOACRIVE Inhibition DTD0031 EXOFACTO Silymarin flavolignans CELLLINE Madin darby canine kidney strain II cell line (MDCKII)-OATP2B1 DTD0031 EXOFACTO Simvastatin HIGHSTIT Approved Drug DTD0031 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 (IC50 = 84.7 microM) DTD0031 EXOFACTO Simvastatin DESCRIPT Simvastatin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Simvastatin MOACRIVE Inhibition DTD0031 EXOFACTO Simvastatin CELLLINE Madin Darby canine kidney strain II (MDCKII) cells-OATP2B1 DTD0031 EXOFACTO Simvastatin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sincalide HIGHSTIT Investigative Drug DTD0031 EXOFACTO Sincalide DESCRIPT Sincalide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sincalide MOACRIVE Inhibition DTD0031 EXOFACTO Sincalide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sodium taurocholate HIGHSTIT Drug in Phase 1/2 Trial DTD0031 EXOFACTO Sodium taurocholate DESCRIPT Sodium taurocholate inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sodium taurocholate MOACRIVE Inhibition DTD0031 EXOFACTO Sodium taurocholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sotalol HIGHSTIT Approved Drug DTD0031 EXOFACTO Sotalol DESCRIPT Sotalol inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sotalol MOACRIVE Inhibition DTD0031 EXOFACTO Sotalol CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Soybean extract HIGHSTIT Natural Product DTD0031 EXOFACTO Soybean extract DESCRIPT Soybean extract inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Soybean extract MOACRIVE Inhibition DTD0031 EXOFACTO Soybean extract CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0031 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0031 EXOFACTO Spironolactone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sulfaphenazole HIGHSTIT Approved Drug DTD0031 EXOFACTO Sulfaphenazole DESCRIPT Sulfaphenazole inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sulfaphenazole MOACRIVE Inhibition DTD0031 EXOFACTO Sulfaphenazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0031 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0031 EXOFACTO Sulfasalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tamoxifen HIGHSTIT Approved Drug DTD0031 EXOFACTO Tamoxifen DESCRIPT Tamoxifen inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tamoxifen MOACRIVE Inhibition DTD0031 EXOFACTO Tamoxifen CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Taurochenodeoxycholate HIGHSTIT Investigative Drug DTD0031 EXOFACTO Taurochenodeoxycholate DESCRIPT Taurochenodeoxycholate inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Taurochenodeoxycholate MOACRIVE Inhibition DTD0031 EXOFACTO Taurochenodeoxycholate CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Telmisartan HIGHSTIT Approved Drug DTD0031 EXOFACTO Telmisartan DESCRIPT Telmisartan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Telmisartan MOACRIVE Inhibition DTD0031 EXOFACTO Telmisartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tenofovir HIGHSTIT Approved Drug DTD0031 EXOFACTO Tenofovir DESCRIPT Tenofovir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tenofovir MOACRIVE Inhibition DTD0031 EXOFACTO Tenofovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Terfenadine HIGHSTIT Drug Withdrawn DTD0031 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Terfenadine MOACRIVE Inhibition DTD0031 EXOFACTO Terfenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0031 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the activity of SLCO2B1 DTD0031 EXOFACTO Testosterone MOACRIVE Inhibition DTD0031 EXOFACTO Testosterone CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tetracycline HIGHSTIT Approved Drug DTD0031 EXOFACTO Tetracycline DESCRIPT Tetracycline inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tetracycline MOACRIVE Inhibition DTD0031 EXOFACTO Tetracycline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0031 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0031 EXOFACTO Tetraethylammonium CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tetramethrin HIGHSTIT Natural Product DTD0031 EXOFACTO Tetramethrin DESCRIPT Tetramethrin induces the transportation of Fluorescein by SLCO2B1 DTD0031 EXOFACTO Tetramethrin MOACRIVE Inducer DTD0031 EXOFACTO Tetramethrin CELLLINE Chinese hamster ovary (CHO) cells-OATP2B1 DTD0031 EXOFACTO Theophylline HIGHSTIT Approved Drug DTD0031 EXOFACTO Theophylline DESCRIPT Theophylline inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Theophylline MOACRIVE Inhibition DTD0031 EXOFACTO Theophylline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Thioridazine HIGHSTIT Approved Drug DTD0031 EXOFACTO Thioridazine DESCRIPT Thioridazine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Thioridazine MOACRIVE Inhibition DTD0031 EXOFACTO Thioridazine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Thiotepa HIGHSTIT Approved Drug DTD0031 EXOFACTO Thiotepa DESCRIPT Thiotepa inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Thiotepa MOACRIVE Inhibition DTD0031 EXOFACTO Thiotepa CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Ticlopidine HIGHSTIT Approved Drug DTD0031 EXOFACTO Ticlopidine DESCRIPT Ticlopidine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Ticlopidine MOACRIVE Inhibition DTD0031 EXOFACTO Ticlopidine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tipranavir HIGHSTIT Approved Drug DTD0031 EXOFACTO Tipranavir DESCRIPT Tipranavir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tipranavir MOACRIVE Inhibition DTD0031 EXOFACTO Tipranavir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Tolbutamide HIGHSTIT Approved Drug DTD0031 EXOFACTO Tolbutamide DESCRIPT Tolbutamide inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Tolbutamide MOACRIVE Inhibition DTD0031 EXOFACTO Tolbutamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Topotecan HIGHSTIT Approved Drug DTD0031 EXOFACTO Topotecan DESCRIPT Topotecan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Topotecan MOACRIVE Inhibition DTD0031 EXOFACTO Topotecan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Triazolam HIGHSTIT Approved Drug DTD0031 EXOFACTO Triazolam DESCRIPT Triazolam inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Triazolam MOACRIVE Inhibition DTD0031 EXOFACTO Triazolam CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Trimethoprim HIGHSTIT Approved Drug DTD0031 EXOFACTO Trimethoprim DESCRIPT Trimethoprim inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Trimethoprim MOACRIVE Inhibition DTD0031 EXOFACTO Trimethoprim CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Valacyclovir HIGHSTIT Approved Drug DTD0031 EXOFACTO Valacyclovir DESCRIPT Valacyclovir inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Valacyclovir MOACRIVE Inhibition DTD0031 EXOFACTO Valacyclovir CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Valproic Acid HIGHSTIT Approved Drug DTD0031 EXOFACTO Valproic Acid DESCRIPT Valproic Acid inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Valproic Acid MOACRIVE Inhibition DTD0031 EXOFACTO Valproic Acid CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Valsartan HIGHSTIT Approved Drug DTD0031 EXOFACTO Valsartan DESCRIPT Valsartan inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Valsartan MOACRIVE Inhibition DTD0031 EXOFACTO Valsartan CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Valspodar HIGHSTIT Discontinued Drug DTD0031 EXOFACTO Valspodar DESCRIPT Valspodar inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Valspodar MOACRIVE Inhibition DTD0031 EXOFACTO Valspodar CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Varenicline HIGHSTIT Approved Drug DTD0031 EXOFACTO Varenicline DESCRIPT Varenicline inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Varenicline MOACRIVE Inhibition DTD0031 EXOFACTO Varenicline CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0031 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Verapamil MOACRIVE Inhibition DTD0031 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Vinblastine HIGHSTIT Approved Drug DTD0031 EXOFACTO Vinblastine DESCRIPT Vinblastine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Vinblastine MOACRIVE Inhibition DTD0031 EXOFACTO Vinblastine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Vincristine HIGHSTIT Approved Drug DTD0031 EXOFACTO Vincristine DESCRIPT Vincristine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Vincristine MOACRIVE Inhibition DTD0031 EXOFACTO Vincristine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Warfarin HIGHSTIT Approved Drug DTD0031 EXOFACTO Warfarin DESCRIPT Warfarin inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Warfarin MOACRIVE Inhibition DTD0031 EXOFACTO Warfarin CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0031 EXOFACTO Zidovudine HIGHSTIT Approved Drug DTD0031 EXOFACTO Zidovudine DESCRIPT Zidovudine inhibits the transportation of Estrone sulfate by SLCO2B1 DTD0031 EXOFACTO Zidovudine MOACRIVE Inhibition DTD0031 EXOFACTO Zidovudine CELLLINE Human embryonic kidney 293 cells (HEK293)-OATP2B1 DTD0034 TRANSPID DTD0034 DTD0034 GENENAME SLC18A2 DTD0034 PROTNAME Vesicular amine transporter 2 DTD0034 GENEDBID 6571 DTD0034 UNIPROID Q05940 DTD0034 EXOFACTO Alkavervir HIGHSTIT Approved Drug DTD0034 EXOFACTO Alkavervir DESCRIPT Alkavervir modulates the activity of SLC18A2 DTD0034 EXOFACTO Alkavervir MOACRIVE Modulator DTD0034 EXOFACTO Alseroxylon HIGHSTIT Approved Drug DTD0034 EXOFACTO Alseroxylon DESCRIPT Alseroxylon blocks the activity of SLC18A2 DTD0034 EXOFACTO Alseroxylon MOACRIVE Blocker DTD0034 EXOFACTO AV-133 HIGHSTIT Drug in Phase 3 Trial DTD0034 EXOFACTO AV-133 DESCRIPT AV 133 enhances the activity of SLC18A2 DTD0034 EXOFACTO AV-133 MOACRIVE Enhancer DTD0034 EXOFACTO Deutetrabenazine HIGHSTIT Approved Drug DTD0034 EXOFACTO Deutetrabenazine DESCRIPT Deutetrabenazine inhibits the activity of SLC18A2 DTD0034 EXOFACTO Deutetrabenazine DESCRIPT Deutetrabenazine modulates the activity of SLC18A2 DTD0034 EXOFACTO Deutetrabenazine MOACRIVE Inhibition DTD0034 EXOFACTO Deutetrabenazine MOACRIVE Modulator DTD0034 EXOFACTO Lobeline HIGHSTIT Drug in Phase 2 Trial DTD0034 EXOFACTO Lobeline DESCRIPT Lobeline inhibits the activity of SLC18A2 DTD0034 EXOFACTO Lobeline MOACRIVE Inhibition DTD0034 EXOFACTO NBI-98854 HIGHSTIT Drug in Phase 3 Trial DTD0034 EXOFACTO NBI-98854 DESCRIPT NBI-98854 inhibits the activity of SLC18A2 DTD0034 EXOFACTO NBI-98854 MOACRIVE Inhibition DTD0034 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0034 EXOFACTO Reserpine DESCRIPT Reserpine blocks the activity of SLC18A2 DTD0034 EXOFACTO Reserpine MOACRIVE Blocker DTD0034 EXOFACTO SOM3355 HIGHSTIT Drug in Phase 1 Trial DTD0034 EXOFACTO SOM3355 DESCRIPT SOM3355 inhibits the activity of SLC18A2 DTD0034 EXOFACTO SOM3355 MOACRIVE Inhibition DTD0034 EXOFACTO Tetrabenazine HIGHSTIT Approved Drug DTD0034 EXOFACTO Tetrabenazine DESCRIPT Tetrabenazine blocks the activity of SLC18A2 DTD0034 EXOFACTO Tetrabenazine DESCRIPT Tetrabenazine inhibits the activity of SLC18A2 DTD0034 EXOFACTO Tetrabenazine MOACRIVE Blocker DTD0034 EXOFACTO Tetrabenazine MOACRIVE Inhibition DTD0034 EXOFACTO Valbenazine tosylate HIGHSTIT Approved Drug DTD0034 EXOFACTO Valbenazine tosylate DESCRIPT Valbenazine tosylate modulates the activity of SLC18A2 DTD0034 EXOFACTO Valbenazine tosylate MOACRIVE Modulator DTD0036 TRANSPID DTD0036 DTD0036 GENENAME ABCA1 DTD0036 PROTNAME ATP-binding cassette sub-family A member 1 DTD0036 GENEDBID 19 DTD0036 UNIPROID O95477 DTD0036 EXOFACTO Clofibrate HIGHSTIT Approved Drug DTD0036 EXOFACTO Clofibrate DESCRIPT Clofibrate induces the activity of ABCA1 DTD0036 EXOFACTO Clofibrate MOACRIVE Inducer DTD0036 EXOFACTO Fenofibric acid HIGHSTIT Approved Drug DTD0036 EXOFACTO Fenofibric acid DESCRIPT Fenofibric acid induces the activity of ABCA1 DTD0036 EXOFACTO Fenofibric acid MOACRIVE Inducer DTD0036 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0036 EXOFACTO Haloperidol DESCRIPT Haloperidol induces the activity of ABCA1 DTD0036 EXOFACTO Haloperidol MOACRIVE Inducer DTD0036 EXOFACTO Probucol HIGHSTIT Approved Drug DTD0036 EXOFACTO Probucol DESCRIPT Probucol inhibits the activity of ABCA1 DTD0036 EXOFACTO Probucol MOACRIVE Inhibition DTD0036 EXOFACTO Propofol HIGHSTIT Approved Drug DTD0036 EXOFACTO Propofol DESCRIPT Propofol induces the activity of ABCA1 DTD0036 EXOFACTO Propofol MOACRIVE Inducer DTD0036 EXOFACTO Rofecoxib HIGHSTIT Approved Drug DTD0036 EXOFACTO Rofecoxib DESCRIPT Rofecoxib inhibits the activity of ABCA1 DTD0036 EXOFACTO Rofecoxib MOACRIVE Inhibition DTD0040 TRANSPID DTD0040 DTD0040 GENENAME ABCA2 DTD0040 PROTNAME ATP-binding cassette sub-family A member 2 DTD0040 GENEDBID 20 DTD0040 UNIPROID Q9BZC7 DTD0040 EXOFACTO Celecoxib HIGHSTIT Approved Drug DTD0040 EXOFACTO Celecoxib DESCRIPT Celecoxib inhibits the activity of ABCA2 DTD0040 EXOFACTO Celecoxib MOACRIVE Inhibition DTD0040 EXOFACTO Celecoxib CELLLINE Human immortalised myelogenous leukemia cell line (K562)-ABCA2 DTD0041 TRANSPID DTD0041 DTD0041 GENENAME ABCA3 DTD0041 PROTNAME ATP-binding cassette sub-family A member 3 DTD0041 GENEDBID 21 DTD0041 UNIPROID Q99758 DTD0041 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0041 EXOFACTO Doxorubicin DESCRIPT Doxorubicin induces the activity of ABCA3 DTD0041 EXOFACTO Doxorubicin MOACRIVE Inducer DTD0041 EXOFACTO Imatinib HIGHSTIT Approved Drug DTD0041 EXOFACTO Imatinib DESCRIPT Imatinib inhibits the activity of ABCA3 DTD0041 EXOFACTO Imatinib MOACRIVE Inhibition DTD0041 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0041 EXOFACTO Methotrexate DESCRIPT Methotrexate induces the activity of ABCA3 DTD0041 EXOFACTO Methotrexate MOACRIVE Inducer DTD0042 TRANSPID DTD0042 DTD0042 GENENAME ABCA4 DTD0042 PROTNAME ATP-binding cassette sub-family A member 4 DTD0042 GENEDBID 24 DTD0042 UNIPROID P78363 DTD0042 EXOFACTO StarGen HIGHSTIT Drug in Phase 1/2 Trial DTD0042 EXOFACTO StarGen DESCRIPT StarGen modulates the activity of ABCA4 DTD0042 EXOFACTO StarGen MOACRIVE Modulator DTD0051 TRANSPID DTD0051 DTD0051 GENENAME ABCB5 DTD0051 PROTNAME ATP-binding cassette sub-family B member 5 DTD0051 GENEDBID 340273 DTD0051 UNIPROID Q2M3G0 DTD0051 EXOFACTO Cucurbitacin E HIGHSTIT Natural Product DTD0051 EXOFACTO Cucurbitacin E DESCRIPT Cucurbitacin E inhibits the activity of ABCB5 DTD0051 EXOFACTO Cucurbitacin E MOACRIVE Inhibition DTD0051 EXOFACTO Cucurbitacin E CELLLINE Drug-resistant tumor cell lines DTD0052 TRANSPID DTD0052 DTD0052 GENENAME ABCB6 DTD0052 PROTNAME ATP-binding cassette sub-family B member 6 DTD0052 GENEDBID 10058 DTD0052 UNIPROID Q9NP58 DTD0052 EXOFACTO Polycyclic aromatic hydrocarbons HIGHSTIT Environmental toxicant DTD0052 EXOFACTO Polycyclic aromatic hydrocarbons DESCRIPT Polycyclic aromatic hydrocarbons induces the activity of ABCB6 DTD0052 EXOFACTO Polycyclic aromatic hydrocarbons MOACRIVE Inducer DTD0052 EXOFACTO Polycyclic aromatic hydrocarbons CELLLINE Human liver-derived cell lines Huh7-ABCB6 DTD0052 EXOFACTO Verteporfin HIGHSTIT Approved Drug DTD0052 EXOFACTO Verteporfin DESCRIPT Verteporfin inhibits the activity of ABCB6 DTD0052 EXOFACTO Verteporfin MOACRIVE Inhibition DTD0054 TRANSPID DTD0054 DTD0054 GENENAME ABCB8 DTD0054 PROTNAME ATP-binding cassette sub-family B member 8 DTD0054 GENEDBID 11194 DTD0054 UNIPROID Q9NUT2 DTD0054 EXOFACTO Mithramycin A HIGHSTIT Investigative Drug DTD0054 EXOFACTO Mithramycin A DESCRIPT Mithramycin A inhibits the activity of ABCB8 DTD0054 EXOFACTO Mithramycin A MOACRIVE Inhibition DTD0054 EXOFACTO Mithramycin A CELLLINE Human embryonic kidney 293 cells (HEK293)-ABCB8 DTD0056 TRANSPID DTD0056 DTD0056 GENENAME ABCC10 DTD0056 PROTNAME Multidrug resistance-associated protein 7 DTD0056 GENEDBID 89845 DTD0056 UNIPROID Q5T3U5 DTD0056 EXOFACTO Cyclosporine HIGHSTIT Approved Drug DTD0056 EXOFACTO Cyclosporine DESCRIPT Cyclosporine inhibits the transportation of 17-estradiol-(17--d-glucuronide) by ABCC10 DTD0056 EXOFACTO Cyclosporine MOACRIVE Inhibition DTD0056 EXOFACTO Cyclosporine CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP7 DTD0056 EXOFACTO Doxorubicin HIGHSTIT Approved Drug DTD0056 EXOFACTO Doxorubicin DESCRIPT Doxorubicin induces the activity of ABCC10 DTD0056 EXOFACTO Doxorubicin MOACRIVE Inducer DTD0056 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0056 EXOFACTO Estradiol DESCRIPT Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 DTD0056 EXOFACTO Estradiol MOACRIVE Inhibition DTD0056 EXOFACTO Estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP7 DTD0056 EXOFACTO Ethinyl estradiol HIGHSTIT Approved Drug DTD0056 EXOFACTO Ethinyl estradiol DESCRIPT Ethinyl estradiol inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 DTD0056 EXOFACTO Ethinyl estradiol MOACRIVE Inhibition DTD0056 EXOFACTO Ethinyl estradiol CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP7 DTD0056 EXOFACTO Etoposide HIGHSTIT Approved Drug DTD0056 EXOFACTO Etoposide DESCRIPT Etoposide inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 DTD0056 EXOFACTO Etoposide MOACRIVE Inhibition DTD0056 EXOFACTO Etoposide CELLLINE Human embryonic kidney 293 cells (HEK293)-MRP7 DTD0056 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0056 EXOFACTO Paclitaxel DESCRIPT Paclitaxel induces the activity of ABCC10 DTD0056 EXOFACTO Paclitaxel MOACRIVE Inducer DTD0056 EXOFACTO Sulfinpyrazone HIGHSTIT Approved Drug DTD0056 EXOFACTO Sulfinpyrazone DESCRIPT Sulfinpyrazone inhibits the activity of ABCC10 DTD0056 EXOFACTO Sulfinpyrazone MOACRIVE Inhibition DTD0057 TRANSPID DTD0057 DTD0057 GENENAME ABCC11 DTD0057 PROTNAME Multidrug resistance-associated protein 8 DTD0057 GENEDBID 85320 DTD0057 UNIPROID Q96J66 DTD0057 EXOFACTO Cyclic adenosine monophosphate HIGHSTIT Investigative Drug DTD0057 EXOFACTO Cyclic adenosine monophosphate DESCRIPT Cyclic adenosine monophosphate inhibits the transportation of Cyclic guanosine monophosphate by ABCC11 DTD0057 EXOFACTO Cyclic adenosine monophosphate MOACRIVE Inhibition DTD0057 EXOFACTO Cyclic adenosine monophosphate CELLLINE LLC-PK1 vesicles-MRP8 DTD0057 EXOFACTO Fluorouracil HIGHSTIT Approved Drug DTD0057 EXOFACTO Fluorouracil DESCRIPT Fluorouracil induces the activity of ABCC11 DTD0057 EXOFACTO Fluorouracil MOACRIVE Inducer DTD0057 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0057 EXOFACTO Methotrexate DESCRIPT Methotrexate induces the activity of ABCC11 DTD0057 EXOFACTO Methotrexate MOACRIVE Inducer DTD0060 TRANSPID DTD0060 DTD0060 GENENAME ABCC7 DTD0060 PROTNAME Cystic fibrosis transmembrane conductance regulator DTD0060 GENEDBID 1080 DTD0060 UNIPROID P13569 DTD0060 EXOFACTO Helicobacter pylori HIGHSTIT Bacterium DTD0060 EXOFACTO Helicobacter pylori DESCRIPT Helicobacter pylori infection inhibits the activity of ABCC7 DTD0060 EXOFACTO Helicobacter pylori MOACRIVE Inhibition DTD0060 EXOFACTO Helicobacter pylori CELLLINE Human duodenal epithelial cells (SCBN)-ABCC7 DTD0060 EXOFACTO Roflumilast HIGHSTIT Approved Drug DTD0060 EXOFACTO Roflumilast DESCRIPT Roflumilast induces the activity of ABCC7 DTD0060 EXOFACTO Roflumilast MOACRIVE Inducer DTD0061 TRANSPID DTD0061 DTD0061 GENENAME ABCC8 DTD0061 PROTNAME Sulfonylurea receptor 1 DTD0061 GENEDBID 6833 DTD0061 UNIPROID Q09428 DTD0061 EXOFACTO Acetohexamide HIGHSTIT Approved Drug DTD0061 EXOFACTO Acetohexamide DESCRIPT Acetohexamide modulates the activity of ABCC8 DTD0061 EXOFACTO Acetohexamide MOACRIVE Modulator DTD0061 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0061 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of ABCC8 DTD0061 EXOFACTO Glibenclamide DESCRIPT Glibenclamide modulates the activity of ABCC8 DTD0061 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0061 EXOFACTO Glibenclamide MOACRIVE Modulator DTD0061 EXOFACTO Gliclazide HIGHSTIT Approved Drug DTD0061 EXOFACTO Gliclazide DESCRIPT Gliclazide blocks the activity of ABCC8 DTD0061 EXOFACTO Gliclazide MOACRIVE Blocker DTD0061 EXOFACTO Glimepiride HIGHSTIT Approved Drug DTD0061 EXOFACTO Glimepiride DESCRIPT Glimepiride blocks the activity of ABCC8 DTD0061 EXOFACTO Glimepiride MOACRIVE Blocker DTD0061 EXOFACTO HBR-985 HIGHSTIT Investigative Drug DTD0061 EXOFACTO HBR-985 DESCRIPT HBR-985 inhibits the activity of ABCC8 DTD0061 EXOFACTO HBR-985 MOACRIVE Inhibition DTD0061 EXOFACTO NN-414 HIGHSTIT Drug in Phase 1 Trial DTD0061 EXOFACTO NN-414 DESCRIPT NN-414 modulates the activity of ABCC8 DTD0061 EXOFACTO NN-414 MOACRIVE Modulator DTD0061 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0061 EXOFACTO Repaglinide DESCRIPT Repaglinide blocks the activity of ABCC8 DTD0061 EXOFACTO Repaglinide MOACRIVE Blocker DTD0061 EXOFACTO Tolbutamide HIGHSTIT Approved Drug DTD0061 EXOFACTO Tolbutamide DESCRIPT Tolbutamide blocks the activity of ABCC8 DTD0061 EXOFACTO Tolbutamide MOACRIVE Blocker DTD0062 TRANSPID DTD0062 DTD0062 GENENAME ABCC9 DTD0062 PROTNAME Sulfonylurea receptor 2 DTD0062 GENEDBID 10060 DTD0062 UNIPROID O60706 DTD0062 EXOFACTO Glimepiride HIGHSTIT Approved Drug DTD0062 EXOFACTO Glimepiride DESCRIPT Glimepiride blocks the activity of ABCC9 DTD0062 EXOFACTO Glimepiride MOACRIVE Blocker DTD0062 EXOFACTO Nicorandil HIGHSTIT Approved Drug DTD0062 EXOFACTO Nicorandil DESCRIPT Nicorandil activates the activity of ABCC9 DTD0062 EXOFACTO Nicorandil MOACRIVE Activator DTD0062 EXOFACTO Repaglinide HIGHSTIT Approved Drug DTD0062 EXOFACTO Repaglinide DESCRIPT Repaglinide blocks the activity of ABCC9 DTD0062 EXOFACTO Repaglinide MOACRIVE Blocker DTD0062 EXOFACTO Tolbutamide HIGHSTIT Approved Drug DTD0062 EXOFACTO Tolbutamide DESCRIPT Tolbutamide blocks the activity of ABCC9 DTD0062 EXOFACTO Tolbutamide MOACRIVE Blocker DTD0082 TRANSPID DTD0082 DTD0082 GENENAME SLC12A1 DTD0082 PROTNAME Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 DTD0082 GENEDBID 6557 DTD0082 UNIPROID Q13621 DTD0082 EXOFACTO Bendroflumethiazide HIGHSTIT Approved Drug DTD0082 EXOFACTO Bendroflumethiazide DESCRIPT Bendroflumethiazide blocks the activity of SLC12A1 DTD0082 EXOFACTO Bendroflumethiazide MOACRIVE Blocker DTD0082 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0082 EXOFACTO Bumetanide DESCRIPT Bumetanide blocks the activity of SLC12A1 DTD0082 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the activity of SLC12A1 DTD0082 EXOFACTO Bumetanide MOACRIVE Blocker DTD0082 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0082 EXOFACTO Chlorthalidone HIGHSTIT Approved Drug DTD0082 EXOFACTO Chlorthalidone DESCRIPT Chlorthalidone blocks the activity of SLC12A1 DTD0082 EXOFACTO Chlorthalidone MOACRIVE Blocker DTD0082 EXOFACTO Ethacrynate sodium HIGHSTIT Approved Drug DTD0082 EXOFACTO Ethacrynate sodium DESCRIPT Ethacrynate sodium modulates the activity of SLC12A1 DTD0082 EXOFACTO Ethacrynate sodium MOACRIVE Modulator DTD0082 EXOFACTO Ethacrynic acid HIGHSTIT Approved Drug DTD0082 EXOFACTO Ethacrynic acid DESCRIPT Ethacrynic acid blocks the activity of SLC12A1 DTD0082 EXOFACTO Ethacrynic acid MOACRIVE Blocker DTD0082 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0082 EXOFACTO Furosemide DESCRIPT Furosemide blocks the activity of SLC12A1 DTD0082 EXOFACTO Furosemide DESCRIPT Furosemide induces the activity of SLC12A1 DTD0082 EXOFACTO Furosemide MOACRIVE Blocker DTD0082 EXOFACTO Furosemide MOACRIVE Inducer DTD0082 EXOFACTO Hydrochlorothiazide HIGHSTIT Approved Drug DTD0082 EXOFACTO Hydrochlorothiazide DESCRIPT Hydrochlorothiazide induces the activity of SLC12A1 DTD0082 EXOFACTO Hydrochlorothiazide MOACRIVE Inducer DTD0082 EXOFACTO Hydroflumethiazide HIGHSTIT Approved Drug DTD0082 EXOFACTO Hydroflumethiazide DESCRIPT Hydroflumethiazide blocks the activity of SLC12A1 DTD0082 EXOFACTO Hydroflumethiazide MOACRIVE Blocker DTD0082 EXOFACTO Methyclothiazide HIGHSTIT Approved Drug DTD0082 EXOFACTO Methyclothiazide DESCRIPT Methyclothiazide blocks the activity of SLC12A1 DTD0082 EXOFACTO Methyclothiazide MOACRIVE Blocker DTD0082 EXOFACTO Nitric oxide HIGHSTIT Drug in Preclinical Test DTD0082 EXOFACTO Nitric oxide DESCRIPT Nitric oxide inhibits the activity of SLC12A1 DTD0082 EXOFACTO Nitric oxide MOACRIVE Inhibition DTD0082 EXOFACTO Potassium chloride HIGHSTIT Approved Drug DTD0082 EXOFACTO Potassium chloride DESCRIPT Potassium chloride modulates the activity of SLC12A1 DTD0082 EXOFACTO Potassium chloride MOACRIVE Modulator DTD0082 EXOFACTO Torsemide HIGHSTIT Approved Drug DTD0082 EXOFACTO Torsemide DESCRIPT Torsemide blocks the activity of SLC12A1 DTD0082 EXOFACTO Torsemide MOACRIVE Blocker DTD0082 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0082 EXOFACTO Trichlormethiazide DESCRIPT Trichloromethiazide blocks the activity of SLC12A1 DTD0082 EXOFACTO Trichlormethiazide MOACRIVE Blocker DTD0082 EXOFACTO Vasopressin HIGHSTIT Approved Drug DTD0082 EXOFACTO Vasopressin DESCRIPT Vasopressin induces the activity of SLC12A1 DTD0082 EXOFACTO Vasopressin MOACRIVE Inducer DTD0083 TRANSPID DTD0083 DTD0083 GENENAME SLC12A2 DTD0083 PROTNAME Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 DTD0083 GENEDBID 6558 DTD0083 UNIPROID P55011 DTD0083 EXOFACTO Bumetanide HIGHSTIT Approved Drug DTD0083 EXOFACTO Bumetanide DESCRIPT Bumetanide inhibits the activity of SLC12A2 DTD0083 EXOFACTO Bumetanide MOACRIVE Inhibition DTD0083 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0083 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of SLC12A2 DTD0083 EXOFACTO Estradiol MOACRIVE Inducer DTD0083 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0083 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the activity of SLC12A2 DTD0083 EXOFACTO Furosemide MOACRIVE Inhibition DTD0083 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0083 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of SLC12A2 DTD0083 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0083 EXOFACTO Kanamycin HIGHSTIT Approved Drug DTD0083 EXOFACTO Kanamycin DESCRIPT Kanamycin inhibits the activity of SLC12A2 DTD0083 EXOFACTO Kanamycin MOACRIVE Inhibition DTD0083 EXOFACTO Methoxamine HIGHSTIT Approved Drug DTD0083 EXOFACTO Methoxamine DESCRIPT Methoxamine induces the activity of SLC12A2 DTD0083 EXOFACTO Methoxamine MOACRIVE Inducer DTD0083 EXOFACTO Nitric oxide HIGHSTIT Drug in Preclinical Test DTD0083 EXOFACTO Nitric oxide DESCRIPT Nitric oxide inhibits the activity of SLC12A2 DTD0083 EXOFACTO Nitric oxide MOACRIVE Inhibition DTD0083 EXOFACTO Nitroprusside HIGHSTIT Approved Drug DTD0083 EXOFACTO Nitroprusside DESCRIPT Nitroprusside inhibits the activity of SLC12A2 DTD0083 EXOFACTO Nitroprusside MOACRIVE Inhibition DTD0083 EXOFACTO Oxytocin HIGHSTIT Approved Drug DTD0083 EXOFACTO Oxytocin DESCRIPT Oxytocin induces the activity of SLC12A2 DTD0083 EXOFACTO Oxytocin MOACRIVE Inducer DTD0083 EXOFACTO Phenylephrine HIGHSTIT Approved Drug DTD0083 EXOFACTO Phenylephrine DESCRIPT Phenylephrine induces the activity of SLC12A2 DTD0083 EXOFACTO Phenylephrine MOACRIVE Inducer DTD0083 EXOFACTO Verteporfin HIGHSTIT Approved Drug DTD0083 EXOFACTO Verteporfin DESCRIPT Verteporfin inhibits the activity of SLC12A2 DTD0083 EXOFACTO Verteporfin MOACRIVE Inhibition DTD0084 TRANSPID DTD0084 DTD0084 GENENAME SLC12A3 DTD0084 PROTNAME Thiazide-sensitive sodium-chloride cotransporter DTD0084 GENEDBID 6559 DTD0084 UNIPROID P55017 DTD0084 EXOFACTO Bendroflumethiazide HIGHSTIT Approved Drug DTD0084 EXOFACTO Bendroflumethiazide DESCRIPT Bendroflumethiazide blocks the activity of SLC12A3 DTD0084 EXOFACTO Bendroflumethiazide MOACRIVE Blocker DTD0084 EXOFACTO Metolazone HIGHSTIT Approved Drug DTD0084 EXOFACTO Metolazone DESCRIPT Metolazone blocks the activity of SLC12A3 DTD0084 EXOFACTO Metolazone MOACRIVE Blocker DTD0084 EXOFACTO Polythiazide HIGHSTIT Approved Drug DTD0084 EXOFACTO Polythiazide DESCRIPT Polythiazide blocks the activity of SLC12A3 DTD0084 EXOFACTO Polythiazide MOACRIVE Blocker DTD0084 EXOFACTO Trichlormethiazide HIGHSTIT Approved Drug DTD0084 EXOFACTO Trichlormethiazide DESCRIPT Trichlormethiazide inhibits the activity of SLC12A3 DTD0084 EXOFACTO Trichlormethiazide MOACRIVE Inhibition DTD0085 TRANSPID DTD0085 DTD0085 GENENAME SLC12A4 DTD0085 PROTNAME Electroneutral potassium-chloride cotransporter 1 DTD0085 GENEDBID 6560 DTD0085 UNIPROID Q9UP95 DTD0085 EXOFACTO Dactinomycin HIGHSTIT Approved Drug DTD0085 EXOFACTO Dactinomycin DESCRIPT Dactinomycin induces the activity of SLC12A4 DTD0085 EXOFACTO Dactinomycin MOACRIVE Inducer DTD0086 TRANSPID DTD0086 DTD0086 GENENAME SLC12A5 DTD0086 PROTNAME Electroneutral potassium-chloride cotransporter 2 DTD0086 GENEDBID 57468 DTD0086 UNIPROID Q9H2X9 DTD0086 EXOFACTO Furosemide HIGHSTIT Approved Drug DTD0086 EXOFACTO Furosemide DESCRIPT Furosemide inhibits the activity of SLC12A5 DTD0086 EXOFACTO Furosemide MOACRIVE Inhibition DTD0086 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0086 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the activity of SLC12A5 DTD0086 EXOFACTO Reserpine MOACRIVE Inhibition DTD0093 TRANSPID DTD0093 DTD0093 GENENAME SLC13A3 DTD0093 PROTNAME Sodium/dicarboxylate cotransporter 3 DTD0093 GENEDBID 64849 DTD0093 UNIPROID Q8WWT9 DTD0093 EXOFACTO Sertraline HIGHSTIT Approved Drug DTD0093 EXOFACTO Sertraline DESCRIPT Sertraline inhibits the activity of SLC13A3 DTD0093 EXOFACTO Sertraline MOACRIVE Inhibition DTD0093 EXOFACTO Sertraline CELLLINE Clear cell renal cell carcinoma cell lines DTD0100 TRANSPID DTD0100 DTD0100 GENENAME SLC16A1 DTD0100 PROTNAME Monocarboxylate transporter 1 DTD0100 GENEDBID 6566 DTD0100 UNIPROID P53985 DTD0100 EXOFACTO BAY-8002 HIGHSTIT Investigative Drug DTD0100 EXOFACTO BAY-8002 DESCRIPT BAY-8002 inhibits the activity of SLC16A1 DTD0100 EXOFACTO BAY-8002 MOACRIVE Inhibition DTD0100 EXOFACTO BAY-8002 CELLLINE Human colorectal adenocarcinoma cell lines (DLD-1)-MCT1 DTD0100 EXOFACTO Butyric acid HIGHSTIT Natural Product DTD0100 EXOFACTO Butyric acid DESCRIPT Butyric acid induces the transportation of Ferulic acid by SLC16A1 DTD0100 EXOFACTO Butyric acid MOACRIVE Inducer DTD0100 EXOFACTO Butyric acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-MCT1 DTD0100 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0100 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the activity of SLC16A1 DTD0100 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0100 EXOFACTO Ketogenic diet HIGHSTIT Dietary Constituent DTD0100 EXOFACTO Ketogenic diet DESCRIPT Ketogenic diet induces the activity of SLC16A1 DTD0100 EXOFACTO Ketogenic diet MOACRIVE Inducer DTD0100 EXOFACTO Mersalyl HIGHSTIT Investigative Drug DTD0100 EXOFACTO Mersalyl DESCRIPT Mersalyl inhibits the activity of SLC16A1 DTD0100 EXOFACTO Mersalyl MOACRIVE Inhibition DTD0100 EXOFACTO Nateglinide HIGHSTIT Approved Drug DTD0100 EXOFACTO Nateglinide DESCRIPT Nateglinide inhibits the activity of SLC16A1 DTD0100 EXOFACTO Nateglinide MOACRIVE Inhibition DTD0100 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0100 EXOFACTO Nicotine DESCRIPT Nicotine induces the activity of SLC16A1 DTD0100 EXOFACTO Nicotine MOACRIVE Inducer DTD0100 EXOFACTO Niflumic acid HIGHSTIT Approved Drug DTD0100 EXOFACTO Niflumic acid DESCRIPT Niflumic acid inhibits the activity of SLC16A1 DTD0100 EXOFACTO Niflumic acid MOACRIVE Inhibition DTD0100 EXOFACTO Nitric oxide HIGHSTIT Drug in Preclinical Test DTD0100 EXOFACTO Nitric oxide DESCRIPT Nitric oxide induces the activity of SLC16A1 DTD0100 EXOFACTO Nitric oxide MOACRIVE Inducer DTD0100 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0100 EXOFACTO Testosterone DESCRIPT Testosterone induces the activity of SLC16A1 DTD0100 EXOFACTO Testosterone MOACRIVE Inducer DTD0106 TRANSPID DTD0106 DTD0106 GENENAME SLC16A2 DTD0106 PROTNAME Monocarboxylate transporter 8 DTD0106 GENEDBID 6567 DTD0106 UNIPROID P36021 DTD0106 EXOFACTO Silychristin HIGHSTIT Natural Product DTD0106 EXOFACTO Silychristin DESCRIPT Silychristin inhibits the transportation of Thyroid hormones by SLC16A2 (IC50 = 0.1 microM) DTD0106 EXOFACTO Silychristin MOACRIVE Inhibition DTD0106 EXOFACTO Silychristin CELLLINE Madin darby canine kidney strain cell line (MDCK)-SLC16A2 DTD0107 TRANSPID DTD0107 DTD0107 GENENAME SLC16A3 DTD0107 PROTNAME Monocarboxylate transporter 4 DTD0107 GENEDBID 9123 DTD0107 UNIPROID O15427 DTD0107 EXOFACTO Butyric acid HIGHSTIT Natural Product DTD0107 EXOFACTO Butyric acid DESCRIPT Butyric acid induces the transportation of Ferulic acid by SLC16A3 DTD0107 EXOFACTO Butyric acid MOACRIVE Inducer DTD0107 EXOFACTO Butyric acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-MCT4 DTD0107 EXOFACTO Diclofenac HIGHSTIT Approved Drug DTD0107 EXOFACTO Diclofenac DESCRIPT Diclofenac inhibits the activity of SLC16A3 DTD0107 EXOFACTO Diclofenac MOACRIVE Inhibition DTD0107 EXOFACTO Diclofenac CELLLINE Human enterocyte-like 2 cell (Caco-2)-MCT4 DTD0107 EXOFACTO Irbesartan HIGHSTIT Approved Drug DTD0107 EXOFACTO Irbesartan DESCRIPT Irbesartan inhibits the activity of SLC16A3 DTD0107 EXOFACTO Irbesartan MOACRIVE Inhibition DTD0109 TRANSPID DTD0109 DTD0109 GENENAME SLC16A5 DTD0109 PROTNAME Monocarboxylate transporter 6 DTD0109 GENEDBID 9121 DTD0109 UNIPROID O15375 DTD0109 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0109 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of SLC16A5 DTD0109 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0111 TRANSPID DTD0111 DTD0111 GENENAME SLC16A7 DTD0111 PROTNAME Monocarboxylate transporter 2 DTD0111 GENEDBID 9194 DTD0111 UNIPROID O60669 DTD0111 EXOFACTO AR-C155858 HIGHSTIT Investigative Drug DTD0111 EXOFACTO AR-C155858 DESCRIPT AR-C155858 inhibits the transportation of Ketone bodies and L-lactate by SLC16A7 (IC50 = 1 microM) DTD0111 EXOFACTO AR-C155858 MOACRIVE Inhibition DTD0111 EXOFACTO AR-C155858 CELLLINE Breast cancer cell lines-MCT2 DTD0111 EXOFACTO Ketogenic diet HIGHSTIT Dietary Constituent DTD0111 EXOFACTO Ketogenic diet DESCRIPT Ketogenic diet induces the activity of SLC16A7 DTD0111 EXOFACTO Ketogenic diet MOACRIVE Inducer DTD0111 EXOFACTO Testosterone HIGHSTIT Approved Drug DTD0111 EXOFACTO Testosterone DESCRIPT Testosterone inhibits the activity of SLC16A7 DTD0111 EXOFACTO Testosterone MOACRIVE Inhibition DTD0123 TRANSPID DTD0123 DTD0123 GENENAME SLC18A1 DTD0123 PROTNAME Vesicular amine transporter 1 DTD0123 GENEDBID 6570 DTD0123 UNIPROID P54219 DTD0123 EXOFACTO Fenfluramine HIGHSTIT Drug Withdrawn DTD0123 EXOFACTO Fenfluramine DESCRIPT Fenfluramine inhibits the activity of SLC18A1 DTD0123 EXOFACTO Fenfluramine MOACRIVE Inhibition DTD0123 EXOFACTO Reserpine HIGHSTIT Approved Drug DTD0123 EXOFACTO Reserpine DESCRIPT Reserpine inhibits the activity of SLC18A1 DTD0123 EXOFACTO Reserpine MOACRIVE Inhibition DTD0123 EXOFACTO Tetrabenazine HIGHSTIT Approved Drug DTD0123 EXOFACTO Tetrabenazine DESCRIPT Tetrabenazine inhibits the activity of SLC18A1 DTD0123 EXOFACTO Tetrabenazine MOACRIVE Inhibition DTD0124 TRANSPID DTD0124 DTD0124 GENENAME SLC18A3 DTD0124 PROTNAME Vesicular acetylcholine transporter DTD0124 GENEDBID 6572 DTD0124 UNIPROID Q16572 DTD0124 EXOFACTO Vesamicol HIGHSTIT Investigative Drug DTD0124 EXOFACTO Vesamicol DESCRIPT Vesamicol inhibits the activity of SLC18A3 DTD0124 EXOFACTO Vesamicol MOACRIVE Inhibition DTD0124 EXOFACTO Vesamicol CELLLINE Rat adrenal chromaffin cells (PC12)-VACHT DTD0126 TRANSPID DTD0126 DTD0126 GENENAME SLC19A1 DTD0126 PROTNAME Folate transporter 1 DTD0126 GENEDBID 6573 DTD0126 UNIPROID P41440 DTD0126 EXOFACTO Folic acid HIGHSTIT Approved Drug DTD0126 EXOFACTO Folic acid DESCRIPT Folic acid modulates the activity of SLC19A1 DTD0126 EXOFACTO Folic acid MOACRIVE Modulator DTD0126 EXOFACTO Leucovorin HIGHSTIT Approved Drug DTD0126 EXOFACTO Leucovorin DESCRIPT Leucovorin inhibits the transportation of Methotrexate by SLC19A1 DTD0126 EXOFACTO Leucovorin DESCRIPT Leucovorin inhibits the activity of SLC19A1 DTD0126 EXOFACTO Leucovorin MOACRIVE Inhibition DTD0126 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0126 EXOFACTO Methotrexate DESCRIPT Methotrexate inhibits the transportation of Methotrexate by SLC19A1 DTD0126 EXOFACTO Methotrexate MOACRIVE Inhibition DTD0126 EXOFACTO Pemetrexed HIGHSTIT Approved Drug DTD0126 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the transportation of Methotrexate by SLC19A1 DTD0126 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the activity of SLC19A1 DTD0126 EXOFACTO Pemetrexed MOACRIVE Inhibition DTD0126 EXOFACTO Raltitrexed HIGHSTIT Approved Drug DTD0126 EXOFACTO Raltitrexed DESCRIPT Raltitrexed inhibits the transportation of Methotrexate by SLC19A1 DTD0126 EXOFACTO Raltitrexed DESCRIPT Raltitrexed inhibits the activity of SLC19A1 DTD0126 EXOFACTO Raltitrexed MOACRIVE Inhibition DTD0126 EXOFACTO Talotrexin HIGHSTIT Drug in Phase 1/2 Trial DTD0126 EXOFACTO Talotrexin DESCRIPT Talotrexin inhibits the transportation of Methotrexate by SLC19A1 DTD0126 EXOFACTO Talotrexin MOACRIVE Inhibition DTD0127 TRANSPID DTD0127 DTD0127 GENENAME SLC19A2 DTD0127 PROTNAME Thiamine transporter 1 DTD0127 GENEDBID 10560 DTD0127 UNIPROID O60779 DTD0127 EXOFACTO [3H]Thiamine HIGHSTIT Investigative Drug DTD0127 EXOFACTO [3H]Thiamine DESCRIPT [3H]Thiamine modulates the activity of SLC19A2 DTD0127 EXOFACTO [3H]Thiamine MOACRIVE Modulator DTD0128 TRANSPID DTD0128 DTD0128 GENENAME SLC19A3 DTD0128 PROTNAME Thiamine transporter 2 DTD0128 GENEDBID 80704 DTD0128 UNIPROID Q9BZV2 DTD0128 EXOFACTO [3H]Thiamine HIGHSTIT Investigative Drug DTD0128 EXOFACTO [3H]Thiamine DESCRIPT [3H]Thiamine modulates the activity of SLC19A3 DTD0128 EXOFACTO [3H]Thiamine MOACRIVE Modulator DTD0129 TRANSPID DTD0129 DTD0129 GENENAME SLC1A1 DTD0129 PROTNAME Excitatory amino acid transporter 3 DTD0129 GENEDBID 6505 DTD0129 UNIPROID P43005 DTD0129 EXOFACTO 2S,4R-4-Methylglutamate HIGHSTIT Investigative Drug DTD0129 EXOFACTO 2S,4R-4-Methylglutamate DESCRIPT 2S,4R-4-Methylglutamate inhibits the activity of SLC1A1 DTD0129 EXOFACTO 2S,4R-4-Methylglutamate MOACRIVE Inhibition DTD0129 EXOFACTO 2S,4R-4-Methylglutamate CELLLINE Human embryonic kidney 293 cells (HEK293)-EAAT3 DTD0129 EXOFACTO Desflurane HIGHSTIT Approved Drug DTD0129 EXOFACTO Desflurane DESCRIPT Desflurane induces the activity of SLC1A1 DTD0129 EXOFACTO Desflurane MOACRIVE Inducer DTD0129 EXOFACTO L-glutamic acid HIGHSTIT Approved Drug DTD0129 EXOFACTO L-glutamic acid DESCRIPT L-glutamic acid inhibits the transportation of D-Aspartate by SLC1A1 DTD0129 EXOFACTO L-glutamic acid MOACRIVE Inhibition DTD0129 EXOFACTO L-glutamic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-EAAT3 DTD0130 TRANSPID DTD0130 DTD0130 GENENAME SLC1A2 DTD0130 PROTNAME Excitatory amino acid transporter 2 DTD0130 GENEDBID 6506 DTD0130 UNIPROID P43004 DTD0130 EXOFACTO 2S,4R-4-Methylglutamate HIGHSTIT Investigative Drug DTD0130 EXOFACTO 2S,4R-4-Methylglutamate DESCRIPT 2S,4R-4-Methylglutamate inhibits the activity of SLC1A2 DTD0130 EXOFACTO 2S,4R-4-Methylglutamate MOACRIVE Inhibition DTD0130 EXOFACTO 2S,4R-4-Methylglutamate CELLLINE Human embryonic kidney 293 cells (HEK293)-EAAT2 DTD0130 EXOFACTO Etanercept HIGHSTIT Approved Drug DTD0130 EXOFACTO Etanercept DESCRIPT Etanercept induces the activity of SLC1A2 DTD0130 EXOFACTO Etanercept MOACRIVE Inducer DTD0130 EXOFACTO Fingolimod HIGHSTIT Approved Drug DTD0130 EXOFACTO Fingolimod DESCRIPT Fingolimod induces the activity of SLC1A2 DTD0130 EXOFACTO Fingolimod MOACRIVE Inducer DTD0130 EXOFACTO L-glutamic acid HIGHSTIT Approved Drug DTD0130 EXOFACTO L-glutamic acid DESCRIPT L-glutamic acid inhibits the transportation of D-Aspartate by SLC1A2 DTD0130 EXOFACTO L-glutamic acid MOACRIVE Inhibition DTD0130 EXOFACTO L-glutamic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-EAAT2 DTD0131 TRANSPID DTD0131 DTD0131 GENENAME SLC1A3 DTD0131 PROTNAME Excitatory amino acid transporter 1 DTD0131 GENEDBID 6507 DTD0131 UNIPROID P43003 DTD0131 EXOFACTO DL-TBOA HIGHSTIT Investigative Drug DTD0131 EXOFACTO DL-TBOA DESCRIPT DL-TBOA inhibits the activity of SLC1A3 DTD0131 EXOFACTO DL-TBOA MOACRIVE Inhibition DTD0131 EXOFACTO Etanercept HIGHSTIT Approved Drug DTD0131 EXOFACTO Etanercept DESCRIPT Etanercept induces the activity of SLC1A3 DTD0131 EXOFACTO Etanercept MOACRIVE Inducer DTD0131 EXOFACTO L-glutamic acid HIGHSTIT Approved Drug DTD0131 EXOFACTO L-glutamic acid DESCRIPT L-glutamic acid inhibits the transportation of D-Aspartate by SLC1A3 DTD0131 EXOFACTO L-glutamic acid MOACRIVE Inhibition DTD0131 EXOFACTO L-glutamic acid CELLLINE Human embryonic kidney 293 cells (HEK293)-EAAT1 DTD0131 EXOFACTO UCPH-101 HIGHSTIT Investigative Drug DTD0131 EXOFACTO UCPH-101 DESCRIPT UCPH-101 inhibits the activity of SLC1A3 DTD0131 EXOFACTO UCPH-101 MOACRIVE Inhibition DTD0132 TRANSPID DTD0132 DTD0132 GENENAME SLC1A4 DTD0132 PROTNAME Alanine/serine/cysteine/threonine transporter 1 DTD0132 GENEDBID 6509 DTD0132 UNIPROID P43007 DTD0132 EXOFACTO L-phenylglycine HIGHSTIT Investigative Drug DTD0132 EXOFACTO L-phenylglycine DESCRIPT L-phenylglycine inhibits the activity of SLC1A4 DTD0132 EXOFACTO L-phenylglycine MOACRIVE Inhibition DTD0133 TRANSPID DTD0133 DTD0133 GENENAME SLC1A5 DTD0133 PROTNAME Alanine/serine/cysteine/threonine transporter 2 DTD0133 GENEDBID 6510 DTD0133 UNIPROID Q15758 DTD0133 EXOFACTO [3H]Glutamine HIGHSTIT Investigative Drug DTD0133 EXOFACTO [3H]Glutamine DESCRIPT [3H]Glutamine induces the activity of SLC1A5 DTD0133 EXOFACTO [3H]Glutamine MOACRIVE Inducer DTD0133 EXOFACTO Benzylserine HIGHSTIT Investigative Drug DTD0133 EXOFACTO Benzylserine DESCRIPT Benzylserine inhibits the activity of SLC1A5 DTD0133 EXOFACTO Benzylserine MOACRIVE Inhibition DTD0133 EXOFACTO Insulin HIGHSTIT Approved Drug DTD0133 EXOFACTO Insulin DESCRIPT Insulin induces the activity of SLC1A5 DTD0133 EXOFACTO Insulin MOACRIVE Inducer DTD0133 EXOFACTO P-Nitrophenyl glutamyl anilide HIGHSTIT Investigative Drug DTD0133 EXOFACTO P-Nitrophenyl glutamyl anilide DESCRIPT P-Nitrophenyl glutamyl anilide inhibits the activity of SLC1A5 DTD0133 EXOFACTO P-Nitrophenyl glutamyl anilide MOACRIVE Inhibition DTD0134 TRANSPID DTD0134 DTD0134 GENENAME SLC1A6 DTD0134 PROTNAME Excitatory amino acid transporter 4 DTD0134 GENEDBID 6511 DTD0134 UNIPROID P48664 DTD0134 EXOFACTO DL-TBOA HIGHSTIT Investigative Drug DTD0134 EXOFACTO DL-TBOA DESCRIPT DL-TBOA inhibits the activity of SLC1A6 DTD0134 EXOFACTO DL-TBOA MOACRIVE Inhibition DTD0134 EXOFACTO Threo-3-methylglutamate HIGHSTIT Investigative Drug DTD0134 EXOFACTO Threo-3-methylglutamate DESCRIPT Threo-3-methylglutamate inhibits the activity of SLC1A6 DTD0134 EXOFACTO Threo-3-methylglutamate MOACRIVE Inhibition DTD0135 TRANSPID DTD0135 DTD0135 GENENAME SLC1A7 DTD0135 PROTNAME Excitatory amino acid transporter 5 DTD0135 GENEDBID 6512 DTD0135 UNIPROID O00341 DTD0135 EXOFACTO DL-TBOA HIGHSTIT Investigative Drug DTD0135 EXOFACTO DL-TBOA DESCRIPT DL-TBOA inhibits the activity of SLC1A7 DTD0135 EXOFACTO DL-TBOA MOACRIVE Inhibition DTD0137 TRANSPID DTD0137 DTD0137 GENENAME SLC20A2 DTD0137 PROTNAME Sodium-dependent phosphate transporter 2 DTD0137 GENEDBID 6575 DTD0137 UNIPROID Q08357 DTD0137 EXOFACTO Phosphonoformate HIGHSTIT Approved Drug DTD0137 EXOFACTO Phosphonoformate DESCRIPT Phosphonoformate inhibits the activity of SLC20A2 DTD0137 EXOFACTO Phosphonoformate MOACRIVE Inhibition DTD0151 TRANSPID DTD0151 DTD0151 GENENAME SLC22A4 DTD0151 PROTNAME Organic cation/carnitine transporter 1 DTD0151 GENEDBID 6583 DTD0151 UNIPROID Q9H015 DTD0151 EXOFACTO Cimetidine HIGHSTIT Approved Drug DTD0151 EXOFACTO Cimetidine DESCRIPT Cimetidine inhibits the activity of SLC22A4 DTD0151 EXOFACTO Cimetidine MOACRIVE Inhibition DTD0151 EXOFACTO L-carnitine HIGHSTIT Approved Drug DTD0151 EXOFACTO L-carnitine DESCRIPT L-carnitine inhibits the transportation of Tetraethylammonium by SLC22A4 DTD0151 EXOFACTO L-carnitine MOACRIVE Inhibition DTD0151 EXOFACTO L-carnitine CELLLINE Oocytes-OCTN1 DTD0151 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0151 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the transportation of Ergothioneine by SLC22A4 DTD0151 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0151 EXOFACTO Linagliptin CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Methimazole HIGHSTIT Approved Drug DTD0151 EXOFACTO Methimazole DESCRIPT Methimazole inhibits the transportation of Ergothioneine by SLC22A4 (Ki = 7520 microM) DTD0151 EXOFACTO Methimazole MOACRIVE Inhibition DTD0151 EXOFACTO Methimazole CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Nicotine HIGHSTIT Approved Drug DTD0151 EXOFACTO Nicotine DESCRIPT Nicotine inhibits the transportation of Tetraethylammonium by SLC22A4 DTD0151 EXOFACTO Nicotine MOACRIVE Inhibition DTD0151 EXOFACTO Nicotine CELLLINE Oocytes-OCTN1 DTD0151 EXOFACTO Ofloxacin HIGHSTIT Approved Drug DTD0151 EXOFACTO Ofloxacin DESCRIPT Ofloxacin inhibits the transportation of Tetraethylammonium by SLC22A4 DTD0151 EXOFACTO Ofloxacin MOACRIVE Inhibition DTD0151 EXOFACTO Ofloxacin CELLLINE Oocytes-OCTN1 DTD0151 EXOFACTO Procainamide HIGHSTIT Approved Drug DTD0151 EXOFACTO Procainamide DESCRIPT Procainamide inhibits the transportation of Tetraethylammonium by SLC22A4 (IC50 < 1000 microM) DTD0151 EXOFACTO Procainamide MOACRIVE Inhibition DTD0151 EXOFACTO Procainamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Pyrilamide HIGHSTIT Approved Drug DTD0151 EXOFACTO Pyrilamide DESCRIPT Pyrilamide inhibits the transportation of Ergothioneine by SLC22A4 (Ki = 182 microM) DTD0151 EXOFACTO Pyrilamide DESCRIPT Pyrilamide inhibits the transportation of Tetraethylammonium by SLC22A4 DTD0151 EXOFACTO Pyrilamide MOACRIVE Inhibition DTD0151 EXOFACTO Pyrilamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Pyrilamide CELLLINE Oocytes-OCTN1 DTD0151 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0151 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Tetraethylammonium by SLC22A4 (IC50 < 1000 microM) DTD0151 EXOFACTO Quinine DESCRIPT Quinine inhibits the transportation of Ergothioneine by SLC22A4 DTD0151 EXOFACTO Quinine MOACRIVE Inhibition DTD0151 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Thioperamide HIGHSTIT Discontinued Drug DTD0151 EXOFACTO Thioperamide DESCRIPT Thioperamide inhibits the transportation of Ergothioneine by SLC22A4 (Ki = 254 microM) DTD0151 EXOFACTO Thioperamide MOACRIVE Inhibition DTD0151 EXOFACTO Thioperamide CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0151 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0151 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of Ergothioneine by SLC22A4 (Ki = 10.8 microM) DTD0151 EXOFACTO Verapamil MOACRIVE Inhibition DTD0151 EXOFACTO Verapamil CELLLINE Human embryonic kidney 293 cells (HEK293)-OCTN1 DTD0158 TRANSPID DTD0158 DTD0158 GENENAME SLC23A1 DTD0158 PROTNAME Sodium-dependent vitamin C transporter 1 DTD0158 GENEDBID 9963 DTD0158 UNIPROID Q9UHI7 DTD0158 EXOFACTO Phloretin HIGHSTIT Investigative Drug DTD0158 EXOFACTO Phloretin DESCRIPT Phloretin inhibits the activity of SLC23A1 DTD0158 EXOFACTO Phloretin MOACRIVE Inhibition DTD0158 EXOFACTO Vitamin C HIGHSTIT Approved Drug DTD0158 EXOFACTO Vitamin C DESCRIPT Vitamin C modulates the activity of SLC23A1 DTD0158 EXOFACTO Vitamin C MOACRIVE Modulator DTD0159 TRANSPID DTD0159 DTD0159 GENENAME SLC23A2 DTD0159 PROTNAME Sodium-dependent vitamin C transporter 2 DTD0159 GENEDBID 9962 DTD0159 UNIPROID Q9UGH3 DTD0159 EXOFACTO Chenodeoxycholic acid HIGHSTIT Approved Drug DTD0159 EXOFACTO Chenodeoxycholic acid DESCRIPT Chenodeoxycholic acid activates the activity of SLC23A2 DTD0159 EXOFACTO Chenodeoxycholic acid MOACRIVE Activator DTD0159 EXOFACTO Vitamin C HIGHSTIT Approved Drug DTD0159 EXOFACTO Vitamin C DESCRIPT Vitamin C modulates the activity of SLC23A2 DTD0159 EXOFACTO Vitamin C MOACRIVE Modulator DTD0168 TRANSPID DTD0168 DTD0168 GENENAME SLC25A10 DTD0168 PROTNAME Mitochondrial dicarboxylate carrier DTD0168 GENEDBID 1468 DTD0168 UNIPROID Q9UBX3 DTD0168 EXOFACTO Metformin HIGHSTIT Approved Drug DTD0168 EXOFACTO Metformin DESCRIPT Metformin inhibits the activity of SLC25A10 DTD0168 EXOFACTO Metformin MOACRIVE Inhibition DTD0168 EXOFACTO Metformin CELLLINE A549 cell lines-DIC DTD0180 TRANSPID DTD0180 DTD0180 GENENAME SLC25A20 DTD0180 PROTNAME Carnitine/acylcarnitine translocase DTD0180 GENEDBID 788 DTD0180 UNIPROID O43772 DTD0180 EXOFACTO Mercury ion HIGHSTIT Environmental toxicant DTD0180 EXOFACTO Mercury ion DESCRIPT Mercury ion inhibits the activity of SLC25A20 (IC50 = 90 microM) DTD0180 EXOFACTO Mercury ion MOACRIVE Inhibition DTD0180 EXOFACTO Mercury ion CELLLINE Human cervical cancer cell line (Hela)-CACT DTD0180 EXOFACTO Methyl mercury ion HIGHSTIT Environmental toxicant DTD0180 EXOFACTO Methyl mercury ion DESCRIPT Methyl mercury ion inhibits the activity of SLC25A20 (IC50 = 1237 microM) DTD0180 EXOFACTO Methyl mercury ion MOACRIVE Inhibition DTD0180 EXOFACTO Methyl mercury ion CELLLINE Human cervical cancer cell line (Hela)-CACT DTD0185 TRANSPID DTD0185 DTD0185 GENENAME SLC25A24 DTD0185 PROTNAME Calcium-binding mitochondrial carrier protein SCaMC-1 DTD0185 GENEDBID 29957 DTD0185 UNIPROID Q6NUK1 DTD0185 EXOFACTO Albendazole HIGHSTIT Approved Drug DTD0185 EXOFACTO Albendazole DESCRIPT Albendazole induces the activity of SLC25A24 DTD0185 EXOFACTO Albendazole MOACRIVE Inducer DTD0185 EXOFACTO Albendazole CELLLINE Liver cells DTD0193 TRANSPID DTD0193 DTD0193 GENENAME SLC25A31 DTD0193 PROTNAME Adenine nucleotide translocator 4 DTD0193 GENEDBID 83447 DTD0193 UNIPROID Q9H0C2 DTD0193 EXOFACTO 2,2'-Methanediylbis (4-nitrophenol) HIGHSTIT Investigative Drug DTD0193 EXOFACTO 2,2'-Methanediylbis (4-nitrophenol) DESCRIPT 2,2'-Methanediylbis(4-nitrophenol) inhibits the activity of SLC25A31 (IC50 = 1.4 microM) DTD0193 EXOFACTO 2,2'-Methanediylbis (4-nitrophenol) MOACRIVE Inhibition DTD0193 EXOFACTO 2,2'-Methanediylbis (4-nitrophenol) CELLLINE Meiotic germ cells DTD0231 TRANSPID DTD0231 DTD0231 GENENAME SLC26A3 DTD0231 PROTNAME Chloride anion exchanger DTD0231 GENEDBID 1811 DTD0231 UNIPROID P40879 DTD0231 EXOFACTO Dimethylcoumarin DRAinh-A250 HIGHSTIT Investigative Drug DTD0231 EXOFACTO Dimethylcoumarin DRAinh-A250 DESCRIPT The dimethylcoumarin DRAinh-A250 inhibits the transportation of Chloride ion by SLC26A3 (IC50 = 0.2 microM) DTD0231 EXOFACTO Dimethylcoumarin DRAinh-A250 MOACRIVE Inhibition DTD0231 EXOFACTO Dimethylcoumarin DRAinh-A250 CELLLINE Fischer rat thyroid (FRT) cells DTD0234 TRANSPID DTD0234 DTD0234 GENENAME SLC26A6 DTD0234 PROTNAME Anion exchange transporter DTD0234 GENEDBID 65010 DTD0234 UNIPROID Q9BXS9 DTD0234 EXOFACTO Helicobacter pylori HIGHSTIT Bacterium DTD0234 EXOFACTO Helicobacter pylori DESCRIPT Helicobacter pylori infection inhibits the activity of SLC26A6 DTD0234 EXOFACTO Helicobacter pylori MOACRIVE Inhibition DTD0234 EXOFACTO Helicobacter pylori CELLLINE Human duodenal epithelial cells (SCBN)-SLC26A6 DTD0235 TRANSPID DTD0235 DTD0235 GENENAME SLC26A7 DTD0235 PROTNAME Anion exchange transporter DTD0235 GENEDBID 115111 DTD0235 UNIPROID Q8TE54 DTD0235 EXOFACTO 5-Nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB) HIGHSTIT Investigative Drug DTD0235 EXOFACTO 5-Nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB) DESCRIPT 5-Nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB) (100 microM) inhibits the activity of SLC26A7 DTD0235 EXOFACTO 5-Nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB) MOACRIVE Inhibition DTD0235 EXOFACTO 5-Nitro-2-(3-phenylpropyl-amino)benzoic acid (NPPB) CELLLINE Xenopus laevis oocytes-SLC26A7 DTD0237 TRANSPID DTD0237 DTD0237 GENENAME SLC26A9 DTD0237 PROTNAME Anion transporter/exchanger protein 9 DTD0237 GENEDBID 115019 DTD0237 UNIPROID Q7LBE3 DTD0237 EXOFACTO 4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid HIGHSTIT Investigative Drug DTD0237 EXOFACTO 4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid DESCRIPT 4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid inhibits the transportation of Chloride ion by SLC26A9 DTD0237 EXOFACTO 4,4''-diisothiocyanato-stilbene-2,2''-disulfonic acid MOACRIVE Inhibition DTD0237 EXOFACTO NS 3623 HIGHSTIT Investigative Drug DTD0237 EXOFACTO NS 3623 DESCRIPT NS 3623 inhibits the transportation of Chloride ion by SLC26A9 DTD0237 EXOFACTO NS 3623 MOACRIVE Inhibition DTD0238 TRANSPID DTD0238 DTD0238 GENENAME SLC27A1 DTD0238 PROTNAME Fatty acid transport protein 1 DTD0238 GENEDBID 376497 DTD0238 UNIPROID Q6PCB7 DTD0238 EXOFACTO Lipofermata HIGHSTIT Investigative Drug DTD0238 EXOFACTO Lipofermata DESCRIPT Lipofermata inhibits the transportation of Lipid by SLC27A1 DTD0238 EXOFACTO Lipofermata MOACRIVE Inhibition DTD0238 EXOFACTO Lipofermata CELLLINE A375 and SKMel28 cells-FATP1 DTD0238 EXOFACTO Tolcapone HIGHSTIT Approved Drug DTD0238 EXOFACTO Tolcapone DESCRIPT Tolcapone induces the transportation of Palmitate by increasing mRNA expression of SLC27A1 DTD0238 EXOFACTO Tolcapone MOACRIVE Inducer DTD0238 EXOFACTO Tolcapone CELLLINE Human hepatoma HepaRG cells DTD0244 TRANSPID DTD0244 DTD0244 GENENAME SLC28A1 DTD0244 PROTNAME Concentrative nucleoside transporter 1 DTD0244 GENEDBID 9154 DTD0244 UNIPROID O00337 DTD0244 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0244 EXOFACTO Adenosine DESCRIPT Adenosine inhibits the transportation of Uridine by SLC28A1 DTD0244 EXOFACTO Adenosine MOACRIVE Inhibition DTD0244 EXOFACTO Tecadenoson HIGHSTIT Discontinued Drug DTD0244 EXOFACTO Tecadenoson DESCRIPT Tecadenoson inhibits the transportation of Uridine by SLC28A1 DTD0244 EXOFACTO Tecadenoson MOACRIVE Inhibition DTD0244 EXOFACTO Uridine HIGHSTIT Approved Drug DTD0244 EXOFACTO Uridine DESCRIPT Uridine inhibits the activity of SLC28A1 DTD0244 EXOFACTO Uridine MOACRIVE Inhibition DTD0245 TRANSPID DTD0245 DTD0245 GENENAME SLC28A2 DTD0245 PROTNAME Concentrative nucleoside transporter 2 DTD0245 GENEDBID 9153 DTD0245 UNIPROID O43868 DTD0245 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0245 EXOFACTO Adenosine DESCRIPT Adenosine inhibits the transportation of Uridine by SLC28A2 DTD0245 EXOFACTO Adenosine MOACRIVE Inhibition DTD0245 EXOFACTO Floxuridine HIGHSTIT Approved Drug DTD0245 EXOFACTO Floxuridine DESCRIPT Floxuridine inhibits the transportation of Inosine by SLC28A2 DTD0245 EXOFACTO Floxuridine MOACRIVE Inhibition DTD0245 EXOFACTO Floxuridine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-CNT2 DTD0245 EXOFACTO Phlorizin HIGHSTIT Investigative Drug DTD0245 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of Inosine by SLC28A2 DTD0245 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0245 EXOFACTO Phlorizin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-CNT2 DTD0245 EXOFACTO Tecadenoson HIGHSTIT Discontinued Drug DTD0245 EXOFACTO Tecadenoson DESCRIPT Tecadenoson inhibits the transportation of Uridine by SLC28A2 DTD0245 EXOFACTO Tecadenoson MOACRIVE Inhibition DTD0245 EXOFACTO Trichostatin A HIGHSTIT Approved Drug DTD0245 EXOFACTO Trichostatin A DESCRIPT Trichostatin A inhibits histone deacetylase, which then enhances Cladribine's transportation via increasing the histone acethylation level of SLC28A2 DTD0245 EXOFACTO Trichostatin A MOACRIVE Inducer DTD0245 EXOFACTO Trichostatin A CELLLINE CRC cell lines HCT15 and HT29 DTD0245 EXOFACTO Uridine HIGHSTIT Approved Drug DTD0245 EXOFACTO Uridine DESCRIPT Uridine inhibits the activity of SLC28A2 DTD0245 EXOFACTO Uridine MOACRIVE Inhibition DTD0246 TRANSPID DTD0246 DTD0246 GENENAME SLC28A3 DTD0246 PROTNAME Concentrative Na(+)-nucleoside cotransporter 3 DTD0246 GENEDBID 64078 DTD0246 UNIPROID Q9HAS3 DTD0246 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0246 EXOFACTO Adenosine DESCRIPT Adenosine inhibits the transportation of Uridine by SLC28A3 DTD0246 EXOFACTO Adenosine MOACRIVE Inhibition DTD0246 EXOFACTO Inosine HIGHSTIT Drug in Phase 3 Trial DTD0246 EXOFACTO Inosine DESCRIPT Inosine inhibits the activity of SLC28A3 DTD0246 EXOFACTO Inosine MOACRIVE Inhibition DTD0246 EXOFACTO Phloretin HIGHSTIT Investigative Drug DTD0246 EXOFACTO Phloretin DESCRIPT Phloretin inhibits the transportation of Uridine by SLC28A3 DTD0246 EXOFACTO Phloretin MOACRIVE Inhibition DTD0246 EXOFACTO Phlorizin HIGHSTIT Investigative Drug DTD0246 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of Uridine by SLC28A3 DTD0246 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0246 EXOFACTO Tecadenoson HIGHSTIT Discontinued Drug DTD0246 EXOFACTO Tecadenoson DESCRIPT Tecadenoson inhibits the transportation of Uridine by SLC28A3 DTD0246 EXOFACTO Tecadenoson MOACRIVE Inhibition DTD0246 EXOFACTO Uridine HIGHSTIT Approved Drug DTD0246 EXOFACTO Uridine DESCRIPT Uridine inhibits the activity of SLC28A3 DTD0246 EXOFACTO Uridine MOACRIVE Inhibition DTD0247 TRANSPID DTD0247 DTD0247 GENENAME SLC29A1 DTD0247 PROTNAME Equilibrative nucleoside transporter 1 DTD0247 GENEDBID 2030 DTD0247 UNIPROID Q99808 DTD0247 EXOFACTO 6-Benzylthioinosine HIGHSTIT Investigative Drug DTD0247 EXOFACTO 6-Benzylthioinosine DESCRIPT 6-Benzylthioinosine inhibits the transportation of 4-Nitrobenzylthioinosine by SLC29A1 DTD0247 EXOFACTO 6-Benzylthioinosine DESCRIPT 6-Benzylthioinosine inhibits the activity of SLC29A1 DTD0247 EXOFACTO 6-Benzylthioinosine MOACRIVE Inhibition DTD0247 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0247 EXOFACTO Adenosine DESCRIPT Adenosine inhibits the transportation of Uridine by SLC29A1 DTD0247 EXOFACTO Adenosine MOACRIVE Inhibition DTD0247 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0247 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the activity of SLC29A1 DTD0247 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0247 EXOFACTO Dipyridamole CELLLINE Myelogenous leukemia cell line (K562)-ENT1 DTD0247 EXOFACTO Lidoflazine HIGHSTIT Approved Drug DTD0247 EXOFACTO Lidoflazine DESCRIPT Lidoflazine inhibits the activity of SLC29A1 DTD0247 EXOFACTO Lidoflazine MOACRIVE Inhibition DTD0247 EXOFACTO Lidoflazine CELLLINE Myelogenous leukemia cell line (K562)-ENT1 DTD0247 EXOFACTO N6-cyclopentyladenosine HIGHSTIT Investigative Drug DTD0247 EXOFACTO N6-cyclopentyladenosine DESCRIPT N6-cyclopentyladenosine inhibits the transportation of 4-Nitrobenzylthioinosine by SLC29A1 DTD0247 EXOFACTO N6-cyclopentyladenosine MOACRIVE Inhibition DTD0247 EXOFACTO Phlorizin HIGHSTIT Investigative Drug DTD0247 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of Uridine by SLC29A1 DTD0247 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0247 EXOFACTO Sulindac HIGHSTIT Approved Drug DTD0247 EXOFACTO Sulindac DESCRIPT Sulindac inhibits the activity of SLC29A1 DTD0247 EXOFACTO Sulindac MOACRIVE Inhibition DTD0247 EXOFACTO Tecadenoson HIGHSTIT Discontinued Drug DTD0247 EXOFACTO Tecadenoson DESCRIPT Tecadenoson inhibits the transportation of Uridine by SLC29A1 DTD0247 EXOFACTO Tecadenoson MOACRIVE Inhibition DTD0247 EXOFACTO Ticagrelor HIGHSTIT Approved Drug DTD0247 EXOFACTO Ticagrelor DESCRIPT Ticagrelor inhibits the activity of SLC29A1 DTD0247 EXOFACTO Ticagrelor MOACRIVE Inhibition DTD0247 EXOFACTO Uridine HIGHSTIT Approved Drug DTD0247 EXOFACTO Uridine DESCRIPT Uridine inhibits the activity of SLC29A1 DTD0247 EXOFACTO Uridine MOACRIVE Inhibition DTD0248 TRANSPID DTD0248 DTD0248 GENENAME SLC29A2 DTD0248 PROTNAME Equilibrative nucleoside transporter 2 DTD0248 GENEDBID 3177 DTD0248 UNIPROID Q14542 DTD0248 EXOFACTO Adenosine HIGHSTIT Approved Drug DTD0248 EXOFACTO Adenosine DESCRIPT Adenosine inhibits the transportation of Uridine by SLC29A2 DTD0248 EXOFACTO Adenosine MOACRIVE Inhibition DTD0248 EXOFACTO Tecadenoson HIGHSTIT Discontinued Drug DTD0248 EXOFACTO Tecadenoson DESCRIPT Tecadenoson inhibits the transportation of Uridine by SLC29A2 DTD0248 EXOFACTO Tecadenoson MOACRIVE Inhibition DTD0248 EXOFACTO Uridine HIGHSTIT Approved Drug DTD0248 EXOFACTO Uridine DESCRIPT Uridine inhibits the activity of SLC29A2 DTD0248 EXOFACTO Uridine MOACRIVE Inhibition DTD0250 TRANSPID DTD0250 DTD0250 GENENAME SLC29A4 DTD0250 PROTNAME Equilibrative nucleoside transporter 4 DTD0250 GENEDBID 222962 DTD0250 UNIPROID Q7RTT9 DTD0250 EXOFACTO Decynium 22 HIGHSTIT Investigative Drug DTD0250 EXOFACTO Decynium 22 DESCRIPT Decynium 22 inhibits the activity of SLC29A4 DTD0250 EXOFACTO Decynium 22 MOACRIVE Inhibition DTD0250 EXOFACTO Dipyridamole HIGHSTIT Approved Drug DTD0250 EXOFACTO Dipyridamole DESCRIPT Dipyridamole inhibits the activity of SLC29A4 DTD0250 EXOFACTO Dipyridamole MOACRIVE Inhibition DTD0251 TRANSPID DTD0251 DTD0251 GENENAME SLC2A1 DTD0251 PROTNAME Glucose transporter type 1 DTD0251 GENEDBID 6513 DTD0251 UNIPROID P11166 DTD0251 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0251 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the transportation of 3-O-methylglucose by SLC2A1 (Ki = 3500 microM) DTD0251 EXOFACTO Caffeine MOACRIVE Inhibition DTD0251 EXOFACTO Caffeine CELLLINE Human erythrocytes-GLUT1 DTD0251 EXOFACTO Dapagliflozin HIGHSTIT Approved Drug DTD0251 EXOFACTO Dapagliflozin DESCRIPT Dapagliflozin inhibits the transportation of 2-Deoxyglucose by SLC2A1 DTD0251 EXOFACTO Dapagliflozin MOACRIVE Inhibition DTD0251 EXOFACTO Dihydroergotamine HIGHSTIT Approved Drug DTD0251 EXOFACTO Dihydroergotamine DESCRIPT Dihydroergotamine induces the activity of SLC2A1 DTD0251 EXOFACTO Dihydroergotamine MOACRIVE Inducer DTD0251 EXOFACTO Ergotamine HIGHSTIT Approved Drug DTD0251 EXOFACTO Ergotamine DESCRIPT Ergotamine induces the activity of SLC2A1 DTD0251 EXOFACTO Ergotamine MOACRIVE Inducer DTD0251 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0251 EXOFACTO Pioglitazone DESCRIPT Pioglitazone induces the activity of SLC2A1 DTD0251 EXOFACTO Pioglitazone MOACRIVE Inducer DTD0251 EXOFACTO Red wine HIGHSTIT Dietary Constituent DTD0251 EXOFACTO Red wine DESCRIPT Red wine inhibits the activity of SLC2A1 DTD0251 EXOFACTO Red wine MOACRIVE Inhibition DTD0251 EXOFACTO Red wine CELLLINE Human erythrocytes-GLUT1 DTD0251 EXOFACTO Tolazamide HIGHSTIT Approved Drug DTD0251 EXOFACTO Tolazamide DESCRIPT Tolazamide induces the activity of SLC2A1 DTD0251 EXOFACTO Tolazamide MOACRIVE Inducer DTD0257 TRANSPID DTD0257 DTD0257 GENENAME SLC2A2 DTD0257 PROTNAME Glucose transporter type 2 DTD0257 GENEDBID 6514 DTD0257 UNIPROID P11168 DTD0257 EXOFACTO Pentoxifylline HIGHSTIT Approved Drug DTD0257 EXOFACTO Pentoxifylline DESCRIPT Pentoxifylline induces the activity of SLC2A2 DTD0257 EXOFACTO Pentoxifylline MOACRIVE Inducer DTD0258 TRANSPID DTD0258 DTD0258 GENENAME SLC2A3 DTD0258 PROTNAME Glucose transporter type 3 DTD0258 GENEDBID 6515 DTD0258 UNIPROID P11169 DTD0258 EXOFACTO Bevacizumab HIGHSTIT Approved Drug DTD0258 EXOFACTO Bevacizumab DESCRIPT Bevacizumab induces the transportation of Glucose by SLC2A3 DTD0258 EXOFACTO Bevacizumab MOACRIVE Inducer DTD0262 TRANSPID DTD0262 DTD0262 GENENAME SLC2A4 DTD0262 PROTNAME Glucose transporter type 4 DTD0262 GENEDBID 6517 DTD0262 UNIPROID P14672 DTD0262 EXOFACTO Dapagliflozin HIGHSTIT Approved Drug DTD0262 EXOFACTO Dapagliflozin DESCRIPT Dapagliflozin inhibits the transportation of 2-Deoxyglucose by SLC2A4 DTD0262 EXOFACTO Dapagliflozin MOACRIVE Inhibition DTD0262 EXOFACTO Diazoxide HIGHSTIT Approved Drug DTD0262 EXOFACTO Diazoxide DESCRIPT Diazoxide induces the activity of SLC2A4 DTD0262 EXOFACTO Diazoxide MOACRIVE Inducer DTD0262 EXOFACTO Salmeterol xinafoate HIGHSTIT Approved Drug DTD0262 EXOFACTO Salmeterol xinafoate DESCRIPT Salmeterol xinafoate inhibits the activity of SLC2A4 DTD0262 EXOFACTO Salmeterol xinafoate MOACRIVE Inhibition DTD0263 TRANSPID DTD0263 DTD0263 GENENAME SLC2A5 DTD0263 PROTNAME Glucose transporter type 5 DTD0263 GENEDBID 6518 DTD0263 UNIPROID P22732 DTD0263 EXOFACTO N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) HIGHSTIT Investigative Drug DTD0263 EXOFACTO N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) DESCRIPT N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) inhibits the transportation of Fructose by SLC2A5 (Ki = 3.2 microM) DTD0263 EXOFACTO N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) MOACRIVE Inhibition DTD0263 EXOFACTO N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine (MSNBA) CELLLINE Human breast adenocarcinoma cell line (MCF-7)-GLUT5 DTD0269 TRANSPID DTD0269 DTD0269 GENENAME SLC30A1 DTD0269 PROTNAME Zinc transporter 1 DTD0269 GENEDBID 7779 DTD0269 UNIPROID Q9Y6M5 DTD0269 EXOFACTO Gallium nitrate HIGHSTIT Approved Drug DTD0269 EXOFACTO Gallium nitrate DESCRIPT Gallium nitrate induces the activity of SLC30A1 DTD0269 EXOFACTO Gallium nitrate MOACRIVE Inducer DTD0269 EXOFACTO Zinc HIGHSTIT Environmental toxicant DTD0269 EXOFACTO Zinc DESCRIPT Zinc induces the activity of SLC30A1 DTD0269 EXOFACTO Zinc MOACRIVE Inducer DTD0269 EXOFACTO Zinc CELLLINE Human prostate cancer cell lines (LNCaP and PC-3) DTD0278 TRANSPID DTD0278 DTD0278 GENENAME SLC31A1 DTD0278 PROTNAME High affinity copper uptake protein 1 DTD0278 GENEDBID 1317 DTD0278 UNIPROID O15431 DTD0278 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0278 EXOFACTO Cisplatin DESCRIPT Cisplatin inhibits the activity of SLC31A1 DTD0278 EXOFACTO Cisplatin MOACRIVE Inhibition DTD0278 EXOFACTO Cupric sulfate HIGHSTIT Approved Drug DTD0278 EXOFACTO Cupric sulfate DESCRIPT Cupric sulfate inhibits the activity of SLC31A1 DTD0278 EXOFACTO Cupric sulfate MOACRIVE Inhibition DTD0278 EXOFACTO Estradiol HIGHSTIT Approved Drug DTD0278 EXOFACTO Estradiol DESCRIPT Estradiol induces the activity of SLC31A1 DTD0278 EXOFACTO Estradiol MOACRIVE Inducer DTD0281 TRANSPID DTD0281 DTD0281 GENENAME SLC32A1 DTD0281 PROTNAME Vesicular inhibitory amino acid transporter DTD0281 GENEDBID 140679 DTD0281 UNIPROID Q9H598 DTD0281 EXOFACTO DQlIdElW HIGHSTIT Investigative Drug DTD0281 EXOFACTO DQlIdElW DESCRIPT DQlIdElW inhibits the activity of SLC32A1 (Ki = 828 +/- 252 microM) DTD0281 EXOFACTO DQlIdElW MOACRIVE Inhibition DTD0281 EXOFACTO Quinoline-2,4-dicarboxylic acids HIGHSTIT Investigative Drug DTD0281 EXOFACTO Quinoline-2,4-dicarboxylic acids DESCRIPT Quinoline-2,4-dicarboxylic acids inhibits the activity of SLC32A1 DTD0281 EXOFACTO Quinoline-2,4-dicarboxylic acids MOACRIVE Inhibition DTD0284 TRANSPID DTD0284 DTD0284 GENENAME SLC34A1 DTD0284 PROTNAME Sodium-dependent phosphate transport protein 2A DTD0284 GENEDBID 6569 DTD0284 UNIPROID Q06495 DTD0284 EXOFACTO PF-06869206 HIGHSTIT Investigative Drug DTD0284 EXOFACTO PF-06869206 DESCRIPT PF-06869206 inhibits the activity of SLC34A1 DTD0284 EXOFACTO PF-06869206 MOACRIVE Inhibition DTD0285 TRANSPID DTD0285 DTD0285 GENENAME SLC34A2 DTD0285 PROTNAME Sodium-dependent phosphate transport protein 2B DTD0285 GENEDBID 10568 DTD0285 UNIPROID O95436 DTD0285 EXOFACTO Phosphonoformate HIGHSTIT Approved Drug DTD0285 EXOFACTO Phosphonoformate DESCRIPT Phosphonoformate inhibits the activity of SLC34A2 DTD0285 EXOFACTO Phosphonoformate MOACRIVE Inhibition DTD0295 TRANSPID DTD0295 DTD0295 GENENAME SLC35B4 DTD0295 PROTNAME UDP-xylose and UDP-N-acetylglucosamine transporter DTD0295 GENEDBID 84912 DTD0295 UNIPROID Q969S0 DTD0295 EXOFACTO Glucose HIGHSTIT Natural Product DTD0295 EXOFACTO Glucose DESCRIPT Glucose induces the activity of SLC35B4 DTD0295 EXOFACTO Glucose MOACRIVE Inducer DTD0295 EXOFACTO Glucose CELLLINE Human hepatocellular carcinoma cell line (HepG2)-SLC35B4 DTD0318 TRANSPID DTD0318 DTD0318 GENENAME SLC36A1 DTD0318 PROTNAME Proton-coupled amino acid transporter 1 DTD0318 GENEDBID 206358 DTD0318 UNIPROID Q7Z2H8 DTD0318 EXOFACTO 5-Hydroxy-L-tryptophan HIGHSTIT Investigative Drug DTD0318 EXOFACTO 5-Hydroxy-L-tryptophan DESCRIPT 5-Hydroxy-L-tryptophan inhibits the activity of SLC36A1 DTD0318 EXOFACTO 5-Hydroxy-L-tryptophan MOACRIVE Inhibition DTD0318 EXOFACTO Aminocaproic acid HIGHSTIT Approved Drug DTD0318 EXOFACTO Aminocaproic acid DESCRIPT Aminocaproic acid inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Aminocaproic acid MOACRIVE Inhibition DTD0318 EXOFACTO Aminocaproic acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Artemisinin HIGHSTIT Approved Drug DTD0318 EXOFACTO Artemisinin DESCRIPT Artemisinin inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Artemisinin MOACRIVE Inhibition DTD0318 EXOFACTO Artemisinin CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Caffeine HIGHSTIT Approved Drug DTD0318 EXOFACTO Caffeine DESCRIPT Caffeine inhibits the activity of SLC36A1 DTD0318 EXOFACTO Caffeine MOACRIVE Inhibition DTD0318 EXOFACTO Creatine ALS-08 HIGHSTIT Drug in Phase 3 Trial DTD0318 EXOFACTO Creatine ALS-08 DESCRIPT Creatine ALS-08 inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Creatine ALS-08 MOACRIVE Inhibition DTD0318 EXOFACTO Creatine ALS-08 CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Cycloserine HIGHSTIT Approved Drug DTD0318 EXOFACTO Cycloserine DESCRIPT Cycloserine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Cycloserine MOACRIVE Inhibition DTD0318 EXOFACTO Cycloserine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Gamma-aminobutyric acid HIGHSTIT Drug in Phase 2 Trial DTD0318 EXOFACTO Gamma-aminobutyric acid DESCRIPT Gamma-aminobutyric acid inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Gamma-aminobutyric acid MOACRIVE Inhibition DTD0318 EXOFACTO Gamma-aminobutyric acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Gamma-hydroxybutyric acid HIGHSTIT Approved Drug DTD0318 EXOFACTO Gamma-hydroxybutyric acid DESCRIPT Gamma-hydroxybutyric acid inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Gamma-hydroxybutyric acid MOACRIVE Inhibition DTD0318 EXOFACTO Gamma-hydroxybutyric acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Glycine HIGHSTIT Approved Drug DTD0318 EXOFACTO Glycine DESCRIPT Glycine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Glycine MOACRIVE Inhibition DTD0318 EXOFACTO Glycine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Infant formula HIGHSTIT Dietary Constituent DTD0318 EXOFACTO Infant formula DESCRIPT Infant formula inhibits the transportation of Vigabatrin by SLC36A1 DTD0318 EXOFACTO Infant formula MOACRIVE Inhibition DTD0318 EXOFACTO Infant formula CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Isonipecotic acid HIGHSTIT Investigative Drug DTD0318 EXOFACTO Isonipecotic acid DESCRIPT Isonipecotic acid inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Isonipecotic acid MOACRIVE Inhibition DTD0318 EXOFACTO Isonipecotic acid CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO L-alanine HIGHSTIT Approved Drug DTD0318 EXOFACTO L-alanine DESCRIPT L-alanine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO L-alanine MOACRIVE Inhibition DTD0318 EXOFACTO L-alanine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO L-isoleucine HIGHSTIT Investigative Drug DTD0318 EXOFACTO L-isoleucine DESCRIPT L-isoleucine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO L-isoleucine MOACRIVE Inhibition DTD0318 EXOFACTO L-isoleucine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO L-leucine HIGHSTIT Investigative Drug DTD0318 EXOFACTO L-leucine DESCRIPT L-leucine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO L-leucine MOACRIVE Inhibition DTD0318 EXOFACTO L-leucine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO L-proline HIGHSTIT Approved Drug DTD0318 EXOFACTO L-proline DESCRIPT L-proline inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO L-proline MOACRIVE Inhibition DTD0318 EXOFACTO L-proline CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO L-serine HIGHSTIT Investigative Drug DTD0318 EXOFACTO L-serine DESCRIPT L-serine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO L-serine MOACRIVE Inhibition DTD0318 EXOFACTO L-serine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Piperidine HIGHSTIT Investigative Drug DTD0318 EXOFACTO Piperidine DESCRIPT Piperidine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Piperidine MOACRIVE Inhibition DTD0318 EXOFACTO Piperidine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Procysteine HIGHSTIT Drug in Phase 2 Trial DTD0318 EXOFACTO Procysteine DESCRIPT Procysteine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Procysteine MOACRIVE Inhibition DTD0318 EXOFACTO Procysteine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Sarcosine HIGHSTIT Investigative Drug DTD0318 EXOFACTO Sarcosine DESCRIPT Sarcosine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Sarcosine MOACRIVE Inhibition DTD0318 EXOFACTO Sarcosine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Taurine HIGHSTIT Investigative Drug DTD0318 EXOFACTO Taurine DESCRIPT Taurine inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Taurine MOACRIVE Inhibition DTD0318 EXOFACTO Taurine CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0318 EXOFACTO Tramiprosate HIGHSTIT Drug in Phase 3 Trial DTD0318 EXOFACTO Tramiprosate DESCRIPT Tramiprosate inhibits the transportation of L-proline by SLC36A1 DTD0318 EXOFACTO Tramiprosate MOACRIVE Inhibition DTD0318 EXOFACTO Tramiprosate CELLLINE Human enterocyte-like 2 cell (Caco-2)-PAT1 DTD0319 TRANSPID DTD0319 DTD0319 GENENAME SLC36A2 DTD0319 PROTNAME Proton-coupled amino acid transporter 2 DTD0319 GENEDBID 153201 DTD0319 UNIPROID Q495M3 DTD0319 EXOFACTO 5-Hydroxy-L-tryptophan HIGHSTIT Investigative Drug DTD0319 EXOFACTO 5-Hydroxy-L-tryptophan DESCRIPT 5-Hydroxy-L-tryptophan inhibits the activity of SLC36A2 DTD0319 EXOFACTO 5-Hydroxy-L-tryptophan MOACRIVE Inhibition DTD0319 EXOFACTO NOX-200 HIGHSTIT Discontinued Drug DTD0319 EXOFACTO NOX-200 DESCRIPT NOX-200 inhibits the activity of SLC36A2 DTD0319 EXOFACTO NOX-200 MOACRIVE Inhibition DTD0325 TRANSPID DTD0325 DTD0325 GENENAME SLC37A4 DTD0325 PROTNAME Glucose-6-phosphate translocase DTD0325 GENEDBID 2542 DTD0325 UNIPROID O43826 DTD0325 EXOFACTO Chlorogenic acid HIGHSTIT Investigative Drug DTD0325 EXOFACTO Chlorogenic acid DESCRIPT Chlorogenic acid inhibits the activity of SLC37A4 DTD0325 EXOFACTO Chlorogenic acid MOACRIVE Inhibition DTD0326 TRANSPID DTD0326 DTD0326 GENENAME SLC38A1 DTD0326 PROTNAME Sodium-coupled neutral amino acid transporter 1 DTD0326 GENEDBID 81539 DTD0326 UNIPROID Q9H2H9 DTD0326 EXOFACTO [3H]Alanine HIGHSTIT Investigative Drug DTD0326 EXOFACTO [3H]Alanine DESCRIPT [3H]Alanine modulates the activity of SLC38A1 DTD0326 EXOFACTO [3H]Alanine MOACRIVE Modulator DTD0329 TRANSPID DTD0329 DTD0329 GENENAME SLC38A2 DTD0329 PROTNAME Sodium-coupled neutral amino acid transporter 2 DTD0329 GENEDBID 54407 DTD0329 UNIPROID Q96QD8 DTD0329 EXOFACTO [3H]Alanine HIGHSTIT Investigative Drug DTD0329 EXOFACTO [3H]Alanine DESCRIPT [3H]Alanine modulates the activity of SLC38A2 DTD0329 EXOFACTO [3H]Alanine MOACRIVE Modulator DTD0330 TRANSPID DTD0330 DTD0330 GENENAME SLC38A3 DTD0330 PROTNAME Sodium-coupled neutral amino acid transporter 3 DTD0330 GENEDBID 10991 DTD0330 UNIPROID Q99624 DTD0330 EXOFACTO [3H]Glutamine HIGHSTIT Investigative Drug DTD0330 EXOFACTO [3H]Glutamine DESCRIPT [3H]Glutamine modulates the activity of SLC38A3 DTD0330 EXOFACTO [3H]Glutamine MOACRIVE Modulator DTD0330 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0330 EXOFACTO Cisplatin DESCRIPT Cisplatin inhibits the activity of SLC38A3 DTD0330 EXOFACTO Cisplatin MOACRIVE Inhibition DTD0330 EXOFACTO Dexamethasone HIGHSTIT Approved Drug DTD0330 EXOFACTO Dexamethasone DESCRIPT Dexamethasone induces the activity of SLC38A3 DTD0330 EXOFACTO Dexamethasone MOACRIVE Inducer DTD0330 EXOFACTO Paclitaxel HIGHSTIT Approved Drug DTD0330 EXOFACTO Paclitaxel DESCRIPT Paclitaxel inhibits the activity of SLC38A3 DTD0330 EXOFACTO Paclitaxel MOACRIVE Inhibition DTD0331 TRANSPID DTD0331 DTD0331 GENENAME SLC38A4 DTD0331 PROTNAME Sodium-coupled neutral amino acid transporter 4 DTD0331 GENEDBID 55089 DTD0331 UNIPROID Q969I6 DTD0331 EXOFACTO [14C]Glycine HIGHSTIT Investigative Drug DTD0331 EXOFACTO [14C]Glycine DESCRIPT [14C]Glycine modulates the activity of SLC38A4 DTD0331 EXOFACTO [14C]Glycine MOACRIVE Modulator DTD0331 EXOFACTO [3H]Alanine HIGHSTIT Investigative Drug DTD0331 EXOFACTO [3H]Alanine DESCRIPT [3H]Alanine modulates the activity of SLC38A4 DTD0331 EXOFACTO [3H]Alanine MOACRIVE Modulator DTD0332 TRANSPID DTD0332 DTD0332 GENENAME SLC38A5 DTD0332 PROTNAME Sodium-coupled neutral amino acid transporter 5 DTD0332 GENEDBID 92745 DTD0332 UNIPROID Q8WUX1 DTD0332 EXOFACTO [14C]Histidine HIGHSTIT Investigative Drug DTD0332 EXOFACTO [14C]Histidine DESCRIPT [14C]Histidine modulates the activity of SLC38A5 DTD0332 EXOFACTO [14C]Histidine MOACRIVE Modulator DTD0332 EXOFACTO [3H]Histidine HIGHSTIT Investigative Drug DTD0332 EXOFACTO [3H]Histidine DESCRIPT [3H]Histidine modulates the activity of SLC38A5 DTD0332 EXOFACTO [3H]Histidine MOACRIVE Modulator DTD0345 TRANSPID DTD0345 DTD0345 GENENAME SLC39A4 DTD0345 PROTNAME Zrt- and Irt-like protein 4 DTD0345 GENEDBID 55630 DTD0345 UNIPROID Q6P5W5 DTD0345 EXOFACTO (-)-epigallocatechin-3-O-gallate HIGHSTIT Natural Product DTD0345 EXOFACTO (-)-epigallocatechin-3-O-gallate DESCRIPT (-)-Epigallocatechin-3-O-gallate induces the activity of SLC39A4 DTD0345 EXOFACTO (-)-epigallocatechin-3-O-gallate MOACRIVE Inducer DTD0348 TRANSPID DTD0348 DTD0348 GENENAME SLC39A7 DTD0348 PROTNAME Zrt- Irt-like protein 7 DTD0348 GENEDBID 7922 DTD0348 UNIPROID Q92504 DTD0348 EXOFACTO NVS-ZP7-4 HIGHSTIT Investigative Drug DTD0348 EXOFACTO NVS-ZP7-4 DESCRIPT NVS-ZP7-4 inhibits the activity of SLC39A7 DTD0348 EXOFACTO NVS-ZP7-4 MOACRIVE Inhibition DTD0351 TRANSPID DTD0351 DTD0351 GENENAME SLC3A1 DTD0351 PROTNAME Neutral and basic amino acid transport protein rBAT DTD0351 GENEDBID 6519 DTD0351 UNIPROID Q07837 DTD0351 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0351 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the activity of SLC3A1 DTD0351 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0351 EXOFACTO Sulfasalazine CELLLINE Human embryonic kidney 293 cells (HEK293)-NBAT DTD0351 EXOFACTO Sulfasalazine CELLLINE Human breast adenocarcinoma cell line (MCF-7)-NBAT DTD0353 TRANSPID DTD0353 DTD0353 GENENAME SLC40A1 DTD0353 PROTNAME Iron-regulated transporter 1 DTD0353 GENEDBID 30061 DTD0353 UNIPROID Q9NP59 DTD0353 EXOFACTO LY2928057 HIGHSTIT Drug in Phase 1 Trial DTD0353 EXOFACTO LY2928057 DESCRIPT LY2928057 modulates the activity of SLC40A1 DTD0353 EXOFACTO LY2928057 MOACRIVE Modulator DTD0359 TRANSPID DTD0359 DTD0359 GENENAME SLC42A3 DTD0359 PROTNAME Ammonium transporter Rh type C DTD0359 GENEDBID 51458 DTD0359 UNIPROID Q9UBD6 DTD0359 EXOFACTO [14C]Methylamine HIGHSTIT Investigative Drug DTD0359 EXOFACTO [14C]Methylamine DESCRIPT [14C]Methylamine modulates the activity of SLC42A3 DTD0359 EXOFACTO [14C]Methylamine MOACRIVE Modulator DTD0360 TRANSPID DTD0360 DTD0360 GENENAME SLC43A1 DTD0360 PROTNAME L-type amino acid transporter 3 DTD0360 GENEDBID 8501 DTD0360 UNIPROID O75387 DTD0360 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0360 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the transportation of L-leucine by SLC43A1 DTD0360 EXOFACTO Verapamil MOACRIVE Inhibition DTD0360 EXOFACTO Verapamil CELLLINE Human prostate cancer cell lines (LNCaP) DTD0362 TRANSPID DTD0362 DTD0362 GENENAME SLC43A3 DTD0362 PROTNAME Equilibrative nucleobase transporter 1 DTD0362 GENEDBID 29015 DTD0362 UNIPROID Q8NBI5 DTD0362 EXOFACTO Erlotinib HIGHSTIT Approved Drug DTD0362 EXOFACTO Erlotinib DESCRIPT Erlotinib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Erlotinib MOACRIVE Inhibition DTD0362 EXOFACTO Gefitinib HIGHSTIT Approved Drug DTD0362 EXOFACTO Gefitinib DESCRIPT Gefitinib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Gefitinib MOACRIVE Inhibition DTD0362 EXOFACTO Imatinib HIGHSTIT Approved Drug DTD0362 EXOFACTO Imatinib DESCRIPT Imatinib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Imatinib MOACRIVE Inhibition DTD0362 EXOFACTO Sorafenib HIGHSTIT Approved Drug DTD0362 EXOFACTO Sorafenib DESCRIPT Sorafenib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Sorafenib MOACRIVE Inhibition DTD0362 EXOFACTO Sunitinib HIGHSTIT Approved Drug DTD0362 EXOFACTO Sunitinib DESCRIPT Sunitinib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Sunitinib MOACRIVE Inhibition DTD0362 EXOFACTO Vandetanib HIGHSTIT Approved Drug DTD0362 EXOFACTO Vandetanib DESCRIPT Vandetanib inhibits the activity of SLC43A3 DTD0362 EXOFACTO Vandetanib MOACRIVE Inhibition DTD0363 TRANSPID DTD0363 DTD0363 GENENAME SLC44A1 DTD0363 PROTNAME Choline transporter-like protein 1 DTD0363 GENEDBID 23446 DTD0363 UNIPROID Q8WWI5 DTD0363 EXOFACTO Hemicholinium-3 HIGHSTIT Investigative Drug DTD0363 EXOFACTO Hemicholinium-3 DESCRIPT Hemicholinium-3 inhibits the activity of SLC44A1 DTD0363 EXOFACTO Hemicholinium-3 MOACRIVE Inhibition DTD0363 EXOFACTO Hemicholinium-3 CELLLINE Human breast adenocarcinoma cell line (MCF-7)-CTL1 DTD0363 EXOFACTO Tanespimycin HIGHSTIT Investigative Drug DTD0363 EXOFACTO Tanespimycin DESCRIPT 17-Allyamino-17-demethoxygeldanamycin (17-AAG) induces the transportation of Zinc by SLC44A1 DTD0363 EXOFACTO Tanespimycin MOACRIVE Inducer DTD0363 EXOFACTO Tanespimycin CELLLINE Human breast adenocarcinoma cell line (MCF-7)-CTL1 DTD0364 TRANSPID DTD0364 DTD0364 GENENAME SLC44A2 DTD0364 PROTNAME Choline transporter-like protein 2 DTD0364 GENEDBID 57153 DTD0364 UNIPROID Q8IWA5 DTD0364 EXOFACTO Ethanol HIGHSTIT Approved Drug DTD0364 EXOFACTO Ethanol DESCRIPT Ethanol induces the activity of SLC44A2 DTD0364 EXOFACTO Ethanol MOACRIVE Inducer DTD0372 TRANSPID DTD0372 DTD0372 GENENAME SLC46A1 DTD0372 PROTNAME Proton-coupled folate transporter DTD0372 GENEDBID 113235 DTD0372 UNIPROID Q96NT5 DTD0372 EXOFACTO Bictegravir HIGHSTIT Approved Drug DTD0372 EXOFACTO Bictegravir DESCRIPT Bictegravir inhibits the activity of SLC46A1 DTD0372 EXOFACTO Bictegravir MOACRIVE Inhibition DTD0372 EXOFACTO Folic acid HIGHSTIT Approved Drug DTD0372 EXOFACTO Folic acid DESCRIPT Folic acid modulates the activity of SLC46A1 DTD0372 EXOFACTO Folic acid MOACRIVE Modulator DTD0372 EXOFACTO Methotrexate HIGHSTIT Approved Drug DTD0372 EXOFACTO Methotrexate DESCRIPT Methotrexate modulates the activity of SLC46A1 DTD0372 EXOFACTO Methotrexate MOACRIVE Modulator DTD0372 EXOFACTO Pemetrexed HIGHSTIT Approved Drug DTD0372 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the transportation of Methotrexate by SLC46A1 DTD0372 EXOFACTO Pemetrexed DESCRIPT Pemetrexed inhibits the activity of SLC46A1 DTD0372 EXOFACTO Pemetrexed MOACRIVE Inhibition DTD0372 EXOFACTO Pemetrexed CELLLINE Chinese hamster ovary (CHO) cells-PCFT DTD0372 EXOFACTO Sulfasalazine HIGHSTIT Approved Drug DTD0372 EXOFACTO Sulfasalazine DESCRIPT Sulfasalazine inhibits the activity of SLC46A1 DTD0372 EXOFACTO Sulfasalazine MOACRIVE Inhibition DTD0383 TRANSPID DTD0383 DTD0383 GENENAME SLC4A2 DTD0383 PROTNAME Anion exchange protein 2 DTD0383 GENEDBID 6522 DTD0383 UNIPROID P04920 DTD0383 EXOFACTO Rifampicin HIGHSTIT Approved Drug DTD0383 EXOFACTO Rifampicin DESCRIPT Rifampicin induces the activity of SLC4A2 DTD0383 EXOFACTO Rifampicin MOACRIVE Inducer DTD0384 TRANSPID DTD0384 DTD0384 GENENAME SLC4A3 DTD0384 PROTNAME Anion exchange protein 3 DTD0384 GENEDBID 6508 DTD0384 UNIPROID P48751 DTD0384 EXOFACTO Sasanquasaponin HIGHSTIT Natural Product DTD0384 EXOFACTO Sasanquasaponin DESCRIPT Sasanquasaponin induces the activity of SLC4A3 DTD0384 EXOFACTO Sasanquasaponin MOACRIVE Inducer DTD0385 TRANSPID DTD0385 DTD0385 GENENAME SLC4A4 DTD0385 PROTNAME Electrogenic sodium bicarbonate cotransporter 1 DTD0385 GENEDBID 8671 DTD0385 UNIPROID Q9Y6R1 DTD0385 EXOFACTO N-cyanosulphonamide S0859 HIGHSTIT Investigative Drug DTD0385 EXOFACTO N-cyanosulphonamide S0859 DESCRIPT The synthetic compound N-cyanosulphonamide S0859 inhibits the activity of SLC4A4 (IC50 = 9 microM) DTD0385 EXOFACTO N-cyanosulphonamide S0859 MOACRIVE Inhibition DTD0385 EXOFACTO N-cyanosulphonamide S0859 CELLLINE Xenopus laevis oocytes-NBCe1 DTD0386 TRANSPID DTD0386 DTD0386 GENENAME SLC4A5 DTD0386 PROTNAME Electrogenic sodium bicarbonate cotransporter 4 DTD0386 GENEDBID 57835 DTD0386 UNIPROID Q9BY07 DTD0386 EXOFACTO Tenidap HIGHSTIT Drug in Phase 3 Trial DTD0386 EXOFACTO Tenidap DESCRIPT Tenidap inhibits the activity of SLC4A5 DTD0386 EXOFACTO Tenidap MOACRIVE Inhibition DTD0389 TRANSPID DTD0389 DTD0389 GENENAME SLC4A9 DTD0389 PROTNAME Anion exchange protein 4 DTD0389 GENEDBID 83697 DTD0389 UNIPROID Q96Q91 DTD0389 EXOFACTO N-cyanosulphonamide S0859 HIGHSTIT Investigative Drug DTD0389 EXOFACTO N-cyanosulphonamide S0859 DESCRIPT The synthetic compound N-cyanosulphonamide S0859 inhibits the activity of SLC4A9 DTD0389 EXOFACTO N-cyanosulphonamide S0859 MOACRIVE Inhibition DTD0389 EXOFACTO N-cyanosulphonamide S0859 CELLLINE Tumor Cells DTD0391 TRANSPID DTD0391 DTD0391 GENENAME SLC51A DTD0391 PROTNAME Organic solute transporter subunit alpha DTD0391 GENEDBID 200931 DTD0391 UNIPROID Q86UW1 DTD0391 EXOFACTO Fidaxomicin HIGHSTIT Approved Drug DTD0391 EXOFACTO Fidaxomicin DESCRIPT Fidaxomicin inhibits the activity of SLC51A DTD0391 EXOFACTO Fidaxomicin MOACRIVE Inhibition DTD0391 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0391 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the activity of SLC51A DTD0391 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0392 TRANSPID DTD0392 DTD0392 GENENAME SLC51B DTD0392 PROTNAME Organic solute transporter subunit beta DTD0392 GENEDBID 123264 DTD0392 UNIPROID Q86UW2 DTD0392 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0392 EXOFACTO Digoxin DESCRIPT Digoxin inhibits the transportation of Estrone sulfate by SLC51B (IC50 < 500 microM) DTD0392 EXOFACTO Digoxin MOACRIVE Inhibition DTD0392 EXOFACTO Digoxin CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0392 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate inhibits the transportation of Estrone sulfate by SLC51B (IC50 > 200 microM) DTD0392 EXOFACTO Estrone sulfate MOACRIVE Inhibition DTD0392 EXOFACTO Estrone sulfate CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Ethinyl estradiol HIGHSTIT Approved Drug DTD0392 EXOFACTO Ethinyl estradiol DESCRIPT Ethinyl estradiol inhibits the transportation of Dehydroepiandrosterone sulfate by SLC51B (IC50 < 200 microM) DTD0392 EXOFACTO Ethinyl estradiol MOACRIVE Inhibition DTD0392 EXOFACTO Ethinyl estradiol CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Fidaxomicin HIGHSTIT Approved Drug DTD0392 EXOFACTO Fidaxomicin DESCRIPT Fidaxomicin inhibits the transportation of Dehydroepiandrosterone sulfate by SLC51B (IC50 < 200 microM) DTD0392 EXOFACTO Fidaxomicin DESCRIPT Fidaxomicin inhibits the activity of SLC51B DTD0392 EXOFACTO Fidaxomicin MOACRIVE Inhibition DTD0392 EXOFACTO Fidaxomicin CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Indomethacin HIGHSTIT Approved Drug DTD0392 EXOFACTO Indomethacin DESCRIPT Indomethacin inhibits the transportation of Estrone sulfate by SLC51B (IC50 = 200 microM) DTD0392 EXOFACTO Indomethacin MOACRIVE Inhibition DTD0392 EXOFACTO Indomethacin CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0392 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the transportation of Estrone sulfate by SLC51B (IC50 > 200 microM) DTD0392 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0392 EXOFACTO Spironolactone CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Taurolithocholate HIGHSTIT Investigative Drug DTD0392 EXOFACTO Taurolithocholate DESCRIPT Taurolithocholate inhibits the transportation of Estrone sulfate by SLC51B (IC50 = 200 microM) DTD0392 EXOFACTO Taurolithocholate MOACRIVE Inhibition DTD0392 EXOFACTO Taurolithocholate CELLLINE Oocytes-OSTalpha-OSTbeta DTD0392 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0392 EXOFACTO Troglitazone DESCRIPT Troglitazone inhibits the transportation of Dehydroepiandrosterone sulfate by SLC51B (IC50 < 200 microM) DTD0392 EXOFACTO Troglitazone MOACRIVE Inhibition DTD0392 EXOFACTO Troglitazone CELLLINE Oocytes-OSTalpha-OSTbeta DTD0394 TRANSPID DTD0394 DTD0394 GENENAME SLC52A2 DTD0394 PROTNAME Riboflavin transporter 3 DTD0394 GENEDBID 79581 DTD0394 UNIPROID Q9HAB3 DTD0394 EXOFACTO 4-Cyclohexyl-4-hydroxy-but-2-enoic acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Cyclohexyl-4-hydroxy-but-2-enoic acid DESCRIPT 4-Cyclohexyl-4-hydroxy-but-2-enoic acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Cyclohexyl-4-hydroxy-but-2-enoic acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-3-methyl-but-2-enoic acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-3-methyl-but-2-enoic acid DESCRIPT 4-Hydroxy-3-methyl-but-2-enoic acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-3-methyl-but-2-enoic acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-3-methyl-butyric acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-3-methyl-butyric acid DESCRIPT 4-Hydroxy-3-methyl-butyric acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-3-methyl-butyric acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-but-2-enoic acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-but-2-enoic acid DESCRIPT 4-Hydroxy-4-phenyl-but-2-enoic acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-but-2-enoic acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-butyric acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-butyric acid DESCRIPT 4-Hydroxy-4-phenyl-butyric acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-4-phenyl-butyric acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-but-2-enoate HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-but-2-enoate DESCRIPT 4-Hydroxy-but-2-enoate inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-but-2-enoate MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-pent-2-enoic acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-pent-2-enoic acid DESCRIPT 4-Hydroxy-pent-2-enoic acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-pent-2-enoic acid MOACRIVE Inhibition DTD0394 EXOFACTO 4-Hydroxy-pentanoic acid HIGHSTIT Investigative Drug DTD0394 EXOFACTO 4-Hydroxy-pentanoic acid DESCRIPT 4-Hydroxy-pentanoic acid inhibits the activity of SLC52A2 DTD0394 EXOFACTO 4-Hydroxy-pentanoic acid MOACRIVE Inhibition DTD0394 EXOFACTO 5-Hydroxy-pentanoate HIGHSTIT Investigative Drug DTD0394 EXOFACTO 5-Hydroxy-pentanoate DESCRIPT 5-Hydroxy-pentanoate inhibits the activity of SLC52A2 DTD0394 EXOFACTO 5-Hydroxy-pentanoate MOACRIVE Inhibition DTD0395 TRANSPID DTD0395 DTD0395 GENENAME SLC52A3 DTD0395 PROTNAME Riboflavin transporter 2 DTD0395 GENEDBID 113278 DTD0395 UNIPROID Q9NQ40 DTD0395 EXOFACTO Methylene blue HIGHSTIT Approved Drug DTD0395 EXOFACTO Methylene blue DESCRIPT Methylene blue inhibits the transportation of Riboflavin by SLC52A3 DTD0395 EXOFACTO Methylene blue MOACRIVE Inhibition DTD0395 EXOFACTO Methylene blue CELLLINE Intestinal epithelial T84 cells-RFVT3 DTD0418 TRANSPID DTD0418 DTD0418 GENENAME SLC5A1 DTD0418 PROTNAME Sodium/glucose cotransporter 1 DTD0418 GENEDBID 6523 DTD0418 UNIPROID P13866 DTD0418 EXOFACTO Acerogenin A HIGHSTIT Investigative Drug DTD0418 EXOFACTO Acerogenin A DESCRIPT Acerogenin A inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Acerogenin A MOACRIVE Inhibition DTD0418 EXOFACTO Acerogenin A CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Acerogenin B HIGHSTIT Investigative Drug DTD0418 EXOFACTO Acerogenin B DESCRIPT Acerogenin B inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Acerogenin B MOACRIVE Inhibition DTD0418 EXOFACTO Acerogenin B CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Acerogenin C HIGHSTIT Investigative Drug DTD0418 EXOFACTO Acerogenin C DESCRIPT Acerogenin C inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Acerogenin C MOACRIVE Inhibition DTD0418 EXOFACTO Acerogenin C CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Alstiphyllanine D HIGHSTIT Investigative Drug DTD0418 EXOFACTO Alstiphyllanine D DESCRIPT Alstiphyllanine D inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Alstiphyllanine D MOACRIVE Inhibition DTD0418 EXOFACTO Alstiphyllanine D CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Alstiphyllanine E HIGHSTIT Investigative Drug DTD0418 EXOFACTO Alstiphyllanine E DESCRIPT Alstiphyllanine E inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Alstiphyllanine E MOACRIVE Inhibition DTD0418 EXOFACTO Alstiphyllanine E CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Alstiphyllanine F HIGHSTIT Investigative Drug DTD0418 EXOFACTO Alstiphyllanine F DESCRIPT Alstiphyllanine F inhibits the transportation of Alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Alstiphyllanine F MOACRIVE Inhibition DTD0418 EXOFACTO Alstiphyllanine F CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Angiotensin II HIGHSTIT Approved Drug DTD0418 EXOFACTO Angiotensin II DESCRIPT Angiotensin II inhibits the transportation of Glucose by SLC5A1 DTD0418 EXOFACTO Angiotensin II MOACRIVE Inhibition DTD0418 EXOFACTO Dapagliflozin HIGHSTIT Approved Drug DTD0418 EXOFACTO Dapagliflozin DESCRIPT Dapagliflozin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Dapagliflozin MOACRIVE Inhibition DTD0418 EXOFACTO Dapagliflozin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-SGLT1 DTD0418 EXOFACTO Formononetin HIGHSTIT Investigative Drug DTD0418 EXOFACTO Formononetin DESCRIPT Formononetin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Formononetin MOACRIVE Inhibition DTD0418 EXOFACTO Formononetin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO GSK1614235 HIGHSTIT Drug in Phase 1 Trial DTD0418 EXOFACTO GSK1614235 DESCRIPT GSK1614235 blocks the activity of SLC5A1 DTD0418 EXOFACTO GSK1614235 MOACRIVE Blocker DTD0418 EXOFACTO GSK1614235 + GSK2330672 HIGHSTIT Drug in Phase 1 Trial DTD0418 EXOFACTO GSK1614235 + GSK2330672 DESCRIPT GSK1614235 + GSK2330672 modulates the activity of SLC5A1 DTD0418 EXOFACTO GSK1614235 + GSK2330672 MOACRIVE Modulator DTD0418 EXOFACTO Kuraidin HIGHSTIT Investigative Drug DTD0418 EXOFACTO Kuraidin DESCRIPT Kuraidin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Kuraidin MOACRIVE Inhibition DTD0418 EXOFACTO Kuraidin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Kurarinone HIGHSTIT Investigative Drug DTD0418 EXOFACTO Kurarinone DESCRIPT Kurarinone inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Kurarinone MOACRIVE Inhibition DTD0418 EXOFACTO Kurarinone CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Kushenol N HIGHSTIT Investigative Drug DTD0418 EXOFACTO Kushenol N DESCRIPT Kushenol N inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Kushenol N MOACRIVE Inhibition DTD0418 EXOFACTO Kushenol N CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO LIK-066 HIGHSTIT Drug in Phase 2 Trial DTD0418 EXOFACTO LIK-066 DESCRIPT LIK-066 inhibits the activity of SLC5A1 DTD0418 EXOFACTO LIK-066 MOACRIVE Inhibition DTD0418 EXOFACTO LX-4211 HIGHSTIT Drug in Phase 3 Trial DTD0418 EXOFACTO LX-4211 DESCRIPT LX-4211 modulates the activity of SLC5A1 DTD0418 EXOFACTO LX-4211 MOACRIVE Modulator DTD0418 EXOFACTO Maackiain HIGHSTIT Investigative Drug DTD0418 EXOFACTO Maackiain DESCRIPT Maackiain inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Maackiain MOACRIVE Inhibition DTD0418 EXOFACTO Maackiain CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Phloretin HIGHSTIT Investigative Drug DTD0418 EXOFACTO Phloretin DESCRIPT Phloretin inhibits the transportation of 2-Deoxyglucose by SLC5A1 DTD0418 EXOFACTO Phloretin DESCRIPT Phloretin inhibits the activity of SLC5A1 DTD0418 EXOFACTO Phloretin MOACRIVE Inhibition DTD0418 EXOFACTO Phloretin CELLLINE Human embryonic kidney 293 cells (HEK293)-SGLT1 DTD0418 EXOFACTO Phlorizin HIGHSTIT Investigative Drug DTD0418 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of 2-Deoxyglucose by SLC5A1 DTD0418 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the activity of SLC5A1 DTD0418 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0418 EXOFACTO Phlorizin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0418 EXOFACTO Phlorizin CELLLINE Human enterocyte-like 2 cell (Caco-2)-SGLT1 DTD0418 EXOFACTO Phlorizin CELLLINE Human embryonic kidney 293 cells (HEK293)-SGLT1 DTD0418 EXOFACTO Sophoraflavanone G HIGHSTIT Investigative Drug DTD0418 EXOFACTO Sophoraflavanone G DESCRIPT Sophoraflavanone G inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A1 DTD0418 EXOFACTO Sophoraflavanone G MOACRIVE Inhibition DTD0418 EXOFACTO Sophoraflavanone G CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT1 DTD0422 TRANSPID DTD0422 DTD0422 GENENAME SLC5A2 DTD0422 PROTNAME Sodium/glucose cotransporter 2 DTD0422 GENEDBID 6524 DTD0422 UNIPROID P31639 DTD0422 EXOFACTO Acerogenin A HIGHSTIT Investigative Drug DTD0422 EXOFACTO Acerogenin A DESCRIPT Acerogenin A inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Acerogenin A MOACRIVE Inhibition DTD0422 EXOFACTO Acerogenin A CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Acerogenin B HIGHSTIT Investigative Drug DTD0422 EXOFACTO Acerogenin B DESCRIPT Acerogenin B inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Acerogenin B MOACRIVE Inhibition DTD0422 EXOFACTO Acerogenin B CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Acerogenin C HIGHSTIT Investigative Drug DTD0422 EXOFACTO Acerogenin C DESCRIPT Acerogenin C inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Acerogenin C MOACRIVE Inhibition DTD0422 EXOFACTO Acerogenin C CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Alstiphyllanine D HIGHSTIT Investigative Drug DTD0422 EXOFACTO Alstiphyllanine D DESCRIPT Alstiphyllanine D inhibits the transportation of Alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Alstiphyllanine D MOACRIVE Inhibition DTD0422 EXOFACTO Alstiphyllanine D CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Alstiphyllanine E HIGHSTIT Investigative Drug DTD0422 EXOFACTO Alstiphyllanine E DESCRIPT Alstiphyllanine E inhibits the transportation of Alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Alstiphyllanine E MOACRIVE Inhibition DTD0422 EXOFACTO Alstiphyllanine E CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Alstiphyllanine F HIGHSTIT Investigative Drug DTD0422 EXOFACTO Alstiphyllanine F DESCRIPT Alstiphyllanine F inhibits the transportation of Alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Alstiphyllanine F MOACRIVE Inhibition DTD0422 EXOFACTO Alstiphyllanine F CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Bexagliflozin HIGHSTIT Drug in Phase 3 Trial DTD0422 EXOFACTO Bexagliflozin DESCRIPT Bexagliflozin inhibits the activity of SLC5A2 DTD0422 EXOFACTO Bexagliflozin MOACRIVE Inhibition DTD0422 EXOFACTO Dapagliflozin HIGHSTIT Approved Drug DTD0422 EXOFACTO Dapagliflozin DESCRIPT Dapagliflozin inhibits the transportation of Methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Dapagliflozin DESCRIPT Dapagliflozin inhibits the activity of SLC5A2 DTD0422 EXOFACTO Dapagliflozin MOACRIVE Inhibition DTD0422 EXOFACTO Dapagliflozin CELLLINE Chinese hamster ovary (CHO) cells-SGLT2 DTD0422 EXOFACTO Ertugliflozin HIGHSTIT Approved Drug DTD0422 EXOFACTO Ertugliflozin DESCRIPT Ertugliflozin inhibits the activity of SLC5A2 DTD0422 EXOFACTO Ertugliflozin MOACRIVE Inhibition DTD0422 EXOFACTO Formononetin HIGHSTIT Investigative Drug DTD0422 EXOFACTO Formononetin DESCRIPT Formononetin inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Formononetin DESCRIPT Formononetin inhibits the activity of SLC5A2 DTD0422 EXOFACTO Formononetin MOACRIVE Inhibition DTD0422 EXOFACTO Formononetin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Kuraidin HIGHSTIT Investigative Drug DTD0422 EXOFACTO Kuraidin DESCRIPT Kuraidin inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Kuraidin MOACRIVE Inhibition DTD0422 EXOFACTO Kuraidin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Kurarinone HIGHSTIT Investigative Drug DTD0422 EXOFACTO Kurarinone DESCRIPT Kurarinone inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Kurarinone MOACRIVE Inhibition DTD0422 EXOFACTO Kurarinone CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Kushenol N HIGHSTIT Investigative Drug DTD0422 EXOFACTO Kushenol N DESCRIPT Kushenol N inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Kushenol N MOACRIVE Inhibition DTD0422 EXOFACTO Kushenol N CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Maackiain HIGHSTIT Investigative Drug DTD0422 EXOFACTO Maackiain DESCRIPT Maackiain inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Maackiain MOACRIVE Inhibition DTD0422 EXOFACTO Maackiain CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Phlorizin HIGHSTIT Investigative Drug DTD0422 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of 2-Deoxyglucose by SLC5A2 DTD0422 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of D-glucose by SLC5A2 DTD0422 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0422 EXOFACTO Phlorizin CELLLINE Human embryonic kidney 293 cells (HEK293)-SGLT2 DTD0422 EXOFACTO Phlorizin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Pioglitazone HIGHSTIT Approved Drug DTD0422 EXOFACTO Pioglitazone DESCRIPT Pioglitazone inhibits the activity of SLC5A2 DTD0422 EXOFACTO Pioglitazone MOACRIVE Inhibition DTD0422 EXOFACTO Sergliflozin A HIGHSTIT Investigative Drug DTD0422 EXOFACTO Sergliflozin A DESCRIPT Sergliflozin A inhibits the transportation of D-glucose by SLC5A2 DTD0422 EXOFACTO Sergliflozin A DESCRIPT Sergliflozin A inhibits the activity of SLC5A2 DTD0422 EXOFACTO Sergliflozin A MOACRIVE Inhibition DTD0422 EXOFACTO Sophoraflavanone G HIGHSTIT Investigative Drug DTD0422 EXOFACTO Sophoraflavanone G DESCRIPT Sophoraflavanone G inhibits the transportation of methyl-alpha-D-glucopyranoside by SLC5A2 DTD0422 EXOFACTO Sophoraflavanone G DESCRIPT Sophoraflavanone G inhibits the activity of SLC5A2 DTD0422 EXOFACTO Sophoraflavanone G MOACRIVE Inhibition DTD0422 EXOFACTO Sophoraflavanone G CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SGLT2 DTD0422 EXOFACTO Troglitazone HIGHSTIT Approved Drug DTD0422 EXOFACTO Troglitazone DESCRIPT Troglitazone induces the activity of SLC5A2 DTD0422 EXOFACTO Troglitazone MOACRIVE Inducer DTD0423 TRANSPID DTD0423 DTD0423 GENENAME SLC5A3 DTD0423 PROTNAME Sodium/myo-inositol cotransporter DTD0423 GENEDBID 6526 DTD0423 UNIPROID P53794 DTD0423 EXOFACTO Phlorizin HIGHSTIT Natural Product DTD0423 EXOFACTO Phlorizin DESCRIPT Phlorizin inhibits the transportation of 3H-D-glucose by SLC5A3 (Ki = 64 microM) DTD0423 EXOFACTO Phlorizin MOACRIVE Inhibition DTD0424 TRANSPID DTD0424 DTD0424 GENENAME SLC5A4 DTD0424 PROTNAME Sodium/glucose cotransporter 3 DTD0424 GENEDBID 6527 DTD0424 UNIPROID Q9NY91 DTD0424 EXOFACTO Remogli ozin-etabonate HIGHSTIT Drug in Phase 2 Trial DTD0424 EXOFACTO Remogli ozin-etabonate DESCRIPT Remogli ozin-etabonate modulates the activity of SLC5A4 DTD0424 EXOFACTO Remogli ozin-etabonate MOACRIVE Modulator DTD0424 EXOFACTO Remogliflozin etabonate HIGHSTIT Drug in Phase 2 Trial DTD0424 EXOFACTO Remogliflozin etabonate DESCRIPT Remogliflozin etabonate blocks the activity of SLC5A4 DTD0424 EXOFACTO Remogliflozin etabonate MOACRIVE Blocker DTD0424 EXOFACTO RG7201 HIGHSTIT Drug in Phase 3 Trial DTD0424 EXOFACTO RG7201 DESCRIPT RG7201 modulates the activity of SLC5A4 DTD0424 EXOFACTO RG7201 MOACRIVE Modulator DTD0424 EXOFACTO SaxaDapa FDC HIGHSTIT Drug in Phase 3 Trial DTD0424 EXOFACTO SaxaDapa FDC DESCRIPT SaxaDapa FDC modulates the activity of SLC5A4 DTD0424 EXOFACTO SaxaDapa FDC MOACRIVE Modulator DTD0425 TRANSPID DTD0425 DTD0425 GENENAME SLC5A5 DTD0425 PROTNAME Sodium/iodide cotransporter DTD0425 GENEDBID 6528 DTD0425 UNIPROID Q92911 DTD0425 EXOFACTO Potassium perchlorate HIGHSTIT Approved Drug DTD0425 EXOFACTO Potassium perchlorate DESCRIPT Potassium perchlorate inhibits the activity of SLC5A5 DTD0425 EXOFACTO Potassium perchlorate MOACRIVE Inhibition DTD0425 EXOFACTO Propylthiouracil HIGHSTIT Approved Drug DTD0425 EXOFACTO Propylthiouracil DESCRIPT Propylthiouracil induces the activity of SLC5A5 DTD0425 EXOFACTO Propylthiouracil MOACRIVE Inducer DTD0425 EXOFACTO Selumetinib HIGHSTIT Investigative Drug DTD0425 EXOFACTO Selumetinib DESCRIPT Selumetinib induces the activity of SLC5A5 DTD0425 EXOFACTO Selumetinib MOACRIVE Inducer DTD0425 EXOFACTO Selumetinib CELLLINE Thyroid cancer cell lines-NIS DTD0426 TRANSPID DTD0426 DTD0426 GENENAME SLC5A6 DTD0426 PROTNAME Sodium-dependent multivitamin transporter DTD0426 GENEDBID 8884 DTD0426 UNIPROID Q9Y289 DTD0426 EXOFACTO Gabapentin enacarbil HIGHSTIT Approved Drug DTD0426 EXOFACTO Gabapentin enacarbil DESCRIPT Gabapentin enacarbil modulates the activity of SLC5A6 DTD0426 EXOFACTO Gabapentin enacarbil MOACRIVE Modulator DTD0426 EXOFACTO Phenylbutazone HIGHSTIT Approved Drug DTD0426 EXOFACTO Phenylbutazone DESCRIPT Phenylbutazone inhibits the activity of SLC5A6 DTD0426 EXOFACTO Phenylbutazone MOACRIVE Inhibition DTD0427 TRANSPID DTD0427 DTD0427 GENENAME SLC5A7 DTD0427 PROTNAME High affinity choline transporter 1 DTD0427 GENEDBID 60482 DTD0427 UNIPROID Q9GZV3 DTD0427 EXOFACTO [3H]Hemicholinium-3 HIGHSTIT Investigative Drug DTD0427 EXOFACTO [3H]Hemicholinium-3 DESCRIPT [3H]Hemicholinium-3 modulates the activity of SLC5A7 DTD0427 EXOFACTO [3H]Hemicholinium-3 MOACRIVE Modulator DTD0439 TRANSPID DTD0439 DTD0439 GENENAME SLC65A2 DTD0439 PROTNAME Niemann-Pick C1-like protein 1 DTD0439 GENEDBID 29881 DTD0439 UNIPROID Q9UHC9 DTD0439 EXOFACTO Ezetimibe HIGHSTIT Approved Drug DTD0439 EXOFACTO Ezetimibe DESCRIPT Ezetimibe inhibits the activity of SLC65A2 DTD0439 EXOFACTO Ezetimibe MOACRIVE Inhibition DTD0439 EXOFACTO Ezetimibe-glucuronide HIGHSTIT Investigative Drug DTD0439 EXOFACTO Ezetimibe-glucuronide DESCRIPT Ezetimibe-glucuronide inhibits the activity of SLC65A2 DTD0439 EXOFACTO Ezetimibe-glucuronide MOACRIVE Inhibition DTD0440 TRANSPID DTD0440 DTD0440 GENENAME SLC6A1 DTD0440 PROTNAME Sodium- and chloride-dependent GABA transporter 1 DTD0440 GENEDBID 6529 DTD0440 UNIPROID P30531 DTD0440 EXOFACTO Hinokinin HIGHSTIT Investigative Drug DTD0440 EXOFACTO Hinokinin DESCRIPT Hinokinin inhibits the transportation of Gamma-aminobutyric acid by SLC6A1 DTD0440 EXOFACTO Hinokinin MOACRIVE Inhibition DTD0440 EXOFACTO Hinokinin CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-GABT1 DTD0440 EXOFACTO ST-1535 HIGHSTIT Investigative Drug DTD0440 EXOFACTO ST-1535 DESCRIPT ST-1535 inhibits the activity of SLC6A1 DTD0440 EXOFACTO ST-1535 MOACRIVE Inhibition DTD0440 EXOFACTO Tiagabine HIGHSTIT Approved Drug DTD0440 EXOFACTO Tiagabine DESCRIPT Tiagabine inhibits the activity of SLC6A1 DTD0440 EXOFACTO Tiagabine MOACRIVE Inhibition DTD0440 EXOFACTO Tiagabine CELLLINE Human embryonic kidney 293 cells (HEK293)-GABT1 DTD0443 TRANSPID DTD0443 DTD0443 GENENAME SLC6A11 DTD0443 PROTNAME Sodium- and chloride-dependent GABA transporter 3 DTD0443 GENEDBID 6538 DTD0443 UNIPROID P48066 DTD0443 EXOFACTO Beta-alanine HIGHSTIT Investigative Drug DTD0443 EXOFACTO Beta-alanine DESCRIPT Beta-alanine blocks the activity of SLC6A11 DTD0443 EXOFACTO Beta-alanine MOACRIVE Blocker DTD0443 EXOFACTO Gamma-aminobutyric acid HIGHSTIT Drug in Phase 2 Trial DTD0443 EXOFACTO Gamma-aminobutyric acid DESCRIPT Gamma-aminobutyric acid inhibits the activity of SLC6A11 DTD0443 EXOFACTO Gamma-aminobutyric acid MOACRIVE Inhibition DTD0444 TRANSPID DTD0444 DTD0444 GENENAME SLC6A12 DTD0444 PROTNAME Na(+)/Cl(-) betaine/GABA transporter DTD0444 GENEDBID 6539 DTD0444 UNIPROID P48065 DTD0444 EXOFACTO (R)-EF-1520 HIGHSTIT Investigative Drug DTD0444 EXOFACTO (R)-EF-1520 DESCRIPT (R)-EF-1520 inhibits the activity of SLC6A12 DTD0444 EXOFACTO (R)-EF-1520 MOACRIVE Inhibition DTD0444 EXOFACTO (R/S) EF-1500 HIGHSTIT Investigative Drug DTD0444 EXOFACTO (R/S) EF-1500 DESCRIPT (R/S) EF-1500 inhibits the activity of SLC6A12 DTD0444 EXOFACTO (R/S) EF-1500 MOACRIVE Inhibition DTD0444 EXOFACTO (S)-EF-1520 HIGHSTIT Investigative Drug DTD0444 EXOFACTO (S)-EF-1520 DESCRIPT (S)-EF-1520 inhibits the activity of SLC6A12 DTD0444 EXOFACTO (S)-EF-1520 MOACRIVE Inhibition DTD0444 EXOFACTO LU32-176B HIGHSTIT Investigative Drug DTD0444 EXOFACTO LU32-176B DESCRIPT LU32-176B inhibits the activity of SLC6A12 DTD0444 EXOFACTO LU32-176B MOACRIVE Inhibition DTD0444 EXOFACTO NNC052090 HIGHSTIT Investigative Drug DTD0444 EXOFACTO NNC052090 DESCRIPT NNC052090 inhibits the activity of SLC6A12 DTD0444 EXOFACTO NNC052090 MOACRIVE Inhibition DTD0445 TRANSPID DTD0445 DTD0445 GENENAME SLC6A13 DTD0445 PROTNAME Sodium- and chloride-dependent GABA transporter 2 DTD0445 GENEDBID 6540 DTD0445 UNIPROID Q9NSD5 DTD0445 EXOFACTO SNAP-5114 HIGHSTIT Investigative Drug DTD0445 EXOFACTO SNAP-5114 DESCRIPT SNAP-5114 inhibits the activity of SLC6A13 DTD0445 EXOFACTO SNAP-5114 MOACRIVE Inhibition DTD0446 TRANSPID DTD0446 DTD0446 GENENAME SLC6A14 DTD0446 PROTNAME Amino acid transporter ATB0+ DTD0446 GENEDBID 11254 DTD0446 UNIPROID Q9UN76 DTD0446 EXOFACTO Bortezomib HIGHSTIT Approved Drug DTD0446 EXOFACTO Bortezomib DESCRIPT Bortezomib inhibits the activity of SLC6A14 DTD0446 EXOFACTO Bortezomib MOACRIVE Inhibition DTD0446 EXOFACTO Bortezomib CELLLINE Human embryonic kidney 293 cells (HEK293)-ATB0 DTD0447 TRANSPID DTD0447 DTD0447 GENENAME SLC6A15 DTD0447 PROTNAME Sodium-dependent neutral amino acid transporter B(0)AT2 DTD0447 GENEDBID 55117 DTD0447 UNIPROID Q9H2J7 DTD0447 EXOFACTO Loratadine HIGHSTIT Approved Drug DTD0447 EXOFACTO Loratadine DESCRIPT Loratadine inhibits the activity of SLC6A15 DTD0447 EXOFACTO Loratadine MOACRIVE Inhibition DTD0447 EXOFACTO Loratadine CELLLINE Human embryonic kidney 293 cells (HEK293)-SLC6A15 DTD0451 TRANSPID DTD0451 DTD0451 GENENAME SLC6A19 DTD0451 PROTNAME Sodium-dependent neutral amino acid transporter B(0)AT1 DTD0451 GENEDBID 340024 DTD0451 UNIPROID Q695T7 DTD0451 EXOFACTO Cinromide HIGHSTIT Natural Product DTD0451 EXOFACTO Cinromide DESCRIPT Cinromide inhibits the activity of SLC6A19 DTD0451 EXOFACTO Cinromide MOACRIVE Inhibition DTD0452 TRANSPID DTD0452 DTD0452 GENENAME SLC6A2 DTD0452 PROTNAME Sodium-dependent noradrenaline transporter DTD0452 GENEDBID 6530 DTD0452 UNIPROID P23975 DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) HIGHSTIT Investigative Drug DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.16 microM) DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) MOACRIVE Inhibition DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) HIGHSTIT Investigative Drug DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.97 microM) DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) MOACRIVE Inhibition DTD0452 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO 4-Fluoroamphetamine HIGHSTIT Approved Drug DTD0452 EXOFACTO 4-Fluoroamphetamine DESCRIPT 4-Fluoroamphetamine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.2 microM) DTD0452 EXOFACTO 4-Fluoroamphetamine MOACRIVE Inhibition DTD0452 EXOFACTO 4-Fluoroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO 4-Fluoroephedrine HIGHSTIT Natural Product DTD0452 EXOFACTO 4-Fluoroephedrine DESCRIPT 4-Fluoroephedrine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 4.5 microM) DTD0452 EXOFACTO 4-Fluoroephedrine MOACRIVE Inhibition DTD0452 EXOFACTO 4-Fluoroephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO 4-Fluoromethamphetamine HIGHSTIT Approved Drug DTD0452 EXOFACTO 4-Fluoromethamphetamine DESCRIPT 4-Fluoromethamphetamine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.22 microM) DTD0452 EXOFACTO 4-Fluoromethamphetamine MOACRIVE Inhibition DTD0452 EXOFACTO 4-Fluoromethamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0452 EXOFACTO Acetaminophen DESCRIPT Acetaminophen inhibits the activity of SLC6A2 DTD0452 EXOFACTO Acetaminophen MOACRIVE Inhibition DTD0452 EXOFACTO alpha-Pyrrolidinopentiophenone HIGHSTIT Approved Drug DTD0452 EXOFACTO alpha-Pyrrolidinopentiophenone DESCRIPT alpha-Pyrrolidinopentiophenone inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.02 microM) DTD0452 EXOFACTO alpha-Pyrrolidinopentiophenone MOACRIVE Inhibition DTD0452 EXOFACTO alpha-Pyrrolidinopentiophenone CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Amfepramone HIGHSTIT Approved Drug DTD0452 EXOFACTO Amfepramone DESCRIPT Amfepramone inhibits the activity of SLC6A2 DTD0452 EXOFACTO Amfepramone MOACRIVE Inhibition DTD0452 EXOFACTO Amitifadine HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Amitifadine DESCRIPT Amitifadine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Amitifadine MOACRIVE Inhibition DTD0452 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0452 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the activity of SLC6A2 DTD0452 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0452 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Amoxapine HIGHSTIT Approved Drug DTD0452 EXOFACTO Amoxapine DESCRIPT Amoxapine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Amoxapine MOACRIVE Inhibition DTD0452 EXOFACTO Amphetamine HIGHSTIT Approved Drug DTD0452 EXOFACTO Amphetamine DESCRIPT Amphetamine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.07 microM) DTD0452 EXOFACTO Amphetamine MOACRIVE Inhibition DTD0452 EXOFACTO Amphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Atomoxetine HIGHSTIT Approved Drug DTD0452 EXOFACTO Atomoxetine DESCRIPT Atomoxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Atomoxetine MOACRIVE Inhibition DTD0452 EXOFACTO BI 201335 HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO BI 201335 DESCRIPT BI 201335 inhibits the activity of SLC6A2 DTD0452 EXOFACTO BI 201335 MOACRIVE Inhibition DTD0452 EXOFACTO Bicifadine HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Bicifadine DESCRIPT Bicifadine modulates the activity of SLC6A2 DTD0452 EXOFACTO Bicifadine MOACRIVE Modulator DTD0452 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0452 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the activity of SLC6A2 DTD0452 EXOFACTO Bupropion MOACRIVE Inhibition DTD0452 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Bupropion + naltrexone HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Bupropion + naltrexone DESCRIPT Bupropion + naltrexone inhibits the activity of SLC6A2 DTD0452 EXOFACTO Bupropion + naltrexone MOACRIVE Inhibition DTD0452 EXOFACTO Citalopram HIGHSTIT Approved Drug DTD0452 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the transportation of Dopamine by SLC6A2 DTD0452 EXOFACTO Citalopram MOACRIVE Inhibition DTD0452 EXOFACTO Citalopram CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-NET DTD0452 EXOFACTO Clomipramine HIGHSTIT Approved Drug DTD0452 EXOFACTO Clomipramine DESCRIPT Clomipramine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Clomipramine MOACRIVE Inhibition DTD0452 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0452 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Dopamine by SLC6A2 DTD0452 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Mazindol by SLC6A2 DTD0452 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of RTI-55 by SLC6A2 DTD0452 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Cocaine MOACRIVE Inhibition DTD0452 EXOFACTO Cocaine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-NET DTD0452 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Dasotraline HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Dasotraline DESCRIPT Dasotraline inhibits the activity of SLC6A2 DTD0452 EXOFACTO Dasotraline MOACRIVE Inhibition DTD0452 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0452 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Nisoxetine by SLC6A2 DTD0452 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Desipramine MOACRIVE Inhibition DTD0452 EXOFACTO Desipramine CELLLINE Madin-Darby Canine Kidney (MDCK) cells-NET DTD0452 EXOFACTO Desvenalfaxine succinate HIGHSTIT Approved Drug DTD0452 EXOFACTO Desvenalfaxine succinate DESCRIPT Desvenalfaxine succinate inhibits the activity of SLC6A2 DTD0452 EXOFACTO Desvenalfaxine succinate MOACRIVE Inhibition DTD0452 EXOFACTO Desvenlafaxine HIGHSTIT Approved Drug DTD0452 EXOFACTO Desvenlafaxine DESCRIPT Desvenlafaxine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Desvenlafaxine MOACRIVE Inhibition DTD0452 EXOFACTO Desvenlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0452 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0452 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Dopamine HIGHSTIT Approved Drug DTD0452 EXOFACTO Dopamine DESCRIPT Dopamine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Dopamine MOACRIVE Inhibition DTD0452 EXOFACTO Dopamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO DOV 21947 HIGHSTIT Drug in Phase 2 Trial DTD0452 EXOFACTO DOV 21947 DESCRIPT DOV 21947 inhibits the activity of SLC6A2 DTD0452 EXOFACTO DOV 21947 MOACRIVE Inhibition DTD0452 EXOFACTO Duloxetine HIGHSTIT Approved Drug DTD0452 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the transportation of Nisoxetine by SLC6A2 DTD0452 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Duloxetine MOACRIVE Inhibition DTD0452 EXOFACTO Duloxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Ephedrine HIGHSTIT Approved Drug DTD0452 EXOFACTO Ephedrine DESCRIPT Ephedrine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.32 microM) DTD0452 EXOFACTO Ephedrine MOACRIVE Inhibition DTD0452 EXOFACTO Ephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0452 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Dopamine by SLC6A2 DTD0452 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0452 EXOFACTO Fluoxetine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-NET DTD0452 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0452 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the activity of SLC6A2 DTD0452 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0452 EXOFACTO Hypericum HIGHSTIT Drug in Phase 4 Trial DTD0452 EXOFACTO Hypericum DESCRIPT Hypericum inhibits the activity of SLC6A2 DTD0452 EXOFACTO Hypericum MOACRIVE Inhibition DTD0452 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0452 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Imipramine MOACRIVE Inhibition DTD0452 EXOFACTO Iobenguane I-123 HIGHSTIT Approved Drug DTD0452 EXOFACTO Iobenguane I-123 DESCRIPT Iobenguane I-123 inhibits the activity of SLC6A2 DTD0452 EXOFACTO Iobenguane I-123 MOACRIVE Inhibition DTD0452 EXOFACTO Levomilnacipran HIGHSTIT Approved Drug DTD0452 EXOFACTO Levomilnacipran DESCRIPT Levomilnacipran modulates the activity of SLC6A2 DTD0452 EXOFACTO Levomilnacipran MOACRIVE Modulator DTD0452 EXOFACTO Maprotiline HIGHSTIT Approved Drug DTD0452 EXOFACTO Maprotiline DESCRIPT Maprotiline inhibits the activity of SLC6A2 DTD0452 EXOFACTO Maprotiline MOACRIVE Inhibition DTD0452 EXOFACTO Mazindol HIGHSTIT Approved Drug DTD0452 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of Mazindol by SLC6A2 DTD0452 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of RTI-55 by SLC6A2 DTD0452 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the activity of SLC6A2 DTD0452 EXOFACTO Mazindol MOACRIVE Inhibition DTD0452 EXOFACTO Mazindol CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Methamphetamine HIGHSTIT Approved Drug DTD0452 EXOFACTO Methamphetamine DESCRIPT Methamphetamine inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.14 microM) DTD0452 EXOFACTO Methamphetamine MOACRIVE Inhibition DTD0452 EXOFACTO Methamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Methcathinone HIGHSTIT Investigative Drug DTD0452 EXOFACTO Methcathinone DESCRIPT Methcathinone inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.12 microM) DTD0452 EXOFACTO Methcathinone MOACRIVE Inhibition DTD0452 EXOFACTO Methcathinone CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Methylenedioxypyrovalerone (MDPV) HIGHSTIT Investigative Drug DTD0452 EXOFACTO Methylenedioxypyrovalerone (MDPV) DESCRIPT Methylenedioxypyrovalerone (MDPV) inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.04 microM) DTD0452 EXOFACTO Methylenedioxypyrovalerone (MDPV) MOACRIVE Inhibition DTD0452 EXOFACTO Methylenedioxypyrovalerone (MDPV) CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Methylphenidate HIGHSTIT Approved Drug DTD0452 EXOFACTO Methylphenidate DESCRIPT Methylphenidate inhibits the activity of SLC6A2 DTD0452 EXOFACTO Methylphenidate MOACRIVE Inhibition DTD0452 EXOFACTO Methylphenidate CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Milnacipran HIGHSTIT Approved Drug DTD0452 EXOFACTO Milnacipran DESCRIPT Milnacipran inhibits the activity of SLC6A2 DTD0452 EXOFACTO Milnacipran MOACRIVE Inhibition DTD0452 EXOFACTO Naphyrone HIGHSTIT Drug Withdrawn DTD0452 EXOFACTO Naphyrone DESCRIPT Naphyrone inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.11 microM) DTD0452 EXOFACTO Naphyrone MOACRIVE Inhibition DTD0452 EXOFACTO Naphyrone CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Nisoxetine HIGHSTIT Investigative Drug DTD0452 EXOFACTO Nisoxetine DESCRIPT Nisoxetine inhibits the transportation of Dopamine by SLC6A2 DTD0452 EXOFACTO Nisoxetine DESCRIPT Nisoxetine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Nisoxetine DESCRIPT Nisoxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Nisoxetine MOACRIVE Inhibition DTD0452 EXOFACTO Nisoxetine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-NET DTD0452 EXOFACTO Nisoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0452 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0452 EXOFACTO Phenmetrazine HIGHSTIT Approved Drug DTD0452 EXOFACTO Phenmetrazine DESCRIPT Phenmetrazine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Phenmetrazine MOACRIVE Inhibition DTD0452 EXOFACTO Phentermine HIGHSTIT Approved Drug DTD0452 EXOFACTO Phentermine DESCRIPT Phentermine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Phentermine MOACRIVE Inhibition DTD0452 EXOFACTO Protriptyline HIGHSTIT Approved Drug DTD0452 EXOFACTO Protriptyline DESCRIPT Protriptyline inhibits the activity of SLC6A2 DTD0452 EXOFACTO Protriptyline MOACRIVE Inhibition DTD0452 EXOFACTO Protriptyline CELLLINE Chinese hamster ovary (CHO) cells-NET DTD0452 EXOFACTO Pyrovalerone HIGHSTIT Investigative Drug DTD0452 EXOFACTO Pyrovalerone DESCRIPT Pyrovalerone inhibits the transportation of Norepinephrine by SLC6A2 (IC50 = 0.05 microM) DTD0452 EXOFACTO Pyrovalerone DESCRIPT Pyrovalerone inhibits the activity of SLC6A2 DTD0452 EXOFACTO Pyrovalerone MOACRIVE Inhibition DTD0452 EXOFACTO Pyrovalerone CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Reboxetine HIGHSTIT Approved Drug DTD0452 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of Nisoxetine by SLC6A2 DTD0452 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Reboxetine MOACRIVE Inhibition DTD0452 EXOFACTO Reboxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO R-Norduloxetine HIGHSTIT Investigative Drug DTD0452 EXOFACTO R-Norduloxetine DESCRIPT R-Norduloxetine inhibits the activity of SLC6A2 DTD0452 EXOFACTO R-Norduloxetine MOACRIVE Inhibition DTD0452 EXOFACTO R-Norduloxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Roclatan HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Roclatan DESCRIPT Roclatan modulates the activity of SLC6A2 DTD0452 EXOFACTO Roclatan MOACRIVE Modulator DTD0452 EXOFACTO Sibutramine HIGHSTIT Approved Drug DTD0452 EXOFACTO Sibutramine DESCRIPT Sibutramine modulates the activity of SLC6A2 DTD0452 EXOFACTO Sibutramine MOACRIVE Modulator DTD0452 EXOFACTO Suronacrine maleate HIGHSTIT Drug in Phase 3 Trial DTD0452 EXOFACTO Suronacrine maleate DESCRIPT Suronacrine maleate modulates the activity of SLC6A2 DTD0452 EXOFACTO Suronacrine maleate MOACRIVE Modulator DTD0452 EXOFACTO Tapentadol HIGHSTIT Approved Drug DTD0452 EXOFACTO Tapentadol DESCRIPT Tapentadol modulates the activity of SLC6A2 DTD0452 EXOFACTO Tapentadol MOACRIVE Modulator DTD0452 EXOFACTO Trimipramine HIGHSTIT Approved Drug DTD0452 EXOFACTO Trimipramine DESCRIPT Trimipramine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Trimipramine MOACRIVE Inhibition DTD0452 EXOFACTO Venlafaxine HIGHSTIT Approved Drug DTD0452 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the transportation of Norepinephrine by SLC6A2 DTD0452 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the activity of SLC6A2 DTD0452 EXOFACTO Venlafaxine MOACRIVE Inhibition DTD0452 EXOFACTO Venlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-NET DTD0452 EXOFACTO Vorinostat HIGHSTIT Approved Drug DTD0452 EXOFACTO Vorinostat DESCRIPT Vorinostat induces the activity of SLC6A2 DTD0452 EXOFACTO Vorinostat MOACRIVE Inducer DTD0455 TRANSPID DTD0455 DTD0455 GENENAME SLC6A3 DTD0455 PROTNAME Sodium-dependent dopamine transporter DTD0455 GENEDBID 6531 DTD0455 UNIPROID Q01959 DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) HIGHSTIT Investigative Drug DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.11 microM) DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) MOACRIVE Inhibition DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) HIGHSTIT Investigative Drug DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.53 microM) DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) MOACRIVE Inhibition DTD0455 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO 4-Fluoroamphetamine HIGHSTIT Approved Drug DTD0455 EXOFACTO 4-Fluoroamphetamine DESCRIPT 4-Fluoroamphetamine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 3.7 microM) DTD0455 EXOFACTO 4-Fluoroamphetamine MOACRIVE Inhibition DTD0455 EXOFACTO 4-Fluoroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO 4-Fluoroephedrine HIGHSTIT Natural Product DTD0455 EXOFACTO 4-Fluoroephedrine DESCRIPT 4-Fluoroephedrine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 163 microM) DTD0455 EXOFACTO 4-Fluoroephedrine MOACRIVE Inhibition DTD0455 EXOFACTO 4-Fluoroephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO 4-Fluoromethamphetamine HIGHSTIT Approved Drug DTD0455 EXOFACTO 4-Fluoromethamphetamine DESCRIPT 4-Fluoromethamphetamine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 7.7 microM) DTD0455 EXOFACTO 4-Fluoromethamphetamine MOACRIVE Inhibition DTD0455 EXOFACTO 4-Fluoromethamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO alpha-Pyrrolidinopentiophenone HIGHSTIT Approved Drug DTD0455 EXOFACTO alpha-Pyrrolidinopentiophenone DESCRIPT alpha-Pyrrolidinopentiophenone inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.04 microM) DTD0455 EXOFACTO alpha-Pyrrolidinopentiophenone MOACRIVE Inhibition DTD0455 EXOFACTO alpha-Pyrrolidinopentiophenone CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Altropane HIGHSTIT Approved Drug DTD0455 EXOFACTO Altropane DESCRIPT Altropane inhibits the activity of SLC6A3 DTD0455 EXOFACTO Altropane MOACRIVE Inhibition DTD0455 EXOFACTO Amfetamine HIGHSTIT Drug in Phase 2 Trial DTD0455 EXOFACTO Amfetamine DESCRIPT Amfetamine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Amfetamine MOACRIVE Inhibition DTD0455 EXOFACTO Amitifadine HIGHSTIT Drug in Phase 3 Trial DTD0455 EXOFACTO Amitifadine DESCRIPT Amitifadine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Amitifadine MOACRIVE Inhibition DTD0455 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0455 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0455 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Amphetamine HIGHSTIT Approved Drug DTD0455 EXOFACTO Amphetamine DESCRIPT Amphetamine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 1.3 microM) DTD0455 EXOFACTO Amphetamine MOACRIVE Inhibition DTD0455 EXOFACTO Amphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Armodafinil HIGHSTIT Approved Drug DTD0455 EXOFACTO Armodafinil DESCRIPT Armodafinil inhibits the activity of SLC6A3 DTD0455 EXOFACTO Armodafinil MOACRIVE Inhibition DTD0455 EXOFACTO Armodafinil CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-DAT1 DTD0455 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0455 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the activity of SLC6A3 DTD0455 EXOFACTO Bupropion MOACRIVE Inhibition DTD0455 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Citalopram HIGHSTIT Approved Drug DTD0455 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Citalopram MOACRIVE Inhibition DTD0455 EXOFACTO Citalopram CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-DAT1 DTD0455 EXOFACTO Clomipramine HIGHSTIT Approved Drug DTD0455 EXOFACTO Clomipramine DESCRIPT Clomipramine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Clomipramine MOACRIVE Inhibition DTD0455 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0455 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of RTI-55 by SLC6A3 DTD0455 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Mazindol by SLC6A3 DTD0455 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Cocaine MOACRIVE Inhibition DTD0455 EXOFACTO Cocaine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-DAT1 DTD0455 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Dasotraline HIGHSTIT Drug in Phase 3 Trial DTD0455 EXOFACTO Dasotraline DESCRIPT Dasotraline inhibits the activity of SLC6A3 DTD0455 EXOFACTO Dasotraline MOACRIVE Inhibition DTD0455 EXOFACTO Decitabine HIGHSTIT Approved Drug DTD0455 EXOFACTO Decitabine DESCRIPT Decitabine inhibits DNA methyltransferase, which then enhances the expression of SLC6A3 via downregulating the promoter hypermethylation level DTD0455 EXOFACTO Decitabine MOACRIVE Inducer DTD0455 EXOFACTO Decitabine CELLLINE Human dopaminergic neuroblastoma cell line (SH-SY-5Y) DTD0455 EXOFACTO Desvenlafaxine HIGHSTIT Approved Drug DTD0455 EXOFACTO Desvenlafaxine DESCRIPT Desvenlafaxine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Desvenlafaxine MOACRIVE Inhibition DTD0455 EXOFACTO Desvenlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Dexmethylphenidate HIGHSTIT Approved Drug DTD0455 EXOFACTO Dexmethylphenidate DESCRIPT Dexmethylphenidate inhibits the activity of SLC6A3 DTD0455 EXOFACTO Dexmethylphenidate MOACRIVE Inhibition DTD0455 EXOFACTO Dexmethylphenidate CELLLINE N2A neuroblastoma cells-DAT1 DTD0455 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0455 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0455 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Dimethyl fumarate HIGHSTIT Approved Drug DTD0455 EXOFACTO Dimethyl fumarate DESCRIPT Dimethyl fumarate induces the activity of SLC6A3 DTD0455 EXOFACTO Dimethyl fumarate MOACRIVE Inducer DTD0455 EXOFACTO Dopamine HIGHSTIT Approved Drug DTD0455 EXOFACTO Dopamine DESCRIPT Dopamine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Dopamine MOACRIVE Inhibition DTD0455 EXOFACTO Dopamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO DOV 21947 HIGHSTIT Drug in Phase 2 Trial DTD0455 EXOFACTO DOV 21947 DESCRIPT DOV 21947 inhibits the activity of SLC6A3 DTD0455 EXOFACTO DOV 21947 MOACRIVE Inhibition DTD0455 EXOFACTO Duloxetine HIGHSTIT Approved Drug DTD0455 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the transportation of WIN-35428 by SLC6A3 DTD0455 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Duloxetine MOACRIVE Inhibition DTD0455 EXOFACTO Duloxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Ephedrine HIGHSTIT Approved Drug DTD0455 EXOFACTO Ephedrine DESCRIPT Ephedrine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 46 microM) DTD0455 EXOFACTO Ephedrine MOACRIVE Inhibition DTD0455 EXOFACTO Ephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0455 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0455 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0455 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the activity of SLC6A3 DTD0455 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0455 EXOFACTO Ioflupane I-123 HIGHSTIT Approved Drug DTD0455 EXOFACTO Ioflupane I-123 DESCRIPT Ioflupane I-123 modulates the activity of SLC6A3 DTD0455 EXOFACTO Ioflupane I-123 MOACRIVE Modulator DTD0455 EXOFACTO Mazindol HIGHSTIT Approved Drug DTD0455 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of Mazindol by SLC6A3 DTD0455 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of RTI-55 by SLC6A3 DTD0455 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of WIN-35428 by SLC6A3 DTD0455 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the activity of SLC6A3 DTD0455 EXOFACTO Mazindol MOACRIVE Inhibition DTD0455 EXOFACTO Mazindol CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Mazindol CELLLINE Chinese hamster ovary (CHO) cells-DAT1 DTD0455 EXOFACTO Methamphetamine HIGHSTIT Approved Drug DTD0455 EXOFACTO Methamphetamine DESCRIPT Methamphetamine inhibits the transportation of Serotonin by SLC6A3 (IC50 = 1.1 microM) DTD0455 EXOFACTO Methamphetamine MOACRIVE Inhibition DTD0455 EXOFACTO Methamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Methcathinone HIGHSTIT Investigative Drug DTD0455 EXOFACTO Methcathinone DESCRIPT Methcathinone inhibits the transportation of Serotonin by SLC6A3 (IC50 = 2.4 microM) DTD0455 EXOFACTO Methcathinone MOACRIVE Inhibition DTD0455 EXOFACTO Methcathinone CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Methylenedioxypyrovalerone (MDPV) HIGHSTIT Investigative Drug DTD0455 EXOFACTO Methylenedioxypyrovalerone (MDPV) DESCRIPT Methylenedioxypyrovalerone (MDPV) inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.05 microM) DTD0455 EXOFACTO Methylenedioxypyrovalerone (MDPV) MOACRIVE Inhibition DTD0455 EXOFACTO Methylenedioxypyrovalerone (MDPV) CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Methylphenidate HIGHSTIT Approved Drug DTD0455 EXOFACTO Methylphenidate DESCRIPT Methylphenidate inhibits the activity of SLC6A3 DTD0455 EXOFACTO Methylphenidate DESCRIPT Methylphenidate blocks the activity of SLC6A3 DTD0455 EXOFACTO Methylphenidate MOACRIVE Inhibition DTD0455 EXOFACTO Methylphenidate MOACRIVE Blocker DTD0455 EXOFACTO Methylphenidate CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Milnacipran HIGHSTIT Approved Drug DTD0455 EXOFACTO Milnacipran DESCRIPT Milnacipran inhibits the activity of SLC6A3 DTD0455 EXOFACTO Milnacipran MOACRIVE Inhibition DTD0455 EXOFACTO Milnacipran CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Modafinil HIGHSTIT Approved Drug DTD0455 EXOFACTO Modafinil DESCRIPT Modafinil inhibits the transportation of Uridine by SLC6A3 DTD0455 EXOFACTO Modafinil DESCRIPT Modafinil inhibits the activity of SLC6A3 DTD0455 EXOFACTO Modafinil DESCRIPT Modafinil modulates the activity of SLC6A3 DTD0455 EXOFACTO Modafinil MOACRIVE Inhibition DTD0455 EXOFACTO Modafinil MOACRIVE Modulator DTD0455 EXOFACTO Modafinil CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-DAT1 DTD0455 EXOFACTO Naphyrone HIGHSTIT Drug Withdrawn DTD0455 EXOFACTO Naphyrone DESCRIPT Naphyrone inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.22 microM) DTD0455 EXOFACTO Naphyrone MOACRIVE Inhibition DTD0455 EXOFACTO Naphyrone CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0455 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0455 EXOFACTO Pyrovalerone HIGHSTIT Investigative Drug DTD0455 EXOFACTO Pyrovalerone DESCRIPT Pyrovalerone inhibits the transportation of Serotonin by SLC6A3 (IC50 = 0.07 microM) DTD0455 EXOFACTO Pyrovalerone MOACRIVE Inhibition DTD0455 EXOFACTO Pyrovalerone CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Reboxetine HIGHSTIT Approved Drug DTD0455 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of WIN-35428 by SLC6A3 DTD0455 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Reboxetine MOACRIVE Inhibition DTD0455 EXOFACTO Reboxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0455 EXOFACTO Sodium butyrate HIGHSTIT Drug in Phase 2/3 Trial DTD0455 EXOFACTO Sodium butyrate DESCRIPT Sodium butyrate inhibits histone deacetylase, which then enhances the expression of SLC6A3 via increasing the histone acethylation level DTD0455 EXOFACTO Sodium butyrate MOACRIVE Inducer DTD0455 EXOFACTO Sodium butyrate CELLLINE Human embryonic kidney 293 cells (HEK293) DTD0455 EXOFACTO Valproic acid HIGHSTIT Approved Drug DTD0455 EXOFACTO Valproic acid DESCRIPT Valproic acid inhibits histone deacetylase, which then enhances the expression of SLC6A3 via increasing the histone acethylation level DTD0455 EXOFACTO Valproic acid MOACRIVE Inducer DTD0455 EXOFACTO Valproic acid CELLLINE Model organism in vivo (rat) DTD0455 EXOFACTO Venlafaxine HIGHSTIT Approved Drug DTD0455 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the transportation of Dopamine by SLC6A3 DTD0455 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the activity of SLC6A3 DTD0455 EXOFACTO Venlafaxine MOACRIVE Inhibition DTD0455 EXOFACTO Venlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-DAT1 DTD0456 TRANSPID DTD0456 DTD0456 GENENAME SLC6A4 DTD0456 PROTNAME Sodium-dependent serotonin transporter DTD0456 GENEDBID 6532 DTD0456 UNIPROID P31645 DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) HIGHSTIT Investigative Drug DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) inhibits the transportation of Dopamine by SLC6A4 (IC50 = 15 microM) DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) MOACRIVE Inhibition DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP) CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) HIGHSTIT Investigative Drug DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) DESCRIPT 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) inhibits the transportation of Dopamine by SLC6A4 (IC50 = 75 microM) DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) MOACRIVE Inhibition DTD0456 EXOFACTO 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP) CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO 4-Fluoroamphetamine HIGHSTIT Approved Drug DTD0456 EXOFACTO 4-Fluoroamphetamine DESCRIPT 4-Fluoroamphetamine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 19 microM) DTD0456 EXOFACTO 4-Fluoroamphetamine MOACRIVE Inhibition DTD0456 EXOFACTO 4-Fluoroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO 4-Fluoroephedrine HIGHSTIT Natural Product DTD0456 EXOFACTO 4-Fluoroephedrine DESCRIPT 4-Fluoroephedrine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 134 microM) DTD0456 EXOFACTO 4-Fluoroephedrine MOACRIVE Inhibition DTD0456 EXOFACTO 4-Fluoroephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO 4-Fluoromethamphetamine HIGHSTIT Approved Drug DTD0456 EXOFACTO 4-Fluoromethamphetamine DESCRIPT 4-Fluoromethamphetamine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 8.7 microM) DTD0456 EXOFACTO 4-Fluoromethamphetamine MOACRIVE Inhibition DTD0456 EXOFACTO 4-Fluoromethamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Acetaminophen HIGHSTIT Approved Drug DTD0456 EXOFACTO Acetaminophen DESCRIPT Acetaminophen inhibits the activity of SLC6A4 DTD0456 EXOFACTO Acetaminophen MOACRIVE Inhibition DTD0456 EXOFACTO Amfepramone HIGHSTIT Approved Drug DTD0456 EXOFACTO Amfepramone DESCRIPT Amfepramone inhibits the activity of SLC6A4 DTD0456 EXOFACTO Amfepramone MOACRIVE Inhibition DTD0456 EXOFACTO Amitifadine HIGHSTIT Drug in Phase 3 Trial DTD0456 EXOFACTO Amitifadine DESCRIPT Amitifadine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Amitifadine MOACRIVE Inhibition DTD0456 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0456 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the activity of SLC6A4 DTD0456 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0456 EXOFACTO Amitriptyline CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Amphetamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Amphetamine DESCRIPT Amphetamine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 45 microM) DTD0456 EXOFACTO Amphetamine MOACRIVE Inhibition DTD0456 EXOFACTO Amphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Aripiprazole HIGHSTIT Approved Drug DTD0456 EXOFACTO Aripiprazole DESCRIPT Aripiprazole inhibits the activity of SLC6A4 DTD0456 EXOFACTO Aripiprazole MOACRIVE Inhibition DTD0456 EXOFACTO Aripiprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Bicifadine HIGHSTIT Drug in Phase 3 Trial DTD0456 EXOFACTO Bicifadine DESCRIPT Bicifadine modulates the activity of SLC6A4 DTD0456 EXOFACTO Bicifadine MOACRIVE Modulator DTD0456 EXOFACTO Bupropion HIGHSTIT Approved Drug DTD0456 EXOFACTO Bupropion DESCRIPT Bupropion inhibits the activity of SLC6A4 DTD0456 EXOFACTO Bupropion MOACRIVE Inhibition DTD0456 EXOFACTO Bupropion CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Chlorphentermine HIGHSTIT Approved Drug DTD0456 EXOFACTO Chlorphentermine DESCRIPT Chlorphentermine modulates the activity of SLC6A4 DTD0456 EXOFACTO Chlorphentermine MOACRIVE Modulator DTD0456 EXOFACTO Chlorpromazine HIGHSTIT Approved Drug DTD0456 EXOFACTO Chlorpromazine DESCRIPT Chlorpromazine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Chlorpromazine MOACRIVE Inhibition DTD0456 EXOFACTO Chlorpromazine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Citalopram HIGHSTIT Approved Drug DTD0456 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the transportation of RTI-55 by SLC6A4 DTD0456 EXOFACTO Citalopram DESCRIPT Citalopram inhibits the activity of SLC6A4 DTD0456 EXOFACTO Citalopram DESCRIPT Citalopram modulates the activity of SLC6A4 DTD0456 EXOFACTO Citalopram MOACRIVE Inhibition DTD0456 EXOFACTO Citalopram MOACRIVE Modulator DTD0456 EXOFACTO Citalopram CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-SERT DTD0456 EXOFACTO Citalopram CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Clomipramine HIGHSTIT Approved Drug DTD0456 EXOFACTO Clomipramine DESCRIPT Clomipramine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Clomipramine MOACRIVE Inhibition DTD0456 EXOFACTO Clomipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Clozapine HIGHSTIT Approved Drug DTD0456 EXOFACTO Clozapine DESCRIPT Clozapine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Clozapine MOACRIVE Inhibition DTD0456 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0456 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of Mazindol by SLC6A4 DTD0456 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the transportation of RTI-55 by SLC6A4 DTD0456 EXOFACTO Cocaine DESCRIPT Cocaine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Cocaine MOACRIVE Inhibition DTD0456 EXOFACTO Cocaine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)1-SERT DTD0456 EXOFACTO Cocaine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Dasotraline HIGHSTIT Drug in Phase 3 Trial DTD0456 EXOFACTO Dasotraline DESCRIPT Dasotraline inhibits the activity of SLC6A4 DTD0456 EXOFACTO Dasotraline MOACRIVE Inhibition DTD0456 EXOFACTO Desvenlafaxine HIGHSTIT Approved Drug DTD0456 EXOFACTO Desvenlafaxine DESCRIPT Desvenlafaxine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Desvenlafaxine DESCRIPT Desvenlafaxine modulates the activity of SLC6A4 DTD0456 EXOFACTO Desvenlafaxine MOACRIVE Inhibition DTD0456 EXOFACTO Desvenlafaxine MOACRIVE Modulator DTD0456 EXOFACTO Desvenlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Dextroamphetamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Dextroamphetamine DESCRIPT Dextroamphetamine inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Dextroamphetamine MOACRIVE Inhibition DTD0456 EXOFACTO Dextroamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Dextromethorphan polistirex HIGHSTIT Approved Drug DTD0456 EXOFACTO Dextromethorphan polistirex DESCRIPT Dextromethorphan polistirex modulates the activity of SLC6A4 DTD0456 EXOFACTO Dextromethorphan polistirex MOACRIVE Modulator DTD0456 EXOFACTO Dopamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Dopamine DESCRIPT Dopamine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Dopamine MOACRIVE Inhibition DTD0456 EXOFACTO Dopamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Duloxetine HIGHSTIT Approved Drug DTD0456 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the transportation of Citalopram by SLC6A4 DTD0456 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the transportation of Paroxetine by SLC6A4 DTD0456 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Duloxetine MOACRIVE Inhibition DTD0456 EXOFACTO Duloxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Ephedrine HIGHSTIT Approved Drug DTD0456 EXOFACTO Ephedrine DESCRIPT Ephedrine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 230 microM) DTD0456 EXOFACTO Ephedrine MOACRIVE Inhibition DTD0456 EXOFACTO Ephedrine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Escitalopram HIGHSTIT Approved Drug DTD0456 EXOFACTO Escitalopram DESCRIPT Escitalopram inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Escitalopram DESCRIPT Escitalopram inhibits the activity of SLC6A4 DTD0456 EXOFACTO Escitalopram MOACRIVE Inhibition DTD0456 EXOFACTO Escitalopram CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-SERT DTD0456 EXOFACTO Escitalopram CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0456 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the transportation of Neurotransmitter by SLC6A4 DTD0456 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Fluoxetine DESCRIPT Fluoxetine modulates the activity of SLC6A4 DTD0456 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0456 EXOFACTO Fluoxetine MOACRIVE Modulator DTD0456 EXOFACTO Fluoxetine CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-SERT DTD0456 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Fluvoxamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Fluvoxamine DESCRIPT Fluvoxamine modulates the activity of SLC6A4 DTD0456 EXOFACTO Fluvoxamine MOACRIVE Inhibition DTD0456 EXOFACTO Fluvoxamine MOACRIVE Modulator DTD0456 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0456 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the activity of SLC6A4 DTD0456 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0456 EXOFACTO Imipramine HIGHSTIT Approved Drug DTD0456 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Imipramine DESCRIPT Imipramine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Imipramine MOACRIVE Inhibition DTD0456 EXOFACTO Imipramine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Imipramine CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Levomilnacipran HIGHSTIT Approved Drug DTD0456 EXOFACTO Levomilnacipran DESCRIPT Levomilnacipran modulates the activity of SLC6A4 DTD0456 EXOFACTO Levomilnacipran MOACRIVE Modulator DTD0456 EXOFACTO Litoxetine HIGHSTIT Drug in Phase 3 Trial DTD0456 EXOFACTO Litoxetine DESCRIPT Litoxetine modulates the activity of SLC6A4 DTD0456 EXOFACTO Litoxetine MOACRIVE Modulator DTD0456 EXOFACTO Mazindol HIGHSTIT Approved Drug DTD0456 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of Mazindol by SLC6A4 DTD0456 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the transportation of RTI-55 by SLC6A4 DTD0456 EXOFACTO Mazindol DESCRIPT Mazindol inhibits the activity of SLC6A4 DTD0456 EXOFACTO Mazindol MOACRIVE Inhibition DTD0456 EXOFACTO Mazindol CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Methamphetamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Methamphetamine DESCRIPT Methamphetamine inhibits the transportation of Dopamine by SLC6A4 (IC50 = 18 microM) DTD0456 EXOFACTO Methamphetamine MOACRIVE Inhibition DTD0456 EXOFACTO Methamphetamine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Methcathinone HIGHSTIT Investigative Drug DTD0456 EXOFACTO Methcathinone DESCRIPT Methcathinone inhibits the transportation of Dopamine by SLC6A4 (IC50 = 46 microM) DTD0456 EXOFACTO Methcathinone MOACRIVE Inhibition DTD0456 EXOFACTO Methcathinone CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Methylenedioxypyrovalerone (MDPV) HIGHSTIT Investigative Drug DTD0456 EXOFACTO Methylenedioxypyrovalerone (MDPV) DESCRIPT Methylenedioxypyrovalerone (MDPV) inhibits the transportation of Dopamine by SLC6A4 (IC50 = 9.6 microM) DTD0456 EXOFACTO Methylenedioxypyrovalerone (MDPV) MOACRIVE Inhibition DTD0456 EXOFACTO Methylenedioxypyrovalerone (MDPV) CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Methylphenidate HIGHSTIT Approved Drug DTD0456 EXOFACTO Methylphenidate DESCRIPT Methylphenidate inhibits the activity of SLC6A4 DTD0456 EXOFACTO Methylphenidate MOACRIVE Inhibition DTD0456 EXOFACTO Methylphenidate CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Moclobemide HIGHSTIT Approved Drug DTD0456 EXOFACTO Moclobemide DESCRIPT Moclobemide inhibits the activity of SLC6A4 DTD0456 EXOFACTO Moclobemide MOACRIVE Inhibition DTD0456 EXOFACTO Moclobemide CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Modafinil HIGHSTIT Approved Drug DTD0456 EXOFACTO Modafinil DESCRIPT Modafinil inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Modafinil MOACRIVE Inhibition DTD0456 EXOFACTO Modafinil CELLLINE Monkey kidney tissue Fibroblast-like cell lines (COS)7-SERT DTD0456 EXOFACTO Naphyrone HIGHSTIT Drug Withdrawn DTD0456 EXOFACTO Naphyrone DESCRIPT Naphyrone inhibits the transportation of Dopamine by SLC6A4 (IC50 = 0.8 microM) DTD0456 EXOFACTO Naphyrone MOACRIVE Inhibition DTD0456 EXOFACTO Naphyrone CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Nortriptyline HIGHSTIT Approved Drug DTD0456 EXOFACTO Nortriptyline DESCRIPT Nortriptyline modulates the activity of SLC6A4 DTD0456 EXOFACTO Nortriptyline MOACRIVE Modulator DTD0456 EXOFACTO Olanzapine HIGHSTIT Approved Drug DTD0456 EXOFACTO Olanzapine DESCRIPT Olanzapine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Olanzapine MOACRIVE Inhibition DTD0456 EXOFACTO Paroxetine HIGHSTIT Approved Drug DTD0456 EXOFACTO Paroxetine DESCRIPT Paroxetine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Paroxetine DESCRIPT Paroxetine modulates the activity of SLC6A4 DTD0456 EXOFACTO Paroxetine MOACRIVE Inhibition DTD0456 EXOFACTO Paroxetine MOACRIVE Modulator DTD0456 EXOFACTO Paroxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Pimozide HIGHSTIT Approved Drug DTD0456 EXOFACTO Pimozide DESCRIPT Pimozide inhibits the activity of SLC6A4 DTD0456 EXOFACTO Pimozide MOACRIVE Inhibition DTD0456 EXOFACTO Pimozide CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Pridopidine HIGHSTIT Drug in Phase 3 Trial DTD0456 EXOFACTO Pridopidine DESCRIPT Pridopidine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Pridopidine MOACRIVE Inhibition DTD0456 EXOFACTO Pridopidine CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Pyrovalerone HIGHSTIT Investigative Drug DTD0456 EXOFACTO Pyrovalerone DESCRIPT Pyrovalerone inhibits the transportation of Dopamine by SLC6A4 (IC50 = 23 microM) DTD0456 EXOFACTO Pyrovalerone MOACRIVE Inhibition DTD0456 EXOFACTO Pyrovalerone CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Quetiapine HIGHSTIT Approved Drug DTD0456 EXOFACTO Quetiapine DESCRIPT Quetiapine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Quetiapine MOACRIVE Inhibition DTD0456 EXOFACTO Reboxetine HIGHSTIT Approved Drug DTD0456 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of Citalopram by SLC6A4 DTD0456 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the transportation of RTI-55 by SLC6A4 DTD0456 EXOFACTO Reboxetine DESCRIPT Reboxetine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Reboxetine MOACRIVE Inhibition DTD0456 EXOFACTO Reboxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Risperidone HIGHSTIT Approved Drug DTD0456 EXOFACTO Risperidone DESCRIPT Risperidone inhibits the activity of SLC6A4 DTD0456 EXOFACTO Risperidone MOACRIVE Inhibition DTD0456 EXOFACTO Risperidone CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Scopolamine HIGHSTIT Approved Drug DTD0456 EXOFACTO Scopolamine DESCRIPT Scopolamine induces the activity of SLC6A4 DTD0456 EXOFACTO Scopolamine MOACRIVE Inducer DTD0456 EXOFACTO Sertraline HIGHSTIT Approved Drug DTD0456 EXOFACTO Sertraline DESCRIPT Sertraline inhibits the activity of SLC6A4 DTD0456 EXOFACTO Sertraline MOACRIVE Inhibition DTD0456 EXOFACTO Sibutramine HIGHSTIT Approved Drug DTD0456 EXOFACTO Sibutramine DESCRIPT Sibutramine modulates the activity of SLC6A4 DTD0456 EXOFACTO Sibutramine MOACRIVE Modulator DTD0456 EXOFACTO Tianeptine HIGHSTIT Approved Drug DTD0456 EXOFACTO Tianeptine DESCRIPT Tianeptine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Tianeptine MOACRIVE Inhibition DTD0456 EXOFACTO Trazodone HIGHSTIT Approved Drug DTD0456 EXOFACTO Trazodone DESCRIPT Trazodone modulates the activity of SLC6A4 DTD0456 EXOFACTO Trazodone MOACRIVE Modulator DTD0456 EXOFACTO Venlafaxine HIGHSTIT Approved Drug DTD0456 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the transportation of Neurotransmitter by SLC6A4 DTD0456 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the transportation of Serotonin by SLC6A4 DTD0456 EXOFACTO Venlafaxine DESCRIPT Venlafaxine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Venlafaxine MOACRIVE Inhibition DTD0456 EXOFACTO Venlafaxine CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0456 EXOFACTO Vilazodone HIGHSTIT Approved Drug DTD0456 EXOFACTO Vilazodone DESCRIPT Vilazodone inhibits the activity of SLC6A4 DTD0456 EXOFACTO Vilazodone DESCRIPT Vilazodone modulates the activity of SLC6A4 DTD0456 EXOFACTO Vilazodone MOACRIVE Inhibition DTD0456 EXOFACTO Vilazodone MOACRIVE Modulator DTD0456 EXOFACTO Vortioxetine HIGHSTIT Approved Drug DTD0456 EXOFACTO Vortioxetine DESCRIPT Vortioxetine inhibits the activity of SLC6A4 DTD0456 EXOFACTO Vortioxetine MOACRIVE Inhibition DTD0456 EXOFACTO Ziprasidone HIGHSTIT Approved Drug DTD0456 EXOFACTO Ziprasidone DESCRIPT Ziprasidone inhibits the activity of SLC6A4 DTD0456 EXOFACTO Ziprasidone MOACRIVE Inhibition DTD0456 EXOFACTO Ziprasidone CELLLINE Chinese hamster ovary (CHO) cells-SERT DTD0456 EXOFACTO Ziprasidone CELLLINE Human embryonic kidney 293 cells (HEK293)-SERT DTD0457 TRANSPID DTD0457 DTD0457 GENENAME SLC6A2 DTD0457 GENENAME SLC6A5 DTD0457 PROTNAME Sodium- and chloride-dependent glycine transporter 2 DTD0457 GENEDBID 9152 DTD0457 UNIPROID Q9Y345 DTD0457 EXOFACTO ALX 1393 HIGHSTIT Investigative Drug DTD0457 EXOFACTO ALX 1393 DESCRIPT ALX 1393 inhibits the activity of SLC6A5 DTD0457 EXOFACTO ALX 1393 MOACRIVE Inhibition DTD0457 EXOFACTO Amitriptyline HIGHSTIT Approved Drug DTD0457 EXOFACTO Amitriptyline DESCRIPT Amitriptyline inhibits the activity of SLC6A5 DTD0457 EXOFACTO Amitriptyline MOACRIVE Inhibition DTD0457 EXOFACTO Atomoxetine HIGHSTIT Approved Drug DTD0457 EXOFACTO Atomoxetine DESCRIPT Atomoxetine inhibits the activity of SLC6A5 DTD0457 EXOFACTO Atomoxetine MOACRIVE Inhibition DTD0457 EXOFACTO Cocaine HIGHSTIT Approved Drug DTD0457 EXOFACTO Cocaine DESCRIPT Cocaine induces the activity of SLC6A5 DTD0457 EXOFACTO Cocaine MOACRIVE Inducer DTD0457 EXOFACTO Desipramine HIGHSTIT Approved Drug DTD0457 EXOFACTO Desipramine DESCRIPT Desipramine inhibits the activity of SLC6A5 DTD0457 EXOFACTO Desipramine MOACRIVE Inhibition DTD0457 EXOFACTO Duloxetine HIGHSTIT Approved Drug DTD0457 EXOFACTO Duloxetine DESCRIPT Duloxetine inhibits the activity of SLC6A5 DTD0457 EXOFACTO Duloxetine MOACRIVE Inhibition DTD0457 EXOFACTO Sibutramine HIGHSTIT Approved Drug DTD0457 EXOFACTO Sibutramine DESCRIPT Sibutramine inhibits the activity of SLC6A5 DTD0457 EXOFACTO Sibutramine MOACRIVE Inhibition DTD0457 EXOFACTO Tramadol HIGHSTIT Approved Drug DTD0457 EXOFACTO Tramadol DESCRIPT Tramadol inhibits the activity of SLC6A5 DTD0457 EXOFACTO Tramadol MOACRIVE Inhibition DTD0457 EXOFACTO Vorinostat HIGHSTIT Approved Drug DTD0457 EXOFACTO Vorinostat DESCRIPT Vorinostat induces the activity of SLC6A5 DTD0457 EXOFACTO Vorinostat MOACRIVE Inducer DTD0459 TRANSPID DTD0459 DTD0459 GENENAME SLC6A7 DTD0459 PROTNAME Sodium-dependent proline transporter DTD0459 GENEDBID 6534 DTD0459 UNIPROID Q99884 DTD0459 EXOFACTO Compound 58 [PMID: 25037917] HIGHSTIT Investigative Drug DTD0459 EXOFACTO Compound 58 [PMID: 25037917] DESCRIPT Compound 58 [PMID: 25037917] inhibits the activity of SLC6A7 DTD0459 EXOFACTO Compound 58 [PMID: 25037917] MOACRIVE Inhibition DTD0459 EXOFACTO LP-403812 HIGHSTIT Investigative Drug DTD0459 EXOFACTO LP-403812 DESCRIPT LP-403812 inhibits the activity of SLC6A7 DTD0459 EXOFACTO LP-403812 MOACRIVE Inhibition DTD0461 TRANSPID DTD0461 DTD0461 GENENAME SLC6A9 DTD0461 PROTNAME Sodium- and chloride-dependent glycine transporter 1 DTD0461 GENEDBID 6536 DTD0461 UNIPROID P48067 DTD0461 EXOFACTO ALX 5407 HIGHSTIT Drug in Phase 1 Trial DTD0461 EXOFACTO ALX 5407 DESCRIPT ALX 5407 blocks the activity of SLC6A9 DTD0461 EXOFACTO ALX 5407 MOACRIVE Blocker DTD0461 EXOFACTO AMG 747 HIGHSTIT Drug in Phase 2 Trial DTD0461 EXOFACTO AMG 747 DESCRIPT AMG 747 modulates the activity of SLC6A9 DTD0461 EXOFACTO AMG 747 MOACRIVE Modulator DTD0461 EXOFACTO DCCCyB HIGHSTIT Drug in Phase 1 Trial DTD0461 EXOFACTO DCCCyB DESCRIPT DCCCyB modulates the activity of SLC6A9 DTD0461 EXOFACTO DCCCyB MOACRIVE Modulator DTD0461 EXOFACTO GlyT1 PET radiotracers HIGHSTIT Drug in Phase 1 Trial DTD0461 EXOFACTO GlyT1 PET radiotracers DESCRIPT GlyT1 PET radiotracers modulates the activity of SLC6A9 DTD0461 EXOFACTO GlyT1 PET radiotracers MOACRIVE Modulator DTD0461 EXOFACTO JNJ-17305600 HIGHSTIT Drug in Phase 1 Trial DTD0461 EXOFACTO JNJ-17305600 DESCRIPT JNJ-17305600 inhibits the activity of SLC6A9 DTD0461 EXOFACTO JNJ-17305600 MOACRIVE Inhibition DTD0461 EXOFACTO MK-2637 HIGHSTIT Drug in Phase 1 Trial DTD0461 EXOFACTO MK-2637 DESCRIPT MK-2637 modulates the activity of SLC6A9 DTD0461 EXOFACTO MK-2637 MOACRIVE Modulator DTD0461 EXOFACTO ORG-25935 HIGHSTIT Drug in Phase 2 Trial DTD0461 EXOFACTO ORG-25935 DESCRIPT ORG-25935 inhibits the activity of SLC6A9 DTD0461 EXOFACTO ORG-25935 MOACRIVE Inhibition DTD0461 EXOFACTO PF-3463275 HIGHSTIT Drug in Phase 2 Trial DTD0461 EXOFACTO PF-3463275 DESCRIPT PF-3463275 inhibits the activity of SLC6A9 DTD0461 EXOFACTO PF-3463275 MOACRIVE Inhibition DTD0461 EXOFACTO R1678 HIGHSTIT Drug in Phase 3 Trial DTD0461 EXOFACTO R1678 DESCRIPT R1678 blocks the activity of SLC6A9 DTD0461 EXOFACTO R1678 MOACRIVE Blocker DTD0462 TRANSPID DTD0462 DTD0462 GENENAME SLC7A1 DTD0462 PROTNAME High affinity cationic amino acid transporter 1 DTD0462 GENEDBID 6541 DTD0462 UNIPROID P30825 DTD0462 EXOFACTO Dimethyl sulfoxide HIGHSTIT Approved Drug DTD0462 EXOFACTO Dimethyl sulfoxide DESCRIPT Dimethyl sulfoxide inhibits the activity of SLC7A1 DTD0462 EXOFACTO Dimethyl sulfoxide MOACRIVE Inhibition DTD0462 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0462 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the activity of SLC7A1 DTD0462 EXOFACTO Spironolactone DESCRIPT Spironolactone induces the activity of SLC7A1 DTD0462 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0462 EXOFACTO Spironolactone MOACRIVE Inducer DTD0462 EXOFACTO Spironolactone CELLLINE Human umbilical vein endothelial cells (HUVEC) DTD0463 TRANSPID DTD0463 DTD0463 GENENAME SLC7A10 DTD0463 PROTNAME Asc-type amino acid transporter 1 DTD0463 GENEDBID 56301 DTD0463 UNIPROID Q9NS82 DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) HIGHSTIT Investigative Drug DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) DESCRIPT (+)-Amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) inhibits the activity of SLC7A10 (IC50 = 0.72 +/- 0.13 microM) DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) DESCRIPT (+)-Amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) inhibits the activity of SLC7A10 (IC50 = 0.8 +/- 0.30 microM) DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) MOACRIVE Inhibition DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) CELLLINE Chinese hamster ovary (CHO) cells-ASC1 DTD0463 EXOFACTO (+)-amino(1-(3,5-dichlorophenyl)-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid (ACPP) CELLLINE Rat primary neurons-ASC1 DTD0463 EXOFACTO BMS-466442 HIGHSTIT Investigative Drug DTD0463 EXOFACTO BMS-466442 DESCRIPT BMS-466442 inhibits the activity of SLC7A10 DTD0463 EXOFACTO BMS-466442 MOACRIVE Inhibition DTD0463 EXOFACTO D-isoleucine HIGHSTIT Natural Product DTD0463 EXOFACTO D-isoleucine DESCRIPT D-isoleucine inhibits the activity of SLC7A10 DTD0463 EXOFACTO D-isoleucine MOACRIVE Inhibition DTD0463 EXOFACTO D-isoleucine CELLLINE Double transgenic mouse line DTD0464 TRANSPID DTD0464 DTD0464 GENENAME SLC7A11 DTD0464 PROTNAME Cystine/glutamate transporter DTD0464 GENEDBID 23657 DTD0464 UNIPROID Q9UPY5 DTD0464 EXOFACTO Vorinostat HIGHSTIT Approved Drug DTD0464 EXOFACTO Vorinostat DESCRIPT Vorinostat inhibits the activity of SLC7A11 DTD0464 EXOFACTO Vorinostat MOACRIVE Inhibition DTD0471 TRANSPID DTD0471 DTD0471 GENENAME SLC7A5 DTD0471 PROTNAME L-type amino acid transporter 1 DTD0471 GENEDBID 8140 DTD0471 UNIPROID Q01650 DTD0471 EXOFACTO Arginine HIGHSTIT Approved Drug DTD0471 EXOFACTO Arginine DESCRIPT Arginine inhibits the transportation of Gabapentin by SLC7A5 DTD0471 EXOFACTO Arginine MOACRIVE Inhibition DTD0471 EXOFACTO Arginine CELLLINE Human embryonic kidney 293 cells (HEK293)-LAT1 DTD0471 EXOFACTO L-leucine HIGHSTIT Investigative Drug DTD0471 EXOFACTO L-leucine DESCRIPT L-leucine inhibits the transportation of Gabapentin by SLC7A5 DTD0471 EXOFACTO L-leucine MOACRIVE Inhibition DTD0471 EXOFACTO L-leucine CELLLINE Human embryonic kidney 293 cells (HEK293)-LAT1 DTD0471 EXOFACTO L-phenylalanine HIGHSTIT Investigative Drug DTD0471 EXOFACTO L-phenylalanine DESCRIPT L-phenylalanine inhibits the transportation of Gabapentin by SLC7A5 DTD0471 EXOFACTO L-phenylalanine MOACRIVE Inhibition DTD0471 EXOFACTO L-phenylalanine CELLLINE Human embryonic kidney 293 cells (HEK293)-LAT1 DTD0471 EXOFACTO L-tyrosine HIGHSTIT Approved Drug DTD0471 EXOFACTO L-tyrosine DESCRIPT L-tyrosine inhibits the transportation of Gabapentin by SLC7A5 DTD0471 EXOFACTO L-tyrosine MOACRIVE Inhibition DTD0471 EXOFACTO L-tyrosine CELLLINE Human embryonic kidney 293 cells (HEK293)-LAT1 DTD0499 TRANSPID DTD0499 DTD0499 GENENAME SLCO1C1 DTD0499 PROTNAME Organic anion transporting polypeptide 1C1 DTD0499 GENEDBID 53919 DTD0499 UNIPROID Q9NYB5 DTD0499 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0499 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein modulates the activity of SLCO1C1 DTD0499 EXOFACTO Bromsulphthalein MOACRIVE Modulator DTD0499 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0499 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate modulates the activity of SLCO1C1 DTD0499 EXOFACTO Estrone sulfate MOACRIVE Modulator DTD0499 EXOFACTO Gadoxetate disodium HIGHSTIT Approved Drug DTD0499 EXOFACTO Gadoxetate disodium DESCRIPT Gadoxetate disodium induces the activity of SLCO1C1 DTD0499 EXOFACTO Gadoxetate disodium MOACRIVE Inducer DTD0500 TRANSPID DTD0500 DTD0500 GENENAME SLCO2A1 DTD0500 PROTNAME Organic anion transporting polypeptide 2A1 DTD0500 GENEDBID 6578 DTD0500 UNIPROID Q92959 DTD0500 EXOFACTO Bromsulphthalein HIGHSTIT Investigative Drug DTD0500 EXOFACTO Bromsulphthalein DESCRIPT Bromsulphthalein inhibits the activity of SLCO2A1 DTD0500 EXOFACTO Bromsulphthalein MOACRIVE Inhibition DTD0500 EXOFACTO Latanoprost HIGHSTIT Approved Drug DTD0500 EXOFACTO Latanoprost DESCRIPT Latanoprost inhibits the transportation of Prostaglandin E2 by SLCO2A1 (Ki > 10 microM) DTD0500 EXOFACTO Latanoprost DESCRIPT Latanoprost inhibits the activity of SLCO2A1 DTD0500 EXOFACTO Latanoprost MOACRIVE Inhibition DTD0500 EXOFACTO Latanoprost CELLLINE Human cervical cancer cell line (Hela)-OATP2A1 DTD0501 TRANSPID DTD0501 DTD0501 GENENAME SLCO3A1 DTD0501 PROTNAME Organic anion transporting polypeptide 3A1 DTD0501 GENEDBID 28232 DTD0501 UNIPROID Q9UIG8 DTD0501 EXOFACTO Aminohippuric acid HIGHSTIT Investigative Drug DTD0501 EXOFACTO Aminohippuric acid DESCRIPT Aminohippuric acid inhibits the transportation of Prostaglandin E2 by SLCO3A1 DTD0501 EXOFACTO Aminohippuric acid MOACRIVE Inhibition DTD0501 EXOFACTO Aminohippuric acid CELLLINE Oocytes-OATP3A1 DTD0501 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0501 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate modulates the activity of SLCO3A1 DTD0501 EXOFACTO Estrone sulfate MOACRIVE Modulator DTD0502 TRANSPID DTD0502 DTD0502 GENENAME SLCO4A1 DTD0502 PROTNAME Organic anion transporting polypeptide 4A1 DTD0502 GENEDBID 28231 DTD0502 UNIPROID Q96BD0 DTD0502 EXOFACTO Estrone sulfate HIGHSTIT Investigative Drug DTD0502 EXOFACTO Estrone sulfate DESCRIPT Estrone sulfate modulates the activity of SLCO4A1 DTD0502 EXOFACTO Estrone sulfate MOACRIVE Modulator DTD0503 TRANSPID DTD0503 DTD0503 GENENAME SLCO4C1 DTD0503 PROTNAME Organic anion transporting polypeptide 4C1 DTD0503 GENEDBID 353189 DTD0503 UNIPROID Q6ZQN7 DTD0503 EXOFACTO Clarithromycin HIGHSTIT Approved Drug DTD0503 EXOFACTO Clarithromycin DESCRIPT Clarithromycin inhibits the activity of SLCO4C1 (IC50 = 200 microM) DTD0503 EXOFACTO Clarithromycin MOACRIVE Inhibition DTD0503 EXOFACTO Crizotinib HIGHSTIT Approved Drug DTD0503 EXOFACTO Crizotinib DESCRIPT Crizotinib inhibits the activity of SLCO4C1 (IC50 = 24 microM) DTD0503 EXOFACTO Crizotinib MOACRIVE Inhibition DTD0503 EXOFACTO Digoxin HIGHSTIT Approved Drug DTD0503 EXOFACTO Digoxin DESCRIPT Digoxin modulates the activity of SLCO4C1 DTD0503 EXOFACTO Digoxin MOACRIVE Modulator DTD0503 EXOFACTO Fluvastatin HIGHSTIT Approved Drug DTD0503 EXOFACTO Fluvastatin DESCRIPT Fluvastatin inhibits the activity of SLCO4C1 (IC50 = 41 microM) DTD0503 EXOFACTO Fluvastatin MOACRIVE Inhibition DTD0503 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0503 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the activity of SLCO4C1 (IC50 = 420 microM) DTD0503 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0503 EXOFACTO Nicardipine HIGHSTIT Approved Drug DTD0503 EXOFACTO Nicardipine DESCRIPT Nicardipine inhibits the activity of SLCO4C1 (IC50 = 51 microM) DTD0503 EXOFACTO Nicardipine MOACRIVE Inhibition DTD0503 EXOFACTO Quinidine HIGHSTIT Drug Withdrawn DTD0503 EXOFACTO Quinidine DESCRIPT Quinidine inhibits the activity of SLCO4C1 (IC50 = 100 microM) DTD0503 EXOFACTO Quinidine MOACRIVE Inhibition DTD0503 EXOFACTO Ritonavir HIGHSTIT Approved Drug DTD0503 EXOFACTO Ritonavir DESCRIPT Ritonavir inhibits the activity of SLCO4C1 (IC50 = 8.5 microM) DTD0503 EXOFACTO Ritonavir MOACRIVE Inhibition DTD0503 EXOFACTO Saquinavir HIGHSTIT Approved Drug DTD0503 EXOFACTO Saquinavir DESCRIPT Saquinavir inhibits the activity of SLCO4C1 (IC50 = 4.3 microM) DTD0503 EXOFACTO Saquinavir MOACRIVE Inhibition DTD0503 EXOFACTO Spironolactone HIGHSTIT Approved Drug DTD0503 EXOFACTO Spironolactone DESCRIPT Spironolactone inhibits the activity of SLCO4C1 (IC50 = 53 microM) DTD0503 EXOFACTO Spironolactone MOACRIVE Inhibition DTD0503 EXOFACTO Verapamil HIGHSTIT Approved Drug DTD0503 EXOFACTO Verapamil DESCRIPT Verapamil inhibits the activity of SLCO4C1 (IC50 = 110 microM) DTD0503 EXOFACTO Verapamil MOACRIVE Inhibition DTD0510 TRANSPID DTD0510 DTD0510 GENENAME KCNH2 DTD0510 PROTNAME Voltage-gated potassium channel Kv11.1 DTD0510 GENEDBID 3757 DTD0510 UNIPROID Q12809 DTD0510 EXOFACTO 1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) HIGHSTIT Investigative Drug DTD0510 EXOFACTO 1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) DESCRIPT 1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 DTD0510 EXOFACTO 1-(1-(2-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) MOACRIVE Inhibition DTD0510 EXOFACTO 1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) HIGHSTIT Investigative Drug DTD0510 EXOFACTO 1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) DESCRIPT 1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 DTD0510 EXOFACTO 1-(1-(4-Fluorophenyl)-2-(2-(Trifluoromethoxy)Phenyl)Ethyl)Piperazine (Enantiomeric Mix) MOACRIVE Inhibition DTD0510 EXOFACTO 1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix) HIGHSTIT Investigative Drug DTD0510 EXOFACTO 1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix) DESCRIPT 1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix) inhibits the activity of KCNH2 DTD0510 EXOFACTO 1-(2-(2-(Difluoromethoxy)Phenyl)-1-Phenylethyl)Piperazine (Enantiomeric Mix) MOACRIVE Inhibition DTD0510 EXOFACTO 1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) HIGHSTIT Investigative Drug DTD0510 EXOFACTO 1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) DESCRIPT 1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) inhibits the activity of KCNH2 DTD0510 EXOFACTO 1-(2,3-Dichlorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) MOACRIVE Inhibition DTD0510 EXOFACTO 1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) HIGHSTIT Investigative Drug DTD0510 EXOFACTO 1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) DESCRIPT 1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) inhibits the activity of KCNH2 DTD0510 EXOFACTO 1-(3-Chloro-4-Fluorophenyl)-2,2,2-Trifluoro-1-(1-(4-Fluorophenyl)-1H-Indazol-5-Yl)Ethanol (Enantiomeric Mix) MOACRIVE Inhibition DTD0510 EXOFACTO 3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A HIGHSTIT Investigative Drug DTD0510 EXOFACTO 3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A DESCRIPT 3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A inhibits the activity of KCNH2 DTD0510 EXOFACTO 3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A MOACRIVE Inhibition DTD0510 EXOFACTO 3,9-Dihydro-N-Desmethyl-N-Isopropylerythromycin A CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Acid-activated omeprazole HIGHSTIT Investigative Drug DTD0510 EXOFACTO Acid-activated omeprazole DESCRIPT Acid-activated omeprazole inhibits the activity of KCNH2 DTD0510 EXOFACTO Acid-activated omeprazole MOACRIVE Inhibition DTD0510 EXOFACTO AR9281 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO AR9281 DESCRIPT AR9281 inhibits the activity of KCNH2 DTD0510 EXOFACTO AR9281 MOACRIVE Inhibition DTD0510 EXOFACTO AR9281 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Aripiprazole HIGHSTIT Approved Drug DTD0510 EXOFACTO Aripiprazole DESCRIPT Aripiprazole inhibits the activity of KCNH2 DTD0510 EXOFACTO Aripiprazole MOACRIVE Inhibition DTD0510 EXOFACTO Aripiprazole CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Astemizole HIGHSTIT Drug Withdrawn DTD0510 EXOFACTO Astemizole DESCRIPT Astemizole inhibits the activity of KCNH2 DTD0510 EXOFACTO Astemizole MOACRIVE Inhibition DTD0510 EXOFACTO Astemizole CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO BAF312 HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO BAF312 DESCRIPT BAF312 inhibits the activity of KCNH2 DTD0510 EXOFACTO BAF312 MOACRIVE Inhibition DTD0510 EXOFACTO Bardoxolone methyl HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO Bardoxolone methyl DESCRIPT Bardoxolone methyl inhibits the activity of KCNH2 DTD0510 EXOFACTO Bardoxolone methyl MOACRIVE Inhibition DTD0510 EXOFACTO Bepridil HIGHSTIT Approved Drug DTD0510 EXOFACTO Bepridil DESCRIPT Bepridil inhibits the activity of KCNH2 DTD0510 EXOFACTO Bepridil MOACRIVE Inhibition DTD0510 EXOFACTO Bepridil CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Betrixaban HIGHSTIT Approved Drug DTD0510 EXOFACTO Betrixaban DESCRIPT Betrixaban inhibits the activity of KCNH2 DTD0510 EXOFACTO Betrixaban MOACRIVE Inhibition DTD0510 EXOFACTO Bicalutamide HIGHSTIT Approved Drug DTD0510 EXOFACTO Bicalutamide DESCRIPT Bicalutamide inhibits the activity of KCNH2 DTD0510 EXOFACTO Bicalutamide MOACRIVE Inhibition DTD0510 EXOFACTO BMS-582949 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO BMS-582949 DESCRIPT BMS-582949 inhibits the activity of KCNH2 DTD0510 EXOFACTO BMS-582949 MOACRIVE Inhibition DTD0510 EXOFACTO BMS-911543 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO BMS-911543 DESCRIPT BMS-911543 inhibits the activity of KCNH2 DTD0510 EXOFACTO BMS-911543 MOACRIVE Inhibition DTD0510 EXOFACTO BMS-927711 HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO BMS-927711 DESCRIPT BMS-927711 inhibits the activity of KCNH2 DTD0510 EXOFACTO BMS-927711 MOACRIVE Inhibition DTD0510 EXOFACTO BMS-927711 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO CEP-32496 HIGHSTIT Drug in Phase 1/2 Trial DTD0510 EXOFACTO CEP-32496 DESCRIPT CEP-32496 inhibits the activity of KCNH2 DTD0510 EXOFACTO CEP-32496 MOACRIVE Inhibition DTD0510 EXOFACTO Chloroquine HIGHSTIT Approved Drug DTD0510 EXOFACTO Chloroquine DESCRIPT Chloroquine inhibits the activity of KCNH2 DTD0510 EXOFACTO Chloroquine MOACRIVE Inhibition DTD0510 EXOFACTO Chloroquine CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Ciprofloxacin HIGHSTIT Approved Drug DTD0510 EXOFACTO Ciprofloxacin DESCRIPT Ciprofloxacin inhibits the activity of KCNH2 DTD0510 EXOFACTO Ciprofloxacin MOACRIVE Inhibition DTD0510 EXOFACTO Cisapride HIGHSTIT Approved Drug DTD0510 EXOFACTO Cisapride DESCRIPT Cisapride inhibits the activity of KCNH2 DTD0510 EXOFACTO Cisapride MOACRIVE Inhibition DTD0510 EXOFACTO Cisapride CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Clozapine HIGHSTIT Approved Drug DTD0510 EXOFACTO Clozapine DESCRIPT Clozapine inhibits the activity of KCNH2 DTD0510 EXOFACTO Clozapine MOACRIVE Inhibition DTD0510 EXOFACTO Clozapine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO CX-4945 HIGHSTIT Drug in Phase 1/2 Trial DTD0510 EXOFACTO CX-4945 DESCRIPT CX-4945 inhibits the activity of KCNH2 DTD0510 EXOFACTO CX-4945 MOACRIVE Inhibition DTD0510 EXOFACTO Cyclorgdfv HIGHSTIT Investigative Drug DTD0510 EXOFACTO Cyclorgdfv DESCRIPT Cyclorgdfv inhibits the activity of KCNH2 DTD0510 EXOFACTO Cyclorgdfv MOACRIVE Inhibition DTD0510 EXOFACTO Cyclorgdfv CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Dihydrotestosterone HIGHSTIT Drug in Phase 4 Trial DTD0510 EXOFACTO Dihydrotestosterone DESCRIPT Dihydrotestosterone inhibits the activity of KCNH2 DTD0510 EXOFACTO Dihydrotestosterone MOACRIVE Inhibition DTD0510 EXOFACTO Diphenyl(Piperidin-4-Yl)Methanol HIGHSTIT Investigative Drug DTD0510 EXOFACTO Diphenyl(Piperidin-4-Yl)Methanol DESCRIPT Diphenyl(Piperidin-4-Yl)Methanol inhibits the activity of KCNH2 DTD0510 EXOFACTO Diphenyl(Piperidin-4-Yl)Methanol MOACRIVE Inhibition DTD0510 EXOFACTO Dofetilide HIGHSTIT Approved Drug DTD0510 EXOFACTO Dofetilide DESCRIPT Dofetilide inhibits the activity of KCNH2 DTD0510 EXOFACTO Dofetilide MOACRIVE Inhibition DTD0510 EXOFACTO Dofetilide CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Erythromycin HIGHSTIT Approved Drug DTD0510 EXOFACTO Erythromycin DESCRIPT Erythromycin inhibits the activity of KCNH2 DTD0510 EXOFACTO Erythromycin MOACRIVE Inhibition DTD0510 EXOFACTO Erythromycin CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Fananserin HIGHSTIT Discontinued Drug DTD0510 EXOFACTO Fananserin DESCRIPT Fananserin inhibits the activity of KCNH2 DTD0510 EXOFACTO Fananserin MOACRIVE Inhibition DTD0510 EXOFACTO Fananserin CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Fasudil HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO Fasudil DESCRIPT Fasudil inhibits the activity of KCNH2 DTD0510 EXOFACTO Fasudil MOACRIVE Inhibition DTD0510 EXOFACTO Fexofenadine HIGHSTIT Approved Drug DTD0510 EXOFACTO Fexofenadine DESCRIPT Fexofenadine inhibits the activity of KCNH2 DTD0510 EXOFACTO Fexofenadine MOACRIVE Inhibition DTD0510 EXOFACTO Gemifloxacin HIGHSTIT Approved Drug DTD0510 EXOFACTO Gemifloxacin DESCRIPT Gemifloxacin inhibits the activity of KCNH2 DTD0510 EXOFACTO Gemifloxacin MOACRIVE Inhibition DTD0510 EXOFACTO GSK163090 HIGHSTIT Discontinued Drug DTD0510 EXOFACTO GSK163090 DESCRIPT GSK163090 inhibits the activity of KCNH2 DTD0510 EXOFACTO GSK163090 MOACRIVE Inhibition DTD0510 EXOFACTO GSK189254A HIGHSTIT Investigative Drug DTD0510 EXOFACTO GSK189254A DESCRIPT GSK189254A inhibits the activity of KCNH2 DTD0510 EXOFACTO GSK189254A MOACRIVE Inhibition DTD0510 EXOFACTO GSK239512 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO GSK239512 DESCRIPT GSK239512 inhibits the activity of KCNH2 DTD0510 EXOFACTO GSK239512 MOACRIVE Inhibition DTD0510 EXOFACTO Halofantrine HIGHSTIT Approved Drug DTD0510 EXOFACTO Halofantrine DESCRIPT Halofantrine inhibits the activity of KCNH2 DTD0510 EXOFACTO Halofantrine MOACRIVE Inhibition DTD0510 EXOFACTO Halofantrine CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Haloperidol HIGHSTIT Approved Drug DTD0510 EXOFACTO Haloperidol DESCRIPT Haloperidol inhibits the activity of KCNH2 DTD0510 EXOFACTO Haloperidol MOACRIVE Inhibition DTD0510 EXOFACTO Haloperidol CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO HP-184 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO HP-184 DESCRIPT HP-184 blocks the activity of KCNH2 DTD0510 EXOFACTO HP-184 MOACRIVE Blocker DTD0510 EXOFACTO Isoquine HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO Isoquine DESCRIPT Isoquine inhibits the activity of KCNH2 DTD0510 EXOFACTO Isoquine MOACRIVE Inhibition DTD0510 EXOFACTO Levofloxacin HIGHSTIT Approved Drug DTD0510 EXOFACTO Levofloxacin DESCRIPT Levofloxacin inhibits the activity of KCNH2 DTD0510 EXOFACTO Levofloxacin MOACRIVE Inhibition DTD0510 EXOFACTO Levofloxacin CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Linagliptin HIGHSTIT Approved Drug DTD0510 EXOFACTO Linagliptin DESCRIPT Linagliptin inhibits the activity of KCNH2 DTD0510 EXOFACTO Linagliptin MOACRIVE Inhibition DTD0510 EXOFACTO Linezolid HIGHSTIT Approved Drug DTD0510 EXOFACTO Linezolid DESCRIPT Linezolid inhibits the activity of KCNH2 DTD0510 EXOFACTO Linezolid MOACRIVE Inhibition DTD0510 EXOFACTO Litoxetine HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO Litoxetine DESCRIPT Litoxetine inhibits the activity of KCNH2 DTD0510 EXOFACTO Litoxetine MOACRIVE Inhibition DTD0510 EXOFACTO Litoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Maraviroc HIGHSTIT Approved Drug DTD0510 EXOFACTO Maraviroc DESCRIPT Maraviroc inhibits the transportation of Dofetilide by KCNH2 DTD0510 EXOFACTO Maraviroc DESCRIPT Maraviroc inhibits the activity of KCNH2 DTD0510 EXOFACTO Maraviroc MOACRIVE Inhibition DTD0510 EXOFACTO Maraviroc CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Mefloquine HIGHSTIT Approved Drug DTD0510 EXOFACTO Mefloquine DESCRIPT Mefloquine inhibits the activity of KCNH2 DTD0510 EXOFACTO Mefloquine MOACRIVE Inhibition DTD0510 EXOFACTO MGCD-0103 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO MGCD-0103 DESCRIPT MGCD-0103 inhibits the activity of KCNH2 DTD0510 EXOFACTO MGCD-0103 MOACRIVE Inhibition DTD0510 EXOFACTO Mibefradil HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO Mibefradil DESCRIPT Mibefradil inhibits the activity of KCNH2 DTD0510 EXOFACTO Mibefradil MOACRIVE Inhibition DTD0510 EXOFACTO Mibefradil CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Mizolastine HIGHSTIT Approved Drug DTD0510 EXOFACTO Mizolastine DESCRIPT Mizolastine inhibits the activity of KCNH2 DTD0510 EXOFACTO Mizolastine MOACRIVE Inhibition DTD0510 EXOFACTO Mizolastine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO MK-3102 HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO MK-3102 DESCRIPT MK-3102 inhibits the activity of KCNH2 DTD0510 EXOFACTO MK-3102 MOACRIVE Inhibition DTD0510 EXOFACTO MK-7246 HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO MK-7246 DESCRIPT MK-7246 inhibits the activity of KCNH2 DTD0510 EXOFACTO MK-7246 MOACRIVE Inhibition DTD0510 EXOFACTO Modafinil HIGHSTIT Approved Drug DTD0510 EXOFACTO Modafinil DESCRIPT Modafinil inhibits the activity of KCNH2 DTD0510 EXOFACTO Modafinil MOACRIVE Inhibition DTD0510 EXOFACTO Moxifloxacin HIGHSTIT Approved Drug DTD0510 EXOFACTO Moxifloxacin DESCRIPT Moxifloxacin inhibits the activity of KCNH2 DTD0510 EXOFACTO Moxifloxacin MOACRIVE Inhibition DTD0510 EXOFACTO Moxifloxacin CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Nifevirocn HIGHSTIT Investigative Drug DTD0510 EXOFACTO Nifevirocn DESCRIPT Nifevirocn inhibits the activity of KCNH2 DTD0510 EXOFACTO Nifevirocn MOACRIVE Inhibition DTD0510 EXOFACTO NVP-AUY922 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO NVP-AUY922 DESCRIPT NVP-AUY922 inhibits the activity of KCNH2 DTD0510 EXOFACTO NVP-AUY922 MOACRIVE Inhibition DTD0510 EXOFACTO NVP-LAQ824 HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO NVP-LAQ824 DESCRIPT NVP-LAQ824 inhibits the activity of KCNH2 DTD0510 EXOFACTO NVP-LAQ824 MOACRIVE Inhibition DTD0510 EXOFACTO Olanzapine HIGHSTIT Approved Drug DTD0510 EXOFACTO Olanzapine DESCRIPT Olanzapine inhibits the activity of KCNH2 DTD0510 EXOFACTO Olanzapine MOACRIVE Inhibition DTD0510 EXOFACTO Olanzapine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO PDX-101 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO PDX-101 DESCRIPT PDX-101 inhibits the activity of KCNH2 DTD0510 EXOFACTO PDX-101 MOACRIVE Inhibition DTD0510 EXOFACTO Pentamidine HIGHSTIT Approved Drug DTD0510 EXOFACTO Pentamidine DESCRIPT Pentamidine inhibits the activity of KCNH2 DTD0510 EXOFACTO Pentamidine MOACRIVE Inhibition DTD0510 EXOFACTO PF-00734200 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO PF-00734200 DESCRIPT PF-00734200 inhibits the activity of KCNH2 DTD0510 EXOFACTO PF-00734200 MOACRIVE Inhibition DTD0510 EXOFACTO PF-00734200 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO PF-03715455 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO PF-03715455 DESCRIPT PF-03715455 inhibits the activity of KCNH2 DTD0510 EXOFACTO PF-03715455 MOACRIVE Inhibition DTD0510 EXOFACTO PF-3893787 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO PF-3893787 DESCRIPT PF-3893787 inhibits the activity of KCNH2 DTD0510 EXOFACTO PF-3893787 MOACRIVE Inhibition DTD0510 EXOFACTO PHA-666859 HIGHSTIT Investigative Drug DTD0510 EXOFACTO PHA-666859 DESCRIPT PHA-666859 inhibits the activity of KCNH2 DTD0510 EXOFACTO PHA-666859 MOACRIVE Inhibition DTD0510 EXOFACTO Phenytoin HIGHSTIT Approved Drug DTD0510 EXOFACTO Phenytoin DESCRIPT Phenytoin inhibits the activity of KCNH2 DTD0510 EXOFACTO Phenytoin MOACRIVE Inhibition DTD0510 EXOFACTO Piboserod HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO Piboserod DESCRIPT Piboserod inhibits the activity of KCNH2 DTD0510 EXOFACTO Piboserod MOACRIVE Inhibition DTD0510 EXOFACTO Pimozide HIGHSTIT Approved Drug DTD0510 EXOFACTO Pimozide DESCRIPT Pimozide inhibits the activity of KCNH2 DTD0510 EXOFACTO Pimozide MOACRIVE Inhibition DTD0510 EXOFACTO Pimozide CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO PNU-282987 HIGHSTIT Discontinued Drug DTD0510 EXOFACTO PNU-282987 DESCRIPT PNU-282987 inhibits the activity of KCNH2 DTD0510 EXOFACTO PNU-282987 MOACRIVE Inhibition DTD0510 EXOFACTO PNU-282987 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Premafloxacin HIGHSTIT Investigative Drug DTD0510 EXOFACTO Premafloxacin DESCRIPT Premafloxacin inhibits the activity of KCNH2 DTD0510 EXOFACTO Premafloxacin MOACRIVE Inhibition DTD0510 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0510 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of KCNH2 DTD0510 EXOFACTO Propafenone MOACRIVE Inhibition DTD0510 EXOFACTO PRX-00023 HIGHSTIT Discontinued Drug DTD0510 EXOFACTO PRX-00023 DESCRIPT PRX-00023 inhibits the activity of KCNH2 DTD0510 EXOFACTO PRX-00023 MOACRIVE Inhibition DTD0510 EXOFACTO PRX-00023 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Quinine HIGHSTIT Approved Drug DTD0510 EXOFACTO Quinine DESCRIPT Quinine inhibits the activity of KCNH2 DTD0510 EXOFACTO Quinine MOACRIVE Inhibition DTD0510 EXOFACTO Quinine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Radiprodil HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO Radiprodil DESCRIPT Radiprodil inhibits the activity of KCNH2 DTD0510 EXOFACTO Radiprodil MOACRIVE Inhibition DTD0510 EXOFACTO Radiprodil CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Risperidone HIGHSTIT Approved Drug DTD0510 EXOFACTO Risperidone DESCRIPT Risperidone inhibits the activity of KCNH2 DTD0510 EXOFACTO Risperidone MOACRIVE Inhibition DTD0510 EXOFACTO Risperidone CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Rofecoxib HIGHSTIT Approved Drug DTD0510 EXOFACTO Rofecoxib DESCRIPT Rofecoxib inhibits the activity of KCNH2 DTD0510 EXOFACTO Rofecoxib MOACRIVE Inhibition DTD0510 EXOFACTO Rofecoxib CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Ronacaleret HIGHSTIT Discontinued Drug DTD0510 EXOFACTO Ronacaleret DESCRIPT Ronacaleret inhibits the activity of KCNH2 DTD0510 EXOFACTO Ronacaleret MOACRIVE Inhibition DTD0510 EXOFACTO Saccharin HIGHSTIT Investigative Drug DTD0510 EXOFACTO Saccharin DESCRIPT Saccharin inhibits the activity of KCNH2 DTD0510 EXOFACTO Saccharin MOACRIVE Inhibition DTD0510 EXOFACTO SNDX-275 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO SNDX-275 DESCRIPT SNDX-275 inhibits the activity of KCNH2 DTD0510 EXOFACTO SNDX-275 MOACRIVE Inhibition DTD0510 EXOFACTO Staurosporine HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO Staurosporine DESCRIPT Staurosporine inhibits the transportation of Astemizole by KCNH2 DTD0510 EXOFACTO Staurosporine MOACRIVE Inhibition DTD0510 EXOFACTO TD-5108 HIGHSTIT Drug in Phase 2 Trial DTD0510 EXOFACTO TD-5108 DESCRIPT TD-5108 inhibits the activity of KCNH2 DTD0510 EXOFACTO TD-5108 MOACRIVE Inhibition DTD0510 EXOFACTO TD-5108 CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Tegaserod HIGHSTIT Approved Drug DTD0510 EXOFACTO Tegaserod DESCRIPT Tegaserod inhibits the activity of KCNH2 DTD0510 EXOFACTO Tegaserod MOACRIVE Inhibition DTD0510 EXOFACTO Tegaserod CELLLINE Chinese hamster ovary (CHO) cells-KCNH2 DTD0510 EXOFACTO Temanogrel HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO Temanogrel DESCRIPT Temanogrel inhibits the activity of KCNH2 DTD0510 EXOFACTO Temanogrel MOACRIVE Inhibition DTD0510 EXOFACTO Terfenadine HIGHSTIT Drug Withdrawn DTD0510 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the transportation of Astemizole by KCNH2 DTD0510 EXOFACTO Terfenadine DESCRIPT Terfenadine inhibits the activity of KCNH2 DTD0510 EXOFACTO Terfenadine MOACRIVE Inhibition DTD0510 EXOFACTO Terfenadine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Thioridazine HIGHSTIT Approved Drug DTD0510 EXOFACTO Thioridazine DESCRIPT Thioridazine inhibits the activity of KCNH2 DTD0510 EXOFACTO Thioridazine MOACRIVE Inhibition DTD0510 EXOFACTO Thioridazine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Tramiprosate HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO Tramiprosate DESCRIPT Tramiprosate inhibits the activity of KCNH2 DTD0510 EXOFACTO Tramiprosate MOACRIVE Inhibition DTD0510 EXOFACTO Tramiprosate CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Triphenylmethanamine HIGHSTIT Investigative Drug DTD0510 EXOFACTO Triphenylmethanamine DESCRIPT Triphenylmethanamine inhibits the activity of KCNH2 DTD0510 EXOFACTO Triphenylmethanamine MOACRIVE Inhibition DTD0510 EXOFACTO Turofexorate isopropyl HIGHSTIT Drug in Phase 1 Trial DTD0510 EXOFACTO Turofexorate isopropyl DESCRIPT Turofexorate isopropyl inhibits the activity of KCNH2 DTD0510 EXOFACTO Turofexorate isopropyl MOACRIVE Inhibition DTD0510 EXOFACTO Vancomycin HIGHSTIT Approved Drug DTD0510 EXOFACTO Vancomycin DESCRIPT Vancomycin inhibits the activity of KCNH2 DTD0510 EXOFACTO Vancomycin MOACRIVE Inhibition DTD0510 EXOFACTO Volinanserin HIGHSTIT Drug in Phase 3 Trial DTD0510 EXOFACTO Volinanserin DESCRIPT Volinanserin inhibits the activity of KCNH2 DTD0510 EXOFACTO Volinanserin MOACRIVE Inhibition DTD0510 EXOFACTO Volinanserin CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0510 EXOFACTO Vorinostat HIGHSTIT Approved Drug DTD0510 EXOFACTO Vorinostat DESCRIPT Vorinostat inhibits the activity of KCNH2 DTD0510 EXOFACTO Vorinostat MOACRIVE Inhibition DTD0510 EXOFACTO Ximelegatran HIGHSTIT Approved Drug DTD0510 EXOFACTO Ximelegatran DESCRIPT Ximelegatran inhibits the activity of KCNH2 DTD0510 EXOFACTO Ximelegatran MOACRIVE Inhibition DTD0510 EXOFACTO YM60828 HIGHSTIT Discontinued Drug DTD0510 EXOFACTO YM60828 DESCRIPT YM60828 inhibits the activity of KCNH2 DTD0510 EXOFACTO YM60828 MOACRIVE Inhibition DTD0510 EXOFACTO YM60828 CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNH2 DTD0511 TRANSPID DTD0511 DTD0511 GENENAME KCNJ11 DTD0511 PROTNAME ATP-sensitive inward rectifier potassium channel 11 DTD0511 GENEDBID 3767 DTD0511 UNIPROID Q14654 DTD0511 EXOFACTO Glibenclamide HIGHSTIT Approved Drug DTD0511 EXOFACTO Glibenclamide DESCRIPT Glibenclamide inhibits the activity of KCNJ11 DTD0511 EXOFACTO Glibenclamide MOACRIVE Inhibition DTD0511 EXOFACTO Glibenclamide CELLLINE Chinese hamster ovary (CHO) cells-KCNJ11 DTD0511 EXOFACTO HBR-985 HIGHSTIT Investigative Drug DTD0511 EXOFACTO HBR-985 DESCRIPT HBR-985 inhibits the activity of KCNJ11 DTD0511 EXOFACTO HBR-985 MOACRIVE Inhibition DTD0511 EXOFACTO HBR-985 CELLLINE Chinese hamster ovary (CHO) cells-KCNJ11 DTD0511 EXOFACTO HMR1883 HIGHSTIT Investigative Drug DTD0511 EXOFACTO HMR1883 DESCRIPT HMR1883 inhibits the activity of KCNJ11 DTD0511 EXOFACTO HMR1883 MOACRIVE Inhibition DTD0511 EXOFACTO HMR1883 CELLLINE Chinese hamster ovary (CHO) cells-KCNJ11 DTD0512 TRANSPID DTD0512 DTD0512 GENENAME KCNMA1 DTD0512 PROTNAME Calcium-activated potassium channel subunit alpha-1 DTD0512 GENEDBID 3778 DTD0512 UNIPROID Q12960 DTD0512 EXOFACTO Iberiotoxin HIGHSTIT Biotoxin DTD0512 EXOFACTO Iberiotoxin DESCRIPT Iberiotoxin inhibits the activity of KCNMA1 DTD0512 EXOFACTO Iberiotoxin MOACRIVE Inhibition DTD0512 EXOFACTO Tetraethylammonium HIGHSTIT Investigative Drug DTD0512 EXOFACTO Tetraethylammonium DESCRIPT Tetraethylammonium inhibits the activity of KCNMA1 DTD0512 EXOFACTO Tetraethylammonium MOACRIVE Inhibition DTD0513 TRANSPID DTD0513 DTD0513 GENENAME KCNQ1 DTD0513 PROTNAME Voltage-gated potassium channel Kv7.1 DTD0513 GENEDBID 3784 DTD0513 UNIPROID P51787 DTD0513 EXOFACTO Indapamide HIGHSTIT Approved Drug DTD0513 EXOFACTO Indapamide DESCRIPT Indapamide blocks the activity of KCNQ1 DTD0513 EXOFACTO Indapamide MOACRIVE Blocker DTD0513 EXOFACTO Volinanserin HIGHSTIT Drug in Phase 3 Trial DTD0513 EXOFACTO Volinanserin DESCRIPT Volinanserin inhibits the activity of KCNQ1 DTD0513 EXOFACTO Volinanserin MOACRIVE Inhibition DTD0518 TRANSPID DTD0518 DTD0518 GENENAME CACNA1A DTD0518 PROTNAME Voltage-gated calcium channel alpha Cav2.1 DTD0518 GENEDBID 773 DTD0518 UNIPROID O00555 DTD0518 EXOFACTO Flunarizine HIGHSTIT Approved Drug DTD0518 EXOFACTO Flunarizine DESCRIPT Flunarizine inhibits the activity of CACNA1A DTD0518 EXOFACTO Flunarizine MOACRIVE Inhibition DTD0518 EXOFACTO XEN007 HIGHSTIT Drug in Phase 1 Trial DTD0518 EXOFACTO XEN007 DESCRIPT XEN007 inhibits the activity of CACNA1A DTD0518 EXOFACTO XEN007 MOACRIVE Inhibition DTD0519 TRANSPID DTD0519 DTD0519 GENENAME CACNA1B DTD0519 PROTNAME Voltage-gated calcium channel alpha Cav2.2 DTD0519 GENEDBID 774 DTD0519 UNIPROID Q00975 DTD0519 EXOFACTO Cilnidipine HIGHSTIT Drug in Phase 3 Trial DTD0519 EXOFACTO Cilnidipine DESCRIPT Cilnidipine blocks the activity of CACNA1B DTD0519 EXOFACTO Cilnidipine MOACRIVE Blocker DTD0519 EXOFACTO Clotrimazole HIGHSTIT Approved Drug DTD0519 EXOFACTO Clotrimazole DESCRIPT Clotrimazole inhibits the activity of CACNA1B DTD0519 EXOFACTO Clotrimazole MOACRIVE Inhibition DTD0519 EXOFACTO Clotrimazole CELLLINE SH-SY5Y neuroblastoma cells-CACNA1B DTD0519 EXOFACTO CNV-2197944 HIGHSTIT Drug in Phase 2 Trial DTD0519 EXOFACTO CNV-2197944 DESCRIPT CNV-2197944 blocks the activity of CACNA1B DTD0519 EXOFACTO CNV-2197944 MOACRIVE Blocker DTD0519 EXOFACTO Econazole HIGHSTIT Approved Drug DTD0519 EXOFACTO Econazole DESCRIPT Econazole inhibits the activity of CACNA1B DTD0519 EXOFACTO Econazole MOACRIVE Inhibition DTD0519 EXOFACTO Econazole CELLLINE SH-SY5Y neuroblastoma cells-CACNA1B DTD0519 EXOFACTO GNF-PF-3464 HIGHSTIT Investigative Drug DTD0519 EXOFACTO GNF-PF-3464 DESCRIPT GNF-PF-3464 inhibits the activity of CACNA1B DTD0519 EXOFACTO GNF-PF-3464 MOACRIVE Inhibition DTD0519 EXOFACTO Hesperidin HIGHSTIT Approved Drug DTD0519 EXOFACTO Hesperidin DESCRIPT Hesperidin inhibits the activity of CACNA1B DTD0519 EXOFACTO Hesperidin MOACRIVE Inhibition DTD0519 EXOFACTO Lomerizine HIGHSTIT Approved Drug DTD0519 EXOFACTO Lomerizine DESCRIPT Lomerizine inhibits the activity of CACNA1B DTD0519 EXOFACTO Lomerizine MOACRIVE Inhibition DTD0519 EXOFACTO Mibefradil HIGHSTIT Drug in Phase 1 Trial DTD0519 EXOFACTO Mibefradil DESCRIPT Mibefradil inhibits the activity of CACNA1B DTD0519 EXOFACTO Mibefradil MOACRIVE Inhibition DTD0519 EXOFACTO Mibefradil CELLLINE Human embryonic kidney 293 cells (HEK293)-CACNA1B DTD0519 EXOFACTO Mibefradil CELLLINE SH-SY5Y neuroblastoma cells-CACNA1B DTD0519 EXOFACTO Miconazole HIGHSTIT Approved Drug DTD0519 EXOFACTO Miconazole DESCRIPT Miconazole inhibits the activity of CACNA1B DTD0519 EXOFACTO Miconazole MOACRIVE Inhibition DTD0519 EXOFACTO Miconazole CELLLINE SH-SY5Y neuroblastoma cells-CACNA1B DTD0519 EXOFACTO Ralfinamide HIGHSTIT Drug in Phase 3 Trial DTD0519 EXOFACTO Ralfinamide DESCRIPT Ralfinamide blocks the activity of CACNA1B DTD0519 EXOFACTO Ralfinamide MOACRIVE Blocker DTD0520 TRANSPID DTD0520 DTD0520 GENENAME CACNA1E DTD0520 PROTNAME Voltage-gated calcium channel alpha Cav2.3 DTD0520 GENEDBID 777 DTD0520 UNIPROID Q15878 DTD0520 EXOFACTO CPU-228 HIGHSTIT Investigative Drug DTD0520 EXOFACTO CPU-228 DESCRIPT CPU-228 modulates the activity of CACNA1E DTD0520 EXOFACTO CPU-228 MOACRIVE Modulator DTD0520 EXOFACTO TH-9229 HIGHSTIT Discontinued Drug DTD0520 EXOFACTO TH-9229 DESCRIPT TH-9229 modulates the activity of CACNA1E DTD0520 EXOFACTO TH-9229 MOACRIVE Modulator DTD0522 TRANSPID DTD0522 DTD0522 GENENAME CACNB4 DTD0522 PROTNAME Voltage-dependent L-type calcium channel beta-4 DTD0522 GENEDBID 785 DTD0522 UNIPROID O00305 DTD0522 EXOFACTO Plasmodium berghei HIGHSTIT Parasite infection DTD0522 EXOFACTO Plasmodium berghei DESCRIPT Plasmodium berghei infection induces the activity of CACNB4 DTD0522 EXOFACTO Plasmodium berghei MOACRIVE Inducer DTD0525 TRANSPID DTD0525 DTD0525 GENENAME KCNJ6 DTD0525 PROTNAME Inward rectifier K(+) channel Kir3.2 DTD0525 GENEDBID 3763 DTD0525 UNIPROID P48051 DTD0525 EXOFACTO 1-Chloro-1,2,2-trifluorocyclobutane HIGHSTIT Investigative Drug DTD0525 EXOFACTO 1-Chloro-1,2,2-trifluorocyclobutane DESCRIPT 1-Chloro-1,2,2-trifluorocyclobutane inhibits the activity of KCNJ6 DTD0525 EXOFACTO 1-Chloro-1,2,2-trifluorocyclobutane MOACRIVE Inhibition DTD0525 EXOFACTO PIP2 HIGHSTIT Investigative Drug DTD0525 EXOFACTO PIP2 DESCRIPT PIP2 activates the activity of KCNJ6 DTD0525 EXOFACTO PIP2 MOACRIVE Activator DTD0526 TRANSPID DTD0526 DTD0526 GENENAME SCN1A DTD0526 PROTNAME Voltage-gated sodium channel alpha Nav1.1 DTD0526 GENEDBID 6323 DTD0526 UNIPROID P35498 DTD0526 EXOFACTO Batrachotoxin HIGHSTIT Investigative Drug DTD0526 EXOFACTO Batrachotoxin DESCRIPT Batrachotoxin activates the activity of SCN1A DTD0526 EXOFACTO Batrachotoxin MOACRIVE Activator DTD0526 EXOFACTO Veratridine HIGHSTIT Investigative Drug DTD0526 EXOFACTO Veratridine DESCRIPT Veratridine activates the activity of SCN1A DTD0526 EXOFACTO Veratridine MOACRIVE Activator DTD0527 TRANSPID DTD0527 DTD0527 GENENAME SCN4A DTD0527 PROTNAME Voltage-gated sodium channel alpha Nav1.4 DTD0527 GENEDBID 6329 DTD0527 UNIPROID P35499 DTD0527 EXOFACTO Sipatrigine HIGHSTIT Discontinued Drug DTD0527 EXOFACTO Sipatrigine DESCRIPT Sipatrigine inhibits the activity of SCN4A DTD0527 EXOFACTO Sipatrigine MOACRIVE Inhibition DTD0527 EXOFACTO Zrccncsskwcrdhsrcc HIGHSTIT Investigative Drug DTD0527 EXOFACTO Zrccncsskwcrdhsrcc DESCRIPT Zrccncsskwcrdhsrcc inhibits the activity of SCN4A DTD0527 EXOFACTO Zrccncsskwcrdhsrcc MOACRIVE Inhibition DTD0529 TRANSPID DTD0529 DTD0529 GENENAME SCN9A DTD0529 PROTNAME Voltage-gated sodium channel alpha Nav1.7 DTD0529 GENEDBID 6335 DTD0529 UNIPROID Q15858 DTD0529 EXOFACTO BIIB074 HIGHSTIT Drug in Phase 2 Trial DTD0529 EXOFACTO BIIB074 DESCRIPT BIIB074 inhibits the activity of SCN9A DTD0529 EXOFACTO BIIB074 MOACRIVE Inhibition DTD0529 EXOFACTO BIIB095 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO BIIB095 DESCRIPT BIIB095 inhibits the activity of SCN9A DTD0529 EXOFACTO BIIB095 MOACRIVE Inhibition DTD0529 EXOFACTO CC8464 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO CC8464 DESCRIPT CC8464 inhibits the activity of SCN9A DTD0529 EXOFACTO CC8464 MOACRIVE Inhibition DTD0529 EXOFACTO DSP-2230 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO DSP-2230 DESCRIPT DSP-2230 inhibits the activity of SCN9A DTD0529 EXOFACTO DSP-2230 MOACRIVE Inhibition DTD0529 EXOFACTO DSP-3905 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO DSP-3905 DESCRIPT DSP-3905 inhibits the activity of SCN9A DTD0529 EXOFACTO DSP-3905 MOACRIVE Inhibition DTD0529 EXOFACTO DWJ-208 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO DWJ-208 DESCRIPT DWJ-208 inhibits the activity of SCN9A DTD0529 EXOFACTO DWJ-208 MOACRIVE Inhibition DTD0529 EXOFACTO GDC0310 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO GDC0310 DESCRIPT GDC0310 inhibits the activity of SCN9A DTD0529 EXOFACTO GDC0310 MOACRIVE Inhibition DTD0529 EXOFACTO PF-05089771 HIGHSTIT Drug in Phase 2 Trial DTD0529 EXOFACTO PF-05089771 DESCRIPT PF-05089771 blocks the activity of SCN9A DTD0529 EXOFACTO PF-05089771 MOACRIVE Blocker DTD0529 EXOFACTO PF-05186462 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO PF-05186462 DESCRIPT PF-05186462 inhibits the activity of SCN9A DTD0529 EXOFACTO PF-05186462 MOACRIVE Inhibition DTD0529 EXOFACTO PF-05241328 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO PF-05241328 DESCRIPT PF-05241328 inhibits the activity of SCN9A DTD0529 EXOFACTO PF-05241328 MOACRIVE Inhibition DTD0529 EXOFACTO RG7893 HIGHSTIT Drug in Phase 1 Trial DTD0529 EXOFACTO RG7893 DESCRIPT RG7893 inhibits the activity of SCN9A DTD0529 EXOFACTO RG7893 MOACRIVE Inhibition DTD0529 EXOFACTO Sipatrigine HIGHSTIT Discontinued Drug DTD0529 EXOFACTO Sipatrigine DESCRIPT Sipatrigine inhibits the activity of SCN9A DTD0529 EXOFACTO Sipatrigine MOACRIVE Inhibition DTD0529 EXOFACTO XEN-402 HIGHSTIT Drug in Phase 2 Trial DTD0529 EXOFACTO XEN-402 DESCRIPT XEN-402 inhibits the activity of SCN9A DTD0529 EXOFACTO XEN-402 MOACRIVE Inhibition DTD0530 TRANSPID DTD0530 DTD0530 GENENAME CACNA1H DTD0530 PROTNAME Voltage-gated calcium channel alpha Cav3.2 DTD0530 GENEDBID 8912 DTD0530 UNIPROID O95180 DTD0530 EXOFACTO ABT-639 HIGHSTIT Drug in Phase 2 Trial DTD0530 EXOFACTO ABT-639 DESCRIPT ABT-639 modulates the activity of CACNA1H DTD0530 EXOFACTO ABT-639 MOACRIVE Modulator DTD0530 EXOFACTO Flunarizine HIGHSTIT Approved Drug DTD0530 EXOFACTO Flunarizine DESCRIPT Flunarizine blocks the activity of CACNA1H DTD0530 EXOFACTO Flunarizine MOACRIVE Blocker DTD0530 EXOFACTO Mibefradil HIGHSTIT Drug in Phase 1 Trial DTD0530 EXOFACTO Mibefradil DESCRIPT Mibefradil inhibits the activity of CACNA1H DTD0530 EXOFACTO Mibefradil MOACRIVE Inhibition DTD0530 EXOFACTO Mibefradil CELLLINE Human embryonic kidney 293 cells (HEK293)-CACNA1H DTD0530 EXOFACTO Mibefradil CELLLINE Oocytes-CACNA1H DTD0530 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0530 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of CACNA1H DTD0530 EXOFACTO Propafenone MOACRIVE Inhibition DTD0530 EXOFACTO Sodium bicarbonate HIGHSTIT Approved Drug DTD0530 EXOFACTO Sodium bicarbonate DESCRIPT Sodium bicarbonate blocks the activity of CACNA1H DTD0530 EXOFACTO Sodium bicarbonate MOACRIVE Blocker DTD0533 TRANSPID DTD0533 DTD0533 GENENAME ATP7B DTD0533 PROTNAME Copper-transporting ATPase 2 DTD0533 GENEDBID 540 DTD0533 UNIPROID P35670 DTD0533 EXOFACTO Cisplatin HIGHSTIT Approved Drug DTD0533 EXOFACTO Cisplatin DESCRIPT Cisplatin induces the activity of ATP7B DTD0533 EXOFACTO Cisplatin MOACRIVE Inducer DTD0533 EXOFACTO High copper levels HIGHSTIT Environmental toxicant DTD0533 EXOFACTO High copper levels DESCRIPT High copper levels induces the activity of ATP7B DTD0533 EXOFACTO High copper levels MOACRIVE Inducer DTD0533 EXOFACTO High copper levels CELLLINE Triple-negative breast cancer cells-ATP7B DTD0534 TRANSPID DTD0534 DTD0534 GENENAME CACNA1C DTD0534 PROTNAME Voltage-gated calcium channel alpha Cav1.2 DTD0534 GENEDBID 775 DTD0534 UNIPROID Q13936 DTD0534 EXOFACTO ARC029 HIGHSTIT Drug in Phase 3 Trial DTD0534 EXOFACTO ARC029 DESCRIPT ARC029 inhibits the activity of CACNA1C DTD0534 EXOFACTO ARC029 MOACRIVE Inhibition DTD0534 EXOFACTO Nifedipine HIGHSTIT Approved Drug DTD0534 EXOFACTO Nifedipine DESCRIPT Nifedipine inhibits the transportation of Nitrendipine by CACNA1C DTD0534 EXOFACTO Nifedipine MOACRIVE Inhibition DTD0534 EXOFACTO Nitrendipine HIGHSTIT Approved Drug DTD0534 EXOFACTO Nitrendipine DESCRIPT Nitrendipine inhibits the transportation of Nitrendipine by CACNA1C DTD0534 EXOFACTO Nitrendipine MOACRIVE Inhibition DTD0534 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0534 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of CACNA1C DTD0534 EXOFACTO Propafenone MOACRIVE Inhibition DTD0534 EXOFACTO Rauwolfia serpentina root HIGHSTIT Approved Drug DTD0534 EXOFACTO Rauwolfia serpentina root DESCRIPT Rauwolfia serpentina root inhibits the activity of CACNA1C DTD0534 EXOFACTO Rauwolfia serpentina root MOACRIVE Inhibition DTD0537 TRANSPID DTD0537 DTD0537 GENENAME RALBP1 DTD0537 PROTNAME RalBP1-associated Eps domain-containing protein 2 DTD0537 GENEDBID 10928 DTD0537 UNIPROID Q8NFH8 DTD0537 EXOFACTO Necrostatin-1 HIGHSTIT Investigative Drug DTD0537 EXOFACTO Necrostatin-1 DESCRIPT Necrostatin-1 inhibits the activity of RALBP1 DTD0537 EXOFACTO Necrostatin-1 MOACRIVE Inhibition DTD0537 EXOFACTO Necrostatin-1 CELLLINE Macrophage cells DTD0540 TRANSPID DTD0540 DTD0540 GENENAME ATP12A DTD0540 PROTNAME Potassium-transporting ATPase alpha chain 2 DTD0540 GENEDBID 479 DTD0540 UNIPROID P54707 DTD0540 EXOFACTO Omeprazole HIGHSTIT Approved Drug DTD0540 EXOFACTO Omeprazole DESCRIPT Omeprazole inhibits the activity of ATP12A DTD0540 EXOFACTO Omeprazole MOACRIVE Inhibition DTD0540 EXOFACTO Ranitidine HIGHSTIT Approved Drug DTD0540 EXOFACTO Ranitidine DESCRIPT Ranitidine inhibits the activity of ATP12A DTD0540 EXOFACTO Ranitidine MOACRIVE Inhibition DTD0541 TRANSPID DTD0541 DTD0541 GENENAME CACNA1G DTD0541 PROTNAME Voltage-gated calcium channel subunit alpha Cav3.1 DTD0541 GENEDBID 8913 DTD0541 UNIPROID O43497 DTD0541 EXOFACTO Mibefradil HIGHSTIT Drug in Phase 1 Trial DTD0541 EXOFACTO Mibefradil DESCRIPT Mibefradil inhibits the transportation of Calcium by CACNA1G DTD0541 EXOFACTO Mibefradil DESCRIPT Mibefradil inhibits the activity of CACNA1G DTD0541 EXOFACTO Mibefradil MOACRIVE Inhibition DTD0541 EXOFACTO Mibefradil CELLLINE Human embryonic kidney 293 cells (HEK293)-CACNA1G DTD0542 TRANSPID DTD0542 DTD0542 GENENAME ANXA2 DTD0542 PROTNAME Annexin A2 DTD0542 GENEDBID 302 DTD0542 UNIPROID P07355 DTD0542 EXOFACTO N-ethylmaleimide HIGHSTIT Investigative Drug DTD0542 EXOFACTO N-ethylmaleimide DESCRIPT N-ethylmaleimide inhibits the activity of ANXA2 DTD0542 EXOFACTO N-ethylmaleimide MOACRIVE Inhibition DTD0543 TRANSPID DTD0543 DTD0543 GENENAME KCNN1 DTD0543 PROTNAME Small conductance calcium-activated potassium channel protein 1 DTD0543 GENEDBID 3780 DTD0543 UNIPROID Q92952 DTD0543 EXOFACTO Apamin HIGHSTIT Investigative Drug DTD0543 EXOFACTO Apamin DESCRIPT Apamin inhibits the activity of KCNN1 DTD0543 EXOFACTO Apamin MOACRIVE Inhibition DTD0544 TRANSPID DTD0544 DTD0544 GENENAME KCNA5 DTD0544 PROTNAME Voltage-gated potassium channel subunit Kv1.5 DTD0544 GENEDBID 3741 DTD0544 UNIPROID P22460 DTD0544 EXOFACTO Propafenone HIGHSTIT Approved Drug DTD0544 EXOFACTO Propafenone DESCRIPT Propafenone inhibits the activity of KCNA5 DTD0544 EXOFACTO Propafenone MOACRIVE Inhibition DTD0545 TRANSPID DTD0545 DTD0545 GENENAME KCNK2 DTD0545 PROTNAME Potassium channel subfamily K member 2 DTD0545 GENEDBID 3776 DTD0545 UNIPROID O95069 DTD0545 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0545 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of KCNK2 DTD0545 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0545 EXOFACTO Sipatrigine HIGHSTIT Discontinued Drug DTD0545 EXOFACTO Sipatrigine DESCRIPT Sipatrigine inhibits the activity of KCNK2 DTD0545 EXOFACTO Sipatrigine MOACRIVE Inhibition DTD0545 EXOFACTO Sipatrigine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNK2 DTD0546 TRANSPID DTD0546 DTD0546 GENENAME KCNK9 DTD0546 PROTNAME Potassium channel subfamily K member 9 DTD0546 GENEDBID 51305 DTD0546 UNIPROID Q9NPC2 DTD0546 EXOFACTO Fluoxetine HIGHSTIT Approved Drug DTD0546 EXOFACTO Fluoxetine DESCRIPT Fluoxetine inhibits the activity of KCNK9 DTD0546 EXOFACTO Fluoxetine MOACRIVE Inhibition DTD0546 EXOFACTO Fluoxetine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNK9 DTD0547 TRANSPID DTD0547 DTD0547 GENENAME KCNK4 DTD0547 PROTNAME Potassium channel subfamily K member 4 DTD0547 GENEDBID 50801 DTD0547 UNIPROID Q9NYG8 DTD0547 EXOFACTO Sipatrigine HIGHSTIT Discontinued Drug DTD0547 EXOFACTO Sipatrigine DESCRIPT Sipatrigine inhibits the activity of KCNK4 DTD0547 EXOFACTO Sipatrigine MOACRIVE Inhibition DTD0547 EXOFACTO Sipatrigine CELLLINE Human embryonic kidney 293 cells (HEK293)-KCNK4